"companyid","keydevid","transcriptid","headline","mostimportantdateutc","keydeveventtypename","companyname","speakertypename","componenttextpreview","word_count","componenttext"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Ladies and gentlemen, thank you for standing by, and welcome to the Q4 of 2020 Teradyne, Inc. Earnings Conference Call. [Operator Instructions]I would now like to hand the conference over to Mr. Andy Blanchard, Vice President of Investor Relations. Plea",44,"Ladies and gentlemen, thank you for standing by, and welcome to the Q4 of 2020 Teradyne, Inc. Earnings Conference Call. [Operator Instructions]
I would now like to hand the conference over to Mr. Andy Blanchard, Vice President of Investor Relations. Please go ahead, sir."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Sharon. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined for our discussion this morning by Teradyne's CEO, Mark Jagiela; and CFO, Sanjay Mehta. Following our opening remarks, we'll p",303,"Thank you, Sharon. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined for our discussion this morning by Teradyne's CEO, Mark Jagiela; and CFO, Sanjay Mehta. Following our opening remarks, we'll provide details of our performance for 2020's fourth quarter and full year, along with our outlook for the first quarter of 2021. The press release containing our results was issued last evening. We are providing slides on the Investor page of the website that may be helpful to you in following the discussion. Replays of this call will be available via the same page after the call ends. The matters that we discuss today will include forward-looking statements that involve risk factors that could cause Teradyne's results to differ materially from management's current expectations. We encourage you to review the safe harbor statement contained in the earnings release as well as our most recent SEC filings. 
Additionally, those forward-looking statements are made as of today, and we take no obligation to update them as a result of developments occurring after this call. 
During today's call, we'll make reference to non-GAAP financial measures. We posted additional information concerning these non-GAAP financial measures, including reconciliation to the most directly comparable GAAP financial measure, where available, on the Investor page of our website. Looking ahead between now and our next earnings call, Teradyne will be participating in technology or industrial-focused investor conferences hosted by Goldman Sachs, Citi and Susquehanna. 
Now let's get on with the rest of the agenda. First, Mark will comment on our recent results and the market conditions as we enter the new year. Sanjay will then offer more details on our results along with our guidance for the first quarter. We'll then answer your questions, and this call is scheduled for 1 hour. Mark?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Good morning, and thanks for joining us. In our call today, I'll summarize our Q4 and 2020 full year highlights and provide some initial comments on our outlook for 2021. Sanjay will then provide the financial details, Q1 outlook and review our updated ea",1521,"Good morning, and thanks for joining us. In our call today, I'll summarize our Q4 and 2020 full year highlights and provide some initial comments on our outlook for 2021. Sanjay will then provide the financial details, Q1 outlook and review our updated earnings model and capital allocation plans. 
Fourth quarter capped off an amazing year for Teradyne, with sales up 16% from the fourth quarter of 2019 and non-GAAP earnings per share up 25%. That brought our full year sales to just over $3.1 billion, up 36% and non-GAAP EPS to $4.62, up 62% versus 2019. These annual results, driven by strength in all of our test businesses, more than made up for a soft industrial automation market that was impacted by COVID. For the full year, our Semi Test business was especially strong, driven by investments in smartphone-related test capacity, our expansion into the compute sector of SOC with our new UltraFLEXplus product and the ramp of our Magnum EPIC product for DRAM test. 
In smartphones, global unit shipments contracted in 2020, but the growth in chipset complexity continued driving tester demand higher. Each subsystem on the phone, cellular power management, connectivity, display, cameras and application processing has its own cycle. And in 2020, both the processor and the cellular areas took big steps up in complexity. We use transistor count as a proxy for complexity and the leading phone applications processors now exceed 10 billion transistors, growing double digits each generation. 
In 2020, we also saw the beginning of meaningful 5G silicon content, which necessitated a build-out of new tester capacity. Together, these listed the mobility test market in 2020, roughly $200 million to about $1.7 billion. This continuous refresh of smartphone silicon should be a tailwind for the semiconductor test business for the foreseeable future. 
In 2020, we also ramped our UltraFLEXplus product in the compute portion of the SOC market. Recall, this has historically been a $500 million to $600 million market, where we've had relatively low share. With the emergence of more players and applications in the processor market, including hyperscalers and AI, we expect this sector to outgrow the general market. The plus brings a powerful value proposition in managing the unique complexity, power dynamics, yield learning and time-to-market requirements of this segment. 
For 2020, we estimate the SOC market was in the range of $3.4 billion to $3.5 billion, up from about $3.3 billion in 2019. We estimate our SOC test market share moved up 15 points to about 54%. However, our internal view of share smooths out year-on-year swings due to the unique timing of investment cycles of both our and our competitors' customers. By that measure, we estimate our normalized 2020 SOC share at about 50%. 
Another notable growth segment of our Semi Test business in 2020 was memory. In this call, a year ago, we noted a significant design win for our Magnum EPIC product in the LPDDR5 portion of the DRAM market. This new entry into DRAM test ramped through the year and combined with healthy growth in our traditional NAND business, drove a 41% increase in memory sales from 2019. We estimate the market was about $900 million in 2020, up from $600 million in 2019 and our normalized 2020 memory share at about 42%. Beyond Semi Test, our System Test group also had a great year, delivering 43% growth with the Storage Test business more than doubling from 2019. This is the second consecutive year of hyper growth in Storage Test, driven by steady test intensity growth of terabyte HDD drives and similar growth in the system-level test of complex semiconductor devices. 
In our wireless test business at LitePoint, sales grew 10% from 2019 with solid demand for both our connectivity and cellular end markets. Wi-Fi 6 ultra-wideband test and increased investments in 5G-related handset tests all contributed. The performance of our test businesses more than offset the weaker results in our Industrial Automation business, which contracted 6% for the year. The global slowdown in manufacturing activity led to a 12% decline in sales at our Universal Robots unit. 
MiR, on the other hand, grew 1% as makers of ultraviolet disinfecting products recognize the value of an easier to deploy fully autonomous mobile robot. 
On a pro forma basis, AutoGuide also grew for the year. While the environment in IA was weaker than expected, the business troughed in the second quarter of 2020 and has improved dramatically in the second half, including record sales at UR in the fourth quarter. Collectively, the business returned to year-over-year growth in Q4, with UR growing 6% year-over-year and 41% sequential growth. With test slowing -- with test showing continued strength and industrial automation returning to growth, we are set up for another exciting year in 2021. Specifically, we are expecting a strong start to the year across all our businesses, with Q1 showing greater than 6% growth at the midpoint compared to Q1 of '19 -- sorry, Q1 of '20. 
As you know, full year visibility is always a challenge, as evidenced by our missing the strength of the test market and the decline of the IA market in our forecast just 1 year ago. That said, let me describe how we see things today and of course, we'll keep you updated in future calls. I will preface my remarks with a note that the well-publicized surge in the forecasted semiconductor CapEx in 2021 is a very bullish sign. However, the impact on test is likely to be felt in 2022 and beyond as fab capacity built this year will drive additional testers in future years aligned to fab commissioning and ramping volumes and yields. 
In SOC test, the dynamics that made 2020 such a strong year continue into 2021. In addition, we have strengthening demand in the long dormant automotive test market with orders for our Eagle test product line surging. Smartphone shipments are expected to grow in 2021 after contracting about 10% in 2020, and 5G content should increase. On the other hand, the SOC test market in China will likely be down in 2021 due to the expanded and full year effects of trade restrictions that were widened in 2020. Also, as always, tester demand from our largest customer will remain opaque until sometime in Q2. Additionally, the global economic impact of COVID and its impact on electronics demand after a surge in 2020, it's hard to forecast with arguments for both positive and negative effects. Taking all of that into account, we have a bit wider range in our SOC market size estimate for 2021 at $3.3 billion to $3.8 billion, up slightly from 2020 at the midpoint. 
In memory test, the transition to LPDDR5 and DDR5 should gain momentum in 2021 and beyond. After growing about 50% in 2020, we view the memory market to be in the $800 million to $1 billion range in 2021, about even with 2020 at the midpoint. In storage test, the underlying demand drivers of increased density in HDD and increased complexity in semi devices driving system-level test remain in place. However, visibility is limited and annual shipments can be very lumpy. After more than tripling over the last 3 years, we expect 2021 sales to be in a band of plus or minus 20% from the 2020 level. For the rest of our test businesses, we expect growth in the 5% to 10% range in 2021. 
In Industrial Automation, 2021 is starting off on a strong footing. Borrowing any additional COVID-related manufacturing sector shutdowns, we expect to deliver the highest ever first quarter sales in each of our automation businesses, and we are well positioned to grow in excess of 30% for the year. 2020's results reflect well on Teradyne's strategy, execution and efficiency. Our test businesses show the successful results of R&D bets made in years past and enable us to increase those bets for the future. Our Industrial Automation investments continue undeterred by short-term impacts of COVID, and we are well positioned to capitalize on a world emerging to invest even more in automation to improve resilience and productivity. 
Equally significant, 2020 show the resilience of Teradyne employees, our global suppliers and our operating model. In the face of unimaginable challenges across communities worldwide, the team dealt with health, safety and operation obstacles daily, met R&D milestones, executed steep new product ramps and delivered record shipments of SOC, memory and storage tech products to meet our customers' needs. We did all this while exercising the cost and schedule discipline expected at Teradyne. This is truly extraordinary and I am very grateful to be part of such a powerful team. 
As we move into 2021, the outlook appears bright across all our markets. As Sanjay will detail, we are returning to our share repurchase program and have an active M&A pipeline. As 2020 taught us, no matter what comes our way in the short term, I am confident our global team and market strategy will deliver exciting long-term returns for our customers, investors and employees. 
Sanjay will now take you through the financial and modeling details. Sanjay?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Mark. Good morning, everyone. Today, I'll cover the financial highlights of Q4 and review the financial details of 2020. Looking forward, I'll provide our Q1 outlook, an update to our midterm earnings model and our capital allocation plans. N",1539,"Thank you, Mark. Good morning, everyone. Today, I'll cover the financial highlights of Q4 and review the financial details of 2020. Looking forward, I'll provide our Q1 outlook, an update to our midterm earnings model and our capital allocation plans. 
Now to Q4. Revenues were $759 million, which were $19 million above the high end of the guidance range. We delivered a non-GAAP operating profit of 30% and EPS of $1.10. Semi Test revenue of $524 million was driven by SOC and memory test demand, enabling 5G handsets and higher speed flash and DRAM devices. System Test group had revenue of $104 million, down quarter-over-quarter driven by lower storage test shipments. Industrial Automation, or IA, revenue of $92 million had a seasonal increase over Q3 and delivered year-over-year growth for the first time in 2020. LitePoint revenue of $40 million was approximately flat with Q3 and down year-over-year with a decline in trailing edge connectivity products, partially offset by new sales of new connectivity technology like WiFi 6 and emerging UWB technology. 
Non-GAAP gross margins were 59%, on plan and up quarter-over-quarter due to product mix. You'll see our non-GAAP operating expenses were up $14 million to $224 million from the third quarter due to increased test spending to support design wins, higher payroll due to 4 extra days in the quarter and ongoing IA investments. We generated $222 million in free cash in the fourth quarter. The tax rate, excluding discrete items for the quarter was 13% on a GAAP basis and 14.5% on a non-GAAP basis. For the full year, it is 14.75% on a GAAP basis and 15.25% on a non-GAAP basis. We ended the year with cash and marketable securities of $1.55 billion. 
Turning to the full year results of 2020. Teradyne revenues of $3.12 billion grew $826 million or 36% year-over-year. $845 million of the growth was from our test portfolio, while IA contracted $18 million due to the pandemic-related slowdown. We had 1 customer that accounted for more than 10% of our revenue in 2020, which we'll disclose in our 10-K filing. 
Gross margins for the year were 57% and operating profit was 30%, which is up from 25% in 2019. 
Non-GAAP EPS was $4.62, an increase of 62% over 2019. We generated $684 million in free cash in 2020. 
Breaking down the components of 2020 revenues. As outlined by Mark, SOC test revenues grew $595 million or 46% on strength in mobility, market-driven by increased by device complexity and new standards like 5G along with growing growth in computing. In memory, revenues were $383 million, up 41%. While LPDDR-related DRAM revenues were a significant contributor to our results, we also continue to see strong NAND test demand through the year. 
In System Test, sales grew for the fourth year running. Revenue of $410 million grew $122 million or 43% year-over-year, primarily on growth in Storage Test for both hard disk drive and system level test. storage Test sales were $242 million, up from $115 million in 2019. We also saw annual growth in our defense and aerospace component of STG. 
At LitePoint, sales grew for the fourth consecutive year to $173 million, 10% above 2019. In 2020, IA revenue was $280 million, a decline of 6% from 2019 on an as-reported basis or 9% on a pro forma basis. As Mark noted, the COVID-related driven slowdown in manufacturing impacted Universal Robots, reducing revenue to $219 million, down 12% year-over-year. 
After troughing in Q2, UR grew in the second half of 2020 versus the first half of the year. In Q4, revenue grew 6% year-over-year, giving confidence heading into 2021. MiR grew slightly year-over-year with annual sales of $45 million and AutoGuide full year's sales grew on a pro forma basis. 
Now to our outlook for Q1. Sales are expected to be between $720 million and $780 million. Non-GAAP EPS range of $0.95 to $1.11 on 175 -- 179 million diluted shares. The first quarter guidance excludes amortization of acquired intangibles and the noncash imputed interest on the convertible debt. First quarter gross margins are estimated at 58% to 59%. First quarter OpEx running at 29% to 31% of first quarter sales, is about flat with Q4 at the midpoint of guidance. The non-GAAP operating profit rate at the midpoint of our first quarter guidance is 29%. 
Regarding our OpEx plans for 2021, we expect our OpEx to grow 8% to 10% from 2020's $840 million. Approximately 2 points of the spend will be in the back half of the year related to travel, which we expect to resume to pre-COVID levels along with trade shows. In our test portfolio, we plan to increase our spending in engineering, sales and marketing, primarily in Semi Test. In IA, we'll continue to invest to reinforce our competitive product and ecosystem position across the sector. Also in IA, go-to-market investments will be made to support expected revenue growth. 
Turning to capital expenditures. In 2020, our CapEx was $185 million. This was used primarily for customer demonstration equipment, operations engineering and initial spending on new facilities to replace leased ones in locations where we plan to grow over the next several years. We'll continue to invest in these new facilities in 2021, so CapEx is expected to be similar to 2020. Recall, we are buying land and developing it to eliminate lease costs and enable a more efficient spend profile over the mid- to long-term. 
For 2021, our GAAP tax rate is estimated at 15.5% and our non-GAAP tax rate is estimated at 16% based on current tax laws. 
Moving to our midterm earnings model. As you've seen with 2020, our non-GAAP EPS of $4.62, we've exceeded our 2022 earnings model 2 years early on the strength of our test businesses. We continue to have confidence in the long-term growth outlook for test, and we expect IA to return to high growth as the global industrial economy improved. When building our midterm model, given our year-on-year demand swings, we've seen both in test and IA, we use the average of 2019 and 2020 revenues as the baseline for our growth projections. From that baseline, we expect test revenue to grow 4% to 8% compounded and IA revenues to grow 20% to 35% through 2024. 
In test, we expect that growth will be driven by steady increase in device complexity across our businesses along with the high single-digit semiconductor unit growth trend line. In IA, market penetration of cobots and autonomous mobile robots and forklifts remains low while the range of applications they economically serve continues to expand, resulting in an attractive long-term growth opportunity for Teradyne. We expect this will drive 2024 company revenue to $3.9 billion and non-GAAP EPS to $6 at the midpoint of our estimates. 
Gross margin is modeled at 58% to 59%, OpEx as a percentage of sales will decline to 28% to 29% and non-GAAP operating margin will improve to 30% to 31%. The model assumes the current tax laws are in place. 
Shifting to capital allocation. We'll continue to balance a strong cash position to support our operating investments and potential M&A with direct shareholder returns through dividends and share repurchases. We are raising our minimum cash levels from $1 billion to $1.25 billion, with the $250 million increase tied to the increased valuations of potential acquisitions. Recall, we held $500 million for M&A and $500 million for severe economic downturn. We will also be increasing our cash balance in 2021 through 2023 to service our convertible bond, which comes due in December 2023. To date, $51 million of that bond has been redeemed early with payment planned in Q1, with the remaining face value of $409 million. 
Regarding share repurchases. In 2020, we bought back $1.5 million -- sorry, 1.5 million shares for $88 million at an average price of $58.32. Recall, we suspended our share repurchase program in April due to COVID-related uncertainty. We are replacing our prior approved program with a new share repurchase authorization of $2 billion with no fixed end date. We plan a minimum of $600 million of repurchases in 2021. As in the past, the plan has both a programmatic and opportunistic components. 
In summary, 2020 inflicted incredible human and economic hardship on societies across the world, and we're respectful of the widespread pain and loss. When the pandemic hit, I noted our priorities were the safety of our employees, supporting our customers and continued execution in achieving our financial objectives. The Teradyne community responded with a collaborative and supportive spirit, incredible energy, ingenuity and purpose, which delivered on all 3 of these priorities. I'm incredibly proud and thankful to be part of this team. 
We enter 2021 in the strongest position in our history. The work in 2020 has made us more resilient and prepared us for the strong market demand that we currently see in both test and IA. While our visibility for the full year is limited, we're confident and the underlying market fundamentals are competitive, diversified portfolio and our team, which will enable long-term growth prospects for the markets we serve. Collectively, we're excited to turn our new financial model into reality. 
With that, I'll turn things back to Andy."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Sanjay. Operator, we'd now like to take some questions. [Operator Instructions]",12,"Thanks, Sanjay. Operator, we'd now like to take some questions. [Operator Instructions]"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","[Operator Instructions] First question comes from Krish Sankar with Cowen.",10,"[Operator Instructions] First question comes from Krish Sankar with Cowen."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, I had two of them. First one, thanks for the color on calendar '21. I'm just kind of curious if you could peel the SOC Test market a little more to say, how much do you think mobility will be? And how much do you think Auto Test would be this year o",61,"Mark, I had two of them. First one, thanks for the color on calendar '21. I'm just kind of curious if you could peel the SOC Test market a little more to say, how much do you think mobility will be? And how much do you think Auto Test would be this year on SOC? And then I have a follow-up."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So good question. Certainly, auto is going to be up sequentially in 2020. We've talked about that market being at a normalized, let's say, maybe more of a peak run rate in the $400 million to $500 million range. It's been come down to sort of $200 mi",162,"Yes. So good question. Certainly, auto is going to be up sequentially in 2020. We've talked about that market being at a normalized, let's say, maybe more of a peak run rate in the $400 million to $500 million range. It's been come down to sort of $200 million last year. So this year, that should be up at least $150 million, maybe $200 million. It's really right now a bit of a rush for capacity. And we don't know exactly when the demand profile of the orders are going to taper off here. So it could go higher if this persists. So that's the color on auto. 
In mobility, I think it's harder for us to see that at the moment because of the significant impact of our largest customer on both us and the market, which doesn't really become solidified until April-ish of the year. So we're looking at it sort of flat, plus or minus $1 million in mobility."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Got it. That's very helpful, Mark. And then just as a follow-up on the IA side. You mentioned 30-plus-percent growth, should we assume a big driver of that is going to be UR? In other words, UR should be higher than 30%? Or do you think UR is goin",59,"Got it. Got it. That's very helpful, Mark. And then just as a follow-up on the IA side. You mentioned 30-plus-percent growth, should we assume a big driver of that is going to be UR? In other words, UR should be higher than 30%? Or do you think UR is going to be in line with Industrial Automation growth?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that's a good question. I think all of the groups are going to be better than 30%. And some of them like AutoGuide are small. So I think they'll pull up the average, albeit ahead of UR. And MiR and UR should be about the same for the year.",52,"Yes. I think that's a good question. I think all of the groups are going to be better than 30%. And some of them like AutoGuide are small. So I think they'll pull up the average, albeit ahead of UR. And MiR and UR should be about the same for the year."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Mehdi Hosseini with SIG.",8,"Next question comes from Mehdi Hosseini with SIG."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","I just want to go back to your SOC commentary. I'm a little bit surprised with your kind of flattish outlook. And I say that because millimeter wave is expected to account for a larger mix of the 5G phones. And I believe last year was just the early inves",71,"I just want to go back to your SOC commentary. I'm a little bit surprised with your kind of flattish outlook. And I say that because millimeter wave is expected to account for a larger mix of the 5G phones. And I believe last year was just the early investment. So why isn't the increased penetration of millimeter wave phone not giving you that incremental confidence? And I have a follow-up."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that's certainly a balloon for the year, Mehdi. Maybe we're going to double the number of millimeter wave-enabled phones in 2021. But yes, last year, if you recall, there was also a significant step-up in the hundreds of millions of units of",143,"Yes. I think that's certainly a balloon for the year, Mehdi. Maybe we're going to double the number of millimeter wave-enabled phones in 2021. But yes, last year, if you recall, there was also a significant step-up in the hundreds of millions of units of millimeter wave-enabled phones were brought to market last year. So if you add another 200 mil to 300 million additional millimeter wave-enabled units this year and, let's say, that brings the global total to 600 million units out of 1.4 billion. You're essentially adding about as much capacity, maybe a little bit more, because there'll be more than -- let's say, last year, added 250 million, this year, might add 350 million units. So yes, there will be a little bit of growth in additional millimeter wave test capacity. But last year was a pretty big year, too."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And then looking at the midterm model 2024. What are the key underlying assumption for market share, especially as you try to capitalize on the synergies between Semi and a System Test? And in that context, are you accounting for any incremental s",51,"Got it. And then looking at the midterm model 2024. What are the key underlying assumption for market share, especially as you try to capitalize on the synergies between Semi and a System Test? And in that context, are you accounting for any incremental share shift in the GPU end market?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Mehdi, it's Sanjay. Yes. So in the earnings model, we see, obviously, growth in the market. As Mark alluded to, more players are coming into the compute space that we can address. And with that, we feel that with the UltraFLEXplus solution, we're ver",110,"Yes. Mehdi, it's Sanjay. Yes. So in the earnings model, we see, obviously, growth in the market. As Mark alluded to, more players are coming into the compute space that we can address. And with that, we feel that with the UltraFLEXplus solution, we're very well positioned and we are projecting share growth. When we think about from a memory perspective, if you go back, let's say, 10 years, we've been on this steady increase of memory share growth, where as we continue to execute, we see continued share growth on that perspective as well. So really, growth in market size as well as continued share growth are our drivers."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","That includes the synergy between different sectors or segments?",9,"That includes the synergy between different sectors or segments?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","You want to expand on that question?",7,"You want to expand on that question?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Yes. Just going back to the question. I see opportunities between your Semi and a System Test, especially as the system-level test diversifies. And I'm just wondering if that's baked into your 2024 model?",34,"Yes. Just going back to the question. I see opportunities between your Semi and a System Test, especially as the system-level test diversifies. And I'm just wondering if that's baked into your 2024 model?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Okay. Thanks for the clarification. Yes, it is. With device complexity, we were going 5-nanometer and then to 3-nanometer, I think both system-level test as well as ATE test take that into account.",34,"Yes. Okay. Thanks for the clarification. Yes, it is. With device complexity, we were going 5-nanometer and then to 3-nanometer, I think both system-level test as well as ATE test take that into account."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Toshiya Hari with Goldman Sachs.",9,"Next question comes from Toshiya Hari with Goldman Sachs."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, I wanted to ask about your largest customer. I appreciate things will remain pretty fuzzy or opaque, as you said, until sort of the April-ish time frame. But can you sort of walk us through the potential range of outcomes you're thinking internally?",89,"Mark, I wanted to ask about your largest customer. I appreciate things will remain pretty fuzzy or opaque, as you said, until sort of the April-ish time frame. But can you sort of walk us through the potential range of outcomes you're thinking internally? Obviously, you've got units, you've got transistor density as it relates to the new Chip. Also curious if their efforts on the notebook side of their business, in-sourcing CPUs, could have an impact on your business as well? And then I've got a quick follow-up."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Okay. I always -- I'm a bit reluctant to be too specific on any 1 customer. So I'm going to speak more to the segment a bit, which I'll bundle compute and mobility together here. So yes, last year was incredibly strong in both our traditional mobility mar",212,"Okay. I always -- I'm a bit reluctant to be too specific on any 1 customer. So I'm going to speak more to the segment a bit, which I'll bundle compute and mobility together here. So yes, last year was incredibly strong in both our traditional mobility market because of the complexity growth of phones, which we alluded to and the fact that we did enter compute as a new segment. So we ended up with additional revenues in compute last year, that north of $50 million for the first year in that market. So as we think about this year, the issue of smartphone unit growth and complexity growth of the apps processor, the camera systems and such in the phones is part of the equation. And we have a reasonably good read on that. 
On the compute side, there's a lot of moving parts there. And there's a lot -- since it's a new market for us and a new market for some of our customers, that has the bigger range of potential outcomes for the year. So that's the one we're triangulating on. That could be up significantly over last year. It could be up modestly over last year. But at this point, we really can't be too specific."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And then as a quick follow-up. On Industrial Automation, I wanted to ask about the profit margin profile of the business, where does it stand today, I guess, as of 2020? You guys have done a great job in improving gross margin at UR and the other",87,"Got it. And then as a quick follow-up. On Industrial Automation, I wanted to ask about the profit margin profile of the business, where does it stand today, I guess, as of 2020? You guys have done a great job in improving gross margin at UR and the other businesses that you've acquired over the past couple of years. At the same time, you've been aggressively spending from an OpEx perspective. So in your 2024 model, what sort of margin profile for IA added in your numbers?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","It's Sanjay. So IA as a whole this year was roughly just a bit better than breakeven. Obviously, with the COVID impact on multiple businesses and the contraction in UR, we're just above breakeven. But fundamentally, we continue to invest in the portfolio,",129,"It's Sanjay. So IA as a whole this year was roughly just a bit better than breakeven. Obviously, with the COVID impact on multiple businesses and the contraction in UR, we're just above breakeven. But fundamentally, we continue to invest in the portfolio, the ecosystem, the go-to-market for product and differentiation, ease of implementation. And so you should expect that to continue over the midterm, and we're focused on driving the revenue growth and the investments. 
And so with that, we expect the margin profile to be roughly consistent with the current profile as we -- as AutoGuide is relatively new to the organization, just over a year, we expect that to improve with our Teradyne supply chain as well as other quality process as we step in."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Just one thing I'm going to add on to that commentary around Industrial Automation business to remind people that what we focus on right now during the high growth phase of that business is sales growth and gross margin. And the bottom line, as Sanjay men",146,"Just one thing I'm going to add on to that commentary around Industrial Automation business to remind people that what we focus on right now during the high growth phase of that business is sales growth and gross margin. And the bottom line, as Sanjay mentioned, if we're at breakeven, we're happy as long as we can sort of adhere to or exceed the rule of 40. And through the midterm, we think we expect to be close to that kind of up top line growth rates. And what we bring down to the bottom line will kind of depend on the size of the growth, what we see ahead of us. And if we're growing at 50% and breakeven, we are happy as clams. And if the growth rates come down below 20%, we'll start dropping more and more down to the bottom line."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Joe Moore Moore with Morgan Stanley.",10,"Next question comes from Joe Moore Moore with Morgan Stanley."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Following on the last question. Can you just characterize the tone of business for the Universal Robotics business? And I guess in the context of it feels like a lot of the business activity in the last 12 months is business continuity and supply chain di",100,"Following on the last question. Can you just characterize the tone of business for the Universal Robotics business? And I guess in the context of it feels like a lot of the business activity in the last 12 months is business continuity and supply chain disruption, maybe that's negative for new technologies and manufacturing. At the same time, I would think social distancing and stuff like that as an opportunity for you. So just kind of characterize those puts and takes? And just what that tells you about what the trends may look like over the course of this year?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Sure. It's Sanjay here. So in the short run, we actually saw a contraction as evidenced by how our revenues were. However, I think your comments hit home with regards to plant and warehouse decision-makers seeking to build resilience into their suppl",89,"Yes. Sure. It's Sanjay here. So in the short run, we actually saw a contraction as evidenced by how our revenues were. However, I think your comments hit home with regards to plant and warehouse decision-makers seeking to build resilience into their supply chains. And we view that over the midterm as a tailwind. We are seeing the market obviously come back with Universal Robots. We've talked in our prepared remarks about the automotive and electronics industry. And then we're also seeing strength in a couple of other verticals."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from C.J. Muse with Evercore.",9,"Next question comes from C.J. Muse with Evercore."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","I wanted to follow-up on Mehdi's question regarding your 2024 model. So if I look at your implied Semi Test revenues versus 2020 actual, you're up about $250 million to $350 million, which seems conservative, particularly when you reflect on what you're d",86,"I wanted to follow-up on Mehdi's question regarding your 2024 model. So if I look at your implied Semi Test revenues versus 2020 actual, you're up about $250 million to $350 million, which seems conservative, particularly when you reflect on what you're doing with system-level Test, new UltraFLEXplus. So can you, I guess, walk through what assumptions you're making in terms of market share for both SOC and memory implied in that number? And where you might point to as areas that might be conservative?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that as I articulated from -- I'll touch on memory first. Our share right now is in the low 40s. We see that -- we could see that growing to the mid-40s in the plan. And then from an SOC perspective, Mark talked about on a normalized share le",63,"Yes. I think that as I articulated from -- I'll touch on memory first. Our share right now is in the low 40s. We see that -- we could see that growing to the mid-40s in the plan. And then from an SOC perspective, Mark talked about on a normalized share level of about 50%. And we see that increasing over the midterm."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","But within the implied model, are you assuming the 50% or the 60% that Mark spoke about back in July as to what a goal could look like?",28,"But within the implied model, are you assuming the 50% or the 60% that Mark spoke about back in July as to what a goal could look like?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","So yes, I think what we've been saying, C.J., is that we can get about 1 point to 1.5 points a share growth a year. So by 2024, as I mentioned, I think our normalized share is somewhere around 50%. We should be up around 55%, 56% by then in SOC. And in me",188,"So yes, I think what we've been saying, C.J., is that we can get about 1 point to 1.5 points a share growth a year. So by 2024, as I mentioned, I think our normalized share is somewhere around 50%. We should be up around 55%, 56% by then in SOC. And in memory, share was a little chunkier because there's only a few players there. So on the memory side, we could be in the mid to upper mid-40s by then, I would say, is one way to think about it. But the other piece of color in terms of aggressive versus conservative that I'd add here is the recent investment profile of the front end with CapEx moving up into the $70 billion range, it's something we haven't modeled into our midterm plan. We've assumed that incremental fab capacity across the midterm would be sort of consistent with the rate that it's been added for the prior 4 years. So if $70-plus billion of investment in WFE is the new normal for the next 4 years, that's certainly going to drive more tests than we modeled."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Very helpful. As my follow-up, can you speak to what we should be thinking about for SOC Test gross margins here in '21 versus 2020? Trying to get a sense of what uplift might look like, particularly from Eagle test.",40,"Very helpful. As my follow-up, can you speak to what we should be thinking about for SOC Test gross margins here in '21 versus 2020? Trying to get a sense of what uplift might look like, particularly from Eagle test."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","I mean gross margins, we -- you should expect a relatively consistent with how we've guided Q1 and in our long-term model.",22,"I mean gross margins, we -- you should expect a relatively consistent with how we've guided Q1 and in our long-term model."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Brian Chin with Stifel.",8,"Next question comes from Brian Chin with Stifel."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","I was going to ask a few questions. Maybe the first question, back on the topic of Industrial Automation. Automotive has historically been a key portion of sales here. And I was curious do you expect or even need the other portion of your sales to grow 30",63,"I was going to ask a few questions. Maybe the first question, back on the topic of Industrial Automation. Automotive has historically been a key portion of sales here. And I was curious do you expect or even need the other portion of your sales to grow 30% year-over-year, given sort of the increasing breadth of market adoption that you might be seeing?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that with an emerging market, there's still a lot of footprint to cover, so we expect that to continue in the automotive vertical as well as electronics and industrials as well as other verticals.",37,"Yes. I think that with an emerging market, there's still a lot of footprint to cover, so we expect that to continue in the automotive vertical as well as electronics and industrials as well as other verticals."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Yes, I would just sort of get -- trying to gauge whether you're seeing a lot of adoption outside of auto? And is it -- in terms of visibility, you're starting the year with pretty good visibility. Does auto kind of starting from a similar point? Or",78,"Okay. Yes, I would just sort of get -- trying to gauge whether you're seeing a lot of adoption outside of auto? And is it -- in terms of visibility, you're starting the year with pretty good visibility. Does auto kind of starting from a similar point? Or is it kind of more -- a little bit more on the whole to start the year, and you're going to expect a bigger snap back later in the year?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. We're seeing also -- we're seeing market drivers in our verticals, adoption and education. R&D, pharma as well as life sciences. But from a starting point, obviously, we have a very strong incumbent installed base over the years that we've built in t",46,"Yes. We're seeing also -- we're seeing market drivers in our verticals, adoption and education. R&D, pharma as well as life sciences. But from a starting point, obviously, we have a very strong incumbent installed base over the years that we've built in the auto vertical."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","And I'd just add to that, that certainly, automotive was one of the most hard hit aspects of UR's business. Automotive has been running in the high 30s, 40% of the business coming into 2020. That contracted dramatically because of COVID, down to the point",171,"And I'd just add to that, that certainly, automotive was one of the most hard hit aspects of UR's business. Automotive has been running in the high 30s, 40% of the business coming into 2020. That contracted dramatically because of COVID, down to the point that it was in the low 20s. And I would say it's certainly, at this point, although back and growing, it hasn't come back yet to where it should be in our portfolio. This has issues around the semiconductor supply chain and other things have sort of crimped some of the ambitions of car companies to ramp volumes here. There's a little bit to go still. But our footprint over time, since we acquired UR has been reducing in the automotive segment, not so much because automotive is not growing, of course, but it's just that our expansion into the other areas that Sanjay mentioned has been. And we expect over time that automotive component will continue to decline as a percentage of our sales."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Great. Yes. I was sort of getting maybe at that. And then in the 2024 model, grant it's 4 years out, but can you give us sort of a rough sense of how much of the IA sales might be AMR or mobile vehicle driven? I think the split roughly is kind of 80% UR,",73,"Great. Yes. I was sort of getting maybe at that. And then in the 2024 model, grant it's 4 years out, but can you give us sort of a rough sense of how much of the IA sales might be AMR or mobile vehicle driven? I think the split roughly is kind of 80% UR, 20% mobile at the moment. Could that be sort of like a 2/3, 1/3 in that time frame?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that, obviously, UR, we've had for a little bit longer, and it is a larger percentage. But I think you're spot on that the AMR portion will grow with AutoGuide and MiR as a percentage of revenue.",40,"Yes. I think that, obviously, UR, we've had for a little bit longer, and it is a larger percentage. But I think you're spot on that the AMR portion will grow with AutoGuide and MiR as a percentage of revenue."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Atif Malik with Citi.",8,"Next question comes from Atif Malik with Citi."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Good job on results and guide. Mark, the first one, following up on the last question, AutoGuide, how is adoption going at larger enterprises and warehouse customers? And then I have a follow-up.",33,"Good job on results and guide. Mark, the first one, following up on the last question, AutoGuide, how is adoption going at larger enterprises and warehouse customers? And then I have a follow-up."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Good question. So to be frank with you, we had a good year. We grew 50-ish-percent in the year, but we didn't hit our target. And part of this is extended evaluations at the large accounts that you're referencing. And it's been very difficult in a sm",196,"Yes. Good question. So to be frank with you, we had a good year. We grew 50-ish-percent in the year, but we didn't hit our target. And part of this is extended evaluations at the large accounts that you're referencing. And it's been very difficult in a small business like AutoGuide's case in a COVID area to acquire new customers and get the pilot production validation work done in the same time frame that we could have gotten it done in a non-COVID world. So we've seen some extension of those e-valves, but we're in some of the boutique name brands for e-valves that you would hope we are in, in both the industrial manufacturing side as well as the e-commerce side and logistics side of life. So we're hoping that this year is going to be the big breakout year. It's the kind of business that should at least be doubling, if not more, once these big accounts latch. But we did -- if any place sort of had a big impact from COVID last year, it was AutoGuide because of the whole -- new customer acquisition is the whole game there at this point."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Great. And as a follow-up, you mentioned the China SOC Test to be down this year, which makes sense given the restrictions from last year, but some of the front end peers have talked about maybe flattish China investments on the front end and back end is",75,"Great. And as a follow-up, you mentioned the China SOC Test to be down this year, which makes sense given the restrictions from last year, but some of the front end peers have talked about maybe flattish China investments on the front end and back end is different. Can you just walk us through the components on where China investments are down? And why you aren't benefiting on some of the mature technologies and nodes?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So if you look at China, I think you need to separate memory and SOC because it's quite different. On the memory side, there will be growth in China this year in test as well and we -- or we expect that at least. And so that's a healthy, growing midt",170,"Yes. So if you look at China, I think you need to separate memory and SOC because it's quite different. On the memory side, there will be growth in China this year in test as well and we -- or we expect that at least. And so that's a healthy, growing midterm profile, I'd say, for China. 
On SOC, it's really a little bit more difficult to see growth occurring this year because the impact of the trade restrictions on Huawei and HiSilicon are tremendous in terms of their buying power in the market historically. What they buy in both silicon and then test capacity for that silicon has been severely hampered. And then further restrictions on other companies like SMIC and such are much smaller factors, but tail or headwinds against growth. So I think SOC is likely to contract. Memory is going to grow. But net-net, it's not going to be hugely down, but it will probably be down a little bit on the test side of life."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Vivek Arya with Bank of America.",10,"Next question comes from Vivek Arya with Bank of America."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","I had two, one on operating leverage and the second on M&A. On operating leverage, Sanjay, I believe you mentioned OpEx growth of 8% to 10% this year. Do you think there is a potential to still drive leverage with that kind of growth? And then when I look",109,"I had two, one on operating leverage and the second on M&A. On operating leverage, Sanjay, I believe you mentioned OpEx growth of 8% to 10% this year. Do you think there is a potential to still drive leverage with that kind of growth? And then when I look at your 2024 model, you're keeping operating margins at about 30%, 31%, kind of where you are already, even though sales are expected to grow and Mark had outlined a number interesting growth driver. So I was hoping you could talk to operating leverage this year, and then what would be the drivers as you look at your '24 model?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Okay. Sure. Yes. So obviously, it's another -- it's an investment year. And I think in my prepared remarks, I noted that we're getting back to travel and trade shows, which is a key point. You really -- if you look at it in 2 portfolios, we -- for the yea",187,"Okay. Sure. Yes. So obviously, it's another -- it's an investment year. And I think in my prepared remarks, I noted that we're getting back to travel and trade shows, which is a key point. You really -- if you look at it in 2 portfolios, we -- for the year, we're going to have leverage in the test business, where the growth in OpEx as a percentage will be lower, but the growth in the IA space, the OpEx growth is higher. And so the leverage from a -- like we're growing in the IA space, but we will see -- we should see a degree of leverage in the short-term in the test business. When you cascade that out to 2024, obviously, with the revenues that we're predicting in IA, I think Mark described it well. If we're growing at 50% and have a forecast to continue to grow, we'll continue to drive the investment. But as the growth starts to go down, let's say, below the Rule 40, then we'll start to drop more to the bottom line. That's how we're thinking about it."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","But when I look at that '24 model, right, you're forecasting overall sales to grow at a 6% CAGR from the 2020 level. So that is below the 16% CAGR you have been at. And you're saying operating margins are going to stay pretty much flattish versus -- I'm j",105,"But when I look at that '24 model, right, you're forecasting overall sales to grow at a 6% CAGR from the 2020 level. So that is below the 16% CAGR you have been at. And you're saying operating margins are going to stay pretty much flattish versus -- I'm just puzzled as to if you're saying sales are not really going to grow as much as they have grown in the last 3, 4 years and operating margins are not going to expand from here, is that model very conservative? Or what needs to be done to either grow faster or drive more operating leverage?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that -- well -- and that's why in my prepared remarks, I comment, we looked at the model, not just off of a point of 2020, but off of an average of '19 and '20, just given the significant balloon in '20 tied to the mobility space and then the",100,"Yes. I think that -- well -- and that's why in my prepared remarks, I comment, we looked at the model, not just off of a point of 2020, but off of an average of '19 and '20, just given the significant balloon in '20 tied to the mobility space and then the contraction in IA. And when you look at it from an average of '19 and '20, we believe in that growth -- overall growth of the 4% to 8%. And then we are, during that period, going to be growing out the investments in the IA portfolio."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","And I would just say, if you go back to what we said, if you look at that pie chart of the mix. When we get out to 2024, IA should be a bigger mix of our revenue than test. So test will continue to grow. It will have a very high drop-through. It will be v",161,"And I would just say, if you go back to what we said, if you look at that pie chart of the mix. When we get out to 2024, IA should be a bigger mix of our revenue than test. So test will continue to grow. It will have a very high drop-through. It will be very efficient. And if that's all you're looking at, yes, bottom line profitability should increase. But on the IA side, it's more likely that we'll be growing more rapidly and we'll be pulling up gross margins for the enterprise with the IA business. But on the bottom line, we're being a bit conservative on how much we plan to drop-through there because we want to keep investing for more and more growth. So it kind of just depends on what's the investment profile in IA. And we've modeled in -- we're not going to optimize for profit in the midterm there, we're optimizing for growth."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Understand. And Mark, just a follow-up to that. You mentioned the prospects for some additional M&A. I presume it's in the IA side of the business, but I was hoping you would talk to that. Do you -- are you contemplating kind of smaller tuck-in technology",88,"Understand. And Mark, just a follow-up to that. You mentioned the prospects for some additional M&A. I presume it's in the IA side of the business, but I was hoping you would talk to that. Do you -- are you contemplating kind of smaller tuck-in technology type transactions? Are you thinking about something that could be bigger and could require the use of stock, just how we should think about what M&A pipeline is and how it could impact this baseline model that you have set for us?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So most of what we have in our pipeline is consistent with the kind of things we've been investing in and acquiring in the past 5 to 6 years, Industrial Automation, modestly sized investments, let's say, relative to our market cap. However, we have e",135,"Yes. So most of what we have in our pipeline is consistent with the kind of things we've been investing in and acquiring in the past 5 to 6 years, Industrial Automation, modestly sized investments, let's say, relative to our market cap. However, we have expanded our aperture a bit to look in the test space and areas that are correlated to test, which bring with it potentially some larger M&A things. It's always governed by the same rich internal rate of return metrics that we always use on these things. So whatever we do is going to be something that's more attractive to the -- our investors than buying back our stock or those kind of -- our internal weighted cost of capital. So that's about all I think I can say about that."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Timothy Arcuri with UBS.",8,"Next question comes from Timothy Arcuri with UBS."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","I had a couple. So for OpEx this year, you're saying it's going to grow about 8% to 10%. So at the midpoint, you're going to grow OpEx about $76 million. I'm wondering, Sanjay, if you can tell us how much of that's going to come in IA? And I guess another",139,"I had a couple. So for OpEx this year, you're saying it's going to grow about 8% to 10%. So at the midpoint, you're going to grow OpEx about $76 million. I'm wondering, Sanjay, if you can tell us how much of that's going to come in IA? And I guess another way of asking that is sort of what sort of op margin do you think you can do this year in IA? I mean you were basically breakeven last year. Can you get to high single digits this year? And is 10% to 15% still the long-term target for that business? I know that Mark's commenting that if growth slows, you can sort of crank back on OpEx and you can drop more. But just wondering if you can comment there. And then I had a follow-up."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Sure. Yes. I think it's spot on. I think when you take out the travel and the trade shows, the majority of the spend will come in OpEx from -- on a year-over-year basis. And from a profit perspective, we're assuming growth, and we expect to improve back t",92,"Sure. Yes. I think it's spot on. I think when you take out the travel and the trade shows, the majority of the spend will come in OpEx from -- on a year-over-year basis. And from a profit perspective, we're assuming growth, and we expect to improve back to our original growth plans. Like if you think about 2020 as the anomaly and you look at the jump-off point of 2019, we were about a 10% profit level. With our growth, we should be in that similar level going forward in 2021."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Got it. So you think you can get to 10% op margin this year?",15,"Okay. Got it. So you think you can get to 10% op margin this year?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes, plus or minus, but yes.",6,"Yes, plus or minus, but yes."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Okay. Great. And then, I guess, a question for you, Mark. So when you were going to your top customer, you presented a couple of scenarios. I know it's very tough to predict. But the scenarios you presented didn't include that revenue from that cust",182,"Okay. Okay. Great. And then, I guess, a question for you, Mark. So when you were going to your top customer, you presented a couple of scenarios. I know it's very tough to predict. But the scenarios you presented didn't include that revenue from that customer is down. I get that the compute piece is going to be up, but they're also not going to shrink this year. And in the past, that's been sort of a harbinger of a potential decline in the number of testers they buy unless they're willing to live with a much larger dye size, which may or may not be the case. So I'm just kind of wondering -- I'm not asking for any specifics on that customer. I'm just sort of wondering if you can look back in the past and draw in your past experience and say, well, yes, in the past, when that happens, that is sort of a harbinger of the potential that it could be down because you didn't present that as a down or as a possible outcome this year?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think it's a possible outcome, but let me go back to what I was outlining in my remarks. When you look at the phone, there's various elements of the phone in terms of technology, depths processors, the modem, the cameras, the memory, those areas of",197,"Yes. I think it's a possible outcome, but let me go back to what I was outlining in my remarks. When you look at the phone, there's various elements of the phone in terms of technology, depths processors, the modem, the cameras, the memory, those areas of the phone refresh and take leaps of complexity in different cadences. And in 2020, the apps processor and 5G -- basically, the apps processor had a big jump in complexity and 5G proliferated throughout all the phones. So as you look at 2021, the need for incremental 5G capacity, whereas in 2020, several, let's say, 100 million units worth of phones needed 5G capacity. This year, it will be less because the incremental unit growth there is one factor in incremental 5G capacity plus complexity growth of the 5G modem itself. So 5G is big in 2020, not as big in 2021. 
That leaves what's happening with the cameras, what's happening with power management, what's happening with the screen resolution. Other things could be balloons that pull it back up. But I do think you do have that 5G has happened for that one area of our mobility customer base."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","And operator, we have time for just one more question, please.",11,"And operator, we have time for just one more question, please."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Last question comes from John Pitzer with Crdit Suisse.",9,"Last question comes from John Pitzer with Crdit Suisse."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, my first question is just on the whole China dynamic. You're clearly guiding it to be down this year. I'm kind of curious if there is a date on between U.S.-China relations, is that a zero-sum game, an exercise in market shift? Or do you think it wo",111,"Mark, my first question is just on the whole China dynamic. You're clearly guiding it to be down this year. I'm kind of curious if there is a date on between U.S.-China relations, is that a zero-sum game, an exercise in market shift? Or do you think it would be accretive? And I guess more importantly, we're now seeing the U.S. government kind of incentivize domestic production of semis. I'm just kind of curious as to whether or not you could benefit from that, either indirectly as some of your customers build capacity domestically, or directly as we think about your long-term tax rate? And then I've got a quick follow-up."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Okay. So China, if for some reason, the restrictions on China ease and more indigenous Chinese makers start to grow again, I think it's neutral. As business shifted out of China in 2020, it was pretty much neutral to us. There was -- the customers that pi",219,"Okay. So China, if for some reason, the restrictions on China ease and more indigenous Chinese makers start to grow again, I think it's neutral. As business shifted out of China in 2020, it was pretty much neutral to us. There was -- the customers that picked up the manufacturing of, let's say, applications processors or modems that would have been done by indigenous Chinese suppliers or Teradyne customers and Advantest customers and a proportion that isn't that different than it was in China. So as it ebbs and flows back and forth, I wouldn't say there's a big ramification. 
On the U.S. domestic supply question, I think it's going to take a long time and many, many years of a steadfast set of incentives from the government for that to mature to something significant to our business. If we stick at that in the U.S. for 7, 8 years and really build up an infrastructure to manufacture semiconductors domestically, I think it could have a bit of a positive impact, but I think it's small. I don't think because semiconductors might be manufactured in the U.S., all of a sudden, there's a propensity that they're going to buy more Teradyne equipment. It's at the margin, but nothing I would bake in as a trend line to count on."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","That's helpful. And then just as my follow-up, going back to the 2024 model. Your explanation as to kind of how you're getting to the op profit targets you're getting to. It makes a ton of sense. I'm just kind of curious, to the extent that the top line p",97,"That's helpful. And then just as my follow-up, going back to the 2024 model. Your explanation as to kind of how you're getting to the op profit targets you're getting to. It makes a ton of sense. I'm just kind of curious, to the extent that the top line proves to be conservative, how should we think about incremental operating margins above sort of the high end of the target model? Or maybe another way of thinking about it, as IA gets scale, where do we think the longer-term op margin of the business can go?"
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that if the test business -- if what drives the incremental revenue, if the test businesses come to fruition, I think you'll see a higher drop-through. If and again, just to repeat myself, if we're growing and we see continued growth, and we'",124,"Yes. I think that if the test business -- if what drives the incremental revenue, if the test businesses come to fruition, I think you'll see a higher drop-through. If and again, just to repeat myself, if we're growing and we see continued growth, and we're going to continue to invest in IA, that drop-through may be lower. But let's say, it comes -- let's say, the revenues grow significantly over the first couple of years. And then at the end, they start to -- the growth starts to tail down, you may see a little bit more leverage. But it's really -- we have to see how the market unfolds in IA. But over the short term, we are planning a significant investment."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","All right, folks. That wraps us up for today. Look forward to talking to you in the days ahead. And those that are still in the queue, I'll get back to you straight away. Thanks so much.",37,"All right, folks. That wraps us up for today. Look forward to talking to you in the days ahead. And those that are still in the queue, I'll get back to you straight away. Thanks so much."
94728,701302321,2183888,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","This concludes today's conference call. You may now disconnect.",10,"This concludes today's conference call. You may now disconnect."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Ladies and gentlemen, thank you for standing by, and welcome to the Q4 of 2020 Teradyne, Inc. Earnings Conference Call. [Operator Instructions]I would now like to hand the conference over to Mr. Andy Blanchard, Vice President of Investor Relations. Plea",44,"Ladies and gentlemen, thank you for standing by, and welcome to the Q4 of 2020 Teradyne, Inc. Earnings Conference Call. [Operator Instructions]
I would now like to hand the conference over to Mr. Andy Blanchard, Vice President of Investor Relations. Please go ahead, sir."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Sharon. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined for our discussion this morning by Teradyne's CEO, Mark Jagiela; and CFO, Sanjay Mehta. Following our opening remarks, we'll p",303,"Thank you, Sharon. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined for our discussion this morning by Teradyne's CEO, Mark Jagiela; and CFO, Sanjay Mehta. Following our opening remarks, we'll provide details of our performance for 2020's fourth quarter and full year, along with our outlook for the first quarter of 2021.
The press release containing our results was issued last evening. We are providing slides on the Investor page of the website that may be helpful to you in following the discussion. Replays of this call will be available via the same page after the call ends. The matters that we discuss today will include forward-looking statements that involve risk factors that could cause Teradyne's results to differ materially from management's current expectations. We encourage you to review the safe harbor statement contained in the earnings release as well as our most recent SEC filings. 
Additionally, those forward-looking statements are made as of today, and we take no obligation to update them as a result of developments occurring after this call. 
During today's call, we'll make reference to non-GAAP financial measures. We posted additional information concerning these non-GAAP financial measures, including reconciliation to the most directly comparable GAAP financial measure, where available, on the Investor page of our website. Looking ahead between now and our next earnings call, Teradyne will be participating in technology or industrial-focused investor conferences hosted by Goldman Sachs, Citi and Susquehanna. 
Now let's get on with the rest of the agenda. First, Mark will comment on our recent results and the market conditions as we enter the new year. Sanjay will then offer more details on our results along with our guidance for the first quarter. We'll then answer your questions, and this call is scheduled for 1 hour. Mark?"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Good morning, and thanks for joining us. In our call today, I'll summarize our Q4 and 2020 full year highlights and provide some initial comments on our outlook for 2021. Sanjay will then provide the financial details, Q1 outlook and review our updated ea",1524,"Good morning, and thanks for joining us. In our call today, I'll summarize our Q4 and 2020 full year highlights and provide some initial comments on our outlook for 2021. Sanjay will then provide the financial details, Q1 outlook and review our updated earnings model and capital allocation plans. 
Fourth quarter capped off an amazing year for Teradyne, with sales up 16% from the fourth quarter of 2019 and non-GAAP earnings per share up 25%. That brought our full year sales to just over $3.1 billion, up 36% and non-GAAP EPS to $4.62, up 62% versus 2019. These annual results, driven by strength in all of our test businesses more than made up for a soft industrial automation market that was impacted by COVID.
For the full year, our Semi Test business was especially strong, driven by investments in smartphone-related test capacity, our expansion into the compute sector of SOC with our new UltraFLEXplus product and the ramp of our Magnum EPIC product for DRAM test. 
In smartphones, global unit shipments contracted in 2020, but the growth in chipset complexity continued driving tester demand higher. Each subsystem on the phone, cellular power management, connectivity, display, cameras and application processing has its own cycle. And in 2020, both the processor and the cellular areas took big steps up in complexity. We use transistor count as a proxy for complexity, and the leading phone applications processors now exceed 10 billion transistors, growing double digits each generation. 
In 2020, we also saw the beginning of meaningful 5G silicon content, which necessitated a build-out of new tester capacity. Together, these listed the mobility test market in 2020, roughly $200 million to about $1.7 billion. This continuous refresh of smartphone silicon should be a tailwind for the semiconductor test business for the foreseeable future. 
In 2020, we also ramped our UltraFLEXplus product in the compute portion of the SOC market. Recall, this has historically been a $500 million to $600 million market, where we've had relatively low share. With the emergence of more players and applications in the processor market, including hyperscalers and AI, we expect this sector to outgrow the general market. The plus brings a powerful value proposition in managing the unique complexity, power dynamics, yield learning and time-to-market requirements of this segment. 
For 2020, we estimate the SOC market was in the range of $3.4 billion to $3.5 billion, up from about $3.3 billion in 2019. We estimate our SOC test market share moved up 15 points to about 54%. However, our internal view of share smooths out year-on-year swings due to the unique timing of investment cycles of both our and our competitors' customers. By that measure, we estimate our normalized 2020 SOC share at about 50%. 
Another notable growth segment of our Semi Test business in 2020 was memory. In this call, a year ago, we noted a significant design win for our Magnum EPIC product in the LPDDR5 portion of the DRAM market. This new entry into DRAM test ramped through the year and combined with healthy growth in our traditional NAND business, drove a 41% increase in memory sales from 2019. We estimate the market was about $900 million in 2020, up from $600 million in 2019 and our normalized 2020 memory share at about 42%.
Beyond Semi Test, our System Test group also had a great year delivering 43% growth, with the Storage Test business more than doubling from 2019. This is the second consecutive year of hyper growth in Storage Test driven by stedy test intensity growth of terabyte HDD drives and similar growth in the system level test of complex semiconductor devices. In our Wireless Test business, our LitePoint sales grew 10% from 2019, with solid demand for both our connectivity and cellular end markets. WiFi 6, also wideband test and increased investments in 5G related handset tests all contributed.
The performance of our test businesses more than offset the weaker results in our industrial automation business, which contracted 6% for the year. The global slowdown in manufacturing activity led to a 12% decline in sales at our Universal Robots unit. MiR, on the other hand, grew 1% as makers of ultraviolet disinfecting products recognize the value of an easier to deploy fully autonomous mobile robot. 
On a pro forma basis, AutoGuide also grew for the year. While the environment in IA was weaker than expected, the business troughed in the second quarter of 2020 and has improved dramatically in the second half, including record sales at UR in the fourth quarter. Collectively, the business returned to year-over-year growth in Q4, with UR growing 6% year-over-year and 41% sequential growth. With test slowing -- with test showing continued strength and industrial automation returning to growth, we are set up for another exciting year in 2021. Specifically, we are expecting a strong start to the year across all our businesses, with Q1 showing greater than 6% growth at the midpoint compared to Q1 of '19 -- sorry, Q1 of '20. 
As you know, full year visibility is always a challenge, as evidenced by our missing the strength of the test market and the decline of the IA market in our forecast just 1 year ago. That said, let me describe how we see things today, and of course, we'll keep you updated in future calls. I will preface my remarks with a note that the well-publicized surge in the forecasted semiconductor CapEx in 2021 is a very bullish sign. However, the impact on test is likely to be felt in 2022 and beyond as fab capacity built this year will drive additional testers in future years aligned to fab commissioning and ramping volumes and yields. 
In SOC test, the dynamics that made 2020 such a strong year continue into 2021. In addition, we have strengthening demand in the long dormant automotive test market with orders for our Eagle Test product line surging. Smartphone shipments are expected to grow in 2021 after contracting about 10% in 2020, and 5G content should increase. On the other hand, the SOC test market in China will likely be down in 2021 due to the expanded and full year effects of trade restrictions that were widened in 2020. Also, as always, tester demand from our largest customer will remain opaque until sometime in Q2.
Additionally, the global economic impact of COVID and its impact on electronics demand after a surge in 2020, it's hard to forecast with arguments for both positive and negative effects. Taking all of that into account, we have a bit wider range in our SOC market size estimate for 2021 at $3.3 billion to $3.8 billion, up slightly from 2020 at the midpoint. 
In memory test, the transition to LPDDR5 and DDR5 should gain momentum in 2021 and beyond. After growing about 50% in 2020, we view the memory market to be in the $800 million to $1 billion range in 2021, about even with 2020 at the midpoint. In Storage Test, the underlying demand drivers of increased density in HDD and increased complexity in semi devices driving system-level test remain in place. However, visibility is limited and annual shipments can be very lumpy. After more than tripling over the last 3 years, we expect 2021 sales to be in a band of plus or minus 20% from the 2020 level. For the rest of our test businesses, we expect growth in the 5% to 10% range in 2021. 
In Industrial Automation, 2021 is starting off on a strong footing. Barring any additional COVID-related manufacturing sector shutdowns, we expect to deliver the highest ever first quarter sales in each of our automation businesses, and we are well positioned to grow in excess of 30% for the year.
2020's results reflect well on Teradyne's strategy, execution and efficiency. Our test businesses show the successful results of R&D bets made in years past and enable us to increase those bets for the future. Our Industrial Automation investments continue undeterred by short-term impacts of COVID, and we are well positioned to capitalize on a world emerging to invest even more in automation to improve resilience and productivity. 
Equally significant, 2020 showed the resilience of Teradyne employees, our global suppliers and our operating model. In the face of unimaginable challenges across communities worldwide, the team dealt with health, safety and operation obstacles daily, met R&D milestones, executed steep new product ramps and delivered record shipments of SOC, memory and storage tech products to meet our customers' needs. We did all this while exercising the cost and schedule discipline expected at Teradyne. This is truly extraordinary, and I am very grateful to be part of such a powerful team. 
As we move into 2021, the outlook appears bright across all our markets. As Sanjay will detail, we are returning to our share repurchase program and have an active M&A pipeline. As 2020 taught us, no matter what comes our way in the short term, I am confident our global team and market strategy will deliver exciting long-term returns for our customers, investors and employees. 
Sanjay will now take you through the financial and modeling details. Sanjay?"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Mark. Good morning, everyone. Today, I'll cover the financial highlights of Q4 and review the financial details of 2020. Looking forward, I'll provide our Q1 outlook, an update to our midterm earnings model and our capital allocation plans. N",1539,"Thank you, Mark. Good morning, everyone. Today, I'll cover the financial highlights of Q4 and review the financial details of 2020. Looking forward, I'll provide our Q1 outlook, an update to our midterm earnings model and our capital allocation plans. 
Now to Q4. Revenues were $759 million, which were $19 million above the high end of the guidance range. We delivered a non-GAAP operating profit of 30% and EPS of $1.10. Semi Test revenue of $524 million was driven by SOC and memory test demand, enabling 5G handsets and higher speed flash and DRAM devices. System Test group had revenue of $104 million, down quarter-over-quarter driven by lower storage test shipments. Industrial Automation, or IA, revenue of $92 million had a seasonal increase over Q3 and delivered year-over-year growth for the first time in 2020. LitePoint revenue of $40 million was approximately flat with Q3 and down year-over-year with a decline in trailing edge connectivity products, partially offset by new sales of new connectivity technology like WiFi 6 and emerging UWB technology. 
Non-GAAP gross margins were 59%, on plan and up quarter-over-quarter due to product mix. You'll see our non-GAAP operating expenses were up $14 million to $224 million from the third quarter due to increased test spending to support design wins, higher payroll due to 4 extra days in the quarter and ongoing IA investments. We generated $222 million in free cash in the fourth quarter. The tax rate, excluding discrete items for the quarter was 13% on a GAAP basis and 14.5% on a non-GAAP basis. For the full year, it is 14.75% on a GAAP basis and 15.25% on a non-GAAP basis. We ended the year with cash and marketable securities of $1.55 billion. 
Turning to the full year results of 2020. Teradyne revenues of $3.12 billion grew $826 million or 36% year-over-year. $845 million of the growth was from our test portfolio, while IA contracted $18 million due to the pandemic-related slowdown. We had 1 customer that accounted for more than 10% of our revenue in 2020, which we'll disclose in our 10-K filing. 
Gross margins for the year were 57% and operating profit was 30%, which is up from 25% in 2019. 
Non-GAAP EPS was $4.62, an increase of 62% over 2019. We generated $684 million in free cash in 2020. 
Breaking down the components of 2020 revenues. As outlined by Mark, SOC test revenues grew $595 million or 46% on strength in mobility, market-driven by increased by device complexity and new standards like 5G along with growing growth in computing. In memory, revenues were $383 million, up 41%. While LPDDR-related DRAM revenues were a significant contributor to our results, we also continue to see strong NAND test demand through the year. 
In System Test, sales grew for the fourth year running. Revenue of $410 million grew $122 million or 43% year-over-year, primarily on growth in Storage Test for both hard disk drive and system level test. Storage Test sales were $242 million, up from $115 million in 2019. We also saw annual growth in our Defense & Aerospace component of STG. 
At LitePoint, sales grew for the fourth consecutive year to $173 million, 10% above 2019. In 2020, IA revenue was $280 million, a decline of 6% from 2019 on an as-reported basis or 9% on a pro forma basis. As Mark noted, the COVID-related driven slowdown in manufacturing impacted Universal Robots, reducing revenue to $219 million, down 12% year-over-year. 
After troughing in Q2, UR grew in the second half of 2020 versus the first half of the year. In Q4, revenue grew 6% year-over-year, giving confidence heading into 2021. MiR grew slightly year-over-year with annual sales of $45 million, and AutoGuide full year's sales grew on a pro forma basis. 
Now to our outlook for Q1. Sales are expected to be between $720 million and $780 million. Non-GAAP EPS range of $0.95 to $1.11 on 175 -- 179 million diluted shares. The first quarter guidance excludes amortization of acquired intangibles and the noncash imputed interest on the convertible debt. First quarter gross margins are estimated at 58% to 59%. First quarter OpEx, running at 29% to 31% of first quarter sales, is about flat with Q4 at the midpoint of guidance. The non-GAAP operating profit rate at the midpoint of our first quarter guidance is 29%. 
Regarding our OpEx plans for 2021, we expect our OpEx to grow 8% to 10% from 2020's $840 million. Approximately 2 points of the spend will be in the back half of the year related to travel, which we expect to resume to pre-COVID levels along with trade shows. In our test portfolio, we plan to increase our spending in engineering, sales and marketing, primarily in Semi Test. In IA, we'll continue to invest to reinforce our competitive product and ecosystem position across the sector. Also in IA, go-to-market investments will be made to support expected revenue growth. 
Turning to capital expenditures. In 2020, our CapEx was $185 million. This was used primarily for customer demonstration equipment, operations, engineering and initial spending on new facilities to replace leased ones in locations where we plan to grow over the next several years. We'll continue to invest in these new facilities in 2021, so CapEx is expected to be similar to 2020. Recall, we are buying land and developing it to eliminate lease costs and enable a more efficient spend profile over the mid- to long-term. 
For 2021, our GAAP tax rate is estimated at 15.5% and our non-GAAP tax rate is estimated at 16% based on current tax laws. 
Moving to our midterm earnings model. As you've seen with 2020, our non-GAAP EPS of $4.62, we've exceeded our 2022 earnings model 2 years early on the strength of our test businesses. We continue to have confidence in the long-term growth outlook for test, and we expect IA to return to high growth as the global industrial economy improved. When building our midterm model, given our year-on-year demand swings, we've seen both in test and IA, we use the average of 2019 and 2020 revenues as the baseline for our growth projections. From that baseline, we expect test revenue to grow 4% to 8% compounded and IA revenues to grow 20% to 35% through 2024. 
In test, we expect that growth will be driven by steady increase in device complexity across our businesses along with the high single-digit semiconductor unit growth trend line. In IA, market penetration of cobots and autonomous mobile robots and forklifts remains low, while the range of applications they economically serve continues to expand, resulting in an attractive long-term growth opportunity for Teradyne. We expect this will drive 2024 company revenue to $3.9 billion and non-GAAP EPS to $6 at the midpoint of our estimates. 
Gross margin is modeled at 58% to 59%, OpEx as a percentage of sales will decline to 28% to 29% and non-GAAP operating margin will improve to 30% to 31%. The model assumes the current tax laws are in place. 
Shifting to capital allocation. We'll continue to balance a strong cash position to support our operating investments and potential M&A with direct shareholder returns through dividends and share repurchases. We are raising our minimum cash levels from $1 billion to $1.25 billion, with the $250 million increase tied to the increased valuations of potential acquisitions.
Recall, we held $500 million for M&A and $500 million for severe economic downturn. We will also be increasing our cash balance in 2021 through 2023 to service our convertible bond, which comes due in December 2023. To date, $51 million of that bond has been redeemed early with payment planned in Q1, with the remaining face value of $409 million. 
Regarding share repurchases. In 2020, we bought back $1.5 million -- sorry, 1.5 million shares for $88 million at an average price of $58.32. Recall, we suspended our share repurchase program in April due to COVID-related uncertainty. We are replacing our prior approved program with a new share repurchase authorization of $2 billion with no fixed end date. We plan a minimum of $600 million of repurchases in 2021. As in the past, the plan has both a programmatic and opportunistic components. 
In summary, 2020 inflicted incredible human and economic hardship on societies across the world, and we're respectful of the widespread pain and loss. When the pandemic hit, I noted our priorities were the safety of our employees, supporting our customers and continued execution in achieving our financial objectives. The Teradyne community responded with a collaborative and supportive spirit, incredible energy, ingenuity and purpose, which delivered on all 3 of these priorities. I'm incredibly proud and thankful to be part of this team. 
We enter 2021 in the strongest position in our history. The work in 2020 has made us more resilient and prepared us for the strong market demand that we currently see in both test and IA. While our visibility for the full year is limited, we're confident in the underlying market fundamentals, our competitive, diversified portfolio and our team, which will enable long-term growth prospects for the markets we serve. Collectively, we're excited to turn our new financial model into reality. 
With that, I'll turn things back to Andy."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Sanjay. Operator, we'd now like to take some questions. [Operator Instructions]",12,"Thanks, Sanjay. Operator, we'd now like to take some questions. [Operator Instructions]"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","[Operator Instructions] First question comes from Krish Sankar with Cowen.",10,"[Operator Instructions] First question comes from Krish Sankar with Cowen."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, I had two of them. First one, thanks for the color on calendar '21. I'm just kind of curious if you could peel the SOC Test market a little more to say, how much do you think mobility will be? And how much do you think Auto Test would be this year o",61,"Mark, I had two of them. First one, thanks for the color on calendar '21. I'm just kind of curious if you could peel the SOC Test market a little more to say, how much do you think mobility will be? And how much do you think Auto Test would be this year on SOC? And then I have a follow-up."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So good question. Certainly, auto is going to be up sequentially in 2020. We've talked about that market being at a normalized -- let's say, maybe more of a peak run rate in the $400 million to $500 million range. It's been down to sort of $200 milli",162,"Yes. So good question. Certainly, auto is going to be up sequentially in 2020. We've talked about that market being at a normalized -- let's say, maybe more of a peak run rate in the $400 million to $500 million range. It's been down to sort of $200 million last year. So this year, that should be up at least $150 million, maybe $200 million. It's really right now a bit of a rush for capacity. And we don't know exactly when the demand profile of the orders are going to taper off here. So it could go higher if this persists. So that's the color on auto. 
In mobility, I think it's harder for us to see that at the moment because of the significant impact of our largest customer on both us and the market, which doesn't really become solidified until April-ish of the year. So we're looking at it sort of flat, plus or minus $1 million in mobility."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Got it. That's very helpful, Mark. And then just as a follow-up on the IA side. You mentioned 30-plus-percent growth, should we assume a big driver of that is going to be UR? In other words, UR should be higher than 30%? Or do you think UR is goin",59,"Got it. Got it. That's very helpful, Mark. And then just as a follow-up on the IA side. You mentioned 30-plus-percent growth, should we assume a big driver of that is going to be UR? In other words, UR should be higher than 30%? Or do you think UR is going to be in line with Industrial Automation growth?"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that's a good question. I think all of the groups are going to be better than 30%. And some of them like AutoGuide are small. So I think they'll pull up the average, albeit ahead of UR. And MiR and UR should be about the same for the year.",52,"Yes. I think that's a good question. I think all of the groups are going to be better than 30%. And some of them like AutoGuide are small. So I think they'll pull up the average, albeit ahead of UR. And MiR and UR should be about the same for the year."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Mehdi Hosseini with SIG.",8,"Next question comes from Mehdi Hosseini with SIG."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","I just want to go back to your SOC commentary. I'm a little bit surprised with your kind of flattish outlook. And I say that because millimeter wave is expected to account for a larger mix of the 5G phones. And I believe last year was just the early inves",71,"I just want to go back to your SOC commentary. I'm a little bit surprised with your kind of flattish outlook. And I say that because millimeter wave is expected to account for a larger mix of the 5G phones. And I believe last year was just the early investment. So why isn't the increased penetration of millimeter wave phone not giving you that incremental confidence? And I have a follow-up."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that's certainly a balloon for the year, Mehdi. Maybe we're going to double the number of millimeter wave-enabled phones in 2021. But yes, last year, if you recall, there was also a significant step-up in the hundreds of millions of units of",143,"Yes. I think that's certainly a balloon for the year, Mehdi. Maybe we're going to double the number of millimeter wave-enabled phones in 2021. But yes, last year, if you recall, there was also a significant step-up in the hundreds of millions of units of millimeter wave-enabled phones were brought to market last year. So if you add another 200 million to 300 million additional millimeter wave-enabled units this year and, let's say, that brings the global total to 600 million units out of 1.4 billion, you're essentially adding about as much capacity, maybe a little bit more because there'll be more than -- let's say, last year, added 250 million, this year, might add 350 million units. So yes, there will be a little bit of growth in additional millimeter wave test capacity. But last year was a pretty big year, too."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And then looking at the midterm model 2024. What are the key underlying assumption for market share, especially as you try to capitalize on the synergies between Semi and a System Test? And in that context, are you accounting for any incremental s",51,"Got it. And then looking at the midterm model 2024. What are the key underlying assumption for market share, especially as you try to capitalize on the synergies between Semi and a System Test? And in that context, are you accounting for any incremental share shift in the GPU end market?"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Mehdi, it's Sanjay. Yes. So in the earnings model, we see, obviously, growth in the market. As Mark alluded to, more players are coming into the compute space that we can address. And with that, we feel that with the UltraFLEXplus solution, we're ver",110,"Yes. Mehdi, it's Sanjay. Yes. So in the earnings model, we see, obviously, growth in the market. As Mark alluded to, more players are coming into the compute space that we can address. And with that, we feel that with the UltraFLEXplus solution, we're very well positioned, and we are projecting share growth. When we think about from a memory perspective, if you go back, let's say, 10 years, we've been on this steady increase of memory share growth, where as we continue to execute, we see continued share growth on that perspective as well. So really, growth in market size as well as continued share growth are our drivers."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","That includes the synergy between different sectors or segments?",9,"That includes the synergy between different sectors or segments?"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","You want to expand on that question?",7,"You want to expand on that question?"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Yes. Just going back to the question. I see opportunities between your Semi and a System Test, especially as the system-level test diversifies. And I'm just wondering if that's baked into your 2024 model?",34,"Yes. Just going back to the question. I see opportunities between your Semi and a System Test, especially as the system-level test diversifies. And I'm just wondering if that's baked into your 2024 model?"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Okay. Thanks for the clarification. Yes, it is. With device complexity, we were going 5-nanometer and then to 3-nanometer, I think both system-level test as well as ATE test take that into account.",34,"Yes. Okay. Thanks for the clarification. Yes, it is. With device complexity, we were going 5-nanometer and then to 3-nanometer, I think both system-level test as well as ATE test take that into account."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Toshiya Hari with Goldman Sachs.",9,"Next question comes from Toshiya Hari with Goldman Sachs."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, I wanted to ask about your largest customer. I appreciate things will remain pretty fuzzy or opaque, as you said, until sort of the April-ish time frame. But can you sort of walk us through the potential range of outcomes you're thinking internally?",89,"Mark, I wanted to ask about your largest customer. I appreciate things will remain pretty fuzzy or opaque, as you said, until sort of the April-ish time frame. But can you sort of walk us through the potential range of outcomes you're thinking internally? Obviously, you've got units, you've got transistor density as it relates to the new chip. Also curious if their efforts on the notebook side of their business, in-sourcing CPUs, could have an impact on your business as well? And then I've got a quick follow-up."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Okay. I always -- I'm a bit reluctant to be too specific on any 1 customer. So I'm going to speak more to the segment a bit, which I'll bundle compute and mobility together here. So yes, last year was incredibly strong in both our traditional mobility mar",212,"Okay. I always -- I'm a bit reluctant to be too specific on any 1 customer. So I'm going to speak more to the segment a bit, which I'll bundle compute and mobility together here. So yes, last year was incredibly strong in both our traditional mobility market because of the complexity growth of phones, which we alluded to and the fact that we did enter compute as a new segment. So we ended up with additional revenues in compute last year, that north of $50 million for the first year in that market.
So as we think about this year, the issue of smartphone unit growth and complexity growth of the apps processor, the camera systems and such in the phones is part of the equation. And we have a reasonably good read on that. 
On the compute side, there's a lot of moving parts there. And there's a lot -- since it's a new market for us and a new market for some of our customers, that has the bigger range of potential outcomes for the year. So that's the one we're triangulating on. That could be up significantly over last year. It could be up modestly over last year. But at this point, we really can't be too specific."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And then as a quick follow-up. On Industrial Automation, I wanted to ask about the profit margin profile of the business, where does it stand today, I guess, as of 2020? You guys have done a great job in improving gross margin at UR and the other",88,"Got it. And then as a quick follow-up. On Industrial Automation, I wanted to ask about the profit margin profile of the business, where does it stand today, I guess, as of 2020? You guys have done a great job in improving gross margin at UR and the other businesses that you've acquired over the past couple of years. At the same time, you've been aggressively spending from an OpEx perspective. So in your 2024 model, what sort of margin profile for IA is embedded in your numbers?"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","It's Sanjay. So IA as a whole this year was roughly just a bit better than breakeven. Obviously, with the COVID impact on multiple businesses and the contraction in UR, we're just above breakeven. But fundamentally, we continue to invest in the portfolio,",128,"It's Sanjay. So IA as a whole this year was roughly just a bit better than breakeven. Obviously, with the COVID impact on multiple businesses and the contraction in UR, we're just above breakeven. But fundamentally, we continue to invest in the portfolio, the ecosystem, the go-to-market for product and differentiation, ease of implementation. And so you should expect that to continue over the midterm, and we're focused on driving the revenue growth and the investments. 
And so with that, we expect the margin profile to be roughly consistent with the current profile as we -- as AutoGuide is relatively new to the organization, just over a year, we expect that to improve with our Teradyne supply chain as well as other quality processes we step in."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Just one thing I'm going to add on to that commentary around the Industrial Automation business to remind people that what we focus on right now during the high growth phase of that business is sales growth and gross margin. And the bottom line, as Sanjay",147,"Just one thing I'm going to add on to that commentary around the Industrial Automation business to remind people that what we focus on right now during the high growth phase of that business is sales growth and gross margin. And the bottom line, as Sanjay mentioned, if we're at breakeven, we're happy as long as we can sort of adhere to or exceed the rule of 40. And through the midterm, we think we expect to be close to that kind of up top line growth rates. And what we bring down to the bottom line will kind of depend on the size of the growth, what we see ahead of us. And if we're growing at 50% and breakeven, we are happy as clams. And if the growth rates come down below 20%, we'll start dropping more and more down to the bottom line."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Joe Moore with Morgan Stanley.",9,"Next question comes from Joe Moore with Morgan Stanley."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Following on the last question. Can you just characterize the tone of business for the Universal Robotics business? And I guess in the context of -- it feels like a lot of the business activity in the last 12 months is business continuity and supply chain",101,"Following on the last question. Can you just characterize the tone of business for the Universal Robotics business? And I guess in the context of -- it feels like a lot of the business activity in the last 12 months is business continuity and supply chain disruption, maybe that's negative for new technologies and manufacturing. At the same time, I would think social distancing and stuff like that as an opportunity for you. So just kind of characterize those puts and takes, and just what that tells you about what the trends may look like over the course of this year."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Sure. It's Sanjay here. So in the short run, we actually saw a contraction as evidenced by how our revenues were. However, I think your comments hit home with regards to plant and warehouse decision-makers seeking to build resilience into their suppl",89,"Yes. Sure. It's Sanjay here. So in the short run, we actually saw a contraction as evidenced by how our revenues were. However, I think your comments hit home with regards to plant and warehouse decision-makers seeking to build resilience into their supply chains. And we view that over the midterm as a tailwind. We are seeing the market obviously come back with Universal Robots. We've talked in our prepared remarks about the automotive and electronics industry. And then we're also seeing strength in a couple of other verticals."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from C.J. Muse with Evercore.",9,"Next question comes from C.J. Muse with Evercore."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","I wanted to follow-up on Mehdi's question regarding your 2024 model. So if I look at your implied Semi Test revenues versus 2020 actual, you're up about $250 million to $350 million, which seems conservative, particularly when you reflect on what you're d",86,"I wanted to follow-up on Mehdi's question regarding your 2024 model. So if I look at your implied Semi Test revenues versus 2020 actual, you're up about $250 million to $350 million, which seems conservative, particularly when you reflect on what you're doing with system-level test, new UltraFLEXplus. So can you, I guess, walk through what assumptions you're making in terms of market share for both SOC and memory implied in that number? And where you might point to as areas that might be conservative?"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that as I articulated from -- I'll touch on memory first. Our share right now is in the low 40s. We see that -- we could see that growing to the mid-40s in the plan. And then from an SOC perspective, Mark talked about on a normalized share le",63,"Yes. I think that as I articulated from -- I'll touch on memory first. Our share right now is in the low 40s. We see that -- we could see that growing to the mid-40s in the plan. And then from an SOC perspective, Mark talked about on a normalized share level of about 50%. And we see that increasing over the midterm."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","But within the implied model, are you assuming the 50% or the 60% that Mark spoke about back in July as to what a goal could look like?",28,"But within the implied model, are you assuming the 50% or the 60% that Mark spoke about back in July as to what a goal could look like?"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","So yes, I think what we've been saying, C.J., is that we can get about 1 point to 1.5 points a share growth a year. So by 2024, as I mentioned, I think our normalized share is somewhere around 50%. We should be up around 55%, 56% by then in SOC.And in m",188,"So yes, I think what we've been saying, C.J., is that we can get about 1 point to 1.5 points a share growth a year. So by 2024, as I mentioned, I think our normalized share is somewhere around 50%. We should be up around 55%, 56% by then in SOC.
And in memory, share was a little chunkier because there's only a few players there. So on the memory side, we could be in the mid to upper mid-40s by then, I would say, is one way to think about it.
But the other piece of color in terms of aggressive versus conservative that I'd add here is the recent investment profile of the front end with CapEx moving up into the $70 billion range, it's something we haven't modeled into our midterm plan. We've assumed that incremental fab capacity across the midterm would be sort of consistent with the rate that it's been added for the prior 4 years. So if $70-plus billion of investment in WFE is the new normal for the next 4 years, that's certainly going to drive more tests than we modeled."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Very helpful. As my follow-up, can you speak to what we should be thinking about for SOC Test gross margins here in '21 versus 2020? Trying to get a sense of what uplift might look like, particularly from Eagle Test.",40,"Very helpful. As my follow-up, can you speak to what we should be thinking about for SOC Test gross margins here in '21 versus 2020? Trying to get a sense of what uplift might look like, particularly from Eagle Test."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","I mean gross margins, we -- you should expect a relatively consistent with how we've guided Q1 and in our long-term model.",22,"I mean gross margins, we -- you should expect a relatively consistent with how we've guided Q1 and in our long-term model."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Brian Chin with Stifel.",8,"Next question comes from Brian Chin with Stifel."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Maybe the first question, back on the topic of Industrial Automation. Automotive has historically been a key portion of sales here. And I was curious, do you expect or even need the other portion of your sales to grow 30% year-over-year, given sort of the",55,"Maybe the first question, back on the topic of Industrial Automation. Automotive has historically been a key portion of sales here. And I was curious, do you expect or even need the other portion of your sales to grow 30% year-over-year, given sort of the increasing breadth of market adoption that you might be seeing?"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that with an emerging market, there's still a lot of footprint to cover, so we expect that to continue in the automotive vertical as well as electronics and industrials as well as other verticals.",37,"Yes. I think that with an emerging market, there's still a lot of footprint to cover, so we expect that to continue in the automotive vertical as well as electronics and industrials as well as other verticals."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Yes, I was just sort of get -- trying to gauge whether you're seeing a lot of adoption outside of auto? And is it -- in terms of visibility, you're starting the year with pretty good visibility. Is auto kind of starting from a similar point? Or is i",78,"Okay. Yes, I was just sort of get -- trying to gauge whether you're seeing a lot of adoption outside of auto? And is it -- in terms of visibility, you're starting the year with pretty good visibility. Is auto kind of starting from a similar point? Or is it kind of more -- a little bit more on the whole to start the year, and you're going to expect a bigger snap back later in the year?"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. We're seeing also -- we're seeing market drivers in our verticals, adoption and education. R&D, pharma as well as life sciences. But from a starting point, obviously, we have a very strong incumbent installed base over the years that we've built in t",46,"Yes. We're seeing also -- we're seeing market drivers in our verticals, adoption and education. R&D, pharma as well as life sciences. But from a starting point, obviously, we have a very strong incumbent installed base over the years that we've built in the auto vertical."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","And I'd just add to that, that certainly, automotive was one of the most hard hit aspects of UR's business. Automotive has been running in the high 30s, 40% of the business coming into 2020. That contracted dramatically because of COVID, down to the point",171,"And I'd just add to that, that certainly, automotive was one of the most hard hit aspects of UR's business. Automotive has been running in the high 30s, 40% of the business coming into 2020. That contracted dramatically because of COVID, down to the point that it was in the low 20s. And I would say it's certainly, at this point, although back and growing, it hasn't come back yet to where it should be in our portfolio. This has issues around the semiconductor supply chain and other things have sort of crimped some of the ambitions of car companies to ramp volumes here. There's a little bit to go still.
But our footprint over time, since we acquired UR has been reducing in the automotive segment, not so much because automotive is not growing, of course, but it's just that our expansion into the other areas that Sanjay mentioned has been. And we expect over time that automotive component will continue to decline as a percentage of our sales."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Great. Yes. I was sort of getting maybe at that. And then in the 2024 model, grant it's 4 years out, but can you give us sort of a rough sense of how much of the IA sales might be AMR or mobile vehicle driven? I think the split roughly is kind of 80% UR,",73,"Great. Yes. I was sort of getting maybe at that. And then in the 2024 model, grant it's 4 years out, but can you give us sort of a rough sense of how much of the IA sales might be AMR or mobile vehicle driven? I think the split roughly is kind of 80% UR, 20% mobile at the moment. Could that be sort of like a 2/3, 1/3 in that time frame?"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that, obviously, UR, we've had for a little bit longer, and it is a larger percentage. But I think you're spot on that the AMR portion will grow with AutoGuide and MiR as a percentage of revenue.",40,"Yes. I think that, obviously, UR, we've had for a little bit longer, and it is a larger percentage. But I think you're spot on that the AMR portion will grow with AutoGuide and MiR as a percentage of revenue."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Atif Malik with Citi.",8,"Next question comes from Atif Malik with Citi."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Good job on results and guide. Mark, the first one, following up on the last question, AutoGuide, how is adoption going at larger enterprises and warehouse customers? And then I have a follow-up.",33,"Good job on results and guide. Mark, the first one, following up on the last question, AutoGuide, how is adoption going at larger enterprises and warehouse customers? And then I have a follow-up."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Good question. So to be frank with you, we had a good year. We grew 50-ish-percent in the year, but we didn't hit our target. And part of this is extended evaluations at the large accounts that you're referencing. And it's been very difficult in a sm",196,"Yes. Good question. So to be frank with you, we had a good year. We grew 50-ish-percent in the year, but we didn't hit our target. And part of this is extended evaluations at the large accounts that you're referencing. And it's been very difficult in a small business like AutoGuide's case in a COVID area to acquire new customers and get the pilot production validation work done in the same time frame that we could have gotten it done in a non-COVID world.
So we've seen some extension of those evals, but we're in some of the boutique name brands for evals that you would hope we are in, in both the industrial manufacturing side as well as the e-commerce side and logistics side of life.
So we're hoping that this year is going to be the big breakout year. It's the kind of business that should at least be doubling, if not more, once these big accounts latch. But we did -- if any place sort of had a big impact from COVID last year, it was AutoGuide because of the whole -- new customer acquisition is the whole game there at this point."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Great. And as a follow-up, you mentioned the China SOC Test to be down this year, which makes sense given the restrictions from last year, but some of the front end peers have talked about maybe flattish China investments on the front end and back end is",75,"Great. And as a follow-up, you mentioned the China SOC Test to be down this year, which makes sense given the restrictions from last year, but some of the front end peers have talked about maybe flattish China investments on the front end and back end is different. Can you just walk us through the components on where China investments are down? And why you aren't benefiting on some of the mature technologies and nodes?"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So if you look at China, I think you need to separate memory and SOC because it's quite different. On the memory side, there will be growth in China this year in test as well and we -- or we expect that at least. And so that's a healthy, growing midt",170,"Yes. So if you look at China, I think you need to separate memory and SOC because it's quite different. On the memory side, there will be growth in China this year in test as well and we -- or we expect that at least. And so that's a healthy, growing midterm profile, I'd say, for China. 
On SOC, it's really a little bit more difficult to see growth occurring this year because the impact of the trade restrictions on Huawei and HiSilicon are tremendous in terms of their buying power in the market historically. What they buy in both silicon and then test capacity for that silicon has been severely hampered. And then further restrictions on other companies like SMIC and such are much smaller factors, but tail or headwinds against growth.
So I think SOC is likely to contract. Memory is going to grow. But net-net, it's not going to be hugely down, but it will probably be down a little bit on the test side of life."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Vivek Arya with Bank of America.",10,"Next question comes from Vivek Arya with Bank of America."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","I had two, one on operating leverage and the second on M&A. On operating leverage, Sanjay, I believe you mentioned OpEx growth of 8% to 10% this year. Do you think there is a potential to still drive leverage with that kind of growth? And then when I look",110,"I had two, one on operating leverage and the second on M&A. On operating leverage, Sanjay, I believe you mentioned OpEx growth of 8% to 10% this year. Do you think there is a potential to still drive leverage with that kind of growth? And then when I look at your 2024 model, you're keeping operating margins at about 30%, 31%, kind of where you are already, even though sales are expected to grow, and Mark had outlined a number of interesting growth drivers. So I was hoping you could talk to operating leverage this year, and then what would be the drivers as you look at your '24 model?"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Okay. Sure. Yes. So obviously, it's another -- it's an investment year. And I think in my prepared remarks, I noted that we're getting back to travel and trade shows, which is a key point. You really -- if you look at it in 2 portfolios, we -- for the yea",188,"Okay. Sure. Yes. So obviously, it's another -- it's an investment year. And I think in my prepared remarks, I noted that we're getting back to travel and trade shows, which is a key point. You really -- if you look at it in 2 portfolios, we -- for the year, we're going to have leverage in the test business, where the growth in OpEx as a percentage will be lower, but the growth in the IA space, the OpEx growth is higher. And so the leverage from a -- like we're growing in the IA space, but we will see -- we should see a degree of leverage in the short-term in the test business.
When you cascade that out to 2024, obviously, with the revenues that we're predicting in IA, I think Mark described it well. If we're growing at 50% and have a forecast to continue to grow, we'll continue to drive the investment. But as the growth starts to go down, let's say, below the rule of 40, then we'll start to drop more to the bottom line. That's how we're thinking about it."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","But when I look at that '24 model, right, you're forecasting overall sales to grow at a 6% CAGR from the 2020 level. So that is below the 16% CAGR you have been at. And you're saying operating margins are going to stay pretty much flattish versus -- I'm j",105,"But when I look at that '24 model, right, you're forecasting overall sales to grow at a 6% CAGR from the 2020 level. So that is below the 16% CAGR you have been at. And you're saying operating margins are going to stay pretty much flattish versus -- I'm just puzzled as to if you're saying sales are not really going to grow as much as they have grown in the last 3, 4 years and operating margins are not going to expand from here, is that model very conservative? Or what needs to be done to either grow faster or drive more operating leverage?"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that -- well -- and that's why in my prepared remarks, I comment, we looked at the model, not just off of a point of 2020, but off of an average of '19 and '20, just given the significant balloon in 2020 tied to the mobility space and then th",100,"Yes. I think that -- well -- and that's why in my prepared remarks, I comment, we looked at the model, not just off of a point of 2020, but off of an average of '19 and '20, just given the significant balloon in 2020 tied to the mobility space and then the contraction in IA. And when you look at it from an average of '19 and '20, we believe in that growth -- overall growth of the 4% to 8%. And then we are, during that period, going to be growing out the investments in the IA portfolio."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","And I would just say, if you go back to what we said, if you look at that pie chart of the mix. When we get out to 2024, IA should be a bigger mix of our revenue than test. So test will continue to grow. It will have a very high drop-through. It will be v",161,"And I would just say, if you go back to what we said, if you look at that pie chart of the mix. When we get out to 2024, IA should be a bigger mix of our revenue than test. So test will continue to grow. It will have a very high drop-through. It will be very efficient. And if that's all you're looking at, yes, bottom line profitability should increase.
But on the IA side, it's more likely that we'll be growing more rapidly, and we'll be pulling up gross margins for the enterprise with the IA business. But on the bottom line, we're being a bit conservative on how much we plan to drop-through there because we want to keep investing for more and more growth. So it kind of just depends on what's the investment profile in IA. And we've modeled in -- we're not going to optimize for profit in the midterm there, we're optimizing for growth."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Understand. And Mark, just a follow-up to that. You mentioned the prospects for some additional M&A. I presume it's in the IA side of the business, but I was hoping you would talk to that. Do you -- are you contemplating kind of smaller tuck-in technology",88,"Understand. And Mark, just a follow-up to that. You mentioned the prospects for some additional M&A. I presume it's in the IA side of the business, but I was hoping you would talk to that. Do you -- are you contemplating kind of smaller tuck-in technology type transactions? Are you thinking about something that could be bigger and could require the use of stock, just how we should think about what M&A pipeline is and how it could impact this baseline model that you have set for us?"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So most of what we have in our pipeline is consistent with the kind of things we've been investing in and acquiring in the past 5 to 6 years, Industrial Automation, modestly sized investments, let's say, relative to our market cap. However, we have e",135,"Yes. So most of what we have in our pipeline is consistent with the kind of things we've been investing in and acquiring in the past 5 to 6 years, Industrial Automation, modestly sized investments, let's say, relative to our market cap. However, we have expanded our aperture a bit to look in the test space and areas that are correlated to test, which bring with it potentially some larger M&A things. It's always governed by the same rich internal rate of return metrics that we always use on these things.
So whatever we do is going to be something that's more attractive to the -- our investors than buying back our stock or those kind of -- our internal weighted cost of capital. So that's about all I think I can say about that."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Timothy Arcuri with UBS.",8,"Next question comes from Timothy Arcuri with UBS."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","I had a couple. So for OpEx this year, you're saying it's going to grow about 8% to 10%. So at the midpoint, you're going to grow OpEx about $76 million. I'm wondering, Sanjay, if you can tell us how much of that's going to come in IA? And I guess another",139,"I had a couple. So for OpEx this year, you're saying it's going to grow about 8% to 10%. So at the midpoint, you're going to grow OpEx about $76 million. I'm wondering, Sanjay, if you can tell us how much of that's going to come in IA? And I guess another way of asking that is sort of what sort of op margin do you think you can do this year in IA? I mean you were basically breakeven last year. Can you get to high single digits this year? And is 10% to 15% still the long-term target for that business? I know that Mark's commenting that if growth slows, you can sort of crank back on OpEx and you can drop more. But just wondering if you can comment there. And then I had a follow-up."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Sure. Yes. I think it's spot on. I think when you take out the travel and the trade shows, the majority of the spend will come in OpEx from -- on a year-over-year basis. And from a profit perspective, we're assuming growth, and we expect to improve back t",92,"Sure. Yes. I think it's spot on. I think when you take out the travel and the trade shows, the majority of the spend will come in OpEx from -- on a year-over-year basis. And from a profit perspective, we're assuming growth, and we expect to improve back to our original growth plans. Like if you think about 2020 as the anomaly and you look at the jump-off point of 2019, we were about a 10% profit level. With our growth, we should be in that similar level going forward in 2021."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Got it. So you think you can get to 10% op margin this year?",15,"Okay. Got it. So you think you can get to 10% op margin this year?"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes, plus or minus, but yes.",6,"Yes, plus or minus, but yes."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Okay. Great. And then, I guess, a question for you, Mark. So when you were going to your top customer, you presented a couple of scenarios. I know it's very tough to predict. But the scenarios you presented didn't include that revenue from that cust",182,"Okay. Okay. Great. And then, I guess, a question for you, Mark. So when you were going to your top customer, you presented a couple of scenarios. I know it's very tough to predict. But the scenarios you presented didn't include that revenue from that customer is down. I get that the compute piece is going to be up, but they're also not going to shrink this year. And in the past, that's been sort of a harbinger of a potential decline in the number of testers they buy unless they're willing to live with a much larger dye size, which may or may not be the case. So I'm just kind of wondering -- I'm not asking for any specifics on that customer. I'm just sort of wondering if you can look back in the past and draw in your past experience and say, well, yes, in the past, when that happens, that is sort of a harbinger of the potential that it could be down because you didn't present that as a down or as a possible outcome this year?"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think it's a possible outcome, but let me go back to what I was outlining in my remarks. When you look at the phone, there's various elements of the phone in terms of technology, depths processors, the modem, the cameras, the memory, those areas of",198,"Yes. I think it's a possible outcome, but let me go back to what I was outlining in my remarks. When you look at the phone, there's various elements of the phone in terms of technology, depths processors, the modem, the cameras, the memory, those areas of the phone refresh and take leaps of complexity in different cadences. And in 2020, the apps processor and 5G -- basically, the apps processor had a big jump in complexity, and 5G proliferated throughout all the phones.
So as you look at 2021, the need for incremental 5G capacity, whereas in 2020, several, let's say, 100 million units worth of phones needed 5G capacity. This year, it will be less because the incremental unit growth there is one factor in incremental 5G capacity plus complexity growth of the 5G modem itself. So 5G is big in 2020, not as big in 2021. 
That leaves what's happening with the cameras, what's happening with power management, what's happening with the screen resolution. Other things could be balloons that pull it back up. But I do think you do have that -- 5G has happened for that one area of our mobility customer base."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","And operator, we have time for just one more question, please.",11,"And operator, we have time for just one more question, please."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Last question comes from John Pitzer with Crdit Suisse.",9,"Last question comes from John Pitzer with Crdit Suisse."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, my first question is just on the whole China dynamic. You're clearly guiding it to be down this year. I'm kind of curious if there is a date on between U.S.-China relations, is that a zero-sum game, an exercise in market shift? Or do you think it wo",111,"Mark, my first question is just on the whole China dynamic. You're clearly guiding it to be down this year. I'm kind of curious if there is a date on between U.S.-China relations, is that a zero-sum game, an exercise in market shift? Or do you think it would be accretive? And I guess more importantly, we're now seeing the U.S. government kind of incentivize domestic production of semis. I'm just kind of curious as to whether or not you could benefit from that, either indirectly as some of your customers build capacity domestically, or directly as we think about your long-term tax rate? And then I've got a quick follow-up."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Okay. So China. If for some reason, the restrictions on China ease and more indigenous Chinese makers start to grow again, I think it's neutral. As business shifted out of China in 2020, it was pretty much neutral to us. There was -- the customers that pi",219,"Okay. So China. If for some reason, the restrictions on China ease and more indigenous Chinese makers start to grow again, I think it's neutral. As business shifted out of China in 2020, it was pretty much neutral to us. There was -- the customers that picked up the manufacturing of, let's say, applications processors or modems that would have been done by indigenous Chinese suppliers or Teradyne customers and Advantest customers and a proportion that isn't that different than it was in China. So as it ebbs and flows back and forth, I wouldn't say there's a big ramification. 
On the U.S. domestic supply question, I think it's going to take a long time and many, many years of a steadfast set of incentives from the government for that to mature to something significant to our business.
If we stick at that in the U.S. for 7, 8 years and really build up an infrastructure to manufacture semiconductors domestically, I think it could have a bit of a positive impact, but I think it's small. I don't think because semiconductors might be manufactured in the U.S., all of a sudden, there's a propensity that they're going to buy more Teradyne equipment. It's at the margin, but nothing I would bake in as a trend line to count on."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","That's helpful. And then just as my follow-up, going back to the 2024 model. Your explanation as to kind of how you're getting to the op profit targets you're getting to. It makes a ton of sense.I'm just kind of curious, to the extent that the top line",97,"That's helpful. And then just as my follow-up, going back to the 2024 model. Your explanation as to kind of how you're getting to the op profit targets you're getting to. It makes a ton of sense.
I'm just kind of curious, to the extent that the top line proves to be conservative, how should we think about incremental operating margins above sort of the high end of the target model? Or maybe another way of thinking about it, as IA gets scale, where do we think the longer-term op margin of the business can go?"
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that if the test business -- if what drives the incremental revenue, if the test businesses come to fruition, I think you'll see a higher drop-through. If and again, just to repeat myself, if we're growing and we see continued growth, and we'",124,"Yes. I think that if the test business -- if what drives the incremental revenue, if the test businesses come to fruition, I think you'll see a higher drop-through. If and again, just to repeat myself, if we're growing and we see continued growth, and we're going to continue to invest in IA, that drop-through may be lower. But let's say, it comes -- let's say, the revenues grow significantly over the first couple of years. And then at the end, they start to -- the growth starts to tail down, you may see a little bit more leverage. But it's really -- we have to see how the market unfolds in IA. But over the short term, we are planning a significant investment."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","All right, folks. That wraps us up for today. Look forward to talking to you in the days ahead. And those that are still in the queue, I'll get back to you straight away. Thanks so much.",37,"All right, folks. That wraps us up for today. Look forward to talking to you in the days ahead. And those that are still in the queue, I'll get back to you straight away. Thanks so much."
94728,701302321,2183960,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","This concludes today's conference call. You may now disconnect.",10,"This concludes today's conference call. You may now disconnect."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Ladies and gentlemen, thank you for standing by, and welcome to the Q4 of 2020 Teradyne, Inc. Earnings Conference Call. [Operator Instructions]I would now like to hand the conference over to Mr. Andy Blanchard, Vice President of Investor Relations. Plea",44,"Ladies and gentlemen, thank you for standing by, and welcome to the Q4 of 2020 Teradyne, Inc. Earnings Conference Call. [Operator Instructions]
I would now like to hand the conference over to Mr. Andy Blanchard, Vice President of Investor Relations. Please go ahead, sir."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Sharon. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined for our discussion this morning by Teradyne's CEO, Mark Jagiela; and CFO, Sanjay Mehta. Following our opening remarks, we'll p",303,"Thank you, Sharon. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined for our discussion this morning by Teradyne's CEO, Mark Jagiela; and CFO, Sanjay Mehta. Following our opening remarks, we'll provide details of our performance for 2020's fourth quarter and full year, along with our outlook for the first quarter of 2021.
The press release containing our results was issued last evening. We are providing slides on the Investor page of the website that may be helpful to you in following the discussion. Replays of this call will be available via the same page after the call ends. The matters that we discuss today will include forward-looking statements that involve risk factors that could cause Teradyne's results to differ materially from management's current expectations. We encourage you to review the safe harbor statement contained in the earnings release as well as our most recent SEC filings. 
Additionally, those forward-looking statements are made as of today, and we take no obligation to update them as a result of developments occurring after this call. 
During today's call, we'll make reference to non-GAAP financial measures. We posted additional information concerning these non-GAAP financial measures, including reconciliation to the most directly comparable GAAP financial measure, where available, on the Investor page of our website. Looking ahead between now and our next earnings call, Teradyne will be participating in technology or industrial-focused investor conferences hosted by Goldman Sachs, Citi and Susquehanna. 
Now let's get on with the rest of the agenda. First, Mark will comment on our recent results and the market conditions as we enter the new year. Sanjay will then offer more details on our results along with our guidance for the first quarter. We'll then answer your questions, and this call is scheduled for 1 hour. Mark?"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Good morning, and thanks for joining us. In our call today, I'll summarize our Q4 and 2020 full year highlights and provide some initial comments on our outlook for 2021. Sanjay will then provide the financial details, Q1 outlook and review our updated ea",1522,"Good morning, and thanks for joining us. In our call today, I'll summarize our Q4 and 2020 full year highlights and provide some initial comments on our outlook for 2021. Sanjay will then provide the financial details, Q1 outlook and review our updated earnings model and capital allocation plans. 
Fourth quarter capped off an amazing year for Teradyne, with sales up 16% from the fourth quarter of 2019 and non-GAAP earnings per share up 25%. That brought our full year sales to just over $3.1 billion, up 36% and non-GAAP EPS to $4.62, up 62% versus 2019. These annual results, driven by strength in all of our test businesses more than made up for a soft industrial automation market that was impacted by COVID.
For the full year, our Semi Test business was especially strong, driven by investments in smartphone-related test capacity, our expansion into the compute sector of SOC with our new UltraFLEXplus product and the ramp of our Magnum EPIC product for DRAM test. 
In smartphones, global unit shipments contracted in 2020, but the growth in chipset complexity continued driving tester demand higher. Each subsystem on the phone, cellular power management, connectivity, display, cameras and application processing has its own cycle. And in 2020, both the processor and the cellular areas took big steps up in complexity. We use transistor count as a proxy for complexity, and the leading phone applications processors now exceed 10 billion transistors, growing double digits each generation. 
In 2020, we also saw the beginning of meaningful 5G silicon content, which necessitated a build-out of new tester capacity. Together, these lifted the mobility test market in 2020, roughly $200 million to about $1.7 billion. This continuous refresh of smartphone silicon should be a tailwind for the semiconductor test business for the foreseeable future. 
In 2020, we also ramped our UltraFLEXplus product in the compute portion of the SOC market. Recall, this has historically been a $500 million to $600 million market, where we've had relatively low share. With the emergence of more players and applications in the processor market, including hyperscalers and AI, we expect this sector to outgrow the general market. The plus brings a powerful value proposition in managing the unique complexity, power dynamics, yield learning and time-to-market requirements of this segment. 
For 2020, we estimate the SOC market was in the range of $3.4 billion to $3.5 billion, up from about $3.3 billion in 2019. We estimate our SOC test market share moved up 15 points to about 54%. However, our internal view of share smooths out year-on-year swings due to the unique timing of investment cycles of both our and our competitors' customers. By that measure, we estimate our normalized 2020 SOC share at about 50%. 
Another notable growth segment of our Semi Test business in 2020 was memory. In this call, a year ago, we noted a significant design win for our Magnum EPIC product in the LPDDR5 portion of the DRAM market. This new entry into DRAM test ramped through the year and combined with healthy growth in our traditional NAND business, drove a 41% increase in memory sales from 2019. We estimate the market was about $900 million in 2020, up from $600 million in 2019 and our normalized 2020 memory share at about 42%.
Beyond Semi Test, our System Test group also had a great year delivering 43% growth, with the Storage Test business more than doubling from 2019. This is the second consecutive year of hyper growth in Storage Test driven by steady test intensity growth of terabyte HDD drives and similar growth in the system level test of complex semiconductor devices. 
In our Wireless Test business at LitePoint sales grew 10% from 2019, with solid demand for both our connectivity and cellular end markets. WiFi 6, ultra-wideband test and increased investments in 5G-related handset tests all contributed. 
The performance of our test businesses more than offset the weaker results in our industrial automation business, which contracted 6% for the year. The global slowdown in manufacturing activity led to a 12% decline in sales at our Universal Robots unit. MiR, on the other hand, grew 1% as makers of ultraviolet disinfecting products recognize the value of an easier to deploy fully autonomous mobile robot. 
On a pro forma basis, AutoGuide also grew for the year. While the environment in IA was weaker than expected, the business troughed in the second quarter of 2020 and has improved dramatically in the second half, including record sales at UR in the fourth quarter. Collectively, the businesses returned to year-over-year growth in Q4, with UR growing 6% year-over-year and 41% sequential growth. With test slowing -- with test showing continued strength and industrial automation returning to growth, we are set up for another exciting year in 2021. Specifically, we are expecting a strong start to the year across all our businesses, with Q1 showing greater than 6% growth at the midpoint compared to Q1 of '19 -- sorry, Q1 of '20. 
As you know, full year visibility is always a challenge, as evidenced by our missing the strength of the test market and the decline of the IA market in our forecast just 1 year ago. That said, let me describe how we see things today, and of course, we'll keep you updated in future calls. I will preface my remarks with a note that the well-publicized surge in the forecasted semiconductor CapEx in 2021 is a very bullish sign. However, the impact on test is likely to be felt in 2022 and beyond as fab capacity built this year will drive additional testers in future years aligned to fab commissioning and ramping volumes and yields. 
In SOC test, the dynamics that made 2020 such a strong year continue into 2021. In addition, we have strengthening demand in the long dormant automotive test market with orders for our Eagle Test product line surging. Smartphone shipments are expected to grow in 2021 after contracting about 10% in 2020, and 5G content should increase. On the other hand, the SOC test market in China will likely be down in 2021 due to the expanded and full year effects of trade restrictions that were widened in 2020. Also, as always, tester demand from our largest customer will remain opaque until sometime in Q2.
Additionally, the global economic impact of COVID and its impact on electronics demand after a surge in 2020, it's hard to forecast with arguments for both positive and negative effects. Taking all of that into account, we have a bit wider range in our SOC market size estimate for 2021 at $3.3 billion to $3.8 billion, up slightly from 2020 at the midpoint. 
In memory test, the transition to LPDDR5 and DDR5 should gain momentum in 2021 and beyond. After growing about 50% in 2020, we view the memory market to be in the $800 million to $1 billion range in 2021, about even with 2020 at the midpoint. In Storage Test, the underlying demand drivers of increased density in HDD and increased complexity in semi devices driving system-level test remain in place. However, visibility is limited and annual shipments can be very lumpy. After more than tripling over the last 3 years, we expect 2021 sales to be in a band of plus or minus 20% from the 2020 level. For the rest of our test businesses, we expect growth in the 5% to 10% range in 2021. 
In Industrial Automation, 2021 is starting off on a strong footing. Barring any additional COVID-related manufacturing sector shutdowns, we expect to deliver the highest ever first quarter sales in each of our automation businesses, and we are well positioned to grow in excess of 30% for the year.
2020's results reflect well on Teradyne's strategy, execution and efficiency. Our test businesses show the successful results of R&D bets made in years past and enable us to increase those bets for the future. Our Industrial Automation investments continue undeterred by short-term impacts of COVID, and we are well positioned to capitalize on a world emerging to invest even more in automation to improve resilience and productivity. 
Equally significant, 2020 showed the resilience of Teradyne employees, our global suppliers and our operating model. In the face of unimaginable challenges across communities worldwide, the team dealt with health, safety and operation obstacles daily, met R&D milestones, executed steep new product ramps and delivered record shipments of SOC, memory and storage tech products to meet our customers' needs. We did all this while exercising the cost and schedule discipline expected at Teradyne. This is truly extraordinary, and I am very grateful to be part of such a powerful team. 
As we move into 2021, the outlook appears bright across all our markets. As Sanjay will detail, we are returning to our share repurchase program and have an active M&A pipeline. As 2020 taught us, no matter what comes our way in the short term, I am confident our global team and market strategy will deliver exciting long-term returns for our customers, investors and employees. 
Sanjay will now take you through the financial and modeling details. Sanjay?"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Mark. Good morning, everyone. Today, I'll cover the financial highlights of Q4 and review the financial details of 2020. Looking forward, I'll provide our Q1 outlook, an update to our midterm earnings model and our capital allocation plans. N",1539,"Thank you, Mark. Good morning, everyone. Today, I'll cover the financial highlights of Q4 and review the financial details of 2020. Looking forward, I'll provide our Q1 outlook, an update to our midterm earnings model and our capital allocation plans. 
Now to Q4. Revenues were $759 million, which were $19 million above the high end of the guidance range. We delivered a non-GAAP operating profit of 30% and EPS of $1.10. Semi Test revenue of $524 million was driven by SOC and memory test demand, enabling 5G handsets and higher speed flash and DRAM devices. System Test group had revenue of $104 million, down quarter-over-quarter driven by lower storage test shipments. Industrial Automation, or IA, revenue of $92 million had a seasonal increase over Q3 and delivered year-over-year growth for the first time in 2020. LitePoint revenue of $40 million was approximately flat with Q3 and down year-over-year with a decline in trailing edge connectivity products, partially offset by new sales of new connectivity technology like WiFi 6 and emerging UWB technology. 
Non-GAAP gross margins were 59%, on plan and up quarter-over-quarter due to product mix. You'll see our non-GAAP operating expenses were up $14 million to $224 million from the third quarter due to increased test spending to support design wins, higher payroll due to 4 extra days in the quarter and ongoing IA investments. We generated $222 million in free cash in the fourth quarter. The tax rate, excluding discrete items for the quarter was 13% on a GAAP basis and 14.5% on a non-GAAP basis. For the full year, it is 14.75% on a GAAP basis and 15.25% on a non-GAAP basis. We ended the year with cash and marketable securities of $1.55 billion. 
Turning to the full year results of 2020. Teradyne revenues of $3.12 billion grew $826 million or 36% year-over-year. $845 million of the growth was from our test portfolio, while IA contracted $18 million due to the pandemic-related slowdown. We had 1 customer that accounted for more than 10% of our revenue in 2020, which we'll disclose in our 10-K filing. 
Gross margins for the year were 57% and operating profit was 30%, which is up from 25% in 2019. 
Non-GAAP EPS was $4.62, an increase of 62% over 2019. We generated $684 million in free cash in 2020. 
Breaking down the components of 2020 revenues. As outlined by Mark, SOC test revenues grew $595 million or 46% on strength in mobility, market-driven by increased by device complexity and new standards like 5G along with growing growth in computing. In memory, revenues were $383 million, up 41%. While LPDDR-related DRAM revenues were a significant contributor to our results, we also continue to see strong NAND test demand through the year. 
In System Test, sales grew for the fourth year running. Revenue of $410 million grew $122 million or 43% year-over-year, primarily on growth in Storage Test for both hard disk drive and system level test. Storage Test sales were $242 million, up from $115 million in 2019. We also saw annual growth in our Defense & Aerospace component of STG. 
At LitePoint, sales grew for the fourth consecutive year to $173 million, 10% above 2019. In 2020, IA revenue was $280 million, a decline of 6% from 2019 on an as-reported basis or 9% on a pro forma basis. As Mark noted, the COVID-related driven slowdown in manufacturing impacted Universal Robots, reducing revenue to $219 million, down 12% year-over-year. 
After troughing in Q2, UR grew in the second half of 2020 versus the first half of the year. In Q4, revenue grew 6% year-over-year, giving confidence heading into 2021. MiR grew slightly year-over-year with annual sales of $45 million, and AutoGuide full year's sales grew on a pro forma basis. 
Now to our outlook for Q1. Sales are expected to be between $720 million and $780 million. Non-GAAP EPS range of $0.95 to $1.11 on 175 -- 179 million diluted shares. The first quarter guidance excludes amortization of acquired intangibles and the noncash imputed interest on the convertible debt. First quarter gross margins are estimated at 58% to 59%. First quarter OpEx, running at 29% to 31% of first quarter sales, is about flat with Q4 at the midpoint of guidance. The non-GAAP operating profit rate at the midpoint of our first quarter guidance is 29%. 
Regarding our OpEx plans for 2021, we expect our OpEx to grow 8% to 10% from 2020's $840 million. Approximately 2 points of the spend will be in the back half of the year related to travel, which we expect to resume to pre-COVID levels along with trade shows. In our test portfolio, we plan to increase our spending in engineering, sales and marketing, primarily in Semi Test. In IA, we'll continue to invest to reinforce our competitive product and ecosystem position across the sector. Also in IA, go-to-market investments will be made to support expected revenue growth. 
Turning to capital expenditures. In 2020, our CapEx was $185 million. This was used primarily for customer demonstration equipment, operations, engineering and initial spending on new facilities to replace leased ones in locations where we plan to grow over the next several years. We'll continue to invest in these new facilities in 2021, so CapEx is expected to be similar to 2020. Recall, we are buying land and developing it to eliminate lease costs and enable a more efficient spend profile over the mid- to long-term. 
For 2021, our GAAP tax rate is estimated at 15.5% and our non-GAAP tax rate is estimated at 16% based on current tax laws. 
Moving to our midterm earnings model. As you've seen with 2020, our non-GAAP EPS of $4.62, we've exceeded our 2022 earnings model 2 years early on the strength of our test businesses. We continue to have confidence in the long-term growth outlook for test, and we expect IA to return to high growth as the global industrial economy improves. When building our midterm model, given our year-on-year demand swings, we've seen both in test and IA, we use the average of 2019 and 2020 revenues as the baseline for our growth projections. From that baseline, we expect test revenue to grow 4% to 8% compounded and IA revenues to grow 20% to 35% through 2024. 
In test, we expect that growth will be driven by steady increase in device complexity across our businesses along with the high single-digit semiconductor unit growth trend line. In IA, market penetration of cobots and autonomous mobile robots and forklifts remains low, while the range of applications they economically serve continues to expand, resulting in an attractive long-term growth opportunity for Teradyne. We expect this will drive 2024 company revenue to $3.9 billion and non-GAAP EPS to $6 at the midpoint of our estimates. 
Gross margin is modeled at 58% to 59%, OpEx as a percentage of sales will decline to 28% to 29% and non-GAAP operating margin will improve to 30% to 31%. The model assumes the current tax laws are in place. 
Shifting to capital allocation. We'll continue to balance a strong cash position to support our operating investments and potential M&A with direct shareholder returns through dividends and share repurchases. We are raising our minimum cash levels from $1 billion to $1.25 billion, with the $250 million increase tied to the increased valuations of potential acquisitions.
Recall, we held $500 million for M&A and $500 million for severe economic downturn. We will also be increasing our cash balance in 2021 through 2023 to service our convertible bond, which comes due in December 2023. To date, $51 million of that bond has been redeemed early with payment planned in Q1, with the remaining face value of $409 million. 
Regarding share repurchases. In 2020, we bought back $1.5 million -- sorry, 1.5 million shares for $88 million at an average price of $58.32. Recall, we suspended our share repurchase program in April due to COVID-related uncertainty. We are replacing our prior approved program with a new share repurchase authorization of $2 billion with no fixed end date. We plan a minimum of $600 million of repurchases in 2021. As in the past, the plan has both a programmatic and opportunistic components. 
In summary, 2020 inflicted incredible human and economic hardship on societies across the world, and we're respectful of the widespread pain and loss. When the pandemic hit, I noted our priorities were the safety of our employees, supporting our customers and continued execution in achieving our financial objectives. The Teradyne community responded with a collaborative and supportive spirit, incredible energy, ingenuity and purpose, which delivered on all 3 of these priorities. I'm incredibly proud and thankful to be part of this team. 
We enter 2021 in the strongest position in our history. The work in 2020 has made us more resilient and prepared us for the strong market demand that we currently see in both test and IA. While our visibility for the full year is limited, we're confident in the underlying market fundamentals, our competitive, diversified portfolio and our team, which will enable long-term growth prospects for the markets we serve. Collectively, we're excited to turn our new financial model into reality. 
With that, I'll turn things back to Andy."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Sanjay. Operator, we'd now like to take some questions. [Operator Instructions]",12,"Thanks, Sanjay. Operator, we'd now like to take some questions. [Operator Instructions]"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","[Operator Instructions] First question comes from Krish Sankar with Cowen.",10,"[Operator Instructions] First question comes from Krish Sankar with Cowen."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, I had two of them. First one, thanks for the color on calendar '21. I'm just kind of curious if you could peel the SOC Test market a little more to say, how much do you think mobility will be? And how much do you think Auto Test would be this year o",61,"Mark, I had two of them. First one, thanks for the color on calendar '21. I'm just kind of curious if you could peel the SOC Test market a little more to say, how much do you think mobility will be? And how much do you think Auto Test would be this year on SOC? And then I have a follow-up."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So good question. Certainly, auto is going to be up sequentially in 2020. We've talked about that market being at a normalized -- let's say, maybe more of a peak run rate in the $400 million to $500 million range. It's been down to sort of $200 milli",162,"Yes. So good question. Certainly, auto is going to be up sequentially in 2020. We've talked about that market being at a normalized -- let's say, maybe more of a peak run rate in the $400 million to $500 million range. It's been down to sort of $200 million last year. So this year, that should be up at least $150 million, maybe $200 million. It's really right now a bit of a rush for capacity. And we don't know exactly when the demand profile of the orders are going to taper off here. So it could go higher if this persists. So that's the color on auto. 
In mobility, I think it's harder for us to see that at the moment because of the significant impact of our largest customer on both us and the market, which doesn't really become solidified until April-ish of the year. So we're looking at it sort of flat, plus or minus $100 million in mobility."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Got it. That's very helpful, Mark. And then just as a follow-up on the IA side. You mentioned 30-plus-percent growth, should we assume a big driver of that is going to be UR? In other words, UR should be higher than 30%? Or do you think UR is goin",59,"Got it. Got it. That's very helpful, Mark. And then just as a follow-up on the IA side. You mentioned 30-plus-percent growth, should we assume a big driver of that is going to be UR? In other words, UR should be higher than 30%? Or do you think UR is going to be in line with Industrial Automation growth?"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that's a good question. I think all of the groups are going to be better than 30%. And some of them like AutoGuide are small. So I think they'll pull up the average, albeit ahead of UR. And MiR and UR should be about the same for the year.",52,"Yes. I think that's a good question. I think all of the groups are going to be better than 30%. And some of them like AutoGuide are small. So I think they'll pull up the average, albeit ahead of UR. And MiR and UR should be about the same for the year."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Mehdi Hosseini with SIG.",8,"Next question comes from Mehdi Hosseini with SIG."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","I just want to go back to your SOC commentary. I'm a little bit surprised with your kind of flattish outlook. And I say that because millimeter wave is expected to account for a larger mix of the 5G phones. And I believe last year was just the early inves",71,"I just want to go back to your SOC commentary. I'm a little bit surprised with your kind of flattish outlook. And I say that because millimeter wave is expected to account for a larger mix of the 5G phones. And I believe last year was just the early investment. So why isn't the increased penetration of millimeter wave phone not giving you that incremental confidence? And I have a follow-up."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that's certainly a balloon for the year, Mehdi. Maybe we're going to double the number of millimeter wave-enabled phones in 2021. But yes, last year, if you recall, there was also a significant step-up in the hundreds of millions of units of",143,"Yes. I think that's certainly a balloon for the year, Mehdi. Maybe we're going to double the number of millimeter wave-enabled phones in 2021. But yes, last year, if you recall, there was also a significant step-up in the hundreds of millions of units of millimeter wave-enabled phones were brought to market last year. So if you add another 200 million to 300 million additional millimeter wave-enabled units this year and, let's say, that brings the global total to 600 million units out of 1.4 billion, you're essentially adding about as much capacity, maybe a little bit more because there'll be more than -- let's say, last year, added 250 million, this year, might add 350 million units. So yes, there will be a little bit of growth in additional millimeter wave test capacity. But last year was a pretty big year, too."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And then looking at the midterm model 2024. What are the key underlying assumption for market share, especially as you try to capitalize on the synergies between Semi and a System Test? And in that context, are you accounting for any incremental s",51,"Got it. And then looking at the midterm model 2024. What are the key underlying assumption for market share, especially as you try to capitalize on the synergies between Semi and a System Test? And in that context, are you accounting for any incremental share shift in the GPU end market?"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Mehdi, it's Sanjay. Yes. So in the earnings model, we see, obviously, growth in the market. As Mark alluded to, more players are coming into the compute space that we can address. And with that, we feel that with the UltraFLEXplus solution, we're ver",110,"Yes. Mehdi, it's Sanjay. Yes. So in the earnings model, we see, obviously, growth in the market. As Mark alluded to, more players are coming into the compute space that we can address. And with that, we feel that with the UltraFLEXplus solution, we're very well positioned, and we are projecting share growth. When we think about from a memory perspective, if you go back, let's say, 10 years, we've been on this steady increase of memory share growth, where as we continue to execute, we see continued share growth on that perspective as well. So really, growth in market size as well as continued share growth are our drivers."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","That includes the synergy between different sectors or segments?",9,"That includes the synergy between different sectors or segments?"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","You want to expand on that question?",7,"You want to expand on that question?"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Yes. Just going back to the question. I see opportunities between your Semi and a System Test, especially as the system-level test diversifies. And I'm just wondering if that's baked into your 2024 model?",34,"Yes. Just going back to the question. I see opportunities between your Semi and a System Test, especially as the system-level test diversifies. And I'm just wondering if that's baked into your 2024 model?"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Okay. Thanks for the clarification. Yes, it is. With device complexity, we were going 5-nanometer and then to 3-nanometer, I think both system-level test as well as ATE test take that into account.",34,"Yes. Okay. Thanks for the clarification. Yes, it is. With device complexity, we were going 5-nanometer and then to 3-nanometer, I think both system-level test as well as ATE test take that into account."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Toshiya Hari with Goldman Sachs.",9,"Next question comes from Toshiya Hari with Goldman Sachs."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, I wanted to ask about your largest customer. I appreciate things will remain pretty fuzzy or opaque, as you said, until sort of the April-ish time frame. But can you sort of walk us through the potential range of outcomes you're thinking internally?",89,"Mark, I wanted to ask about your largest customer. I appreciate things will remain pretty fuzzy or opaque, as you said, until sort of the April-ish time frame. But can you sort of walk us through the potential range of outcomes you're thinking internally? Obviously, you've got units, you've got transistor density as it relates to the new chip. Also curious if their efforts on the notebook side of their business, in-sourcing CPUs, could have an impact on your business as well? And then I've got a quick follow-up."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Okay. I always am a bit reluctant to be too specific on any 1 customer. So I'm going to speak more to the segment a bit, which I'll bundle compute and mobility together here. So yes, last year was incredibly strong in both our traditional mobility market",211,"Okay. I always am a bit reluctant to be too specific on any 1 customer. So I'm going to speak more to the segment a bit, which I'll bundle compute and mobility together here. So yes, last year was incredibly strong in both our traditional mobility market because of the complexity growth of phones, which we alluded to and the fact that we did enter compute as a new segment. So we ended up with additional revenues in compute last year, that north of $50 million for the first year in that market.
So as we think about this year, the issue of smartphone unit growth and complexity growth of the apps processor, the camera systems and such in the phones is part of the equation. And we have a reasonably good read on that. 
On the compute side, there's a lot of moving parts there. And there's a lot -- since it's a new market for us and a new market for some of our customers, that has the bigger range of potential outcomes for the year. So that's the one we're triangulating on. That could be up significantly over last year. It could be up modestly over last year. But at this point, we really can't be too specific."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And then as a quick follow-up. On Industrial Automation, I wanted to ask about the profit margin profile of the business, where does it stand today, I guess, as of 2020? You guys have done a great job in improving gross margin at UR and the other",88,"Got it. And then as a quick follow-up. On Industrial Automation, I wanted to ask about the profit margin profile of the business, where does it stand today, I guess, as of 2020? You guys have done a great job in improving gross margin at UR and the other businesses that you've acquired over the past couple of years. At the same time, you've been aggressively spending from an OpEx perspective. So in your 2024 model, what sort of margin profile for IA is embedded in your numbers?"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","It's Sanjay. So IA as a whole this year was roughly just a bit better than breakeven. Obviously, with the COVID impact on multiple businesses and the contraction in UR, we're just above breakeven. But fundamentally, we continue to invest in the portfolio,",128,"It's Sanjay. So IA as a whole this year was roughly just a bit better than breakeven. Obviously, with the COVID impact on multiple businesses and the contraction in UR, we're just above breakeven. But fundamentally, we continue to invest in the portfolio, the ecosystem, the go-to-market for product and differentiation, ease of implementation. And so you should expect that to continue over the midterm, and we're focused on driving the revenue growth and the investments. 
And so with that, we expect the margin profile to be roughly consistent with the current profile as we -- as AutoGuide is relatively new to the organization, just over a year, we expect that to improve with our Teradyne supply chain as well as other quality processes we step in."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Just one thing I'm going to add on to that commentary around the Industrial Automation business to remind people that what we focus on right now during the high growth phase of that business is sales growth and gross margin. And the bottom line, as Sanjay",147,"Just one thing I'm going to add on to that commentary around the Industrial Automation business to remind people that what we focus on right now during the high growth phase of that business is sales growth and gross margin. And the bottom line, as Sanjay mentioned, if we're at breakeven, we're happy as long as we can sort of adhere to or exceed the rule of 40. And through the midterm, we think we expect to be close to that kind of up top line growth rates. And what we bring down to the bottom line will kind of depend on the size of the growth, what we see ahead of us. And if we're growing at 50% and breakeven, we are happy as clams. And if the growth rates come down below 20%, we'll start dropping more and more down to the bottom line."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Joe Moore with Morgan Stanley.",9,"Next question comes from Joe Moore with Morgan Stanley."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Following on the last question. Can you just characterize the tone of business for the Universal Robotics business? And I guess in the context of -- it feels like a lot of the business activity in the last 12 months is business continuity and supply chain",101,"Following on the last question. Can you just characterize the tone of business for the Universal Robotics business? And I guess in the context of -- it feels like a lot of the business activity in the last 12 months is business continuity and supply chain disruption, maybe that's negative for new technologies and manufacturing. At the same time, I would think social distancing and stuff like that as an opportunity for you. So just kind of characterize those puts and takes, and just what that tells you about what the trends may look like over the course of this year."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Sure. It's Sanjay here. So in the short run, we actually saw a contraction as evidenced by how our revenues were. However, I think your comments hit home with regards to plant and warehouse decision-makers seeking to build resilience into their suppl",89,"Yes. Sure. It's Sanjay here. So in the short run, we actually saw a contraction as evidenced by how our revenues were. However, I think your comments hit home with regards to plant and warehouse decision-makers seeking to build resilience into their supply chains. And we view that over the midterm as a tailwind. We are seeing the market obviously come back with Universal Robots. We've talked in our prepared remarks about the automotive and electronics industry. And then we're also seeing strength in a couple of other verticals."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from C.J. Muse with Evercore.",9,"Next question comes from C.J. Muse with Evercore."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","I wanted to follow-up on Mehdi's question regarding your 2024 model. So if I look at your implied Semi Test revenues versus 2020 actual, you're up about $250 million to $350 million, which seems conservative, particularly when you reflect on what you're d",86,"I wanted to follow-up on Mehdi's question regarding your 2024 model. So if I look at your implied Semi Test revenues versus 2020 actual, you're up about $250 million to $350 million, which seems conservative, particularly when you reflect on what you're doing with system-level test, new UltraFLEXplus. So can you, I guess, walk through what assumptions you're making in terms of market share for both SOC and memory implied in that number? And where you might point to as areas that might be conservative?"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that as I articulated from -- I'll touch on memory first. Our share right now is in the low 40s. We see that -- we could see that growing to the mid-40s in the plan. And then from an SOC perspective, Mark talked about a normalized share level",62,"Yes. I think that as I articulated from -- I'll touch on memory first. Our share right now is in the low 40s. We see that -- we could see that growing to the mid-40s in the plan. And then from an SOC perspective, Mark talked about a normalized share level of about 50%. And we see that increasing over the midterm."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","But within the implied model, are you assuming the 50% or the 60% that Mark spoke about back in July as to what a goal could look like?",28,"But within the implied model, are you assuming the 50% or the 60% that Mark spoke about back in July as to what a goal could look like?"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","So yes, I think what we've been saying, C.J., is that we can get about 1 point to 1.5 points a share growth a year. So by 2024, as I mentioned, I think our normalized share is somewhere around 50%. We should be up around 55%, 56% by then in SOC.And in m",188,"So yes, I think what we've been saying, C.J., is that we can get about 1 point to 1.5 points a share growth a year. So by 2024, as I mentioned, I think our normalized share is somewhere around 50%. We should be up around 55%, 56% by then in SOC.
And in memory, share was a little chunkier because there's only a few players there. So on the memory side, we could be in the mid to upper mid-40s by then, I would say, is one way to think about it.
But the other piece of color in terms of aggressive versus conservative that I'd add here is the recent investment profile of the front end with CapEx moving up into the $70 billion range, is something we haven't modeled into our midterm plan. We've assumed that incremental fab capacity across the midterm would be sort of consistent with the rate that it's been added for the prior 4 years. So if $70-plus billion of investment in WFE is the new normal for the next 4 years, that's certainly going to drive more tests than we modeled."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Very helpful. As my follow-up, can you speak to what we should be thinking about for SOC Test gross margins here in '21 versus 2020? I'm trying to get a sense of what uplift might look like, particularly from Eagle Test.",41,"Very helpful. As my follow-up, can you speak to what we should be thinking about for SOC Test gross margins here in '21 versus 2020? I'm trying to get a sense of what uplift might look like, particularly from Eagle Test."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","I mean gross margins, we -- you should expect a relatively consistent with how we've guided Q1 and in our long-term model.",22,"I mean gross margins, we -- you should expect a relatively consistent with how we've guided Q1 and in our long-term model."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Brian Chin with Stifel.",8,"Next question comes from Brian Chin with Stifel."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Maybe the first question, back on the topic of Industrial Automation. Automotive has historically been a key portion of sales here. And I was curious, do you expect or even need the auto portion of your sales to grow 30% year-over-year, given sort of the",55,"Maybe the first question, back on the topic of Industrial Automation. Automotive has historically been a key portion of sales here. And I was curious, do you expect or even need the auto portion of your sales to grow 30% year-over-year, given sort of the increasing breadth of market adoption that you might be seeing?"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that with an emerging market, there's still a lot of footprint to cover, so we expect that to continue in the automotive vertical as well as electronics and industrials as well as other verticals.",37,"Yes. I think that with an emerging market, there's still a lot of footprint to cover, so we expect that to continue in the automotive vertical as well as electronics and industrials as well as other verticals."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Yes, I was just sort of get -- trying to gauge whether you're seeing a lot of adoption outside of auto? And is it -- in terms of visibility, you're starting the year with pretty good visibility. Is auto kind of starting from a similar point? Or is i",78,"Okay. Yes, I was just sort of get -- trying to gauge whether you're seeing a lot of adoption outside of auto? And is it -- in terms of visibility, you're starting the year with pretty good visibility. Is auto kind of starting from a similar point? Or is it kind of more -- a little bit more on the whole to start the year, and you're going to expect a bigger snap back later in the year?"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. We're seeing also -- we're seeing market drivers in our verticals, adoption and education. R&D, pharma as well as life sciences. But from a starting point, obviously, we have a very strong incumbent installed base over the years that we've built in t",46,"Yes. We're seeing also -- we're seeing market drivers in our verticals, adoption and education. R&D, pharma as well as life sciences. But from a starting point, obviously, we have a very strong incumbent installed base over the years that we've built in the auto vertical."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","And I'd just add to that, that certainly, automotive was one of the most hard hit aspects of UR's business. Automotive has been running in the high 30s, 40% of the business coming into 2020. That contracted dramatically because of COVID, down to the point",171,"And I'd just add to that, that certainly, automotive was one of the most hard hit aspects of UR's business. Automotive has been running in the high 30s, 40% of the business coming into 2020. That contracted dramatically because of COVID, down to the point that it was in the low 20s. And I would say it's certainly, at this point, although back and growing, it hasn't come back yet to where it should be in our portfolio. This has issues around the semiconductor supply chain and other things have sort of crimped some of the ambitions of car companies to ramp volumes here. There's a little bit to go still.
But our footprint over time, since we acquired UR has been reducing in the automotive segment, not so much because automotive is not growing, of course, but it's just that our expansion into the other areas that Sanjay mentioned has been. And we expect over time that automotive component will continue to decline as a percentage of our sales."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Great. Yes. I was sort of getting maybe at that. And then in the 2024 model, granted it's 4 years out, but can you give us sort of a rough sense of how much of the IA sales might be AMR or mobile vehicle driven? I think the split roughly is kind of 80% UR",73,"Great. Yes. I was sort of getting maybe at that. And then in the 2024 model, granted it's 4 years out, but can you give us sort of a rough sense of how much of the IA sales might be AMR or mobile vehicle driven? I think the split roughly is kind of 80% UR, 20% mobile at the moment. Could that be sort of like a 2/3, 1/3 in that time frame?"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that, obviously, UR, we've had for a little bit longer, and it is a larger percentage. But I think you're spot on that the AMR portion will grow with AutoGuide and MiR as a percentage of revenue.",40,"Yes. I think that, obviously, UR, we've had for a little bit longer, and it is a larger percentage. But I think you're spot on that the AMR portion will grow with AutoGuide and MiR as a percentage of revenue."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Atif Malik with Citi.",8,"Next question comes from Atif Malik with Citi."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Good job on results and guide. Mark, the first one, following up on the last question, AutoGuide, how is adoption going at larger enterprises and warehouse customers? And then I have a follow-up.",33,"Good job on results and guide. Mark, the first one, following up on the last question, AutoGuide, how is adoption going at larger enterprises and warehouse customers? And then I have a follow-up."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Good question. So to be frank with you, we had a good year. We grew 50-ish-percent in the year, but we didn't hit our target. And part of this is extended evaluations at the large accounts that you're referencing. And it's been very difficult in a sm",196,"Yes. Good question. So to be frank with you, we had a good year. We grew 50-ish-percent in the year, but we didn't hit our target. And part of this is extended evaluations at the large accounts that you're referencing. And it's been very difficult in a small business like AutoGuide's case in a COVID area to acquire new customers and get the pilot production validation work done in the same time frame that we could have gotten it done in a non-COVID world.
So we've seen some extension of those evals, but we're in some of the boutique name brands for evals that you would hope we are in, in both the industrial manufacturing side as well as the e-commerce side and logistics side of life.
So we're hoping that this year is going to be the big breakout year. It's the kind of business that should at least be doubling, if not more, once these big accounts latch. But we did -- if any place sort of had a big impact from COVID last year, it was AutoGuide because of the whole -- new customer acquisition is the whole game there at this point."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Great. And as a follow-up, you mentioned the China SOC Test to be down this year, which makes sense given the restrictions from last year, but some of the front end peers have talked about maybe flattish China investments on the front end and back end is",75,"Great. And as a follow-up, you mentioned the China SOC Test to be down this year, which makes sense given the restrictions from last year, but some of the front end peers have talked about maybe flattish China investments on the front end and back end is different. Can you just walk us through the components on where China investments are down? And why you aren't benefiting on some of the mature technologies and nodes?"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So if you look at China, I think you need to separate memory and SOC because it's quite different. On the memory side, there will be growth in China this year in test as well and we -- or we expect that at least. And so that's a healthy, growing midt",170,"Yes. So if you look at China, I think you need to separate memory and SOC because it's quite different. On the memory side, there will be growth in China this year in test as well and we -- or we expect that at least. And so that's a healthy, growing midterm profile, I'd say, for China. 
On SOC, it's really a little bit more difficult to see growth occurring this year because the impact of the trade restrictions on Huawei and HiSilicon are tremendous in terms of their buying power in the market historically. What they buy in both silicon and then test capacity for that silicon has been severely hampered. And then further restrictions on other companies like SMIC and such are much smaller factors, but tail or headwinds against growth.
So I think SOC is likely to contract. Memory is going to grow. But net-net, it's not going to be hugely down, but it will probably be down a little bit on the test side of life."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Vivek Arya with Bank of America.",10,"Next question comes from Vivek Arya with Bank of America."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","I had two, one on operating leverage and the second on M&A. On operating leverage, Sanjay, I believe you mentioned OpEx growth of 8% to 10% this year. Do you think there is a potential to still drive leverage with that kind of growth? And then when I look",110,"I had two, one on operating leverage and the second on M&A. On operating leverage, Sanjay, I believe you mentioned OpEx growth of 8% to 10% this year. Do you think there is a potential to still drive leverage with that kind of growth? And then when I look at your 2024 model, you're keeping operating margins at about 30%, 31%, kind of where you are already, even though sales are expected to grow, and Mark had outlined a number of interesting growth drivers. So I was hoping you could talk to operating leverage this year, and then what would be the drivers as you look at your '24 model?"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Okay. Sure. Yes. So obviously, it's another -- it's an investment year. And I think in my prepared remarks, I noted that we're getting back to travel and trade shows, which is a key point. You really -- if you look at it in 2 portfolios, we -- for the yea",188,"Okay. Sure. Yes. So obviously, it's another -- it's an investment year. And I think in my prepared remarks, I noted that we're getting back to travel and trade shows, which is a key point. You really -- if you look at it in 2 portfolios, we -- for the year, we're going to have leverage in the test business, where the growth in OpEx as a percentage will be lower, but the growth in the IA space, the OpEx growth is higher. And so the leverage from a -- like we're growing in the IA space, but we will see -- we should see a degree of leverage in the short-term in the test business.
When you cascade that out to 2024, obviously, with the revenues that we're predicting in IA, I think Mark described it well. If we're growing at 50% and have a forecast to continue to grow, we'll continue to drive the investment. But as the growth starts to go down, let's say, below the rule of 40, then we'll start to drop more to the bottom line. That's how we're thinking about it."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","But when I look at that '24 model, right, you're forecasting overall sales to grow at a 6% CAGR from the 2020 level. So that is below the 16% CAGR you have been at. And you're saying operating margins are going to stay pretty much flattish versus -- I'm j",105,"But when I look at that '24 model, right, you're forecasting overall sales to grow at a 6% CAGR from the 2020 level. So that is below the 16% CAGR you have been at. And you're saying operating margins are going to stay pretty much flattish versus -- I'm just puzzled as to if you're saying sales are not really going to grow as much as they have grown in the last 3, 4 years and operating margins are not going to expand from here, is that model very conservative? Or what needs to be done to either grow faster or drive more operating leverage?"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that -- well -- and that's why in my prepared remarks, I comment, we looked at the model, not just off of a point of 2020, but off of an average of '19 and '20, just given the significant balloon in 2020 tied to the mobility space and then th",100,"Yes. I think that -- well -- and that's why in my prepared remarks, I comment, we looked at the model, not just off of a point of 2020, but off of an average of '19 and '20, just given the significant balloon in 2020 tied to the mobility space and then the contraction in IA. And when you look at it from an average of '19 and '20, we believe in that growth -- overall growth of the 4% to 8%. And then we are, during that period, going to be growing out the investments in the IA portfolio."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","And I would just say, if you go back to what we said, if you look at that pie chart of the mix. When we get out to 2024, IA should be a bigger mix of our revenue than test. So test will continue to grow. It will have a very high drop-through. It will be v",161,"And I would just say, if you go back to what we said, if you look at that pie chart of the mix. When we get out to 2024, IA should be a bigger mix of our revenue than test. So test will continue to grow. It will have a very high drop-through. It will be very efficient. And if that's all you're looking at, yes, bottom line profitability should increase.
But on the IA side, it's more likely that we'll be growing more rapidly, and we'll be pulling up gross margins for the enterprise with the IA business. But on the bottom line, we're being a bit conservative on how much we plan to drop-through there because we want to keep investing for more and more growth. So it kind of just depends on what's the investment profile in IA. And we've modeled in -- we're not going to optimize for profit in the midterm there, we're optimizing for growth."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Understand. And Mark, just a follow-up to that. You mentioned the prospects for some additional M&A. I presume it's in the IA side of the business, but I was hoping you would talk to that. Do you -- are you contemplating kind of smaller tuck-in technology",88,"Understand. And Mark, just a follow-up to that. You mentioned the prospects for some additional M&A. I presume it's in the IA side of the business, but I was hoping you would talk to that. Do you -- are you contemplating kind of smaller tuck-in technology type transactions? Are you thinking about something that could be bigger and could require the use of stock, just how we should think about what M&A pipeline is and how it could impact this baseline model that you have set for us?"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So most of what we have in our pipeline is consistent with the kind of things we've been investing in and acquiring in the past 5 to 6 years, Industrial Automation, modestly sized investments, let's say, relative to our market cap. However, we have e",135,"Yes. So most of what we have in our pipeline is consistent with the kind of things we've been investing in and acquiring in the past 5 to 6 years, Industrial Automation, modestly sized investments, let's say, relative to our market cap. However, we have expanded our aperture a bit to look in the test space and areas that are correlated to test, which bring with it potentially some larger M&A things. It's always governed by the same rich internal rate of return metrics that we always use on these things.
So whatever we do is going to be something that's more attractive to the -- our investors than buying back our stock or those kind of -- our internal weighted cost of capital. So that's about all I think I can say about that."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Timothy Arcuri with UBS.",8,"Next question comes from Timothy Arcuri with UBS."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","I had a couple. So for OpEx this year, you're saying it's going to grow about 8% to 10%. So at the midpoint, you're going to grow OpEx about $76 million. I'm wondering, Sanjay, if you can tell us how much of that's going to come in IA? And I guess another",139,"I had a couple. So for OpEx this year, you're saying it's going to grow about 8% to 10%. So at the midpoint, you're going to grow OpEx about $76 million. I'm wondering, Sanjay, if you can tell us how much of that's going to come in IA? And I guess another way of asking that is sort of what sort of op margin do you think you can do this year in IA? I mean you were basically breakeven last year. Can you get to high single digits this year? And is 10% to 15% still the long-term target for that business? I know that Mark's commenting that if growth slows, you can sort of crank back on OpEx and you can drop more. But just wondering if you can comment there. And then I had a follow-up."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Sure. Yes. I think it's spot on. I think when you take out the travel and the trade shows, the majority of the spend will come in OpEx from -- on a year-over-year basis. And from a profit perspective, we're assuming growth, and we expect to improve back t",92,"Sure. Yes. I think it's spot on. I think when you take out the travel and the trade shows, the majority of the spend will come in OpEx from -- on a year-over-year basis. And from a profit perspective, we're assuming growth, and we expect to improve back to our original growth plans. Like if you think about 2020 as the anomaly and you look at the jump-off point of 2019, we were about a 10% profit level. With our growth, we should be in that similar level going forward in 2021."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Got it. So you think you can get to 10% op margin this year?",15,"Okay. Got it. So you think you can get to 10% op margin this year?"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes, plus or minus, but yes.",6,"Yes, plus or minus, but yes."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Okay. Great. And then, I guess, a question for you, Mark. So when you were going to your top customer, you presented a couple of scenarios. I know it's very tough to predict. But the scenarios you presented didn't include that revenue from that cust",182,"Okay. Okay. Great. And then, I guess, a question for you, Mark. So when you were going to your top customer, you presented a couple of scenarios. I know it's very tough to predict. But the scenarios you presented didn't include that revenue from that customer is down. I get that the compute piece is going to be up, but they're also not going to shrink this year. And in the past, that's been sort of a harbinger of a potential decline in the number of testers they buy unless they're willing to live with a much larger die size, which may or may not be the case. So I'm just kind of wondering -- I'm not asking for any specifics on that customer. I'm just sort of wondering if you can look back in the past and draw in your past experience and say, well, yes, in the past, when that happens, that is sort of a harbinger of the potential that it could be down because you didn't present that as a down or as a possible outcome this year?"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think it's a possible outcome, but let me go back to what I was outlining in my remarks. When you look at the phone, there's various elements of the phone in terms of technology, dapps processors, the modem, the cameras, the memory, those areas of",198,"Yes. I think it's a possible outcome, but let me go back to what I was outlining in my remarks. When you look at the phone, there's various elements of the phone in terms of technology, dapps processors, the modem, the cameras, the memory, those areas of the phone refresh and take leaps of complexity in different cadences. And in 2020, the apps processor and 5G -- basically, the apps processor had a big jump in complexity, and 5G proliferated throughout all the phones.
So as you look at 2021, the need for incremental 5G capacity, whereas in 2020, several, let's say, 100 million units worth of phones needed 5G capacity. This year, it will be less because the incremental unit growth there is one factor in incremental 5G capacity plus complexity growth of the 5G modem itself. So 5G is big in 2020, not as big in 2021. 
That leaves what's happening with the cameras, what's happening with power management, what's happening with the screen resolution. Other things could be balloons that pull it back up. But I do think you do have that -- 5G has happened for that one area of our mobility customer base."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","And operator, we have time for just one more question, please.",11,"And operator, we have time for just one more question, please."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Last question comes from John Pitzer with Crdit Suisse.",9,"Last question comes from John Pitzer with Crdit Suisse."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, my first question is just on the whole China dynamic. You're clearly guiding it to be down this year. I'm kind of curious if there is a date on between U.S.-China relations, is that a zero-sum game, an exercise in market shift? Or do you think it wo",111,"Mark, my first question is just on the whole China dynamic. You're clearly guiding it to be down this year. I'm kind of curious if there is a date on between U.S.-China relations, is that a zero-sum game, an exercise in market shift? Or do you think it would be accretive? And I guess more importantly, we're now seeing the U.S. government kind of incentivize domestic production of semis. I'm just kind of curious as to whether or not you could benefit from that, either indirectly as some of your customers build capacity domestically, or directly as we think about your long-term tax rate? And then I've got a quick follow-up."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Okay. So China. If for some reason, the restrictions on China ease and more indigenous Chinese makers start to grow again, I think it's neutral. As business shifted out of China in 2020, it was pretty much neutral to us. There was -- the customers that pi",219,"Okay. So China. If for some reason, the restrictions on China ease and more indigenous Chinese makers start to grow again, I think it's neutral. As business shifted out of China in 2020, it was pretty much neutral to us. There was -- the customers that picked up the manufacturing of, let's say, applications processors or modems that would have been done by indigenous Chinese suppliers or Teradyne customers and Advantest customers and a proportion that isn't that different than it was in China. So as it ebbs and flows back and forth, I wouldn't say there's a big ramification. 
On the U.S. domestic supply question, I think it's going to take a long time and many, many years of a steadfast set of incentives from the government for that to mature to something significant to our business.
If we stick at that in the U.S. for 7, 8 years and really build up an infrastructure to manufacture semiconductors domestically, I think it could have a bit of a positive impact, but I think it's small. I don't think because semiconductors might be manufactured in the U.S., all of a sudden, there's a propensity that they're going to buy more Teradyne equipment. It's at the margin, but nothing I would bake in as a trend line to count on."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","That's helpful. And then just as my follow-up, going back to the 2024 model. Your explanation as to kind of how you're getting to the op profit targets you're getting to makes a ton of sense.I'm just kind of curious, to the extent that the top line prov",96,"That's helpful. And then just as my follow-up, going back to the 2024 model. Your explanation as to kind of how you're getting to the op profit targets you're getting to makes a ton of sense.
I'm just kind of curious, to the extent that the top line proves to be conservative, how should we think about incremental operating margins above sort of the high end of the target model? Or maybe another way of thinking about it, as IA gets scale, where do we think the longer-term op margin of the business can go?"
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that if the test business -- if what drives the incremental revenue, if the test businesses come to fruition, I think you'll see a higher drop-through. If and again, just to repeat myself, if we're growing and we see continued growth, and we'",124,"Yes. I think that if the test business -- if what drives the incremental revenue, if the test businesses come to fruition, I think you'll see a higher drop-through. If and again, just to repeat myself, if we're growing and we see continued growth, and we're going to continue to invest in IA, that drop-through may be lower. But let's say, it comes -- let's say, the revenues grow significantly over the first couple of years. And then at the end, they start to -- the growth starts to tail down, you may see a little bit more leverage. But it's really -- we have to see how the market unfolds in IA. But over the short term, we are planning a significant investment."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","All right, folks. That wraps us up for today. Look forward to talking to you in the days ahead. And those that are still in the queue, I'll get back to you straight away. Thanks so much.",37,"All right, folks. That wraps us up for today. Look forward to talking to you in the days ahead. And those that are still in the queue, I'll get back to you straight away. Thanks so much."
94728,701302321,2236771,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","This concludes today's conference call. You may now disconnect.",10,"This concludes today's conference call. You may now disconnect."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Ladies and gentlemen, thank you for standing by, and welcome to the Q4 of 2020 Teradyne, Inc. Earnings Conference Call. [Operator Instructions]I would now like to hand the conference over to Mr. Andy Blanchard, Vice President of Investor Relations. Plea",44,"Ladies and gentlemen, thank you for standing by, and welcome to the Q4 of 2020 Teradyne, Inc. Earnings Conference Call. [Operator Instructions]
I would now like to hand the conference over to Mr. Andy Blanchard, Vice President of Investor Relations. Please go ahead, sir."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Sharon. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined for our discussion this morning by Teradyne's CEO, Mark Jagiela; and CFO, Sanjay Mehta. Following our opening remarks, we'll p",303,"Thank you, Sharon. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined for our discussion this morning by Teradyne's CEO, Mark Jagiela; and CFO, Sanjay Mehta. Following our opening remarks, we'll provide details of our performance for 2020's fourth quarter and full year, along with our outlook for the first quarter of 2021.
The press release containing our results was issued last evening. We are providing slides on the Investor page of the website that may be helpful to you in following the discussion. Replays of this call will be available via the same page after the call ends. The matters that we discuss today will include forward-looking statements that involve risk factors that could cause Teradyne's results to differ materially from management's current expectations. We encourage you to review the safe harbor statement contained in the earnings release as well as our most recent SEC filings. 
Additionally, those forward-looking statements are made as of today, and we take no obligation to update them as a result of developments occurring after this call. 
During today's call, we'll make reference to non-GAAP financial measures. We posted additional information concerning these non-GAAP financial measures, including reconciliation to the most directly comparable GAAP financial measure, where available, on the Investor page of our website. Looking ahead between now and our next earnings call, Teradyne will be participating in technology or industrial-focused investor conferences hosted by Goldman Sachs, Citi and Susquehanna. 
Now let's get on with the rest of the agenda. First, Mark will comment on our recent results and the market conditions as we enter the new year. Sanjay will then offer more details on our results along with our guidance for the first quarter. We'll then answer your questions, and this call is scheduled for 1 hour. Mark?"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Good morning, and thanks for joining us. In our call today, I'll summarize our Q4 and 2020 full year highlights and provide some initial comments on our outlook for 2021. Sanjay will then provide the financial details, Q1 outlook and review our updated ea",1522,"Good morning, and thanks for joining us. In our call today, I'll summarize our Q4 and 2020 full year highlights and provide some initial comments on our outlook for 2021. Sanjay will then provide the financial details, Q1 outlook and review our updated earnings model and capital allocation plans. 
Fourth quarter capped off an amazing year for Teradyne, with sales up 16% from the fourth quarter of 2019 and non-GAAP earnings per share up 25%. That brought our full year sales to just over $3.1 billion, up 36% and non-GAAP EPS to $4.62, up 62% versus 2019. These annual results, driven by strength in all of our test businesses more than made up for a soft industrial automation market that was impacted by COVID.
For the full year, our Semi Test business was especially strong, driven by investments in smartphone-related test capacity, our expansion into the compute sector of SOC with our new UltraFLEXplus product and the ramp of our Magnum EPIC product for DRAM test. 
In smartphones, global unit shipments contracted in 2020, but the growth in chipset complexity continued driving tester demand higher. Each subsystem on the phone, cellular power management, connectivity, display, cameras and application processing has its own cycle. And in 2020, both the processor and the cellular areas took big steps up in complexity. We use transistor count as a proxy for complexity, and the leading phone applications processors now exceed 10 billion transistors, growing double digits each generation. 
In 2020, we also saw the beginning of meaningful 5G silicon content, which necessitated a build-out of new tester capacity. Together, these lifted the mobility test market in 2020, roughly $200 million to about $1.7 billion. This continuous refresh of smartphone silicon should be a tailwind for the semiconductor test business for the foreseeable future. 
In 2020, we also ramped our UltraFLEXplus product in the compute portion of the SOC market. Recall, this has historically been a $500 million to $600 million market, where we've had relatively low share. With the emergence of more players and applications in the processor market, including hyperscalers and AI, we expect this sector to outgrow the general market. The plus brings a powerful value proposition in managing the unique complexity, power dynamics, yield learning and time-to-market requirements of this segment. 
For 2020, we estimate the SOC market was in the range of $3.4 billion to $3.5 billion, up from about $3.3 billion in 2019. We estimate our SOC test market share moved up 15 points to about 54%. However, our internal view of share smooths out year-on-year swings due to the unique timing of investment cycles of both our and our competitors' customers. By that measure, we estimate our normalized 2020 SOC share at about 50%. 
Another notable growth segment of our Semi Test business in 2020 was memory. In this call, a year ago, we noted a significant design win for our Magnum EPIC product in the LPDDR5 portion of the DRAM market. This new entry into DRAM test ramped through the year and combined with healthy growth in our traditional NAND business, drove a 41% increase in memory sales from 2019. We estimate the market was about $900 million in 2020, up from $600 million in 2019 and our normalized 2020 memory share at about 42%.
Beyond Semi Test, our System Test group also had a great year delivering 43% growth, with the Storage Test business more than doubling from 2019. This is the second consecutive year of hyper growth in Storage Test driven by steady test intensity growth of terabyte HDD drives and similar growth in the system level test of complex semiconductor devices. 
In our Wireless Test business at LitePoint sales grew 10% from 2019, with solid demand for both our connectivity and cellular end markets. WiFi 6, ultra-wideband test and increased investments in 5G-related handset tests all contributed. 
The performance of our test businesses more than offset the weaker results in our industrial automation business, which contracted 6% for the year. The global slowdown in manufacturing activity led to a 12% decline in sales at our Universal Robots unit. MiR, on the other hand, grew 1% as makers of ultraviolet disinfecting products recognize the value of an easier to deploy fully autonomous mobile robot. 
On a pro forma basis, AutoGuide also grew for the year. While the environment in IA was weaker than expected, the business troughed in the second quarter of 2020 and has improved dramatically in the second half, including record sales at UR in the fourth quarter. Collectively, the businesses returned to year-over-year growth in Q4, with UR growing 6% year-over-year and 41% sequential growth. With test slowing -- with test showing continued strength and industrial automation returning to growth, we are set up for another exciting year in 2021. Specifically, we are expecting a strong start to the year across all our businesses, with Q1 showing greater than 6% growth at the midpoint compared to Q1 of '19 -- sorry, Q1 of '20. 
As you know, full year visibility is always a challenge, as evidenced by our missing the strength of the test market and the decline of the IA market in our forecast just 1 year ago. That said, let me describe how we see things today, and of course, we'll keep you updated in future calls. I will preface my remarks with a note that the well-publicized surge in the forecasted semiconductor CapEx in 2021 is a very bullish sign. However, the impact on test is likely to be felt in 2022 and beyond as fab capacity built this year will drive additional testers in future years aligned to fab commissioning and ramping volumes and yields. 
In SOC test, the dynamics that made 2020 such a strong year continue into 2021. In addition, we have strengthening demand in the long dormant automotive test market with orders for our Eagle Test product line surging. Smartphone shipments are expected to grow in 2021 after contracting about 10% in 2020, and 5G content should increase. On the other hand, the SOC test market in China will likely be down in 2021 due to the expanded and full year effects of trade restrictions that were widened in 2020. Also, as always, tester demand from our largest customer will remain opaque until sometime in Q2.
Additionally, the global economic impact of COVID and its impact on electronics demand after a surge in 2020, it's hard to forecast with arguments for both positive and negative effects. Taking all of that into account, we have a bit wider range in our SOC market size estimate for 2021 at $3.3 billion to $3.8 billion, up slightly from 2020 at the midpoint. 
In memory test, the transition to LPDDR5 and DDR5 should gain momentum in 2021 and beyond. After growing about 50% in 2020, we view the memory market to be in the $800 million to $1 billion range in 2021, about even with 2020 at the midpoint. In Storage Test, the underlying demand drivers of increased density in HDD and increased complexity in semi devices driving system-level test remain in place. However, visibility is limited and annual shipments can be very lumpy. After more than tripling over the last 3 years, we expect 2021 sales to be in a band of plus or minus 20% from the 2020 level. For the rest of our test businesses, we expect growth in the 5% to 10% range in 2021. 
In Industrial Automation, 2021 is starting off on a strong footing. Barring any additional COVID-related manufacturing sector shutdowns, we expect to deliver the highest ever first quarter sales in each of our automation businesses, and we are well positioned to grow in excess of 30% for the year.
2020's results reflect well on Teradyne's strategy, execution and efficiency. Our test businesses show the successful results of R&D bets made in years past and enable us to increase those bets for the future. Our Industrial Automation investments continue undeterred by short-term impacts of COVID, and we are well positioned to capitalize on a world emerging to invest even more in automation to improve resilience and productivity. 
Equally significant, 2020 showed the resilience of Teradyne employees, our global suppliers and our operating model. In the face of unimaginable challenges across communities worldwide, the team dealt with health, safety and operation obstacles daily, met R&D milestones, executed steep new product ramps and delivered record shipments of SOC, memory and storage tech products to meet our customers' needs. We did all this while exercising the cost and schedule discipline expected at Teradyne. This is truly extraordinary, and I am very grateful to be part of such a powerful team. 
As we move into 2021, the outlook appears bright across all our markets. As Sanjay will detail, we are returning to our share repurchase program and have an active M&A pipeline. As 2020 taught us, no matter what comes our way in the short term, I am confident our global team and market strategy will deliver exciting long-term returns for our customers, investors and employees. 
Sanjay will now take you through the financial and modeling details. Sanjay?"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Mark. Good morning, everyone. Today, I'll cover the financial highlights of Q4 and review the financial details of 2020. Looking forward, I'll provide our Q1 outlook, an update to our midterm earnings model and our capital allocation plans. N",1539,"Thank you, Mark. Good morning, everyone. Today, I'll cover the financial highlights of Q4 and review the financial details of 2020. Looking forward, I'll provide our Q1 outlook, an update to our midterm earnings model and our capital allocation plans. 
Now to Q4. Revenues were $759 million, which were $19 million above the high end of the guidance range. We delivered a non-GAAP operating profit of 30% and EPS of $1.10. Semi Test revenue of $524 million was driven by SOC and memory test demand, enabling 5G handsets and higher speed flash and DRAM devices. System Test group had revenue of $104 million, down quarter-over-quarter driven by lower storage test shipments. Industrial Automation, or IA, revenue of $92 million had a seasonal increase over Q3 and delivered year-over-year growth for the first time in 2020. LitePoint revenue of $40 million was approximately flat with Q3 and down year-over-year with a decline in trailing edge connectivity products, partially offset by new sales of new connectivity technology like WiFi 6 and emerging UWB technology. 
Non-GAAP gross margins were 59%, on plan and up quarter-over-quarter due to product mix. You'll see our non-GAAP operating expenses were up $14 million to $224 million from the third quarter due to increased test spending to support design wins, higher payroll due to 4 extra days in the quarter and ongoing IA investments. We generated $222 million in free cash in the fourth quarter. The tax rate, excluding discrete items for the quarter was 13% on a GAAP basis and 14.5% on a non-GAAP basis. For the full year, it is 14.75% on a GAAP basis and 15.25% on a non-GAAP basis. We ended the year with cash and marketable securities of $1.55 billion. 
Turning to the full year results of 2020. Teradyne revenues of $3.12 billion grew $826 million or 36% year-over-year. $845 million of the growth was from our test portfolio, while IA contracted $18 million due to the pandemic-related slowdown. We had 1 customer that accounted for more than 10% of our revenue in 2020, which we'll disclose in our 10-K filing. 
Gross margins for the year were 57% and operating profit was 30%, which is up from 25% in 2019. 
Non-GAAP EPS was $4.62, an increase of 62% over 2019. We generated $684 million in free cash in 2020. 
Breaking down the components of 2020 revenues. As outlined by Mark, SOC test revenues grew $595 million or 46% on strength in mobility, market-driven by increased by device complexity and new standards like 5G along with growing growth in computing. In memory, revenues were $383 million, up 41%. While LPDDR-related DRAM revenues were a significant contributor to our results, we also continue to see strong NAND test demand through the year. 
In System Test, sales grew for the fourth year running. Revenue of $410 million grew $122 million or 43% year-over-year, primarily on growth in Storage Test for both hard disk drive and system level test. Storage Test sales were $242 million, up from $115 million in 2019. We also saw annual growth in our Defense & Aerospace component of STG. 
At LitePoint, sales grew for the fourth consecutive year to $173 million, 10% above 2019. In 2020, IA revenue was $280 million, a decline of 6% from 2019 on an as-reported basis or 9% on a pro forma basis. As Mark noted, the COVID-related driven slowdown in manufacturing impacted Universal Robots, reducing revenue to $219 million, down 12% year-over-year. 
After troughing in Q2, UR grew in the second half of 2020 versus the first half of the year. In Q4, revenue grew 6% year-over-year, giving confidence heading into 2021. MiR grew slightly year-over-year with annual sales of $45 million, and AutoGuide full year's sales grew on a pro forma basis. 
Now to our outlook for Q1. Sales are expected to be between $720 million and $780 million. Non-GAAP EPS range of $0.95 to $1.11 on 175 -- 179 million diluted shares. The first quarter guidance excludes amortization of acquired intangibles and the noncash imputed interest on the convertible debt. First quarter gross margins are estimated at 58% to 59%. First quarter OpEx, running at 29% to 31% of first quarter sales, is about flat with Q4 at the midpoint of guidance. The non-GAAP operating profit rate at the midpoint of our first quarter guidance is 29%. 
Regarding our OpEx plans for 2021, we expect our OpEx to grow 8% to 10% from 2020's $840 million. Approximately 2 points of the spend will be in the back half of the year related to travel, which we expect to resume to pre-COVID levels along with trade shows. In our test portfolio, we plan to increase our spending in engineering, sales and marketing, primarily in Semi Test. In IA, we'll continue to invest to reinforce our competitive product and ecosystem position across the sector. Also in IA, go-to-market investments will be made to support expected revenue growth. 
Turning to capital expenditures. In 2020, our CapEx was $185 million. This was used primarily for customer demonstration equipment, operations, engineering and initial spending on new facilities to replace leased ones in locations where we plan to grow over the next several years. We'll continue to invest in these new facilities in 2021, so CapEx is expected to be similar to 2020. Recall, we are buying land and developing it to eliminate lease costs and enable a more efficient spend profile over the mid- to long-term. 
For 2021, our GAAP tax rate is estimated at 15.5% and our non-GAAP tax rate is estimated at 16% based on current tax laws. 
Moving to our midterm earnings model. As you've seen with 2020, our non-GAAP EPS of $4.62, we've exceeded our 2022 earnings model 2 years early on the strength of our test businesses. We continue to have confidence in the long-term growth outlook for test, and we expect IA to return to high growth as the global industrial economy improves. When building our midterm model, given our year-on-year demand swings, we've seen both in test and IA, we use the average of 2019 and 2020 revenues as the baseline for our growth projections. From that baseline, we expect test revenue to grow 4% to 8% compounded and IA revenues to grow 20% to 35% through 2024. 
In test, we expect that growth will be driven by steady increase in device complexity across our businesses along with the high single-digit semiconductor unit growth trend line. In IA, market penetration of cobots and autonomous mobile robots and forklifts remains low, while the range of applications they economically serve continues to expand, resulting in an attractive long-term growth opportunity for Teradyne. We expect this will drive 2024 company revenue to $3.9 billion and non-GAAP EPS to $6 at the midpoint of our estimates. 
Gross margin is modeled at 58% to 59%, OpEx as a percentage of sales will decline to 28% to 29% and non-GAAP operating margin will improve to 30% to 31%. The model assumes the current tax laws are in place. 
Shifting to capital allocation. We'll continue to balance a strong cash position to support our operating investments and potential M&A with direct shareholder returns through dividends and share repurchases. We are raising our minimum cash levels from $1 billion to $1.25 billion, with the $250 million increase tied to the increased valuations of potential acquisitions.
Recall, we held $500 million for M&A and $500 million for severe economic downturn. We will also be increasing our cash balance in 2021 through 2023 to service our convertible bond, which comes due in December 2023. To date, $51 million of that bond has been redeemed early with payment planned in Q1, with the remaining face value of $409 million. 
Regarding share repurchases. In 2020, we bought back $1.5 million -- sorry, 1.5 million shares for $88 million at an average price of $58.32. Recall, we suspended our share repurchase program in April due to COVID-related uncertainty. We are replacing our prior approved program with a new share repurchase authorization of $2 billion with no fixed end date. We plan a minimum of $600 million of repurchases in 2021. As in the past, the plan has both a programmatic and opportunistic components. 
In summary, 2020 inflicted incredible human and economic hardship on societies across the world, and we're respectful of the widespread pain and loss. When the pandemic hit, I noted our priorities were the safety of our employees, supporting our customers and continued execution in achieving our financial objectives. The Teradyne community responded with a collaborative and supportive spirit, incredible energy, ingenuity and purpose, which delivered on all 3 of these priorities. I'm incredibly proud and thankful to be part of this team. 
We enter 2021 in the strongest position in our history. The work in 2020 has made us more resilient and prepared us for the strong market demand that we currently see in both test and IA. While our visibility for the full year is limited, we're confident in the underlying market fundamentals, our competitive, diversified portfolio and our team, which will enable long-term growth prospects for the markets we serve. Collectively, we're excited to turn our new financial model into reality. 
With that, I'll turn things back to Andy."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Sanjay. Operator, we'd now like to take some questions. [Operator Instructions]",12,"Thanks, Sanjay. Operator, we'd now like to take some questions. [Operator Instructions]"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","[Operator Instructions] First question comes from Krish Sankar with Cowen.",10,"[Operator Instructions] First question comes from Krish Sankar with Cowen."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, I had two of them. First one, thanks for the color on calendar '21. I'm just kind of curious if you could peel the SOC Test market a little more to say, how much do you think mobility will be? And how much do you think Auto Test would be this year o",61,"Mark, I had two of them. First one, thanks for the color on calendar '21. I'm just kind of curious if you could peel the SOC Test market a little more to say, how much do you think mobility will be? And how much do you think Auto Test would be this year on SOC? And then I have a follow-up."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So good question. Certainly, auto is going to be up sequentially in 2020. We've talked about that market being at a normalized -- let's say, maybe more of a peak run rate in the $400 million to $500 million range. It's been down to sort of $200 milli",162,"Yes. So good question. Certainly, auto is going to be up sequentially in 2020. We've talked about that market being at a normalized -- let's say, maybe more of a peak run rate in the $400 million to $500 million range. It's been down to sort of $200 million last year. So this year, that should be up at least $150 million, maybe $200 million. It's really right now a bit of a rush for capacity. And we don't know exactly when the demand profile of the orders are going to taper off here. So it could go higher if this persists. So that's the color on auto. 
In mobility, I think it's harder for us to see that at the moment because of the significant impact of our largest customer on both us and the market, which doesn't really become solidified until April-ish of the year. So we're looking at it sort of flat, plus or minus $100 million in mobility."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Got it. That's very helpful, Mark. And then just as a follow-up on the IA side. You mentioned 30-plus-percent growth, should we assume a big driver of that is going to be UR? In other words, UR should be higher than 30%? Or do you think UR is goin",59,"Got it. Got it. That's very helpful, Mark. And then just as a follow-up on the IA side. You mentioned 30-plus-percent growth, should we assume a big driver of that is going to be UR? In other words, UR should be higher than 30%? Or do you think UR is going to be in line with Industrial Automation growth?"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that's a good question. I think all of the groups are going to be better than 30%. And some of them like AutoGuide are small. So I think they'll pull up the average, albeit ahead of UR. And MiR and UR should be about the same for the year.",52,"Yes. I think that's a good question. I think all of the groups are going to be better than 30%. And some of them like AutoGuide are small. So I think they'll pull up the average, albeit ahead of UR. And MiR and UR should be about the same for the year."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Mehdi Hosseini with SIG.",8,"Next question comes from Mehdi Hosseini with SIG."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","I just want to go back to your SOC commentary. I'm a little bit surprised with your kind of flattish outlook. And I say that because millimeter wave is expected to account for a larger mix of the 5G phones. And I believe last year was just the early inves",71,"I just want to go back to your SOC commentary. I'm a little bit surprised with your kind of flattish outlook. And I say that because millimeter wave is expected to account for a larger mix of the 5G phones. And I believe last year was just the early investment. So why isn't the increased penetration of millimeter wave phone not giving you that incremental confidence? And I have a follow-up."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that's certainly a balloon for the year, Mehdi. Maybe we're going to double the number of millimeter wave-enabled phones in 2021. But yes, last year, if you recall, there was also a significant step-up in the hundreds of millions of units of",143,"Yes. I think that's certainly a balloon for the year, Mehdi. Maybe we're going to double the number of millimeter wave-enabled phones in 2021. But yes, last year, if you recall, there was also a significant step-up in the hundreds of millions of units of millimeter wave-enabled phones were brought to market last year. So if you add another 200 million to 300 million additional millimeter wave-enabled units this year and, let's say, that brings the global total to 600 million units out of 1.4 billion, you're essentially adding about as much capacity, maybe a little bit more because there'll be more than -- let's say, last year, added 250 million, this year, might add 350 million units. So yes, there will be a little bit of growth in additional millimeter wave test capacity. But last year was a pretty big year, too."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And then looking at the midterm model 2024. What are the key underlying assumption for market share, especially as you try to capitalize on the synergies between Semi and a System Test? And in that context, are you accounting for any incremental s",51,"Got it. And then looking at the midterm model 2024. What are the key underlying assumption for market share, especially as you try to capitalize on the synergies between Semi and a System Test? And in that context, are you accounting for any incremental share shift in the GPU end market?"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Mehdi, it's Sanjay. Yes. So in the earnings model, we see, obviously, growth in the market. As Mark alluded to, more players are coming into the compute space that we can address. And with that, we feel that with the UltraFLEXplus solution, we're ver",110,"Yes. Mehdi, it's Sanjay. Yes. So in the earnings model, we see, obviously, growth in the market. As Mark alluded to, more players are coming into the compute space that we can address. And with that, we feel that with the UltraFLEXplus solution, we're very well positioned, and we are projecting share growth. When we think about from a memory perspective, if you go back, let's say, 10 years, we've been on this steady increase of memory share growth, where as we continue to execute, we see continued share growth on that perspective as well. So really, growth in market size as well as continued share growth are our drivers."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","That includes the synergy between different sectors or segments?",9,"That includes the synergy between different sectors or segments?"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","You want to expand on that question?",7,"You want to expand on that question?"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Yes. Just going back to the question. I see opportunities between your Semi and a System Test, especially as the system-level test diversifies. And I'm just wondering if that's baked into your 2024 model?",34,"Yes. Just going back to the question. I see opportunities between your Semi and a System Test, especially as the system-level test diversifies. And I'm just wondering if that's baked into your 2024 model?"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Okay. Thanks for the clarification. Yes, it is. With device complexity, we were going 5-nanometer and then to 3-nanometer, I think both system-level test as well as ATE test take that into account.",34,"Yes. Okay. Thanks for the clarification. Yes, it is. With device complexity, we were going 5-nanometer and then to 3-nanometer, I think both system-level test as well as ATE test take that into account."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Toshiya Hari with Goldman Sachs.",9,"Next question comes from Toshiya Hari with Goldman Sachs."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, I wanted to ask about your largest customer. I appreciate things will remain pretty fuzzy or opaque, as you said, until sort of the April-ish time frame. But can you sort of walk us through the potential range of outcomes you're thinking internally?",89,"Mark, I wanted to ask about your largest customer. I appreciate things will remain pretty fuzzy or opaque, as you said, until sort of the April-ish time frame. But can you sort of walk us through the potential range of outcomes you're thinking internally? Obviously, you've got units, you've got transistor density as it relates to the new chip. Also curious if their efforts on the notebook side of their business, in-sourcing CPUs, could have an impact on your business as well? And then I've got a quick follow-up."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Okay. I always am a bit reluctant to be too specific on any 1 customer. So I'm going to speak more to the segment a bit, which I'll bundle compute and mobility together here. So yes, last year was incredibly strong in both our traditional mobility market",211,"Okay. I always am a bit reluctant to be too specific on any 1 customer. So I'm going to speak more to the segment a bit, which I'll bundle compute and mobility together here. So yes, last year was incredibly strong in both our traditional mobility market because of the complexity growth of phones, which we alluded to and the fact that we did enter compute as a new segment. So we ended up with additional revenues in compute last year, that north of $50 million for the first year in that market.
So as we think about this year, the issue of smartphone unit growth and complexity growth of the apps processor, the camera systems and such in the phones is part of the equation. And we have a reasonably good read on that. 
On the compute side, there's a lot of moving parts there. And there's a lot -- since it's a new market for us and a new market for some of our customers, that has the bigger range of potential outcomes for the year. So that's the one we're triangulating on. That could be up significantly over last year. It could be up modestly over last year. But at this point, we really can't be too specific."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And then as a quick follow-up. On Industrial Automation, I wanted to ask about the profit margin profile of the business, where does it stand today, I guess, as of 2020? You guys have done a great job in improving gross margin at UR and the other",88,"Got it. And then as a quick follow-up. On Industrial Automation, I wanted to ask about the profit margin profile of the business, where does it stand today, I guess, as of 2020? You guys have done a great job in improving gross margin at UR and the other businesses that you've acquired over the past couple of years. At the same time, you've been aggressively spending from an OpEx perspective. So in your 2024 model, what sort of margin profile for IA is embedded in your numbers?"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","It's Sanjay. So IA as a whole this year was roughly just a bit better than breakeven. Obviously, with the COVID impact on multiple businesses and the contraction in UR, we're just above breakeven. But fundamentally, we continue to invest in the portfolio,",128,"It's Sanjay. So IA as a whole this year was roughly just a bit better than breakeven. Obviously, with the COVID impact on multiple businesses and the contraction in UR, we're just above breakeven. But fundamentally, we continue to invest in the portfolio, the ecosystem, the go-to-market for product and differentiation, ease of implementation. And so you should expect that to continue over the midterm, and we're focused on driving the revenue growth and the investments. 
And so with that, we expect the margin profile to be roughly consistent with the current profile as we -- as AutoGuide is relatively new to the organization, just over a year, we expect that to improve with our Teradyne supply chain as well as other quality processes we step in."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Just one thing I'm going to add on to that commentary around the Industrial Automation business to remind people that what we focus on right now during the high growth phase of that business is sales growth and gross margin. And the bottom line, as Sanjay",147,"Just one thing I'm going to add on to that commentary around the Industrial Automation business to remind people that what we focus on right now during the high growth phase of that business is sales growth and gross margin. And the bottom line, as Sanjay mentioned, if we're at breakeven, we're happy as long as we can sort of adhere to or exceed the rule of 40. And through the midterm, we think we expect to be close to that kind of up top line growth rates. And what we bring down to the bottom line will kind of depend on the size of the growth, what we see ahead of us. And if we're growing at 50% and breakeven, we are happy as clams. And if the growth rates come down below 20%, we'll start dropping more and more down to the bottom line."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Joe Moore with Morgan Stanley.",9,"Next question comes from Joe Moore with Morgan Stanley."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Following on the last question. Can you just characterize the tone of business for the Universal Robotics business? And I guess in the context of -- it feels like a lot of the business activity in the last 12 months is business continuity and supply chain",101,"Following on the last question. Can you just characterize the tone of business for the Universal Robotics business? And I guess in the context of -- it feels like a lot of the business activity in the last 12 months is business continuity and supply chain disruption, maybe that's negative for new technologies and manufacturing. At the same time, I would think social distancing and stuff like that as an opportunity for you. So just kind of characterize those puts and takes, and just what that tells you about what the trends may look like over the course of this year."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Sure. It's Sanjay here. So in the short run, we actually saw a contraction as evidenced by how our revenues were. However, I think your comments hit home with regards to plant and warehouse decision-makers seeking to build resilience into their suppl",89,"Yes. Sure. It's Sanjay here. So in the short run, we actually saw a contraction as evidenced by how our revenues were. However, I think your comments hit home with regards to plant and warehouse decision-makers seeking to build resilience into their supply chains. And we view that over the midterm as a tailwind. We are seeing the market obviously come back with Universal Robots. We've talked in our prepared remarks about the automotive and electronics industry. And then we're also seeing strength in a couple of other verticals."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from C.J. Muse with Evercore.",9,"Next question comes from C.J. Muse with Evercore."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","I wanted to follow-up on Mehdi's question regarding your 2024 model. So if I look at your implied Semi Test revenues versus 2020 actual, you're up about $250 million to $350 million, which seems conservative, particularly when you reflect on what you're d",86,"I wanted to follow-up on Mehdi's question regarding your 2024 model. So if I look at your implied Semi Test revenues versus 2020 actual, you're up about $250 million to $350 million, which seems conservative, particularly when you reflect on what you're doing with system-level test, new UltraFLEXplus. So can you, I guess, walk through what assumptions you're making in terms of market share for both SOC and memory implied in that number? And where you might point to as areas that might be conservative?"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that as I articulated from -- I'll touch on memory first. Our share right now is in the low 40s. We see that -- we could see that growing to the mid-40s in the plan. And then from an SOC perspective, Mark talked about a normalized share level",62,"Yes. I think that as I articulated from -- I'll touch on memory first. Our share right now is in the low 40s. We see that -- we could see that growing to the mid-40s in the plan. And then from an SOC perspective, Mark talked about a normalized share level of about 50%. And we see that increasing over the midterm."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","But within the implied model, are you assuming the 50% or the 60% that Mark spoke about back in July as to what a goal could look like?",28,"But within the implied model, are you assuming the 50% or the 60% that Mark spoke about back in July as to what a goal could look like?"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","So yes, I think what we've been saying, C.J., is that we can get about 1 point to 1.5 points a share growth a year. So by 2024, as I mentioned, I think our normalized share is somewhere around 50%. We should be up around 55%, 56% by then in SOC.And in m",188,"So yes, I think what we've been saying, C.J., is that we can get about 1 point to 1.5 points a share growth a year. So by 2024, as I mentioned, I think our normalized share is somewhere around 50%. We should be up around 55%, 56% by then in SOC.
And in memory, share was a little chunkier because there's only a few players there. So on the memory side, we could be in the mid to upper mid-40s by then, I would say, is one way to think about it.
But the other piece of color in terms of aggressive versus conservative that I'd add here is the recent investment profile of the front end with CapEx moving up into the $70 billion range, is something we haven't modeled into our midterm plan. We've assumed that incremental fab capacity across the midterm would be sort of consistent with the rate that it's been added for the prior 4 years. So if $70-plus billion of investment in WFE is the new normal for the next 4 years, that's certainly going to drive more tests than we modeled."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Very helpful. As my follow-up, can you speak to what we should be thinking about for SOC Test gross margins here in '21 versus 2020? I'm trying to get a sense of what uplift might look like, particularly from Eagle Test.",41,"Very helpful. As my follow-up, can you speak to what we should be thinking about for SOC Test gross margins here in '21 versus 2020? I'm trying to get a sense of what uplift might look like, particularly from Eagle Test."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","I mean gross margins, we -- you should expect a relatively consistent with how we've guided Q1 and in our long-term model.",22,"I mean gross margins, we -- you should expect a relatively consistent with how we've guided Q1 and in our long-term model."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Brian Chin with Stifel.",8,"Next question comes from Brian Chin with Stifel."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Maybe the first question, back on the topic of Industrial Automation. Automotive has historically been a key portion of sales here. And I was curious, do you expect or even need the auto portion of your sales to grow 30% year-over-year, given sort of the",55,"Maybe the first question, back on the topic of Industrial Automation. Automotive has historically been a key portion of sales here. And I was curious, do you expect or even need the auto portion of your sales to grow 30% year-over-year, given sort of the increasing breadth of market adoption that you might be seeing?"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that with an emerging market, there's still a lot of footprint to cover, so we expect that to continue in the automotive vertical as well as electronics and industrials as well as other verticals.",37,"Yes. I think that with an emerging market, there's still a lot of footprint to cover, so we expect that to continue in the automotive vertical as well as electronics and industrials as well as other verticals."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Yes, I was just sort of get -- trying to gauge whether you're seeing a lot of adoption outside of auto? And is it -- in terms of visibility, you're starting the year with pretty good visibility. Is auto kind of starting from a similar point? Or is i",78,"Okay. Yes, I was just sort of get -- trying to gauge whether you're seeing a lot of adoption outside of auto? And is it -- in terms of visibility, you're starting the year with pretty good visibility. Is auto kind of starting from a similar point? Or is it kind of more -- a little bit more on the whole to start the year, and you're going to expect a bigger snap back later in the year?"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. We're seeing also -- we're seeing market drivers in our verticals, adoption and education. R&D, pharma as well as life sciences. But from a starting point, obviously, we have a very strong incumbent installed base over the years that we've built in t",46,"Yes. We're seeing also -- we're seeing market drivers in our verticals, adoption and education. R&D, pharma as well as life sciences. But from a starting point, obviously, we have a very strong incumbent installed base over the years that we've built in the auto vertical."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","And I'd just add to that, that certainly, automotive was one of the most hard hit aspects of UR's business. Automotive has been running in the high 30s, 40% of the business coming into 2020. That contracted dramatically because of COVID, down to the point",171,"And I'd just add to that, that certainly, automotive was one of the most hard hit aspects of UR's business. Automotive has been running in the high 30s, 40% of the business coming into 2020. That contracted dramatically because of COVID, down to the point that it was in the low 20s. And I would say it's certainly, at this point, although back and growing, it hasn't come back yet to where it should be in our portfolio. This has issues around the semiconductor supply chain and other things have sort of crimped some of the ambitions of car companies to ramp volumes here. There's a little bit to go still.
But our footprint over time, since we acquired UR has been reducing in the automotive segment, not so much because automotive is not growing, of course, but it's just that our expansion into the other areas that Sanjay mentioned has been. And we expect over time that automotive component will continue to decline as a percentage of our sales."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Great. Yes. I was sort of getting maybe at that. And then in the 2024 model, granted it's 4 years out, but can you give us sort of a rough sense of how much of the IA sales might be AMR or mobile vehicle driven? I think the split roughly is kind of 80% UR",73,"Great. Yes. I was sort of getting maybe at that. And then in the 2024 model, granted it's 4 years out, but can you give us sort of a rough sense of how much of the IA sales might be AMR or mobile vehicle driven? I think the split roughly is kind of 80% UR, 20% mobile at the moment. Could that be sort of like a 2/3, 1/3 in that time frame?"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that, obviously, UR, we've had for a little bit longer, and it is a larger percentage. But I think you're spot on that the AMR portion will grow with AutoGuide and MiR as a percentage of revenue.",40,"Yes. I think that, obviously, UR, we've had for a little bit longer, and it is a larger percentage. But I think you're spot on that the AMR portion will grow with AutoGuide and MiR as a percentage of revenue."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Atif Malik with Citi.",8,"Next question comes from Atif Malik with Citi."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Good job on results and guide. Mark, the first one, following up on the last question, AutoGuide, how is adoption going at larger enterprises and warehouse customers? And then I have a follow-up.",33,"Good job on results and guide. Mark, the first one, following up on the last question, AutoGuide, how is adoption going at larger enterprises and warehouse customers? And then I have a follow-up."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Good question. So to be frank with you, we had a good year. We grew 50-ish-percent in the year, but we didn't hit our target. And part of this is extended evaluations at the large accounts that you're referencing. And it's been very difficult in a sm",196,"Yes. Good question. So to be frank with you, we had a good year. We grew 50-ish-percent in the year, but we didn't hit our target. And part of this is extended evaluations at the large accounts that you're referencing. And it's been very difficult in a small business like AutoGuide's case in a COVID area to acquire new customers and get the pilot production validation work done in the same time frame that we could have gotten it done in a non-COVID world.
So we've seen some extension of those evals, but we're in some of the boutique name brands for evals that you would hope we are in, in both the industrial manufacturing side as well as the e-commerce side and logistics side of life.
So we're hoping that this year is going to be the big breakout year. It's the kind of business that should at least be doubling, if not more, once these big accounts latch. But we did -- if any place sort of had a big impact from COVID last year, it was AutoGuide because of the whole -- new customer acquisition is the whole game there at this point."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Great. And as a follow-up, you mentioned the China SOC Test to be down this year, which makes sense given the restrictions from last year, but some of the front end peers have talked about maybe flattish China investments on the front end and back end is",75,"Great. And as a follow-up, you mentioned the China SOC Test to be down this year, which makes sense given the restrictions from last year, but some of the front end peers have talked about maybe flattish China investments on the front end and back end is different. Can you just walk us through the components on where China investments are down? And why you aren't benefiting on some of the mature technologies and nodes?"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So if you look at China, I think you need to separate memory and SOC because it's quite different. On the memory side, there will be growth in China this year in test as well and we -- or we expect that at least. And so that's a healthy, growing midt",170,"Yes. So if you look at China, I think you need to separate memory and SOC because it's quite different. On the memory side, there will be growth in China this year in test as well and we -- or we expect that at least. And so that's a healthy, growing midterm profile, I'd say, for China. 
On SOC, it's really a little bit more difficult to see growth occurring this year because the impact of the trade restrictions on Huawei and HiSilicon are tremendous in terms of their buying power in the market historically. What they buy in both silicon and then test capacity for that silicon has been severely hampered. And then further restrictions on other companies like SMIC and such are much smaller factors, but tail or headwinds against growth.
So I think SOC is likely to contract. Memory is going to grow. But net-net, it's not going to be hugely down, but it will probably be down a little bit on the test side of life."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Vivek Arya with Bank of America.",10,"Next question comes from Vivek Arya with Bank of America."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","I had two, one on operating leverage and the second on M&A. On operating leverage, Sanjay, I believe you mentioned OpEx growth of 8% to 10% this year. Do you think there is a potential to still drive leverage with that kind of growth? And then when I look",110,"I had two, one on operating leverage and the second on M&A. On operating leverage, Sanjay, I believe you mentioned OpEx growth of 8% to 10% this year. Do you think there is a potential to still drive leverage with that kind of growth? And then when I look at your 2024 model, you're keeping operating margins at about 30%, 31%, kind of where you are already, even though sales are expected to grow, and Mark had outlined a number of interesting growth drivers. So I was hoping you could talk to operating leverage this year, and then what would be the drivers as you look at your '24 model?"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Okay. Sure. Yes. So obviously, it's another -- it's an investment year. And I think in my prepared remarks, I noted that we're getting back to travel and trade shows, which is a key point. You really -- if you look at it in 2 portfolios, we -- for the yea",188,"Okay. Sure. Yes. So obviously, it's another -- it's an investment year. And I think in my prepared remarks, I noted that we're getting back to travel and trade shows, which is a key point. You really -- if you look at it in 2 portfolios, we -- for the year, we're going to have leverage in the test business, where the growth in OpEx as a percentage will be lower, but the growth in the IA space, the OpEx growth is higher. And so the leverage from a -- like we're growing in the IA space, but we will see -- we should see a degree of leverage in the short-term in the test business.
When you cascade that out to 2024, obviously, with the revenues that we're predicting in IA, I think Mark described it well. If we're growing at 50% and have a forecast to continue to grow, we'll continue to drive the investment. But as the growth starts to go down, let's say, below the rule of 40, then we'll start to drop more to the bottom line. That's how we're thinking about it."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","But when I look at that '24 model, right, you're forecasting overall sales to grow at a 6% CAGR from the 2020 level. So that is below the 16% CAGR you have been at. And you're saying operating margins are going to stay pretty much flattish versus -- I'm j",105,"But when I look at that '24 model, right, you're forecasting overall sales to grow at a 6% CAGR from the 2020 level. So that is below the 16% CAGR you have been at. And you're saying operating margins are going to stay pretty much flattish versus -- I'm just puzzled as to if you're saying sales are not really going to grow as much as they have grown in the last 3, 4 years and operating margins are not going to expand from here, is that model very conservative? Or what needs to be done to either grow faster or drive more operating leverage?"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that -- well -- and that's why in my prepared remarks, I comment, we looked at the model, not just off of a point of 2020, but off of an average of '19 and '20, just given the significant balloon in 2020 tied to the mobility space and then th",100,"Yes. I think that -- well -- and that's why in my prepared remarks, I comment, we looked at the model, not just off of a point of 2020, but off of an average of '19 and '20, just given the significant balloon in 2020 tied to the mobility space and then the contraction in IA. And when you look at it from an average of '19 and '20, we believe in that growth -- overall growth of the 4% to 8%. And then we are, during that period, going to be growing out the investments in the IA portfolio."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","And I would just say, if you go back to what we said, if you look at that pie chart of the mix. When we get out to 2024, IA should be a bigger mix of our revenue than test. So test will continue to grow. It will have a very high drop-through. It will be v",161,"And I would just say, if you go back to what we said, if you look at that pie chart of the mix. When we get out to 2024, IA should be a bigger mix of our revenue than test. So test will continue to grow. It will have a very high drop-through. It will be very efficient. And if that's all you're looking at, yes, bottom line profitability should increase.
But on the IA side, it's more likely that we'll be growing more rapidly, and we'll be pulling up gross margins for the enterprise with the IA business. But on the bottom line, we're being a bit conservative on how much we plan to drop-through there because we want to keep investing for more and more growth. So it kind of just depends on what's the investment profile in IA. And we've modeled in -- we're not going to optimize for profit in the midterm there, we're optimizing for growth."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Understand. And Mark, just a follow-up to that. You mentioned the prospects for some additional M&A. I presume it's in the IA side of the business, but I was hoping you would talk to that. Do you -- are you contemplating kind of smaller tuck-in technology",88,"Understand. And Mark, just a follow-up to that. You mentioned the prospects for some additional M&A. I presume it's in the IA side of the business, but I was hoping you would talk to that. Do you -- are you contemplating kind of smaller tuck-in technology type transactions? Are you thinking about something that could be bigger and could require the use of stock, just how we should think about what M&A pipeline is and how it could impact this baseline model that you have set for us?"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So most of what we have in our pipeline is consistent with the kind of things we've been investing in and acquiring in the past 5 to 6 years, Industrial Automation, modestly sized investments, let's say, relative to our market cap. However, we have e",135,"Yes. So most of what we have in our pipeline is consistent with the kind of things we've been investing in and acquiring in the past 5 to 6 years, Industrial Automation, modestly sized investments, let's say, relative to our market cap. However, we have expanded our aperture a bit to look in the test space and areas that are correlated to test, which bring with it potentially some larger M&A things. It's always governed by the same rich internal rate of return metrics that we always use on these things.
So whatever we do is going to be something that's more attractive to the -- our investors than buying back our stock or those kind of -- our internal weighted cost of capital. So that's about all I think I can say about that."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from Timothy Arcuri with UBS.",8,"Next question comes from Timothy Arcuri with UBS."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","I had a couple. So for OpEx this year, you're saying it's going to grow about 8% to 10%. So at the midpoint, you're going to grow OpEx about $76 million. I'm wondering, Sanjay, if you can tell us how much of that's going to come in IA? And I guess another",139,"I had a couple. So for OpEx this year, you're saying it's going to grow about 8% to 10%. So at the midpoint, you're going to grow OpEx about $76 million. I'm wondering, Sanjay, if you can tell us how much of that's going to come in IA? And I guess another way of asking that is sort of what sort of op margin do you think you can do this year in IA? I mean you were basically breakeven last year. Can you get to high single digits this year? And is 10% to 15% still the long-term target for that business? I know that Mark's commenting that if growth slows, you can sort of crank back on OpEx and you can drop more. But just wondering if you can comment there. And then I had a follow-up."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Sure. Yes. I think it's spot on. I think when you take out the travel and the trade shows, the majority of the spend will come in OpEx from -- on a year-over-year basis. And from a profit perspective, we're assuming growth, and we expect to improve back t",92,"Sure. Yes. I think it's spot on. I think when you take out the travel and the trade shows, the majority of the spend will come in OpEx from -- on a year-over-year basis. And from a profit perspective, we're assuming growth, and we expect to improve back to our original growth plans. Like if you think about 2020 as the anomaly and you look at the jump-off point of 2019, we were about a 10% profit level. With our growth, we should be in that similar level going forward in 2021."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Got it. So you think you can get to 10% op margin this year?",15,"Okay. Got it. So you think you can get to 10% op margin this year?"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes, plus or minus, but yes.",6,"Yes, plus or minus, but yes."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Okay. Great. And then, I guess, a question for you, Mark. So when you were going to your top customer, you presented a couple of scenarios. I know it's very tough to predict. But the scenarios you presented didn't include that revenue from that cust",182,"Okay. Okay. Great. And then, I guess, a question for you, Mark. So when you were going to your top customer, you presented a couple of scenarios. I know it's very tough to predict. But the scenarios you presented didn't include that revenue from that customer is down. I get that the compute piece is going to be up, but they're also not going to shrink this year. And in the past, that's been sort of a harbinger of a potential decline in the number of testers they buy unless they're willing to live with a much larger die size, which may or may not be the case. So I'm just kind of wondering -- I'm not asking for any specifics on that customer. I'm just sort of wondering if you can look back in the past and draw in your past experience and say, well, yes, in the past, when that happens, that is sort of a harbinger of the potential that it could be down because you didn't present that as a down or as a possible outcome this year?"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think it's a possible outcome, but let me go back to what I was outlining in my remarks. When you look at the phone, there's various elements of the phone in terms of technology, dapps processors, the modem, the cameras, the memory, those areas of",198,"Yes. I think it's a possible outcome, but let me go back to what I was outlining in my remarks. When you look at the phone, there's various elements of the phone in terms of technology, dapps processors, the modem, the cameras, the memory, those areas of the phone refresh and take leaps of complexity in different cadences. And in 2020, the apps processor and 5G -- basically, the apps processor had a big jump in complexity, and 5G proliferated throughout all the phones.
So as you look at 2021, the need for incremental 5G capacity, whereas in 2020, several, let's say, 100 million units worth of phones needed 5G capacity. This year, it will be less because the incremental unit growth there is one factor in incremental 5G capacity plus complexity growth of the 5G modem itself. So 5G is big in 2020, not as big in 2021. 
That leaves what's happening with the cameras, what's happening with power management, what's happening with the screen resolution. Other things could be balloons that pull it back up. But I do think you do have that -- 5G has happened for that one area of our mobility customer base."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","And operator, we have time for just one more question, please.",11,"And operator, we have time for just one more question, please."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","Last question comes from John Pitzer with Crdit Suisse.",9,"Last question comes from John Pitzer with Crdit Suisse."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, my first question is just on the whole China dynamic. You're clearly guiding it to be down this year. I'm kind of curious if there is a date on between U.S.-China relations, is that a zero-sum game, an exercise in market shift? Or do you think it wo",111,"Mark, my first question is just on the whole China dynamic. You're clearly guiding it to be down this year. I'm kind of curious if there is a date on between U.S.-China relations, is that a zero-sum game, an exercise in market shift? Or do you think it would be accretive? And I guess more importantly, we're now seeing the U.S. government kind of incentivize domestic production of semis. I'm just kind of curious as to whether or not you could benefit from that, either indirectly as some of your customers build capacity domestically, or directly as we think about your long-term tax rate? And then I've got a quick follow-up."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Okay. So China. If for some reason, the restrictions on China ease and more indigenous Chinese makers start to grow again, I think it's neutral. As business shifted out of China in 2020, it was pretty much neutral to us. There was -- the customers that pi",219,"Okay. So China. If for some reason, the restrictions on China ease and more indigenous Chinese makers start to grow again, I think it's neutral. As business shifted out of China in 2020, it was pretty much neutral to us. There was -- the customers that picked up the manufacturing of, let's say, applications processors or modems that would have been done by indigenous Chinese suppliers or Teradyne customers and Advantest customers and a proportion that isn't that different than it was in China. So as it ebbs and flows back and forth, I wouldn't say there's a big ramification. 
On the U.S. domestic supply question, I think it's going to take a long time and many, many years of a steadfast set of incentives from the government for that to mature to something significant to our business.
If we stick at that in the U.S. for 7, 8 years and really build up an infrastructure to manufacture semiconductors domestically, I think it could have a bit of a positive impact, but I think it's small. I don't think because semiconductors might be manufactured in the U.S., all of a sudden, there's a propensity that they're going to buy more Teradyne equipment. It's at the margin, but nothing I would bake in as a trend line to count on."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Analysts","That's helpful. And then just as my follow-up, going back to the 2024 model. Your explanation as to kind of how you're getting to the op profit targets you're getting to makes a ton of sense.I'm just kind of curious, to the extent that the top line prov",96,"That's helpful. And then just as my follow-up, going back to the 2024 model. Your explanation as to kind of how you're getting to the op profit targets you're getting to makes a ton of sense.
I'm just kind of curious, to the extent that the top line proves to be conservative, how should we think about incremental operating margins above sort of the high end of the target model? Or maybe another way of thinking about it, as IA gets scale, where do we think the longer-term op margin of the business can go?"
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think that if the test business -- if what drives the incremental revenue, if the test businesses come to fruition, I think you'll see a higher drop-through. If and again, just to repeat myself, if we're growing and we see continued growth, and we'",124,"Yes. I think that if the test business -- if what drives the incremental revenue, if the test businesses come to fruition, I think you'll see a higher drop-through. If and again, just to repeat myself, if we're growing and we see continued growth, and we're going to continue to invest in IA, that drop-through may be lower. But let's say, it comes -- let's say, the revenues grow significantly over the first couple of years. And then at the end, they start to -- the growth starts to tail down, you may see a little bit more leverage. But it's really -- we have to see how the market unfolds in IA. But over the short term, we are planning a significant investment."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Executives","All right, folks. That wraps us up for today. Look forward to talking to you in the days ahead. And those that are still in the queue, I'll get back to you straight away. Thanks so much.",37,"All right, folks. That wraps us up for today. Look forward to talking to you in the days ahead. And those that are still in the queue, I'll get back to you straight away. Thanks so much."
94728,701302321,2236774,"Teradyne, Inc., Q4 2020 Earnings Call, Jan 28, 2021",2021-01-28,"Earnings Calls","Teradyne, Inc.","Operator","This concludes today's conference call. You may now disconnect.",10,"This concludes today's conference call. You may now disconnect."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Ladies and gentlemen, thank you for standing by, and welcome to the Q1 2021 Teradyne Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Andy Blanchard. Thank you, sir. You may begin.",41,"Ladies and gentlemen, thank you for standing by, and welcome to the Q1 2021 Teradyne Earnings Conference Call. [Operator Instructions] 
I would now like to hand the conference over to your speaker today, Andy Blanchard. Thank you, sir. You may begin."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, April. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined this morning by our CEO, Mark Jagiela; and our CFO, Sanjay Mehta. Following our opening remarks, we'll provide details of our p",306,"Thank you, April. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined this morning by our CEO, Mark Jagiela; and our CFO, Sanjay Mehta. Following our opening remarks, we'll provide details of our performance for 2021's first quarter, along with our outlook for the second quarter of '21. The press release containing our first quarter results was issued last evening. We're providing slides on the investor page of the website that may be helpful to you in following the discussions. Replays of this call will be available via the same page after the call ends. 
The matters that we discuss today will include forward-looking statements that involve risk factors that could cause Teradyne's results to differ materially from management's current expectations. We encourage you to review the safe harbor statement contained in the earnings release as well as our most recent SEC filings. Additionally, these forward-looking statements are made as of today, and we take no obligation to update them as a result of developments occurring after this call. 
During today's call, we'll make reference to non-GAAP financial measures. We've posted additional information concerning these non-GAAP financial measures, including reconciliation to the most directly comparable GAAP financial measure were available on the Investor page of the website. Looking ahead between now and our next earnings call, Teradyne expects to participate in technology or industrial-focused investor conferences hosted by Wolfe Research, ISI Evercore, Baird, Bank of America, Bernstein and Stifel. 
Now let's get on with the rest of the agenda. First, Mark will comment on our recent results and the market conditions as we enter the new quarter. Sanjay will then offer more details on our quarterly results along with our guidance for the second quarter, and we'll then answer your questions. 
The call is scheduled for 1 hour. Mark?"
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Hello, everyone, and thanks for joining us today. In my remarks, I'll summarize our Q1 results, review current market conditions and provide an update on how we're looking at Q2 and the full year. Sanjay will then take you through the financial details of",1219,"Hello, everyone, and thanks for joining us today. In my remarks, I'll summarize our Q1 results, review current market conditions and provide an update on how we're looking at Q2 and the full year. Sanjay will then take you through the financial details of the quarter and our outlook for the second quarter. As you saw in our press release, our Q1 sales and profits grew double digits from Q1 of 2020's record level. Test sales grew 9% on broad-based demand with notable strength in automotive, industrial compute, memory and storage. Industrial Automation sales grew 33% in the quarter with strong demand at both UR and MiR. Notably, since our January call, the market demand in both Test and IA has been greater than we expected, as you can see from our Q2 guidance. In Semiconductor Test, customer orders are very strong as complexity continues to increase and chip units are expected to grow almost 15% this year, more than twice last year's rate. Regarding the sustainability of this demand, our visibility is limited to just a quarter or 2 but the growth in WFE from $50 billion in 2017 to $60 billion last year to over $75 billion this year should translate into a healthy tester market in the years ahead. 
Looking at SOC demand, the auto industrial segment is especially robust, with our Q1 Eagle shipments up nearly 90% year-on-year, and deliveries expected to grow further in Q2. Test demand for mobility and compute devices is also running ahead of our January estimates as these end markets push the performance limits of advanced process nodes and drive the highest complexity growth. This higher complexity drives longer chip test times and often demand's unique tester capabilities. Our UltraFLEX platforms are well aligned to these performance dynamics. 
As a result of this demand strength, we now expect the SOC test market to be in the $4 billion to $4.4 billion range, up about $700 million at the midpoint from our January estimate. This equates to about 16% growth from 2020, and we expect our share in SOC to be at about the 50% level. In memory test, we are seeing continued strength in both flash and DRAM. We now expect the full year memory test market to be in the $900 million to $1.1 billion range, up about $100 million from our January estimate and up about 5% from 2020 levels. 
Our Magnum platform is in lockstep with the performance trends in both markets, and we expect another strong year in 2021. However, since most of the test market growth is expected to be wafer test applications, where we have less exposure, we're likely to see our share dip a few points into the upper 30s. 
In System Test, revenue grew 14% from Q1 '20, primarily on higher Storage Test shipments. As we've noted in past calls, Storage Test is linked to increasing density and complexity of data center hard disk drives and the expanding adoption of system-level test per chip test. Our full year outlook for this business has improved from January as well on strength in both applications. The defense and aerospace and Board test units of STG are also performing well, and we expect the overall group will grow revenue 5% to 10% this year. 
Our LitePoint business is driven by the complexity of new wireless standards and the connectivity cellular and other wireless markets. In Q1, connectivity demand was the dominant revenue driver as WiFi 6E ramps in smartphones and access points. We expect LitePoint to grow in the 0% to 5% range in 2021. 
Shifting to Industrial Automation. We are on track to grow 30-plus percent for the year. At the macro level, industrial economies are recovering with global PMIs above 50, indicating growing manufacturing investments. At the ground level, we are seeing increasing customer buying driven by economics, quality and lack of available shop floor labor. At UR, revenue grew 32% from Q1 '20 with a notable recovery in China where sales more than doubled in the quarter. Our China performance reflects the compelling value proposition UR offers, even in the face of low-cost competitors. 
We not only have the durability to operate in high-intensity production environments where downtime can't be tolerated, but we also offer a unique suite of organic and ecosystem provided software and peripherals to address a wide range of tasks with short deployment times. We're also seeing growth outside of the traditional manufacturing tasks. In the last several quarters, we've seen volume shipments of cobots to perform industrial service tasks, such as maintenance of high-power transmission lines while energized and robotic inspection of wind turbine blades. Together, these 2 applications account for over 500 installed cobots, and this should approximately double in 2021. Both examples highlight the flexibility of UR arms and value in performing dangerous service tasks. 
MiR also delivered strong results in the quarter, growing 55% year-on-year. A big part of that success has been the new MiR 250, which was introduced in March of last year and was our leading seller in Q1. We are also seeing a nice expansion of applications for mere products. Initially, most applications were moving goods to and fro. Last year, we saw a dramatic expansion in the use of MiR robots as a platform for mobile tasks such as disinfected workspaces. And now we're seeing growing use in the conveyor market where our mobile platform replaces fixed conveyors. This provides owners greater flexibility than traditional fixed conveyor system and allows them to reconfigure their factory on the fly as production requirements dictate. 
Although both you are in -- had both UR and MiR, our expanding range of plug-and-play apps, now totaling over 430 in our UR+ and MiRGo ecosystem shortens the deployment time and increases the addressable market for cobots, adding additional growth factors for us. But we're not firing on all cylinders in IA yet. At AutoGuide, we have lowered our expectations for 2021. The this year, we will focus on expanding existing customer deployments while we complete a series of engineering projects designed to scale and win new customers in the future. While this is surely a reset at our AutoGuide plan, we remain confident in the potential of the nascent market for high payload autonomous mobile robots and our ability to leverage AutoGuide's unique product architecture to deliver differentiated value to this growing market. 
Rolling it all up, the demand environment in our test businesses has strengthened dramatically since January and the wafer front end equipment forecasts suggest that tester demand over the next few years will continue to grow. In Industrial Automation, UR and MiR are benefiting from their differentiated products and the improving global economy, which puts us on track for a total IA group revenue growth of 30-plus percent for the year. Our employees are doing a great job, and our operating model is delivering strong financial profits and free cash flow. 
And finally, I'd like to recognize and thank our Board chair, Roy Valley, who will be retiring next month after 20 years on the Teradyne Board. Roy's leadership, integrity and wise counsel have been invaluable to me and the executive team, and we all wish him the best in his future pursuits. 
Sanjay will now take you through the financial details. Sanjay?"
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Mark. Good morning, everyone. Today, I'll provide details on our Q1 results, offer additional color on the operating environment, along with our plans to address a very strong demand environment and describe our Q2 outlook.  During the appropri",1586,"Thank you, Mark. Good morning, everyone. Today, I'll provide details on our Q1 results, offer additional color on the operating environment, along with our plans to address a very strong demand environment and describe our Q2 outlook.  During the appropriate sections, I'll provide some full year expectations. 
Now to Q1. First year -- or sorry, first quarter sales were $782 million with non-GAAP EPS of $1.11. Non-GAAP gross margins were 59.1% and our non-GAAP operating expenses were $230 million, above our high guidance due to high variable compensation and G&A expenses. Non-GAAP operating profit rate was 29.6%. We had 2 10% customers in the quarter. Tax rate, excluding discrete items for the quarter, was 14.75% on both a GAAP and non-GAAP basis. Looking at the results from a business unit perspective, semi test revenue was $528 million, was up 9% from Q1 '21. SOC revenue was $420 million, up from prior year, driven by strength in compute, industrial and automotive markets, offset by a decline and our mobility shipments. 
Memory revenue was $108 million, up from prior year, driven by strength in flash final test segment. System Test Group had revenue of $133 million which was up 14% year-over-year. This was driven by $95 million in storage test sales, including HDD and SLT solutions and $38 million in defense and aerospace and production board test. At LitePoint, revenue of $41 million was above plan, but down about 6% from prior year due to lower cellular test shipments. 
Looking at our test portfolio overall. We're very optimistic about the market and technology trends unfolding over the midterm. The growing attach rate of electronics across the economy, the increasing complexity of those devices and significantly, a faster refresh rate for many of these complex devices benefit all of our test businesses. Looking at a significant example, the increasing number of companies creating high-performance processors to serve a growing range of end applications, each with unique performance and design cycles, is driving an estimated doubling of the compute portion of the SOC test market this year compared with 2018. We've designed our UltraFLEXplus platform to serve this growing market and are having early success. This trend has complementary impacts on memory and SLT markets as well. 
Now to Industrial Automation. Given 2020 was a contraction year, I'll provide revenue metrics comparing Q1 '21 results with Q1 '20 and Q1 '19. Industrial Automation revenue was $80 million, was up 33% year-over-year and 21% over Q1 '19. Q1 '21 was a record for the seasonally soft first quarter of the year. U.S. and Europe represented over 70% of our IA revenue in the first quarter. As Mark noted, strength in China for UR, I'll add that we saw the IA group revenue in China more than double year-over-year and grow greater than 50% over Q1 '19. UR sales were $66 million in Q1, up 32% year-over-year and 15% over Q1 '19. MiR sales were $14 million, up 55% from both Q1 '20 and Q1 '19. Sales increased in every region over Q1 '20. In addition to the success of MiR 250 that Mark noted, we also are starting to see a positive shipment trend towards higher payload MiR 500 and MiR 1,000 models, which should improve our ASPs over time. 
Demand at both UR and MiR continues to improve as the global economy recovers and companies work to add production capacity. The opportunity of automation is growing. Our IA portfolio is solving problems for companies such as improving economics with a typical ROI of approximately 1 year, addressing labor shortages experienced by manufacturing and warehousing firms and adding supply chain resilience over the long term. From a financial perspective in IA, we continue to lean into engineering, ecosystem and distribution investments to expand the range of applications in our IA products  address and extend our global distribution reach. 
Our goal in the short-term is to balance investments with sales growth in order to deliver an annual IA group operating profit of between 5% and 15%. And however, given the reset mark described at AutoGuide, we now expect ag revenues of less than $10 million in 2021, and ag will not be profitable in '21. As a result, at the IA group level, we expect we'll operate above breakeven in '21, but below that target profit range. We do expect both UR and MiR each operate above the rule of 40 in 2021. That is the sum of the operating profit, revenue growth will be over $40 million. We continue to have confidence in our IA growth over the midterm, as articulated in our January earnings model update and expect the overall group to grow revenue over 30% in 2021. 
Shifting to supply. As Mark noted, the test market size has increased significantly across the board. From a supply perspective, we are dealing with increasing lead times and cost increases, predominantly in the semiconductor area. Given the significant demand increase in the challenging supply environment, we are experiencing some shipment delays. This is most acute in the automotive and industrial tester markets where demand is significantly outstripping supply. We are working with our customers on a daily basis to minimize the impact of these delays. We see this challenge accelerating into the third quarter with supplier lead times increasing. 
I appreciate the incredible pace of our operations team and partners around the world have operated for over a year and continue to be impressed with their efforts to meet the needs of our customers. To sustain that pace and create a more resilient operation, we're continuing to invest in manufacturing capacity around the world. This includes qualifying redundant suppliers, production sites for critical components and redundant manufacturing capacity in new locations. 
Shifting to the balance sheet and cash flow. Our cash and marketable securities at the end of the quarter totaled $1.43 billion. We had $1 million in negative free cash flow in the quarter and spent $45 million and $17 million on buybacks and dividends, respectively. To date, $67 million of the RTI convertible bondholders have elected to convert early. And in Q1, we paid $51 million of it to the bondholders. Regarding the buyback, we plan to increase our daily buying throughout the year and expect to purchase a minimum of $600 million in 2021, as noted in January. The relatively low volume of buybacks in Q1 was planned for 3 reasons. 
First, recall Q1 is a seasonally high use of cash, where we typically pay out our variable compensation and ramp up our prepayments to support increased Q2 test production. Second, we wanted to understand how much of our convertible debt would be redeemed in Q1. Third, we wanted to confirm the global recovery from the pandemic remained on track. 
Now to Q2. As you've heard this morning, customer demand is strong and in nearly all parts of the business, our guidance assumes that we'll continue to be successful dealing with the numerous material shortages we noted earlier and that we won't see additional pandemic related issues. With that said, sales in Q2 are expected to be between $1.01 billion and $1.09 billion, with non-GAAP EPS in a range of $1.62 and to $1.83 on 177 million diluted shares. The second quarter guidance excludes the amortization of acquired intangibles and the noncash imputed interest on the convertible debt. Second quarter gross margins are estimated at 58%. OpEx is expected to run at 23% to 25% of second quarter sales. The non-GAAP operating profit at the midpoint of our second quarter guidance is 34%. 
Regarding OpEx for the full year. We now expect OpEx will grow 17% to 19% over 2020. Note that this is up from our January plan for 2021, where we guided growth over 2020 at 8% to 10%. The increase from January in order of magnitude is in 3 general categories. One, higher revenue-driving higher estimated variable compensation and higher engineering costs related to mitigating supply constraints. Two, higher incremental spending to accelerate several engineering projects in test and IA. And three, higher-than-expected G&A spending related to legal, insurance and IT costs. As we noted in January and included in the estimate, we expect travel and marketing expenses to increase through the remainder of the year as pandemic restrictions ease. As outlined last quarter, we set our sight on reaching $5.25 to $6.75 in EPS by 2024 in our earnings model. In 2021, we expect our largest end market, semi test, to grow 14% and at the estimated midpoint above the estimate in our earnings model. 
Combined with industrial end markets recovering from the pandemic slump, these data points reinforce that our midterm earnings plan is on a solid foundation. We update our earnings model each January. In our next update, we'll look closely at both the WFE forecast and test growth rates. To sum up, the demand environment across nearly all of our markets remain strong, and we're working closely with our suppliers and customers to expand shipments and minimize the impact of material shortages. We've had an outstanding start to the year, and we are on a path to healthy sales growth and profit growth for 2021. 
At the midpoint of our Q2 guidance, we'll see sales grow 19% and non-GAAP EPS grow 21% above the first half of 2020, which itself was a record. We are well on our way to achieving our midterm revenue and earnings goals we set in our new earnings model. 
With that, I'll turn things back to Andy."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Sanjay. April, would now like to take some questions. And as a reminder, please limit yourself to 1 question and a follow-up.",23,"Thanks, Sanjay. April, would now like to take some questions. And as a reminder, please limit yourself to 1 question and a follow-up."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","[Operator Instructions] And your first question is from C.J. Muse with Evercore.",12,"[Operator Instructions] 
And your first question is from C.J. Muse with Evercore."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","I guess first question, as it relates to the higher SOC test outlook, can you share with us what you're seeing in terms of arm gaining momentum in both servers and PCs? And how we should think about that impacting your SOC test revenue growth and market s",48,"I guess first question, as it relates to the higher SOC test outlook, can you share with us what you're seeing in terms of arm gaining momentum in both servers and PCs? And how we should think about that impacting your SOC test revenue growth and market share?"
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think it's a sub theme of what's happening in the compute area. The compute market for test this year will potentially double. Arm is eroding certain established share positions, and we're doing very well with arm. So -- but I think we're still in",119,"Yes. I think it's a sub theme of what's happening in the compute area. The compute market for test this year will potentially double. Arm is eroding certain established share positions, and we're doing very well with arm. So -- but I think we're still in early innings there. I don't think this is sort of the end, it's sort of the beginning. And the proliferation of other bespoke architectures that are high -- 10 billion plus transistor count devices is proliferating, at least in design. They haven't started to ramp yet, but they're being worked on in design.  So it looks to me like over the next few years, that compute segment is going to be very strong."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Very helpful. I guess as a follow-up, can you share with us your outlook for system-level test combined with HDD growth in '21? And then thinking about the acceleration in nearline demand, how we should think about the growth CAGR there beyond 2021?",43,"Very helpful. I guess as a follow-up, can you share with us your outlook for system-level test combined with HDD growth in '21? And then thinking about the acceleration in nearline demand, how we should think about the growth CAGR there beyond 2021?"
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think the system-level test and HDD markets are both still on a growth trajectory. We had a big, big year last year. We didn't expect that we might have a little digestion this year, but no, it's still heading north. And I think on the HDD front, t",213,"Yes. I think the system-level test and HDD markets are both still on a growth trajectory. We had a big, big year last year. We didn't expect that we might have a little digestion this year, but no, it's still heading north. And I think on the HDD front, that 1 looks like line of sight for several years ahead is positive. The exabyte growth in the 18-terabyte and above drive space just is very test intensive. And I don't see anything sort of blunting the transitions in the cloud storage to anything but those high-intensity drives. 
SLT is a little more of a, I think, a lumpy market at this point. It could continue to sequentially grow, but it's still limited to very, I would say, a small subset of the market. Manufacturers building very high complexity devices in high volumes. Now engineering work is going on to make SLT more meaningful to lower complexity devices. And I think as those products come to market over the next few years, you'll start to see customer expansion in SLT and the market will grow. But I would sort of say, I wouldn't be surprised to see plus or minus 25% year-over-year swings as we try to get to a broader adoption of SLT."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question is from Atif Malik with Citi.",9,"Your next question is from Atif Malik with Citi."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Congratulations on another strong quarter in guide. Mark, can you compare or contrast the mobility and compute piece at your largest customer, which was 25% of sales last year versus the 2018, 2019 period where you saw correction, obviously, the dynamics",53,"Congratulations on another strong quarter in guide. Mark, can you compare or contrast the mobility and compute piece at your largest customer, which was 25% of sales last year versus the 2018, 2019 period where you saw correction, obviously, the dynamics are quite different with 5G and now the compute piece this year?"
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Unfortunately, I'm not going to be able to break down anything related to any customer's mix. So I can't address your question specifically. I do think though that the lumpiness compared to prior years has smoothed a bit because of the bigger portfol",129,"Yes. Unfortunately, I'm not going to be able to break down anything related to any customer's mix. So I can't address your question specifically. I do think though that the lumpiness compared to prior years has smoothed a bit because of the bigger portfolio of devices that are at play here. So -- and one of the big revisions, I would say, to our market size estimate as we move through the year. I've always talked about and our largest customer, the demand profile becomes clear in April. And up until April, there's a lot of variability. And it is starting to become clear, and it is stronger than we had expected. So that's part of the story of what's driving up the market and our revenue this year."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Great. And as a follow-up for Sanjay. Sanjay, if you can comment on the M&A strategy from here on the last earnings call, you mentioned that even some areas in Semi Test are interesting to you guys. So just curious with the setback in the AutoGuide area,",53,"Great. And as a follow-up for Sanjay. Sanjay, if you can comment on the M&A strategy from here on the last earnings call, you mentioned that even some areas in Semi Test are interesting to you guys. So just curious with the setback in the AutoGuide area, what are you thinking of M&A?"
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Sure. Thanks. Yes. So as you know, M&A is to keep of our allocation strategy. And over the years, we've had a focus on industrial automation. We have an active business development organization that continues to look at different opportunities. And we'll",80,"Sure. Thanks. Yes. So as you know, M&A is to keep of our allocation strategy. And over the years, we've had a focus on industrial automation. We have an active business development organization that continues to look at different opportunities. And we'll continue to do so. And we're spending time as a management team kind of reviewing them. And when an opportunity makes sense both financially and a strategic product fit, we will act, and we'll advise at that time."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Our next question is from Vivek Arya with Bank of America.",11,"Our next question is from Vivek Arya with Bank of America."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","I think, Mark, you mentioned something interesting in your prepared remarks, which is that there could be some correlation between the rising front end WFE investments at some point, they will have a pull-through effect on testers. I'm curious, what have",131,"I think, Mark, you mentioned something interesting in your prepared remarks, which is that there could be some correlation between the rising front end WFE investments at some point, they will have a pull-through effect on testers. I'm curious, what have been your impressions over this correlation from a historical perspective? Because this year will be kind of the second very strong year for WFE. And that are expectations for almost 30% kind of growth this year. When do you see that impacting the demand for testers? Does it happen with a 6 month lag? Does it happen with a 1 year lag? And what is the kind of -- should we be expecting a 30% growth in testers next year, right? So just curious what you think the correlation is?"
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So there is a correlation and a lag, as you alluded to. So front end equipment usually goes into fabs, there's a period of time then after all of that is installed. Revenue gets recognized on behalf of those equipment makers and the fab gets tuned. T",378,"Yes. So there is a correlation and a lag, as you alluded to. So front end equipment usually goes into fabs, there's a period of time then after all of that is installed. Revenue gets recognized on behalf of those equipment makers and the fab gets tuned. The recipe, the yields and things before the fab has put into commission for real customer shipments. So that can take anywhere from -- the good suppliers these days maybe get through that phase in about 3 to 4 months. But then it's not a light switch that turns on. It's more like a knob on a faucet because you start to ramp wafer outs slowly and you proportionately start adding testers. 
So what you can expect to see is, let's say, maybe the beginning of tester orders lag 4 to 5 months, but they really get going kind of a year after the fab equipment goes in. So if you offset the tester market from the fab investments by about, let's say, a year plus or minus 3 months, you get a good indication of growth. Now if you go back for the past 5 years, you'll see there's been pretty steady monotonic growth in WFE and there's been pretty steady monotonic growth in the tester market. It's just -- I think the most recent step, though, from 60 to 70 plus is larger than we've seen historically. So if all of that happens and it's truly put into commission, I would expect it to be something that pulls up the growth rate a little bit higher than we've seen in the past. 
But the 1 caution I would add is that what drives test again is transistor count, which we sometimes call complexity, but it's transistor count. And the capital intensity to build transistors at 3 nanometers and such on a per transistor basis, is getting to be quite high. So it may turn out that it takes more CapEx per transistor at some of these nodes than it has historically. So that could mute a little bit the cause and effect. If you follow what I'm saying. But overall, the big, big picture is, you're right, it's correlated. Maybe it's a year plus or minus 3 month delay."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And for my follow-up, maybe 1 for Sanjay on the cost and the operating leverage perspective. So on the cost side, are you seeing any rise in your input costs? And what are you doing in response? Are you passing those along? And will those be stick",99,"Got it. And for my follow-up, maybe 1 for Sanjay on the cost and the operating leverage perspective. So on the cost side, are you seeing any rise in your input costs? And what are you doing in response? Are you passing those along? And will those be sticky over time? And then kind of part b of that, I think, Sanjay, you mentioned operating expenses could grow 17% to 19%. Do you think when you grow OpEx that much, there is still leverage left in the model that could sales also grow in that neighborhood somewhere this year?"
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Sure. So first on the cost of sales. Yes, we have seen certain cost increase. Raw materials, semiconductor components, et cetera. And fundamentally, we've been able to manage through those. And we expect, from a full year perspective, we'll be at model fr",98,"Sure. So first on the cost of sales. Yes, we have seen certain cost increase. Raw materials, semiconductor components, et cetera. And fundamentally, we've been able to manage through those. And we expect, from a full year perspective, we'll be at model from a gross margin, 58% to 59%. And so we're just kind of managing through those cost increases. And from an operating expense perspective, yes, we are seeing a lower operating leverage in Q1, really some OpEx increases, but really throughout the year, you should expect to see us improve our operating leverage throughout the year."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question is from Mehdi Hosseini with SIG.",9,"Your next question is from Mehdi Hosseini with SIG."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, I just want to go back to your earlier comment regarding transistor. It's interesting in your press release last night, you also talked about a smartphone unit as contributing to upside to SOC Test growth. So in that context, can you -- test growth.",90,"Mark, I just want to go back to your earlier comment regarding transistor. It's interesting in your press release last night, you also talked about a smartphone unit as contributing to upside to SOC Test growth. So in that context, can you -- test growth. So in that context, can you please help us understand how smartphone unit growth? And transistor density are driving the SOC Test growth? Or which one do you think is going to be a bigger factor this year versus 2020? And I have a follow-up."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Okay. Good question. Obviously, they're related, they're correlated. But for example, in 2020, we saw a dramatic increase in the tester market when cell phone units weren't growing. And that was all driven by complexity growth. So you can see the power of",164,"Okay. Good question. Obviously, they're related, they're correlated. But for example, in 2020, we saw a dramatic increase in the tester market when cell phone units weren't growing. And that was all driven by complexity growth. So you can see the power of complexity growth alone by examining 2020, it's big. Now in 2021, interestingly, we're getting a year where the, I would say, complexity growth of the silicon going into phones is less than it was in 2020, but that's been more than offset by the fact that units are going to grow. So now we have units working for us a little more in a year where complexity, it's going up, but not as dramatically as it did last year. So it's almost a multiplicative effect of the 2. And this year is really a story of both, but I'd say the -- without the unit growth, we would be looking at a smaller market, a smaller overall TAM than we're seeing."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And just moving on to system test. What is the mix between SLT and HDD? And how are each one of these 2 pieces growing on a year-over-year basis.",31,"Got it. And just moving on to system test. What is the mix between SLT and HDD? And how are each one of these 2 pieces growing on a year-over-year basis."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Mehdi, it's Sanjay here. It's roughly a 50-50 split, plus or minus a bit. And as Mark indicated, from an HDD perspective, really strong end market growth and SLT, there's some investments going to expand that market. But we see growth in both.",44,"Yes. Mehdi, it's Sanjay here. It's roughly a 50-50 split, plus or minus a bit. And as Mark indicated, from an HDD perspective, really strong end market growth and SLT, there's some investments going to expand that market. But we see growth in both."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question is from Toshiya Hari with Goldman Sachs.",10,"Your next question is from Toshiya Hari with Goldman Sachs."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, I wanted to ask about your market share traction in memory test. 2020 was a very strong year for you guys. Particularly in DRAM package test. You talked about customer mix or spending mix this year, driving maybe a little bit of a decline year-over-",66,"Mark, I wanted to ask about your market share traction in memory test. 2020 was a very strong year for you guys. Particularly in DRAM package test. You talked about customer mix or spending mix this year, driving maybe a little bit of a decline year-over-year. But in terms of customer pull and your expectations through cycle, what are you seeing in memory test right now?"
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So memory test is strengthening. It's -- At the midpoint of the new market estimate, it will actually grow compared to last year, which again was a good year. It's the sort of areas that are growing, some of them were participating in and some of the",179,"Yes. So memory test is strengthening. It's -- At the midpoint of the new market estimate, it will actually grow compared to last year, which again was a good year. It's the sort of areas that are growing, some of them were participating in and some of them were not. So China is growing dramatically, and we're doing very well in China. So we're seeing good pickup there of the products in both flash and DRAM, and we're gaining market share. 
In other geographies where DRAM is growing. The piece of the DRAM market, final test for LPDDR5 that we targeted our new product for and have a design wins. That's also looking very good and growing. But what's growing even faster is wafer test for DRAM, which is an area we really don't participate. It tends to be a low technology tester product that serves that market, it's not a big profit pool. And because of that, I alluded to the fact that our share might drop from 40%, 41% down to maybe 38%, 39% for the year."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. That's helpful. And then as a quick follow-up, I just wanted to go back to the AutoGuide reset. And sorry if I missed this, Mark, but what's changed in that business over the past 3 to 6 months? And perhaps more importantly, does this change how y",60,"Got it. That's helpful. And then as a quick follow-up, I just wanted to go back to the AutoGuide reset. And sorry if I missed this, Mark, but what's changed in that business over the past 3 to 6 months? And perhaps more importantly, does this change how you think about your growth strategy, our M&A strategy within overall IA?"
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. It doesn't change anything about our thinking on M&A and growth strategy in IA, just to sort of take that one first. And over the course of many acquisitions we've done in the past 10 years, we've had various levels of success, I would say. The bigge",280,"Yes. It doesn't change anything about our thinking on M&A and growth strategy in IA, just to sort of take that one first. And over the course of many acquisitions we've done in the past 10 years, we've had various levels of success, I would say. The bigger acquisitions like the Nextest, the Eagles, the URs and the MiRs of the world have gone really, really well. And some of the smaller ones have taken longer to realize their potential than we expected at the beginning. 
And so AutoGuide is a case where we're kind of in that same situation. We've -- We started out last year, deploying the product into multiple big name, high potential accounts. And we're sort of lilly pad getting these initial deployments up and running. As we reflected back on where we stood, we were getting overextended on new accounts where the current accounts potential could be jeopardized by not doing more to augment the product with the ability to dock into other factory automation systems that these customers are implementing. So we've just decided, let's retrench around the 5 or 6 big accounts we have today. Get them rock solid, develop these linkages to warehouse automation, manufacturing systems, strengthen our linkage to our mere product line, so we have more of a seamless connection there. And just grow within those accounts and then go on to a more expensive footprint. 
So it's absolutely not what we planned a year ago when we acquired AutoGuide. But in the light of today, the opportunity looks so large that we think better off doing -- taking this tax than just trying to proliferate more and more accounts."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question is from John Pitzer with Crdit Suisse.",10,"Your next question is from John Pitzer with Crdit Suisse."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Congratulations on the solid results. Sanjay, I just want to go back to your commentaries around supply constraints and duration. It sounds like from your prepared remarks, that this is going to last at least into the calendar third quarter. Do things get",92,"Congratulations on the solid results. Sanjay, I just want to go back to your commentaries around supply constraints and duration. It sounds like from your prepared remarks, that this is going to last at least into the calendar third quarter. Do things get worse from here? Is there any way to quantify the impact it's having to your revenue? And usually, when customers can't get what they want, they tend to order more than they need. So how are you safeguarding against the inevitable sort of double ordering and excess build out?"
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes, great question. So we are seeing shortages, and we've been able to -- through our inventory strategies as well as multiple suppliers been able to work through them. Fundamentally, in the rise of the demand in 2020 and through COVID and then in  [ 202",211,"Yes, great question. So we are seeing shortages, and we've been able to -- through our inventory strategies as well as multiple suppliers been able to work through them. Fundamentally, in the rise of the demand in 2020 and through COVID and then in  [ 2021 ]  in Q1. We're seeing it in Q2, and we see it getting supply getting tighter. We're seeing lead times increase from our suppliers across the board. And we're booked out pretty much for the year. And we're -- as I said in my prepared remarks, we're spending more engineering dollars and qualifying different suppliers. So it is getting tighter as demand continues to increase throughout the year. 
And Q2, we feel pretty good about where we're at in the range. Of course, there's always things we're managing. And -- but Q3, we see it getting tighter. Visibility, we have good visibility into Q3, some issues we're working through. And then Q4, the visibility, obviously, further out, it goes down. I'd say on the duplicate orders perspective, I don't really see in the demand statement, a whole set of duplication of orders. We're working with our customers, we're understanding their specific needs and working to get them what they need and just working through that."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","That's helpful. And then, Mark, as my follow-up, clearly, a lot of conversation coming out of Washington about trying to get more domestic front end production inside the U.S. if the goal here is to kind of secure the supply chain, it seems kind of silly",122,"That's helpful. And then, Mark, as my follow-up, clearly, a lot of conversation coming out of Washington about trying to get more domestic front end production inside the U.S. if the goal here is to kind of secure the supply chain, it seems kind of silly to build a wafer here that you have to then ship over to Asia to test and package. I'm just kind of curious from your perspective, are you seeing any drive towards sort of regionalization test capacity, what might that mean for your business in the future? And maybe beyond even Semi Test, are you seeing across other supply chains, sort of a redomiciling of that supply chain that might actually help your IA business."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So I think there's a lot in what you just said. It's interesting and also possibly a deterrent to these regional fabs because a regional fab is, in my view, meaningless without the associated infrastructure around it, including test, supply of the ch",275,"Yes. So I think there's a lot in what you just said. It's interesting and also possibly a deterrent to these regional fabs because a regional fab is, in my view, meaningless without the associated infrastructure around it, including test, supply of the chemistry, the local supply thing makes the whole venture economical. And as an alternative to doing everything in Taiwan, if you want to do in the U.S. or Japan or Europe, you really need a competitive infrastructure to get it done. So it will necessarily require test if it's not going to be an orphan. 
And I'm a little bit skeptical, will all of these jurisdictions have the 10-year sort of intestinal fortitude to move forward and invest in that kind of infrastructure build-out. But I think in the U.S. case, my read is that the answer is probably yes. The national security issues, there's just a lot behind this that suggests it's probably going to happen. And in the case of test and robots as well, I think the fracturing of the supply chain to be more geographically dispersed, on the 1 hand, maybe for a global economy is a little bad because it creates some inefficiency in the market, but for a supplier of equipment into that market. It's a helpful, it's a tailwind. And so I do think you're going to find probably globally a little bit less utilization efficiency of equipment because of this trend. 
But the national instincts around secure supply chains are going to overdrive that and probably subsidize it to some level. And I think both of our businesses will be a beneficiary of that."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Our next question is from Timothy Arcuri with UBS.",9,"Our next question is from Timothy Arcuri with UBS."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","I guess, a couple of things. First, Mark, I think you said that compute. So I guess my question really is for you to break down what the Semi Test TAM, if I take your $4.2 billion midpoint this year for SOC. I'm just wondering if you can break that down.",136,"I guess, a couple of things. First, Mark, I think you said that compute. So I guess my question really is for you to break down what the Semi Test TAM, if I take your $4.2 billion midpoint this year for SOC. I'm just wondering if you can break that down. I think you had said last year, of the 3.45 billion, it was like 600 million compute and so I'm wondering, out of the 800 million that's going to grow this year from 3.45 billion up to 4.2 billion. I'm wondering if you can kind of break that down. It sounds like most of it's compute because you said compute is going to double from 600 million last year. But I'm just wondering if you can sort of reset the segments for us as well."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I'll give you some rough numbers, but take it a little bit with a grain of salt because here we are 3 months later, talking about a big revision to our view of what the market size is. So I don't profess to be overly wise on this. But our current vie",315,"Yes. I'll give you some rough numbers, but take it a little bit with a grain of salt because here we are 3 months later, talking about a big revision to our view of what the market size is. So I don't profess to be overly wise on this. But our current view on compute would be about $1 billion-ish market this year, for example. So not quite doubling. It's only -- the year is not even halfway over. So who knows what could happen, but that's our current view. Mobility compared to last year is probably flattish, could be down a little bit compared to last year. The 1 part of mobility we haven't talked about that of all the places that are surging for demand, there is a pocket where demand is softer this year, and that's in millimeter wave test capability. 
And last year, there was a lot of tooling for millimeter wave as some of the phones were early adopters of millimeter wave technology. But the fact of the matter is that telcos globally aren't deploying millimeter wave to any large extent. Spotty deployment in the U.S. and almost nothing outside of the U.S. And so that's suppressing demand this year for millimeter wave test equipment. That makes the -- is a little bit of a headwind for the mobility market. So call it flat to slightly down in mobility. At about, let's say, it's about $1.6 billion or $1.65 billion or so. 
The automotive and MCU market is closer to [ $450 million ] for the year. That's up from about [ $225 million ] last year. So big, big jump there. And the last segment that we sort of track is industrial, and that one is up to about $500 million from maybe $340 million, [ $325 million ] last year. So that's how we segment it right now."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Awesome. Awesome. And then I guess I just wanted to maybe push back a little bit on the correlation between WFE and Test TAM. It's been a little more consistent in memory the past couple of years, of course, when you get these big pricing swings, that's g",187,"Awesome. Awesome. And then I guess I just wanted to maybe push back a little bit on the correlation between WFE and Test TAM. It's been a little more consistent in memory the past couple of years, of course, when you get these big pricing swings, that's going to probably go away. But on the SOC side, wouldn't you agree, your big customer is a significantly larger portion of the SOC Test TAM than they are of consumption in the front end non-memory WFE world. So doesn't the SOC market depends a lot more on what the large customer is doing in the test world than in the WFE world. So the correlation in SOC could sort of break down a bit because of what the large customer is doing. And I guess on that point, they've never been good 3 years in a row, not once, and this is the second big year. So how do you handicap the odds that next year is a big down year and that works against you in terms of share, even if the market doesn't come down that much."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","All right. I'll add in there, [ Timothy ], I'll try to take it on. So your point about the large customer or our large customer, never having sort of as a proportion of our revenue, 3 big years in a row. I think there's truth to that, but there's also a d",386,"All right. I'll add in there, [ Timothy ], I'll try to take it on. So your point about the large customer or our large customer, never having sort of as a proportion of our revenue, 3 big years in a row. I think there's truth to that, but there's also a difference in what's happening because the portfolio there is growing. If you go back to the sort of 2014, '15 -- '13, '14, '15, '16 area. It was kind of 1 device type that was driving the story and the demand. And now we're into a much broader portfolio, so I would just offer that, that dynamics changed. And that's a fact that could propel this more sequential growth for a longer period of time. 
On the correlation between WFE test, SOC Test demand and whether that's stronger than who's buying, let's say, big -- certainly, customers have different test intensities. And so part of the noise that's running under the hood, certainly as it relates to our revenue is related to large high test intensity customers and how much they're buying. We're fortunate that we participate in segments of the market that tend to have high test intensities, but that's by design. We target those segments. And it's not just 1 large customer that produces devices that have high test intensity. There's others, and that's where we play. 
So I would agree with you that if the market shifted away from high test intensity customers meeting high complexity devices, you could see a disconnect, an anchor on the test market that was disconnected from WFE. But it just doesn't seem likely because the reason these investments are being made in the front end. And the reason they're so expensive to make is that they're going after 3-nanometer EUV lines to build devices for these very customers we're talking about. So I just don't see that the disconnect can emerge unless the fab sit idle. If the fabs are going to say, idle, yes. But if the fabs aren't going to be idle, it's the exact customers we're talking about that are going to utilize them. 
So I don't disabuse your point. It actually has some merit, but I just think the correlation, almost by definition, has to occur unless the fabs are idle."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Our next question is from Krish Sankar with Cowen.",9,"Our next question is from Krish Sankar with Cowen."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","And Mark, thanks for the color on the SOC Test. I just wanted like focus on the compute test market. And it looks like you said it's going from $600 million to $1 billion. Is the incremental growth all coming from custom silicon? And if that is the case,",82,"And Mark, thanks for the color on the SOC Test. I just wanted like focus on the compute test market. And it looks like you said it's going from $600 million to $1 billion. Is the incremental growth all coming from custom silicon? And if that is the case, can you just tell us how much your market share in compute was last year? And how much do you think it's going to be this year? And then I have a follow-up."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So most of the growth is, I would say, coming -- what is it non custom silicon, I couldn't say that. I think growth is coming from the nontraditional suppliers of compute devices is a disproportionate amount of it. But the other usual suspects are gr",182,"Yes. So most of the growth is, I would say, coming -- what is it non custom silicon, I couldn't say that. I think growth is coming from the nontraditional suppliers of compute devices is a disproportionate amount of it. But the other usual suspects are growing too. AMD, obviously, is growing. And NVIDIA is obviously growing. So it's broad-based. But as a proportion, I'd say, yes, you're right. It's probably some of the newer players that are growing the market faster than others. And as to our share position, historically, our share in compute has been below our overall market share. So maybe in the 30s, and it moves around in the 30s is where it's been. 
This -- we're trending into a period of time because of this change of who's building these devices where our share is more likely to move up closer to our overall average share in the market. So if our SOC average share is somewhere in the 50-ish range, it might take a little bit of time, but that's kind of where we're trending to."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Got it. That's really helpful, Mark. And then just a follow-up, I think you made a comment that you're kind of booked out for the rest of the year. Is that a Semi Test and a Storage Test comment? And if so, should we assume that you would not see",77,"Got it. Got it. That's really helpful, Mark. And then just a follow-up, I think you made a comment that you're kind of booked out for the rest of the year. Is that a Semi Test and a Storage Test comment? And if so, should we assume that you would not see seasonality in the back half in Q4 because the demand is strong. Or in other words, it's your Q2 Semi Test revenue run rate sustainable?"
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","It's Sanjay. So I made the comment that we were booked at, and it was really tied to our supply perspective. We're working with our -- both contract manufacturers and our direct suppliers to fundamentally make sure that we have orders on the books until t",57,"It's Sanjay. So I made the comment that we were booked at, and it was really tied to our supply perspective. We're working with our -- both contract manufacturers and our direct suppliers to fundamentally make sure that we have orders on the books until the end of the year, just given the supply constraints environment."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Our next question is from Brian Chin with Stifel.",9,"Our next question is from Brian Chin with Stifel."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","First, on the Semi Test business, I definitely respect that visibility in this or any year has limitations. But if I do take the midpoint of your new expectations for the test markets, take your market share projection and assume the majority of the secon",93,"First, on the Semi Test business, I definitely respect that visibility in this or any year has limitations. But if I do take the midpoint of your new expectations for the test markets, take your market share projection and assume the majority of the second quarter growth will be Semi Test driven. I think I back into about a 10% or so sales decline in Semi Test in the second half of the year. Am I kind of in the ballpark here? And to what extent is your backlog coverage supportive of this?"
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. When you take a look at the numbers, that's a we do -- overall, maybe I'll comment overall. We are expecting to see, given the visibility and obviously, with a significant reset of the market size, and as we move throughout the year, the lack of visi",89,"Yes. When you take a look at the numbers, that's a we do -- overall, maybe I'll comment overall. We are expecting to see, given the visibility and obviously, with a significant reset of the market size, and as we move throughout the year, the lack of visibility in the second half. But with all of those provisions, we are seeing overall an expectation that the second half of the year revenue will be slightly down, both for the enterprise. And that's a similar direction down for Semi Test."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Got it. And then maybe just on the industrial automation business, and sorry if I missed some of this, but I definitely heard about China as a geography showing strong year-over-year growth. A lot of growth in MiR and a snapback in the UR business",84,"Got it. Got it. And then maybe just on the industrial automation business, and sorry if I missed some of this, but I definitely heard about China as a geography showing strong year-over-year growth. A lot of growth in MiR and a snapback in the UR business as well. Can you characterize maybe Europe and North America, obviously, key markets as well. Sort of where are they in terms of their snapping back relative to where you might expect them to get this year?"
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. It's Sanjay. Yes. So from a U.S. perspective, we are seeing the snapback, whether you look at increases over Q1 of '19, pre-COVID year or even Q1 of '20. Similar with Europe, a very strong kind of double-digit snapback over either year.",43,"Yes. It's Sanjay. Yes. So from a U.S. perspective, we are seeing the snapback, whether you look at increases over Q1 of '19, pre-COVID year or even Q1 of '20. Similar with Europe, a very strong kind of double-digit snapback over either year."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question is from Joe Moore with Morgan Stanley.",9,"Next question is from Joe Moore with Morgan Stanley."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","I wonder if you could talk about in the automotive and the broader markets. The degree to which test is one of the bottlenecks they're dealing with, like we hear about shortages on wafers packaging, a little bit test just how severe do you think your bott",80,"I wonder if you could talk about in the automotive and the broader markets. The degree to which test is one of the bottlenecks they're dealing with, like we hear about shortages on wafers packaging, a little bit test just how severe do you think your bottlenecking them? And then when you look at a 90% comparison in auto, it would seem like there's some catch-up in that, like does that create sustainability risk in your mind maybe next year?"
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think the big issue is wafers, not in terms of bottlenecking, the automotive manufacturers. That doesn't mean that we're completely aligned on deliveries for test equipment to the chip suppliers who are trying to ramp shipments. We are misaligned b",112,"Yes. I think the big issue is wafers, not in terms of bottlenecking, the automotive manufacturers. That doesn't mean that we're completely aligned on deliveries for test equipment to the chip suppliers who are trying to ramp shipments. We are misaligned by a few weeks here and there. And we're pulling like mad and they're pulling like mad. But the big, big, bigger issue is getting wafer capacity. So no big -- we're not in the headlights quite yet, but we're certainly in tens conversations to try to pick up a week or 2 here or there so that they can get a little bit more out a week or so sooner."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Great. And absolute level? Yes.",5,"Great. And absolute level? Yes."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","The sustainability of -- automotive always kind of goes in fits and starts. And I think the supply chain in automotive is going to come out of this, having learned a lesson that they can't be so lean on just in time. And I know that raises the specter of",224,"The sustainability of -- automotive always kind of goes in fits and starts. And I think the supply chain in automotive is going to come out of this, having learned a lesson that they can't be so lean on just in time. And I know that raises the specter of everybody's worry that there's inventory being going to be built in addition to real line demand. And I think that will happen. That's certainly not happening yet, that's to come. So there's going to be a phase here where we get through the urgency, then there will be investments made to build more, I'd say, slack in the system for the devices that go into automotive. So that will be a bit of a balloon. But then it will settle back to, I think it's normal rhythm. Where increasing electronic and chip attach rates in automobiles will drive the market. And we're going to get to kind of a peak level of test investment in automotive this year, close to that $500 million number. And that could even -- certainly, I think it could sustain through the end of the year because of this inventory catch up. But my guess is as we get into the 2022 area and beyond, it'll sort of back into oscillating between the $300 million to $500 million rate."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Our next question is from Blake Gendron with Wolfe Research.",10,"Our next question is from Blake Gendron with Wolfe Research."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","I want to come back to the arm's SOC commentary, not from a market share perspective, but rather the complexity discussion. Because as we've seen large customers accelerating this arm's rollout here a bit. So it seems like the architecture consolidates th",77,"I want to come back to the arm's SOC commentary, not from a market share perspective, but rather the complexity discussion. Because as we've seen large customers accelerating this arm's rollout here a bit. So it seems like the architecture consolidates the number of wafers for various compute functions, simplify the circuit a bit. So share opportunity is notwithstanding. I'm wondering what the complexity in test intensity puts and takes are with this arms trend specifically?"
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. That's a little tricky. So first of all, let me say that most of the applications processors in your phone, which is a $1.5 billion -- billion unit market are arm-based processors. And those devices in the high-end phones, which comprise maybe 400 mi",193,"Yes. That's a little tricky. So first of all, let me say that most of the applications processors in your phone, which is a $1.5 billion -- billion unit market are arm-based processors. And those devices in the high-end phones, which comprise maybe 400 million to 500 million units out of the [ 1.5 ], have transistor counts on par with any desktop or laptop computer you might buy. 10 billion-plus kind of transistors. So the test -- when you look at the test intensity there compared to a traditional microprocessor, it's a little bit more efficient, I would say than a traditional microprocessor, but not a lot, more efficient. So for the same, let's say, 10 billion transistor x86 architecture compared to a map device in your phone, maybe it's at 90% versus 100% kind of test time delta, so not big. 
Now when you get into arm-based compute devices for more non phone applications. There's different cash requirements, different IO technologies needed that further complexify the arm implementation that bring it back up to test intensity is very similar to the x86 world. So I don't see a big difference there."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","That's really helpful. And then a follow-up on industrial automation. You noted peripheral services that demand additional software apps and likely hardware. We've seen a bit of proliferation of companies that are attacking things like computer vision, ma",87,"That's really helpful. And then a follow-up on industrial automation. You noted peripheral services that demand additional software apps and likely hardware. We've seen a bit of proliferation of companies that are attacking things like computer vision, machine learning, other AI capabilities. So wondering what kind of artificial intelligence capabilities Teradyne has in IA to keep up with these trends. It seems like robotics peers, both large and smaller really descending on the cobot space here. Or could this be a focus of M&A moving forward?"
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","So it's certainly in our M&A funnel, there's various opportunities like that. But what I would say is that many of the startups in the IA and machine learning space that are exploring ways to enhance robots, cobots, are doing it on our platform as a partn",159,"So it's certainly in our M&A funnel, there's various opportunities like that. But what I would say is that many of the startups in the IA and machine learning space that are exploring ways to enhance robots, cobots, are doing it on our platform as a partner. If you go into our -- again, UR+ ecosystem or a MiRGo ecosystem, you'll see a variety of machine learning and AI tools. That have been targeted and customized for our products. So we're benefiting from them whether we own them or not. We do have organic IA products that we have on our MiR platform already. But it's going to be important for the evolution of ease of use and applications expansion for cobots, for sure. And whether we need to own it, or whether we need to be the preferred platform that they all write their apps for, I think, is still kind of a case-by-case consideration for us."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","We're just about at the limit, but we can sneak 1 quick question in, if you would, April, please.",20,"We're just about at the limit, but we can sneak 1 quick question in, if you would, April, please."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Okay. And your last question is from Sidney Ho with Deutsche Bank.",12,"Okay. And your last question is from Sidney Ho with Deutsche Bank."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Just can you give us an update on your revenue opportunity related to 5G for both SOC Test and LitePoint? And maybe in the 5G infrastructure side, are you seeing a recovery of that market in any region right now?",40,"Just can you give us an update on your revenue opportunity related to 5G for both SOC Test and LitePoint? And maybe in the 5G infrastructure side, are you seeing a recovery of that market in any region right now?"
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think infrastructure is really not driving much tester demand generally. It did for us back in 2019 when China was going crazy, rolling out sub-6G and Huawei was investing heavily at the time. But the kind of what is now a $5 billion tester market,",240,"Yes. I think infrastructure is really not driving much tester demand generally. It did for us back in 2019 when China was going crazy, rolling out sub-6G and Huawei was investing heavily at the time. But the kind of what is now a $5 billion tester market, infrastructure, 5G investments are, I think, always going to be sub-$100 million and maybe more in the sort of $60 million to $70 million range. The bigger one is what happens with the phones and the terminals and such. And there, the U.S., the spectrum auction around sub-6G is concluded. I think that carriers are kind of clearly going to roll that out as their next step. 
That's, as I said earlier, going to suppress the demand for millimeter wave, which is the most test intensive portion of 5G. And so in the past calls, I've talked about LitePoint and Semi Test combined driving an incremental $400 million to $500 million worth of tester demand in the 5G era. And I think where we are in that now is we're probably in that $250 million to $300 million piece of it and I think it's going to go sideways here for a while because of the fact that millimeter wave this year will be less probably investment than last year. And that will be the last kicker. Maybe it's still a couple of years out to bring it up to that full potential."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Great. Maybe just lastly on the system level test. What is the size of that market today and how big could that be when those lower complexity devices that you alluded to starting to come into the market? And maybe just a little bit on the competition sid",58,"Great. Maybe just lastly on the system level test. What is the size of that market today and how big could that be when those lower complexity devices that you alluded to starting to come into the market? And maybe just a little bit on the competition side, how do you sustain your market share in that market?"
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think the market is pretty thin. We don't have a good number to give you on market size. But I think if you look at us in Advantest, you can kind of get a general sense. We probably, again, have 80% of the market between us. There's some other besp",236,"Yes. I think the market is pretty thin. We don't have a good number to give you on market size. But I think if you look at us in Advantest, you can kind of get a general sense. We probably, again, have 80% of the market between us. There's some other bespoke custom products that certain suppliers provide, but that's the way you could get at the market. And Advantest and Teradyne are kind of, I think, both hard-core players here. We each have our own benefits. And as we said earlier, this additional test step that high complexity devices are requiring. Is likely to proliferate into other markets. But 2 things are kind of important. I think some like the automotive market, as an example, is a very high-quality demanding market. But the volumes, frankly, are relatively low compared to something like a phone, 100 million cars versus 1.5 billion phones. 
So for a market like that with lower volume devices to take advantage of SLT, which they would love to. We need a different architecture that we're developing to address these, I'd say, higher mix, lower volume markets. And I think our position and the sustainability of this is pretty good. It's like semiconductor tests, where the changeover costs are pretty high. Once you're in, somebody else has really got to have a better mousetrap by a long shot to sort of dislodge you."
94728,711666829,2260392,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Okay. We are out of time. Thanks so much for joining us today, and we look forward to talking to you in the days and weeks ahead. Thanks again. Bye-bye.",30,"Okay. We are out of time. Thanks so much for joining us today, and we look forward to talking to you in the days and weeks ahead. Thanks again. Bye-bye."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Ladies and gentlemen, thank you for standing by, and welcome to the Q1 2021 Teradyne Earnings Conference Call. [Operator Instructions]I would now like to hand the conference over to your speaker today, Andy Blanchard. Thank you, sir. You may begin.",41,"Ladies and gentlemen, thank you for standing by, and welcome to the Q1 2021 Teradyne Earnings Conference Call. [Operator Instructions]
I would now like to hand the conference over to your speaker today, Andy Blanchard. Thank you, sir. You may begin."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, April. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined this morning by our CEO, Mark Jagiela; and our CFO, Sanjay Mehta. Following our opening remarks, we'll provide details of our p",306,"Thank you, April. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined this morning by our CEO, Mark Jagiela; and our CFO, Sanjay Mehta. Following our opening remarks, we'll provide details of our performance for 2021's first quarter, along with our outlook for the second quarter of '21. The press release containing our first quarter results was issued last evening. We're providing slides on the Investor page of the website that may be helpful to you in following the discussions. Replays of this call will be available via the same page after the call ends. 
The matters that we discuss today will include forward-looking statements that involve risk factors that could cause Teradyne's results to differ materially from management's current expectations. We encourage you to review the safe harbor statement contained in the earnings release as well as our most recent SEC filings. Additionally, these forward-looking statements are made as of today, and we take no obligation to update them as a result of developments occurring after this call. 
During today's call, we'll make reference to non-GAAP financial measures. We've posted additional information concerning these non-GAAP financial measures, including reconciliation to the most directly comparable GAAP financial measure where available on the Investor page of the website. Looking ahead between now and our next earnings call, Teradyne expects to participate in technology or industrial-focused investor conferences hosted by Wolfe Research, ISI Evercore, Baird, Bank of America, Bernstein and Stifel. 
Now let's get on with the rest of the agenda. First, Mark will comment on our recent results and the market conditions as we enter the new quarter. Sanjay will then offer more details on our quarterly results along with our guidance for the second quarter, and we'll then answer your questions. 
The call is scheduled for 1 hour. Mark?"
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Hello, everyone, and thanks for joining us today. In my remarks, I'll summarize our Q1 results, review current market conditions and provide an update on how we're looking at Q2 and the full year. Sanjay will then take you through the financial details of",1216,"Hello, everyone, and thanks for joining us today. In my remarks, I'll summarize our Q1 results, review current market conditions and provide an update on how we're looking at Q2 and the full year. Sanjay will then take you through the financial details of the quarter and our outlook for the second quarter. As you saw in our press release, our Q1 sales and profits grew double digits from Q1 of 2020's record level. 
Test sales grew 9% on broad-based demand with notable strength in automotive, industrial compute, memory and storage. Industrial Automation sales grew 33% in the quarter with strong demand at both UR and MiR. Notably, since our January call, the market demand in both Test and IA has been greater than we expected, as you can see from our Q2 guidance. In Semiconductor Test, customer orders are very strong as complexity continues to increase and chip units are expected to grow almost 15% this year, more than twice last year's rate. Regarding the sustainability of this demand, our visibility is limited to just a quarter or 2, but the growth in WFE from $50 billion in 2017 to $60 billion last year to over $75 billion this year should translate into a healthy tester market in the years ahead. 
Looking at SOC demand, the auto industrial segment is especially robust, with our Q1 Eagle shipments up nearly 90% year-on-year, and deliveries expected to grow further in Q2. Test demand for mobility and compute devices is also running ahead of our January estimates as these end markets push the performance limits of advanced process nodes and drive the highest complexity growth. This higher complexity drives longer chip test times and often demands unique tester capabilities. Our UltraFLEX platforms are well aligned to these performance dynamics. 
As a result of this demand strength, we now expect the SOC Test market to be in the $4 billion to $4.4 billion range, up about $700 million at the midpoint from our January estimate. This equates to about 16% growth from 2020, and we expect our share in SOC to be at about the 50% level. In memory test, we are seeing continued strength in both flash and DRAM. We now expect the full year memory test market to be in the $900 million to $1.1 billion range, up about $100 million from our January estimate and up about 5% from 2020 levels. 
Our Magnum platform is in lockstep with the performance trends in both markets, and we expect another strong year in 2021. However, since most of the test market growth is expected to be wafer test applications, where we have less exposure, we're likely to see our share dip a few points into the upper 30s. 
In System Test, revenue grew 14% from Q1 '20, primarily on higher Storage Test shipments. As we've noted in past calls, Storage Test is linked to increasing density and complexity of data center hard disk drives and the expanding adoption of system-level test per chip test. Our full year outlook for this business has improved from January as well on strength in both applications. The defense and aerospace and Board test units of STG are also performing well, and we expect the overall group will grow revenue 5% to 10% this year. 
Our LitePoint business is driven by the complexity of new wireless standards in the connectivity, cellular and other wireless markets. In Q1, connectivity demand was the dominant revenue driver as WiFi 6E ramps in smartphones and access points. We expect LitePoint to grow in the 0% to 5% range in 2021. 
Shifting to Industrial Automation. We are on track to grow 30-plus percent for the year. At the macro level, industrial economies are recovering with global PMIs above 50, indicating growing manufacturing investments. At the ground level, we are seeing increasing customer buying driven by economics, quality and lack of available shop floor labor. At UR, revenue grew 32% from Q1 '20 with a notable recovery in China where sales more than doubled in the quarter. Our China performance reflects the compelling value proposition UR offers, even in the face of low-cost competitors. 
We not only have the durability to operate in high-intensity production environments where downtime can't be tolerated, but we also offer a unique suite of organic and ecosystem provided software and peripherals to address a wide range of tasks with short deployment times. We're also seeing growth outside of the traditional manufacturing tasks. In the last several quarters, we've seen volume shipments of cobots to perform industrial service tasks, such as maintenance of high-power transmission lines while energized and robotic inspection of wind turbine blades. Together, these 2 applications account for over 500 installed cobots, and this should approximately double in 2021. Both examples highlight the flexibility of UR arms and value in performing dangerous service tasks. 
MiR also delivered strong results in the quarter, growing 55% year-on-year. A big part of that success has been the new MiR250, which was introduced in March of last year and was our leading seller in Q1. We are also seeing a nice expansion of applications for MiR products. Initially, most applications were moving goods to and fro. Last year, we saw a dramatic expansion in the use of MiR robots as the platform for mobile tasks such as disinfecting workspaces. And now we're seeing growing use in the conveyor market where our mobile platform replaces fixed conveyors. This provides owners greater flexibility than traditional fixed conveyor system and allows them to reconfigure their factory on the fly as production requirements dictate. 
Although both UR and -- at both UR and MiR, our expanding range of plug-and-play apps, now totaling over 430 in our UR+ and MiRGo ecosystem, shortens the deployment time and increases the addressable market for cobots, adding additional growth factors for us. But we're not firing on all cylinders in IA yet. At AutoGuide, we have lowered our expectations for 2021. This year, we will focus on expanding existing customer deployments while we complete a series of engineering projects designed to scale and win new customers in the future. While this is surely a reset at our AutoGuide plan, we remain confident in the potential of the nascent market for high payload autonomous mobile robots and our ability to leverage AutoGuide's unique product architecture to deliver differentiated value to this growing market. 
Rolling it all up, the demand environment in our test businesses has strengthened dramatically since January and the wafer front end equipment forecasts suggest that tester demand over the next few years will continue to grow. In Industrial Automation, UR and MiR are benefiting from their differentiated products and the improving global economy, which puts us on track for a total IA group revenue growth of 30-plus percent for the year. Our employees are doing a great job, and our operating model is delivering strong financial profits and free cash flow. 
And finally, I'd like to recognize and thank our Board Chair, Roy Vallee, who will be retiring next month after 20 years on the Teradyne Board. Roy's leadership, integrity and wise counsel have been invaluable to me and the executive team, and we all wish him the best in his future pursuits. 
Sanjay will now take you through the financial details. Sanjay?"
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Mark. Good morning, everyone. Today, I'll provide details on our Q1 results, offer additional color on the operating environment, along with our plans to address a very strong demand environment and describe our Q2 outlook.  During the appropri",1582,"Thank you, Mark. Good morning, everyone. Today, I'll provide details on our Q1 results, offer additional color on the operating environment, along with our plans to address a very strong demand environment and describe our Q2 outlook.  During the appropriate sections, I'll provide some full year expectations. 
Now to Q1. First year -- or sorry, first quarter sales were $782 million with non-GAAP EPS of $1.11. Non-GAAP gross margins were 59.1% and our non-GAAP operating expenses were $230 million, above our high guidance due to high variable compensation and G&A expenses. Non-GAAP operating profit rate was 29.6%. We had 2 10% customers in the quarter. Tax rate, excluding discrete items for the quarter, was 14.75% on both a GAAP and non-GAAP basis. Looking at the results from a business unit perspective, Semi Test revenue was $528 million, was up 9% from Q1 '21. SOC revenue was $420 million, up from prior year, driven by strength in compute, industrial and automotive markets, offset by a decline in our mobility shipments. 
Memory revenue was $108 million, up from prior year, driven by strength in flash final test segment. System Test group had revenue of $133 million which was up 14% year-over-year. This was driven by $95 million in Storage Test sales, including HDD and SLT solutions and $38 million in defense and aerospace and production board test. At LitePoint, revenue of $41 million was above plan, but down about 6% from prior year due to lower cellular test shipments. 
Looking at our test portfolio overall. We're very optimistic about the market and technology trends unfolding over the midterm. The growing attach rate of electronics across the economy, the increasing complexity of those devices and significantly, a faster refresh rate for many of these complex devices benefit all of our test businesses. Looking at a significant example, the increasing number of companies creating high-performance processors to serve a growing range of end applications, each with unique performance and design cycles, is driving an estimated doubling of the compute portion of the SOC Test market this year compared with 2018. We've designed our UltraFLEXplus platform to serve this growing market and are having early success. This trend has complementary impacts on memory and SLT markets as well. 
Now to Industrial Automation. Given 2020 was a contraction year, I'll provide revenue metrics comparing Q1 '21 results with Q1 '20 and Q1 '19. Industrial Automation revenue was $80 million, was up 33% year-over-year and 21% over Q1 '19. Q1 '21 was a record for the seasonally soft first quarter of the year. U.S. and Europe represented over 70% of our IA revenue in the first quarter. As Mark noted, strength in China for UR, I'll add that we saw the IA group revenue in China more than double year-over-year and grow greater than 50% over Q1 '19. UR sales were $66 million in Q1, up 32% year-over-year and 15% over Q1 '19. MiR sales were $14 million, up 55% from both Q1 '20 and Q1 '19. Sales increased in every region over Q1 '20. In addition to the success of MiR250 that Mark noted, we also are starting to see a positive shipment trend towards higher payload MiR500 and MiR1000 models, which should improve our ASPs over time. 
Demand at both UR and MiR continues to improve as the global economy recovers and companies work to add production capacity. The opportunity of automation is growing. Our IA portfolio is solving problems for companies such as improving economics with a typical ROI of approximately 1 year, addressing labor shortages experienced by manufacturing and warehousing firms and adding supply chain resilience over the long term. From a financial perspective in IA, we continue to lean into engineering, ecosystem and distribution investments to expand the range of applications in our IA products -- our IA products address and extend our global distribution reach. 
Our goal in the short-term is to balance investments with sales growth in order to deliver an annual IA group operating profit of between 5% and 15%. However, given the reset Mark described at AutoGuide, we now expect AG revenues of less than $10 million in 2021, and AG will not be profitable in '21. As a result, at the IA group level, we expect we'll operate above breakeven in '21, but below that target profit range. We do expect both UR and MiR each to operate above the Rule of 40 in 2021. That is, the sum of the operating profit, revenue growth will be over 40%. We continue to have confidence in our IA growth over the midterm, as articulated in our January earnings model update and expect the overall group to grow revenue over 30% in 2021. 
Shifting to supply. As Mark noted, the test market size has increased significantly across the board. From a supply perspective, we are dealing with increasing lead times and cost increases, predominantly in the semiconductor area. Given the significant demand increase and the challenging supply environment, we are experiencing some shipment delays. This is most acute in the automotive and industrial tester markets where demand is significantly outstripping supply. We are working with our customers on a daily basis to minimize the impact of these delays. We see this challenge accelerating into the third quarter with supplier lead times increasing. 
I appreciate the incredible pace of our operations team and partners around the world have operated for over a year and continue to be impressed with their efforts to meet the needs of our customers. To sustain that pace and create a more resilient operation, we're continuing to invest in manufacturing capacity around the world. This includes qualifying redundant suppliers, production sites for critical components and redundant manufacturing capacity in new locations. 
Shifting to the balance sheet and cash flow. Our cash and marketable securities at the end of the quarter totaled $1.43 billion. We had $1 million in negative free cash flow in the quarter and spent $45 million and $17 million on buybacks and dividends, respectively. To date, $67 million of the convertible bondholders have elected to convert early. And in Q1, we paid $51 million of it to the bondholders. Regarding the buyback, we plan to increase our daily buying throughout the year and expect to purchase a minimum of $600 million in 2021, as noted in January. The relatively low volume of buybacks in Q1 was planned for 3 reasons. 
First, recall Q1 is a seasonally high use of cash, where we typically pay out our variable compensation and ramp up our prepayments to support increased Q2 test production. Second, we wanted to understand how much of our convertible debt would be redeemed in Q1. Third, we wanted to confirm the global recovery from the pandemic remained on track. 
Now to Q2. As you've heard this morning, customer demand is strong and in nearly all parts of the business, our guidance assumes that we'll continue to be successful dealing with the numerous material shortages we noted earlier and that we won't see additional pandemic-related issues. With that said, sales in Q2 are expected to be between $1.01 billion and $1.09 billion, with non-GAAP EPS in a range of $1.62 to $1.83 on 177 million diluted shares. The second quarter guidance excludes the amortization of acquired intangibles and the noncash imputed interest on the convertible debt. Second quarter gross margins are estimated at 58%. OpEx is expected to run at 23% to 25% of second quarter sales. The non-GAAP operating profit at the midpoint of our second quarter guidance is 34%. 
Regarding OpEx for the full year. We now expect OpEx will grow 17% to 19% over 2020. Note that this is up from our January plan for 2021, where we guided growth over 2020 at 8% to 10%. The increase from January in order of magnitude is in 3 general categories. One, higher revenue-driving, higher estimated variable compensation and higher engineering costs related to mitigating supply constraints. Two, higher incremental spending to accelerate several engineering projects in test and IA. And three, higher-than-expected G&A spending related to legal, insurance and IT costs. As we noted in January and included in the estimate, we expect travel and marketing expenses to increase through the remainder of the year as pandemic restrictions ease. As outlined last quarter, we set our sight on reaching $5.25 to $6.75 in EPS by 2024 in our earnings model. In 2021, we expect our largest end market, semi test, to grow 14% at the estimated midpoint above the estimate in our earnings model. 
Combined with industrial end markets recovering from the pandemic slump, these data points reinforce that our midterm earnings plan is on a solid foundation. We update our earnings model each January. In our next update, we'll look closely at both the WFE forecasts and test growth rates. 
To sum up, the demand environment across nearly all of our markets remain strong, and we're working closely with our suppliers and customers to expand shipments and minimize the impact of material shortages. We've had an outstanding start to the year, and we are on a path to healthy sales growth and profit growth for 2021. At the midpoint of our Q2 guidance, we'll see sales grow 19% and non-GAAP EPS grow 21% above the first half of 2020, which itself was a record. We are well on our way to achieving our midterm revenue and earnings goals we set in our new earnings model. 
With that, I'll turn things back to Andy."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Sanjay. April, we'd now like to take some questions. [Operator Instructions]",12,"Thanks, Sanjay. April, we'd now like to take some questions. [Operator Instructions]"
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","[Operator Instructions] And your first question is from C.J. Muse with Evercore.",12,"[Operator Instructions] And your first question is from C.J. Muse with Evercore."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","I guess first question, as it relates to the higher SOC Test outlook, can you share with us what you're seeing in terms of arm gaining momentum in both servers and PCs? And how we should think about that impacting your SOC Test revenue growth and market s",48,"I guess first question, as it relates to the higher SOC Test outlook, can you share with us what you're seeing in terms of arm gaining momentum in both servers and PCs? And how we should think about that impacting your SOC Test revenue growth and market share?"
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think it's a subtheme of what's happening in the compute area. The compute market for test this year will potentially double. Arm is eroding certain established share positions, and we're doing very well with arm. So -- but I think we're still in e",118,"Yes. I think it's a subtheme of what's happening in the compute area. The compute market for test this year will potentially double. Arm is eroding certain established share positions, and we're doing very well with arm. So -- but I think we're still in early innings there. I don't think this is sort of the end, it's sort of the beginning. And the proliferation of other bespoke architectures that are high -- 10 billion plus transistor count devices is proliferating, at least in design. They haven't started to ramp yet, but they're being worked on in design.  So it looks to me like over the next few years, that compute segment is going to be very strong."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Very helpful. I guess as a follow-up, can you share with us your outlook for System Level Test combined with HDD growth in '21? And then thinking about the acceleration in near-line demand, how we should think about the growth CAGR there beyond 2021?",44,"Very helpful. I guess as a follow-up, can you share with us your outlook for System Level Test combined with HDD growth in '21? And then thinking about the acceleration in near-line demand, how we should think about the growth CAGR there beyond 2021?"
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think the System Level Test and HDD markets are both still on a growth trajectory. We had a big, big year last year. We didn't expect that. We might have a little digestion this year, but no, it's still heading north. And I think on the HDD front,",213,"Yes. I think the System Level Test and HDD markets are both still on a growth trajectory. We had a big, big year last year. We didn't expect that. We might have a little digestion this year, but no, it's still heading north. And I think on the HDD front, that one looks like line of sight for several years ahead is positive. The exabyte growth in the 18-terabyte and above drive space just is very test intensive. And I don't see anything sort of blunting the transitions in the cloud storage to anything but those high-intensity drives. 
SLT is a little more of, I think, a lumpy market at this point. It could continue to sequentially grow, but it's still limited to very, I would say, a small subset of the market. Manufacturers building very high complexity devices in high volumes. Now engineering work is going on to make SLT more meaningful to lower complexity devices. And I think as those products come to market over the next few years, you'll start to see customer expansion in SLT and the market will grow. But I would sort of say, I wouldn't be surprised to see plus or minus 25% year-over-year swings as we try to get to a broader adoption of SLT."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question is from Atif Malik with Citi.",9,"Your next question is from Atif Malik with Citi."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Congratulations on another strong quarter and guide. Mark, can you compare or contrast the mobility and compute piece at your largest customer, which was 25% of sales last year versus the 2018, 2019 period where you saw correction? Obviously, the dynamics",53,"Congratulations on another strong quarter and guide. Mark, can you compare or contrast the mobility and compute piece at your largest customer, which was 25% of sales last year versus the 2018, 2019 period where you saw correction? Obviously, the dynamics are quite different with 5G and now the compute piece this year."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Unfortunately, I'm not going to be able to break down anything related to any customer's mix. So I can't address your question specifically. I do think though that the lumpiness compared to prior years has smoothed a bit because of the bigger portfol",132,"Yes. Unfortunately, I'm not going to be able to break down anything related to any customer's mix. So I can't address your question specifically. I do think though that the lumpiness compared to prior years has smoothed a bit because of the bigger portfolio of devices that are at play here. So -- and one of the big revisions, I would say, to our market size estimate as we move through the year, I've always talked about that our -- in our largest customer, the demand profile becomes clear in April. And up until April, there's a lot of variability. And it is starting to become clear, and it is stronger than we had expected. So that's part of the story of what's driving up the market and our revenue this year."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Great. And as a follow-up for Sanjay. Sanjay, if you can comment on the M&A strategy from here. On the last earnings call, you mentioned that even some areas in Semiconductor Test are interesting to you guys. So just curious with the setback in the AutoGu",53,"Great. And as a follow-up for Sanjay. Sanjay, if you can comment on the M&A strategy from here. On the last earnings call, you mentioned that even some areas in Semiconductor Test are interesting to you guys. So just curious with the setback in the AutoGuide area, what are you thinking about M&A?"
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Sure. Thanks. Yes. So as you know, M&A is a key part of our allocation strategy. And over the years, we've had a focus on industrial automation. We have an active business development organization that continues to look at different opportunities and will",81,"Sure. Thanks. Yes. So as you know, M&A is a key part of our allocation strategy. And over the years, we've had a focus on industrial automation. We have an active business development organization that continues to look at different opportunities and will continue to do so. And we're spending time as a management team kind of reviewing them. And when an opportunity makes sense both financially and a strategic product fit, we will act, and we'll advise at that time."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question is from Vivek Arya with Bank of America.",11,"Your next question is from Vivek Arya with Bank of America."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","I think, Mark, you mentioned something interesting in your prepared remarks, which is that there could be some correlation between the rising front end WFE investments, that at some point, they will have a pull-through effect on testers. I'm curious, what",130,"I think, Mark, you mentioned something interesting in your prepared remarks, which is that there could be some correlation between the rising front end WFE investments, that at some point, they will have a pull-through effect on testers. I'm curious, what have been your impressions over this correlation from a historical perspective. Because this year will be kind of the second very strong year for WFE. And there are expectations for almost 30% kind of growth this year. When do you see that impacting the demand for testers? Does it happen with a 6-month lag? Does it happen with a 1-year lag? And what is the kind of -- should we be expecting a 30% growth in testers next year, right? So just curious what you think the correlation is?"
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So there is a correlation and a lag, as you alluded to. So front end equipment usually goes into fabs. There's a period of time then after all of that is installed. Revenue gets recognized on behalf of those equipment makers and the fab gets tuned. T",379,"Yes. So there is a correlation and a lag, as you alluded to. So front end equipment usually goes into fabs. There's a period of time then after all of that is installed. Revenue gets recognized on behalf of those equipment makers and the fab gets tuned. The recipe, the yields and things before the fab is put into commission for real customer shipments. So that can take anywhere from -- the good suppliers these days maybe get through that phase in about 3 to 4 months. But then it's not a light switch that turns on. It's more like a knob on a faucet because you start to ramp wafer outs slowly and you proportionately start adding testers. 
So what you can expect to see is, let's say, maybe, in the beginning, the tester orders lag 4 to 5 months, but they really get going kind of a year after the fab equipment goes in. So if you offset the tester market from the fab investments by about, let's say, a year plus or minus 3 months, you get a good indication of growth. Now if you go back for the past 5 years, you'll see there's been pretty steady monotonic growth in WFE and there's been pretty steady monotonic growth in the tester market. It's just -- I think the most recent step, though, from 60 to 70 plus is larger than we've seen historically. So if all of that happens and it's truly put into commission, I would expect it to be something that pulls up the growth rate a little bit higher than we've seen in the past. 
But the one caution I would add is that what drives test again is transistor count, which we sometimes call complexity, but it's transistor count. And the capital intensity to build transistors at 3 nanometers and such on a per transistor basis, is getting to be quite high. So it may turn out that it takes more CapEx per transistor at some of these nodes than it has historically. So that could mute a little bit the cause and effect, if you follow what I'm saying. But overall, the big, big picture is, you're right, it's correlated. Maybe it's a year plus or minus 3 months delay."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And for my follow-up, maybe one for Sanjay on the cost and the operating leverage perspective. So on the cost side, are you seeing any rise in your input costs? And what are you doing in response? Are you passing those along? And will those be sti",99,"Got it. And for my follow-up, maybe one for Sanjay on the cost and the operating leverage perspective. So on the cost side, are you seeing any rise in your input costs? And what are you doing in response? Are you passing those along? And will those be sticky over time? And then kind of part b of that, I think, Sanjay, you mentioned operating expenses could grow 17% to 19%. Do you think, when you grow OpEx that much, there is still leverage left in the model that could sales also grow in that neighborhood somewhere this year?"
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Sure. So first on the cost of sales. Yes, we have seen certain cost increase. Raw materials, semiconductor components, et cetera. And fundamentally, we've been able to manage through those. And we expect, from a full year perspective, we'll be at model fr",98,"Sure. So first on the cost of sales. Yes, we have seen certain cost increase. Raw materials, semiconductor components, et cetera. And fundamentally, we've been able to manage through those. And we expect, from a full year perspective, we'll be at model from a gross margin, 58% to 59%. And so we're just kind of managing through those cost increases. And from an operating expense perspective, yes, we are seeing a lower operating leverage in Q1, really some OpEx increases, but really throughout the year, you should expect to see us improve our operating leverage throughout the year."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question is from Mehdi Hosseini with SIG.",9,"Your next question is from Mehdi Hosseini with SIG."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, I just want to go back to your earlier comment regarding transistor. It's interesting in your press release last night, you also talked about a smartphone unit as contributing to upside to SOC Test growth. So in that context, can you -- test growth.",90,"Mark, I just want to go back to your earlier comment regarding transistor. It's interesting in your press release last night, you also talked about a smartphone unit as contributing to upside to SOC Test growth. So in that context, can you -- test growth. So in that context, can you please help us understand how smartphone unit growth and transistor density are driving the SOC Test growth? Or which one do you think is going to be a bigger factor this year versus 2020? And I have a follow-up."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Okay. Good question. Obviously, they're related, they're correlated. But for example, in 2020, we saw a dramatic increase in the tester market when cell phone units weren't growing. And that was all driven by complexity growth. So you can see the power of",164,"Okay. Good question. Obviously, they're related, they're correlated. But for example, in 2020, we saw a dramatic increase in the tester market when cell phone units weren't growing. And that was all driven by complexity growth. So you can see the power of complexity growth alone by examining 2020, it's big. Now in 2021, interestingly, we're getting a year where the, I would say, complexity growth of the silicon going into phones is less than it was in 2020, but that's been more than offset by the fact that units are going to grow. So now we have units working for us a little more in a year where complexity, it's going up, but not as dramatically as it did last year. So it's almost a multiplicative effect of the 2. And this year is really a story of both, but I'd say the -- without the unit growth, we would be looking at a smaller market, a smaller overall TAM than we're seeing."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And just moving on to System Test. What is the mix between SLT and HDD? And how are each one of these 2 pieces growing on a year-over-year basis.",31,"Got it. And just moving on to System Test. What is the mix between SLT and HDD? And how are each one of these 2 pieces growing on a year-over-year basis."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Mehdi, it's Sanjay here. It's roughly a 50-50 split, plus or minus a bit. And as Mark indicated, from an HDD perspective, really strong end market growth. And SLT, there's some investments going to expand that market. But we see growth in both.",44,"Yes. Mehdi, it's Sanjay here. It's roughly a 50-50 split, plus or minus a bit. And as Mark indicated, from an HDD perspective, really strong end market growth. And SLT, there's some investments going to expand that market. But we see growth in both."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question is from Toshiya Hari with Goldman Sachs.",10,"Your next question is from Toshiya Hari with Goldman Sachs."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, I wanted to ask about your market share traction in memory test. 2020 was a very strong year for you guys, particularly in DRAM package test. You talked about customer mix or spending mix this year driving maybe a little bit of a decline year-over-y",66,"Mark, I wanted to ask about your market share traction in memory test. 2020 was a very strong year for you guys, particularly in DRAM package test. You talked about customer mix or spending mix this year driving maybe a little bit of a decline year-over-year. But in terms of customer pull and your expectations through cycle, what are you seeing in memory test right now?"
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So memory test is strengthening. It's -- at the midpoint of the new market estimate, it will actually grow compared to last year, which again was a pretty good year. It's -- the sort of areas that are growing, some of them we're participating in and",180,"Yes. So memory test is strengthening. It's -- at the midpoint of the new market estimate, it will actually grow compared to last year, which again was a pretty good year. It's -- the sort of areas that are growing, some of them we're participating in and some of them we're not. So China is growing dramatically, and we're doing very well in China. So we're seeing good pickup there of the products in both flash and DRAM, and we're gaining market share. 
In other geographies where DRAM is growing, the piece of the DRAM market, final test for LPDDR5 that we targeted our new product for and have design wins, that's also looking very good and growing. But what's growing even faster is wafer test for DRAM, which is an area we really don't participate. It tends to be a low technology tester product that serves that market, it's not a big profit pool. And because of that, I alluded to the fact that our share might drop from 40%, 41% down to maybe 38%, 39% for the year."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. That's helpful. And then as a quick follow-up, I just wanted to go back to the AutoGuide reset. And sorry if I missed this, Mark, but what's changed in that business over the past 3 to 6 months? And perhaps more importantly, does this change how y",60,"Got it. That's helpful. And then as a quick follow-up, I just wanted to go back to the AutoGuide reset. And sorry if I missed this, Mark, but what's changed in that business over the past 3 to 6 months? And perhaps more importantly, does this change how you think about your growth strategy or M&A strategy within overall IA?"
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. It doesn't change anything about our thinking on M&A and growth strategy in IA, just to sort of take that one first. And over the course of many acquisitions we've done in the past 10 years, we've had various levels of success, I would say. The bigge",282,"Yes. It doesn't change anything about our thinking on M&A and growth strategy in IA, just to sort of take that one first. And over the course of many acquisitions we've done in the past 10 years, we've had various levels of success, I would say. The bigger acquisitions like the Nextest, the Eagles, the URs and the MiRs of the world have gone really, really well. And some of the smaller ones have taken longer to realize their potential than we expected at the beginning. 
And so AutoGuide is a case where we're kind of in that same situation. We've -- We started out last year deploying the product into multiple big name, high potential accounts. And we're sort of a lily pad getting these initial deployments up and running. As we reflected back on where we stood, we were getting overextended on new accounts where the current accounts' potential could be jeopardized by not doing more to augment the product with the ability to dock into other factory automation systems that these customers are implementing. So we've just decided, let's retrench around the 5 or 6 big accounts we have today, get them rock solid, develop these linkages to warehouse automation, manufacturing systems, strengthen our linkage to our MiR product line, so we have more of a seamless connection there. And just grow within those accounts and then go on to a more expansive footprint. 
So it's absolutely not what we planned a year ago when we acquired AutoGuide. But in the light of today, the opportunity looks so large that we think we're better off doing -- taking this tack than just trying to proliferate more and more accounts."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question is from John Pitzer with Crdit Suisse.",10,"Your next question is from John Pitzer with Crdit Suisse."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Congratulations on the solid results. Sanjay, I just want to go back to your commentaries around supply constraints and duration. It sounds like from your prepared remarks, that this is going to last at least into the calendar third quarter. Do things get",92,"Congratulations on the solid results. Sanjay, I just want to go back to your commentaries around supply constraints and duration. It sounds like from your prepared remarks, that this is going to last at least into the calendar third quarter. Do things get worse from here? Is there any way to quantify the impact it's having to your revenue? And usually, when customers can't get what they want, they tend to order more than they need. So how are you safeguarding against the inevitable sort of double ordering and excess build out?"
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes, great question. So we are seeing shortages, and we've been able to -- through our inventory strategies as well as multiple suppliers been able to work through them. Fundamentally, in the rise of the demand in 2020 and through COVID and then in 2021 i",210,"Yes, great question. So we are seeing shortages, and we've been able to -- through our inventory strategies as well as multiple suppliers been able to work through them. Fundamentally, in the rise of the demand in 2020 and through COVID and then in 2021 in Q1. We're seeing it in Q2, and we see it getting -- supply getting tighter. We're seeing lead times increase from our suppliers across the board. And we're booked out pretty much for the year. And we're -- as I said in my prepared remarks, we're spending more engineering dollars and qualifying different suppliers. So it is getting tighter as demand continues to increase throughout the year. 
And Q2, we feel pretty good about where we're at and the range. Of course, there's always things we're managing. And -- but Q3, we see it getting tighter. Visibility, we have good visibility into Q3, some issues we're working through. And then Q4, the visibility, obviously, further out, it goes down. I'd say on the duplicate orders perspective, I don't really see in the demand statement a whole set of duplication of orders. We're working with our customers, we're understanding their specific needs and working to get them what they need and just working through that."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","That's helpful. And then, Mark, as my follow-up, clearly, a lot of conversation coming out of Washington about trying to get more domestic front end production inside the U.S. If the goal here is to kind of secure the supply chain, it seems kind of silly",123,"That's helpful. And then, Mark, as my follow-up, clearly, a lot of conversation coming out of Washington about trying to get more domestic front end production inside the U.S. If the goal here is to kind of secure the supply chain, it seems kind of silly to build a wafer here that you have to then ship over to Asia to test and package. I'm just kind of curious from your perspective, are you seeing any drive towards sort of regionalization of test capacity, what might that mean for your business in the future? And maybe beyond even Semi Test, are you seeing across other supply chains, sort of a redomiciling of that supply chain that might actually help your IA business."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So I think there's a lot in what you just said that's interesting and also possibly a deterrent to these regional fabs because a regional fab is, in my view, meaningless without the associated infrastructure around it, including test, supply of the c",275,"Yes. So I think there's a lot in what you just said that's interesting and also possibly a deterrent to these regional fabs because a regional fab is, in my view, meaningless without the associated infrastructure around it, including test, supply of the chemistry. The local supply thing makes the whole venture economical. And as an alternative to doing everything in Taiwan, if you want to do in the U.S. or Japan or Europe, you really need a competitive infrastructure to get it done. So it will necessarily require test if it's not going to be an orphan. 
And I'm a little bit skeptical, will all of these jurisdictions have the 10-year sort of intestinal fortitude to move forward and invest in that kind of infrastructure build-out. But I think in the U.S. case, my read is that the answer is probably yes. The national security issues, there's just a lot behind this that suggests it's probably going to happen. And in the case of test and robots as well, I think the fracturing of the supply chain to be more geographically disperse, on the one hand, maybe for a global economy is a little bad because it creates some inefficiency in the market, but for a supplier of equipment into that market, it's a helpful, it's a tailwind. And so I do think you're going to find probably globally a little bit less utilization efficiency of equipment because of this trend. 
But the national instincts around secure supply chains are going to overdrive that and probably subsidize it to some level. And I think both of our businesses will be a beneficiary of that."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question is from Timothy Arcuri with UBS.",9,"Your next question is from Timothy Arcuri with UBS."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","I guess, a couple of things. First, Mark, I think you said that compute -- so I guess my question really is for you to break down what the Semi Test TAM, if I take your $4.2 billion midpoint this year for SOC, I'm just wondering if you can break that down",137,"I guess, a couple of things. First, Mark, I think you said that compute -- so I guess my question really is for you to break down what the Semi Test TAM, if I take your $4.2 billion midpoint this year for SOC, I'm just wondering if you can break that down. I think you had said last year of the $3.45 billion, it was like $600 million compute. And so I'm wondering, out of the $800 million that's going to grow this year from $3.45 billion up to $4.2 billion, I'm wondering if you can kind of break that down. It sounds like most of it's compute because you said compute is going to double from $600 million last year. But I'm just wondering if you can sort of reset the segments for us as well."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I'll give you some rough numbers, but take it a little bit with a grain of salt because here we are 3 months later, talking about a big revision to our view of what the market size is. So I don't profess to be overly wise on this. But our current vie",310,"Yes. I'll give you some rough numbers, but take it a little bit with a grain of salt because here we are 3 months later, talking about a big revision to our view of what the market size is. So I don't profess to be overly wise on this. But our current view on compute would be about $1 billion-ish market this year, for example. So not quite doubling. It's only -- the year is not even halfway over, so who knows what could happen, but that's our current view. Mobility compared to last year is probably flattish, could be down a little bit compared to last year. The one part of mobility we haven't talked about that of all the places that are surging for demand, there is a pocket where demand is softer this year, and that's in millimeter wave test capability. 
And last year, there was a lot of tooling for millimeter wave as some of the phones were early adopters of millimeter wave technology. But the fact of the matter is that telcos globally aren't deploying millimeter wave to any large extent. Spotty deployment in the U.S. and almost nothing outside of the U.S. And so that's suppressing demand this year for millimeter wave test equipment. That makes the -- is a little bit of a headwind for the mobility market. So call it flat to slightly down in mobility at about -- let's say, it's about $1.6 billion or $1.65 billion or so. 
The automotive and MCU market is closer to $450 million for the year. That's up from about $225 million last year. So big, big jump there. And the last segment that we sort of track is industrial, and that one is up to about $500 million from maybe $340 million, $325 million last year. So that's how we segment it right now."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Awesome. Awesome. And then I guess I just wanted to maybe push back a little bit on the correlation between WFE and Test TAM. It's been a little more consistent in memory the past couple of years. Of course, when you get these big pricing swings, that's g",187,"Awesome. Awesome. And then I guess I just wanted to maybe push back a little bit on the correlation between WFE and Test TAM. It's been a little more consistent in memory the past couple of years. Of course, when you get these big pricing swings, that's going to probably go away. But on the SOC side, wouldn't you agree, your big customer is a significantly larger portion of the SOC Test TAM than they are of consumption in the front end non-memory WFE world. So doesn't the SOC market depend a lot more on what the large customer is doing in the test world than in the WFE world. So the correlation in SOC could sort of break down a bit because of what the large customer is doing. And I guess on that point, they've never been good 3 years in a row, not once, and this is the second big year. So how do you handicap the odds that next year is a big down year and that works against you in terms of share, even if the market doesn't come down that much."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","All right. A lot in there, Tim, but I'll try to take it on. So your point about the large customer or our large customer never having sort of as a proportion of our revenue, 3 big years in a row, I think there's truth to that, but there's also a differenc",388,"All right. A lot in there, Tim, but I'll try to take it on. So your point about the large customer or our large customer never having sort of as a proportion of our revenue, 3 big years in a row, I think there's truth to that, but there's also a difference in what's happening because the portfolio there is growing. If you go back to the sort of 2014, '15 -- '13, '14, '15, '16 area, it was kind of one device type that was driving the story and the demand. And now we're into a much broader portfolio than that. So I would just offer that, that dynamic's changed. And that's a fact that could propel this more sequential growth for a longer period of time. 
On the correlation between WFE, Test -- SOC Test demand and whether that's stronger than who's buying, let's say, big -- certainly, customers have different test intensities. And so part of the noise that's running under the hood, certainly as it relates to our revenue, is related to large high test intensity customers and how much they're buying. We're fortunate that we participate in segments of the market that tend to have high test intensities, but that's by design. We target those segments. And it's not just one large customer that produces devices that have high test intensity. There's others, and that's where we play. 
So I would agree with you that if the market shifted away from high test intensity customers, meaning high complexity devices, you could see a disconnect, an anchor on the test market that was disconnected from WFE. But it just doesn't seem likely because the reason these investments are being made in the front end and the reason they're so expensive to make is that they're going after 3-nanometer EUV lines to build devices for these very customers we're talking about. So I just don't see that the disconnect can emerge unless the fabs sit idle. If the fabs are going to sit idle, yes. But if the fabs aren't going to be idle, it's the exact customers we're talking about that are going to utilize them. So I don't disabuse your point. It actually has some merit, but I just think the correlation, almost by definition, has to occur unless the fabs are idle."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question is from Krish Sankar with Cowen.",9,"Your next question is from Krish Sankar with Cowen."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","And Mark, thanks for the color on the SOC Test. I just wanted to like focus on the compute test market. And it looks like you said it's going from $600 million to $1 billion. Is the incremental growth all coming from custom silicon? And if that is the cas",83,"And Mark, thanks for the color on the SOC Test. I just wanted to like focus on the compute test market. And it looks like you said it's going from $600 million to $1 billion. Is the incremental growth all coming from custom silicon? And if that is the case, can you just tell us how much your market share in compute was last year? And how much do you think it's going to be this year? And then I have a follow-up."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So most of the growth is, I would say, coming -- what, is it non-custom-silicon, I couldn't say that. No, I think growth is coming from the nontraditional suppliers of compute devices, is a disproportionate amount of it. But the other usual suspects",182,"Yes. So most of the growth is, I would say, coming -- what, is it non-custom-silicon, I couldn't say that. No, I think growth is coming from the nontraditional suppliers of compute devices, is a disproportionate amount of it. But the other usual suspects are growing too. AMD, obviously, is growing. And NVIDIA is obviously growing. So it's broad-based. But as a proportion, I'd say, yes, you're right. It's probably some of the newer players that are growing the market faster than others. And as to our share position, historically, our share in compute has been below our overall market share. So maybe in the 30s, and it moves around in the 30s, is where it's been. 
This -- we're trending into a period of time because of this change of who's building these devices where our share is more likely to move up closer to our overall average share in the market. So if our SOC average share is somewhere in the 50-ish percent range, it might take a little bit of time, but that's kind of where we're trending to."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Got it. That's really helpful, Mark. And then just a follow-up. I think you made a comment that you're kind of booked out for the rest of the year. Is that a Semi Test and a Storage Test comment? And if so, should we assume that you would not see",78,"Got it. Got it. That's really helpful, Mark. And then just a follow-up. I think you made a comment that you're kind of booked out for the rest of the year. Is that a Semi Test and a Storage Test comment? And if so, should we assume that you would not see seasonality in the back half or in Q4 because the demand is strong. Or in other words, is your Q2 Semi Test revenue run rate sustainable?"
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","It's Sanjay. So I made the comment that we were booked out, and it was really tied to our supply perspective. We're working with our -- both contract manufacturers and our direct suppliers to fundamentally make sure that we have orders on the books until",59,"It's Sanjay. So I made the comment that we were booked out, and it was really tied to our supply perspective. We're working with our -- both contract manufacturers and our direct suppliers to fundamentally make sure that we have orders on the books until the end of the year, just given the supply constraints in the environment."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question is from Brian Chin with Stifel.",9,"Your next question is from Brian Chin with Stifel."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","First, on the Semi Test business, I definitely respect that visibility in this or any year has limitations. But if I do take the midpoint of your new expectations for the test markets, take your market share projection and assume the majority of the secon",93,"First, on the Semi Test business, I definitely respect that visibility in this or any year has limitations. But if I do take the midpoint of your new expectations for the test markets, take your market share projection and assume the majority of the second quarter growth will be Semi Test driven. I think I'd back into about a 10% or so sales decline in Semi Test in the second half of the year, am I kind of in the ballpark here? And to what extent is your backlog coverage supportive of this?"
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. When you take a look at the numbers, that's a -- we do -- overall, maybe I'll comment overall, we are expecting to see, given the visibility and obviously, with a significant reset of the market size, and as we move throughout the year, the lack of v",90,"Yes. When you take a look at the numbers, that's a -- we do -- overall, maybe I'll comment overall, we are expecting to see, given the visibility and obviously, with a significant reset of the market size, and as we move throughout the year, the lack of visibility in the second half. But with all of those provisions, we are seeing overall an expectation that the second half of the year revenue will be slightly down, both for the enterprise and that's a similar direction down for Semi Test."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Got it. And then maybe just on the Industrial Automation business, and sorry if I missed some of this, but I definitely heard about China as a geography showing strong year-over-year growth. A lot of growth in MiR and a snapback in the UR business",85,"Got it. Got it. And then maybe just on the Industrial Automation business, and sorry if I missed some of this, but I definitely heard about China as a geography showing strong year-over-year growth. A lot of growth in MiR and a snapback in the UR business as well. Can you characterize maybe Europe and North America, obviously, clear key markets as well. Sort of where are they in terms of their snapping back relative to where you might expect them to get this year?"
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. It's Sanjay. Yes. So from a U.S. perspective, we are seeing the snapback, whether you look at increases over Q1 of '19, pre-COVID year or even Q1 of '20. Similar with Europe, a very strong kind of double-digit snapback over either year.",43,"Yes. It's Sanjay. Yes. So from a U.S. perspective, we are seeing the snapback, whether you look at increases over Q1 of '19, pre-COVID year or even Q1 of '20. Similar with Europe, a very strong kind of double-digit snapback over either year."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question is from Joe Moore with Morgan Stanley.",10,"Your next question is from Joe Moore with Morgan Stanley."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","I wonder if you could talk about in the automotive and the broader markets, the degree to which test is one of the bottlenecks they're dealing with? Like we hear about shortages on wafers packaging, a little bit test. Just how severe do you think you're b",80,"I wonder if you could talk about in the automotive and the broader markets, the degree to which test is one of the bottlenecks they're dealing with? Like we hear about shortages on wafers packaging, a little bit test. Just how severe do you think you're bottlenecking them? And then when you look at a 90% comparison in auto, it would seem like there's some catch-up in that, like does that create sustainability risk in your mind maybe next year?"
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think the big, big issue is wafers, not tests in terms of bottlenecking the automotive manufacturers. That doesn't mean that we're completely aligned on deliveries for test equipment to the chip suppliers who are trying to ramp shipments. We are mi",114,"Yes. I think the big, big issue is wafers, not tests in terms of bottlenecking the automotive manufacturers. That doesn't mean that we're completely aligned on deliveries for test equipment to the chip suppliers who are trying to ramp shipments. We are misaligned by a few weeks here and there. And we're pulling like mad and they're pulling like mad. But the big, big, bigger issue is getting wafer capacity. So no big -- we're not in the headlights quite yet, but we're certainly in tense conversations to try to pick up a week or 2 here or there so that they can get a little bit more out a week or so sooner."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Great. And how many absolute level you have?",8,"Great. And how many absolute level you have?"
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","The sustainability of -- automotive always kind of goes in fits and starts. And I think the supply chain in automotive is going to come out of this, having learned a lesson that they can't be so lean on just in time. And I know that raises the specter of",224,"The sustainability of -- automotive always kind of goes in fits and starts. And I think the supply chain in automotive is going to come out of this, having learned a lesson that they can't be so lean on just in time. And I know that raises the specter of everybody's worry that there's inventory being going to be built in addition to real line demand. And I think that will happen. That's certainly not happening yet, that's to come. So there's going to be a phase here where we get through the urgency, then there will be investments made to build more, I'd say, slack in the system for the devices that go into automotives. 
So that will be a bit of a balloon. But then it will settle back to, I think, its normal rhythm, where increasing electronic and chip attach rates in automobiles will drive the market. And we're going to get to kind of a peak level of test investment in automotive this year, close to that $500 million number. And that could even -- certainly, I think it could sustain through the end of the year because of this inventory catch up. But my guess is as we get into the 2022 area and beyond, it'll sort of back into oscillating between the $300 million to $500 million rate."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question is from Blake Gendron with Wolfe Research.",10,"Your next question is from Blake Gendron with Wolfe Research."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","I want to come back to the arm's SOC commentary, not from a market share perspective, but rather the complexity discussion. Because as we've seen large customers accelerating this arm's rollout here a bit. So it seems like the architecture consolidates th",76,"I want to come back to the arm's SOC commentary, not from a market share perspective, but rather the complexity discussion. Because as we've seen large customers accelerating this arm's rollout here a bit. So it seems like the architecture consolidates the number of wafers for various compute functions, simplify the circuit a bit. So share opportunities notwithstanding, I'm wondering what the complexity in test intensity puts and takes are with this arms trend specifically?"
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. That's a little tricky. So first of all, let me say that most of the applications processors in your phone, which is a $1.5 billion -- 1.5 billion unit market are arm-based processors. And those devices in the high-end phones, which comprise maybe 40",191,"Yes. That's a little tricky. So first of all, let me say that most of the applications processors in your phone, which is a $1.5 billion -- 1.5 billion unit market are arm-based processors. And those devices in the high-end phones, which comprise maybe 400 million to 500 million units out of the 1.5 billion, have transistor counts on par with any desktop or laptop computer you might buy. 10 billion-plus kind of transistors. So the test -- when you look at the test intensity there compared to a traditional microprocessor, it's a little bit more efficient, I would say, than a traditional microprocessor, but not a lot more efficient. So for the same, let's say, 10 billion transistor x86 architecture compared to a map device in your phone, maybe it's at 90% versus 100% kind of test time delta, so not big. 
Now when you get into arm-based compute devices for more non-phone applications, there's different cash requirements, different IO technologies needed that further complexify the arm implementation that bring it back up to test intensities very similar to the x86 world. So I don't see a big difference there."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","That's really helpful. And then a follow-up on Industrial Automation. You noted peripheral services that demand additional software apps and likely hardware. We've seen a bit of proliferation of companies that are attacking things like computer vision, ma",88,"That's really helpful. And then a follow-up on Industrial Automation. You noted peripheral services that demand additional software apps and likely hardware. We've seen a bit of proliferation of companies that are attacking things like computer vision, machine learning, other AI capabilities. So wondering what kind of artificial intelligence capabilities Teradyne has in IA to keep up with these trends. It seems like robotics peers, both large and small, are really descending on the cobot space here. Or could this be a focus of M&A moving forward?"
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","So certainly in our M&A funnel, there's various opportunities like that. But what I would say is that many of the startups in the IA and machine learning space that are exploring ways to enhance robots, cobots, are doing it on our platform as a partner. I",158,"So certainly in our M&A funnel, there's various opportunities like that. But what I would say is that many of the startups in the IA and machine learning space that are exploring ways to enhance robots, cobots, are doing it on our platform as a partner. If you go into our -- again, UR+ ecosystem or a MiRGo ecosystem, you'll see a variety of machine learning and AI tools that have been targeted and customized for our products. So we're benefiting from them whether we own them or not. We do have organic IA products that we have on our MiR platform already. But it's going to be important for the evolution of ease of use and applications expansion for cobots, for sure. And whether we need to own it or whether we need to be the preferred platform that they all write their apps for, I think, is still kind of a case-by-case consideration for us."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","We're just about at the limit, but we can sneak 1 quick question in, if you would, April, please.",20,"We're just about at the limit, but we can sneak 1 quick question in, if you would, April, please."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Operator","Okay. And your last question is from Sidney Ho with Deutsche Bank.",12,"Okay. And your last question is from Sidney Ho with Deutsche Bank."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Just can you give us an update on your revenue opportunity related to 5G for both SOC Test and LitePoint? And maybe in the 5G infrastructure side, are you seeing a recovery of that market in any regions right now?",40,"Just can you give us an update on your revenue opportunity related to 5G for both SOC Test and LitePoint? And maybe in the 5G infrastructure side, are you seeing a recovery of that market in any regions right now?"
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think infrastructure is really not driving much tester demand generally. It did for us back in 2019 when China was going crazy, rolling out sub-6G and Huawei was investing heavily at the time. But the kind of what is now a $5 billion tester market,",240,"Yes. I think infrastructure is really not driving much tester demand generally. It did for us back in 2019 when China was going crazy, rolling out sub-6G and Huawei was investing heavily at the time. But the kind of what is now a $5 billion tester market, infrastructure, 5G investments are, I think, always going to be sub-$100 million and maybe more in the sort of $60 million to $70 million range. The bigger one is what happens with the phones and the terminals and such. And there, the U.S., the spectrum auction around sub-6G is concluded. I think that carriers are kind of clearly going to roll that out as their next step. 
That's, as I said earlier, going to suppress the demand for millimeter wave, which is the most test intensive portion of 5G. And so in the past calls, I've talked about LitePoint and Semi Test combined driving an incremental $400 million to $500 million worth of tester demand in the 5G era. And I think where we are in that now is we're probably in that $250 million to $300 million piece of it. And I think it's going to go sideways here for a while because of the fact that millimeter wave this year will be less probably investment than last year. And that will be the last kicker. Maybe it's still a couple of years out to bring it up to that full potential."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Analysts","Great. Maybe just lastly on the System Level Test. What is the size of that market today? And how big could that be when those lower complexity devices that you alluded to start to come into the market? And maybe just a little bit on the competition side,",58,"Great. Maybe just lastly on the System Level Test. What is the size of that market today? And how big could that be when those lower complexity devices that you alluded to start to come into the market? And maybe just a little bit on the competition side, how do you sustain your market share in that market?"
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think the market is pretty thin. We don't have a good number to give you on market size. But I think if you look at us and Advantest, you can kind of get a general sense. We probably, again, have 80% of the market between us. There's some other bes",236,"Yes. I think the market is pretty thin. We don't have a good number to give you on market size. But I think if you look at us and Advantest, you can kind of get a general sense. We probably, again, have 80% of the market between us. There's some other bespoke custom products that certain suppliers provide, but that's the way you could get at the market. And Advantest and Teradyne are kind of, I think, both hard-core players here. We each have our own benefits. And as we said earlier, this additional test step that high complexity devices are requiring is likely to proliferate into other markets. But 2 things are kind of important. I think from like the automotive market, as an example, is a very high-quality demanding market. But the volumes, frankly, are relatively low compared to something like a phone, 100 million cars versus 1.5 billion phones. 
So for a market like that with lower volume devices to take advantage of SLT, which they would love to, we need a different architecture that we're developing to address these, I'd say, higher mix, lower volume markets. And I think our position and the sustainability of this is pretty good. It's like semiconductor tests, where the changeover costs are pretty high. Once you're in, somebody else has really got to have a better mousetrap by a long shot to sort of dislodge you."
94728,711666829,2261094,"Teradyne, Inc., Q1 2021 Earnings Call, Apr 28, 2021",2021-04-28,"Earnings Calls","Teradyne, Inc.","Executives","Okay. We are out of time. Thanks so much for joining us today, and we look forward to talking to you in the days and weeks ahead. Thanks, again. Bye-bye.",30,"Okay. We are out of time. Thanks so much for joining us today, and we look forward to talking to you in the days and weeks ahead. Thanks, again. Bye-bye."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Good morning, ladies and gentlemen, and welcome to the Q2 2021 Teradyne Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is not -- this conference call will resume -- I would now like to turn the conference over to you",47,"Good morning, ladies and gentlemen, and welcome to the Q2 2021 Teradyne Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is not -- this conference call will resume -- I would now like to turn the conference over to your host, Mr. Andy Blanchard."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Phyllis. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined this morning by our CEO, Mark Jagelio; and our CFO, Sanjay Mehta. Following our opening remarks, we'll provide details of our",295,"Thank you, Phyllis. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined this morning by our CEO, Mark Jagelio; and our CFO, Sanjay Mehta. Following our opening remarks, we'll provide details of our performance for 2021's second quarter, along with our outlook for the third quarter of 2021. The press release containing our second quarter results was issued last -- is on the Investor page of the website that may be helpful to you when following the discussion. Replays of this call will be available via the same page after the call ends. 
Matters that we discuss today will include looking statements that involve risk factors that could cause Teradyne's results to differ materially from management's current expectations. We encourage you to review the safe harbor statement contained in the earnings release as well as our most recent SEC filings. Additionally, those forward-looking statements are made as of today, and we take no obligation to update them as a result of developments occurring after this call. 
During today's call, we'll make reference to non-GAAP measures. We've posted additional information concerning those non-GAAP financial measures, including conciliation to the most directly comparable GAAP financial measures, where available, on the of our website. 
Looking ahead between now and our next earnings call, Teradyne expects to participate in technology or industrial-focused investor conferences hosted by KeyBanc, Rosenblatt Securities, Deutsche Bank and Citi. 
Now let's get on with the agenda. First, Mark will comment on our recent results and the market conditions as we enter the new quarter. Sanjay will then offer more details on our quarterly results, along with our guidance for the third quarter. We'll then answer your questions, and this call is scheduled for [ 1 hour ].
Mark?"
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Good morning, everyone, and thanks for joining us. Today, I'll summarize our results for the second quarter and first half of 2021, update on current conditions in both test and Industrial Automation, and comment on our view for the second half of the yea",1220,"Good morning, everyone, and thanks for joining us. Today, I'll summarize our results for the second quarter and first half of 2021, update on current conditions in both test and Industrial Automation, and comment on our view for the second half of the year. Sanjay will then provide the financial details on the quarter and our guidance for Q3. 
The strong demand we saw in Q1 accelerated in Q2 as both our Test and Industrial Automation groups grew substantially in the quarter. The long-term demand drivers we've discussed in the past continue to power demand for our products. In Test, it's device complexity and unit growth, in Industrial Automation, it's labor scarcity, the need for resiliency and productivity improvement. 
Opening further, performance at the company level from 2016 through 2020 saw our sales and non-GAAP EPS grow at a compounded rate of 16% and 32%, respectively. For the first half of this year, sales are running ahead of that rate at 21%, and non-GAAP earnings per share grew at 29% compared with last year. This demonstrates both the vitality of the markets we serve and the efficiency of our operating model. 
Significantly, in Q2, we saw Industrial Automation demand recover in all major regions, but particularly in North America. As a result, our production teams operated at a high pace in Q2, and that pace is seen in Q3. 
For the year, our IA business is on track to grow about 30% from 2019 and about 40% from 2020. 
Looking closely at the segment level. In Semi Test, SOC shipments grew 29% in Q2 from Q2 of 2020, with particular strength in both the compute and mobility end markets. For the first half, SoC sales grew 19%. For the first time in several years, smartphone unit shipments are helping growth in the mobility segment, where as recent years have mostly relied on complexity growth. 
Commodity and compute are the 2 largest subsegments in SOC. Automotive, electric and industrial demand continues to be strong. The auto-related semi test market is expected to exceed $500 million this year, the highest level since 2017. This is despite the fact that automobile unit production will be lower in 2017 -- lower than 2017. A portion of this strength is Test. We're also seeing the impact of increased semi content and complexity per automobile, driving the test market. 
Our Memory Test shipments also grew in Q2 -- from Q2 of 2020, up 9%, led by flash tester demand. For the 6-month period, overall shipments were up 18% from last year on solid demand for both flash wafer and systems. This reflects significant growth in smartphone demand, the build-out of new memory capacity in China and the growth of SSD demand. Looking at the full year we are again revising up the SOC market for 2021 to now be in the range of $4.3 billion to $4.7 billion, with increasing strength in the x86 GPU and display driver segments. 
Recall that we have lower customer exposure in those markets, with much of this incremental growth going to our competitors. So we'll likely see our SoC share around 48% for the year. 
In Memory, at the macro level, our market estimates are unchanged with the test market this year expected to be about $1 billion and our share to be at about the 40% level. I will note that the expected ramp of DDR5 for server applications and the broader adoption of LPDDR5 is pushing out into 2022. 
Shifting to our System Test group. Sales were up 26% in the first half compared with 2020 with strong storage test demand and a recovery in our production board test unit driving the growth. For the full year, we see System Test group -- the System Test group grow in the 10% to 20% range. 
At LitePoint, sales in Q2 were up 12% over 2Q 2020. While 5G millimeter wave demand is lower than expected, the environment in wireless test is improving as we move through the year due to the continued WiFi 6 growth and early WiFi 7 investments. In addition, ultra wideband adoption is increasing, adding a new growth vector for LitePoint. For the full year, LitePoint will likely grow in the 10% range. 
Moving on to Industrial Automation. The combination of expanding demand across our major markets and the increase in the range of tests served by our universal robots and mirror units drove group sales up 57% in Q2 last year in the first half. Compared to pre-pandemic 2019, first half sales are up 22%. Supply chain issues have constrained growth a little bit, with lead times pushing out about 1 week. 
The demand environment for IA has recovered in most regions from last year's slowdown. America was the fastest-growing major region in Q2, with sales up over 90% from last year. Although we did see a lull in some countries in Asia where COVID has spiked in recent months, the second half of the year outlook is quite strong in all our major regions. 
Our long-term growth strategy in IA continues unchanged, and we expect long-term annual growth in the [Audio Gap] gross margins get a 5% to 15% operating margin during these high-growth years. [Audio Gap] We are also expanding our sales to OEMs that integrate our robots into their products. 
Last quarter, we noted the expanding range of applications for UR robots in a high-voltage line application with hundreds of being deployed. Today, I'd like to highlight the success of UR+ plug-and-play applications for industrial. There is a long-standing and chronic shortage of qualified welders worldwide, with an estimated 100,000 unfilled welding jobs in the U.S. alone. While automated solutions exist for large applications like auto manufacturing, customers with lower volume and higher mix products are not well served by traditional automation. 
The integration of a forced Torch sensor into E-Series cobots enabled the precision needed for this application, and with UR+ integrating with our partners, we began serving this about 3 years ago. During this time, welding applications have grown to be about 6% of our global and our [ 1,000 cobots ] sold in 2021, more than tripling our 2020 pace. 
As we continue to extend the performance of our UR platform, we expect these applications had vectors to traditional industrial applications. We have similar market expanding initiatives in play on our mirror, but I'll save those details for a future call. 
Summing it all up, the first half of the year has been a strong sales, strong gross margins and earnings growth. Longer term, the markets we serve are showing a future global economy. The importance, pervasiveness and enabling capability of electronics in every facet of our lives and industry is driving more fab investment, more complexity and more test. Likewise, the broadening application and fast ROI of robots in a world with labor shortages and productivity challenges is another growth trend. 
Strategically, we positioned ourselves in line with and plan to continue to make the Test and IA as our full potential while driving world-class returns. 
While the rate of change in our markets is accelerating; we are well positioned to thrive as a company and to bring additional value to customers and shareholders. 
I'll now turn things over to Sanjay to provide additional color on the financials."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Mark. Good morning, everyone. Today, I'll on our Q2 results, comment on current business conditions and describe Q3. Now to Q2. Second quarter sales were $1.086 billion with non-GAAP EPS of $1.91, up 29% and 44%, respectively, from Q2 '20. No",1024,"Thank you, Mark. Good morning, everyone. Today, I'll on our Q2 results, comment on current business conditions and describe Q3. 
Now to Q2. Second quarter sales were $1.086 billion with non-GAAP EPS of $1.91, up 29% and 44%, respectively, from Q2 '20. Non-GAAP gross margins were 59.6% and our non-GAAP operating expenses were $250 million, $5 million below the high guidance due to the timing of some nonrecurring engineering expenses. Non operating profit rate was 36.5%. In the quarter was 59% compared with our of 58%. The increase was tied to favorable product mix in the quarter versus planned. 
For context, Q2 2020 gross margin was approximately. In April, the earnings noted that this level of gross margin would continue in the near term, driven by the introduction of several key test systems in early 2020, which would take quarters to come down the cost curve. These new product introductions, coupled with heightened costs driven by COVID shortages, were impacting our gross margins in 2020. One year later, we have now most of these test solutions at volume, and they have come down the cost curve as expected. 
The result contributed to higher margins in the second quarter, which we expect will continue in the second half of the year. A component of gross margin improvement over 2020 is higher revenue-yielding of leverage in the gross margin line. We had one 10% customer in the quarter. 
Excluding discrete items for the 14.5% on both GAAP and non-GAAP basis. 
Looking at the results from a business unit perspective, revenue of $834 million was up 27% from Q2 2020. SOC revenue was $742 million, up 29%, driven by strength in compute, mobility, industrial and automotive. Memory revenue was $92 million, up 9% from prior year, driven by strength in flash test and flash wafer sort segments. 
System Test group had revenue of $105 million, which was up 46% year-over-year. This is driven by $58 million in storage test sales, including both and SLT solutions. In defense and aerospace and production board test. 
Storage Test, HDD and SLT demand remains robust as drive densities continue to increase and the number of devices adopting. 
At LitePoint, revenue of $55 million was 2% -- was up 12% prior year due to continued strength in, increases in and ultra-wide band test market segments. 
Now to Industrial Automation. As we did in April, I'll provide revenue metrics comparing Q2 '21 results with both Q2 '20 and Q2 '19, so you'll have the full context given the impact of a contracting market tied to COVID last year. Industrial revenue of $92 million was up 57% year-over-year and 23% over Q2 '19. Revenue expanded in all regions in Q2 over last year, with North America delivering the highest absolute revenue growth. U.S. and Europe represented about 77% of IA revenue in the quarter, with China contributing about 14%. 
UR sales were $76 million in Q2, up 75% year-over-year and up over 2019. Mir sales were $16 million, up 41% from Q2 '20 and 51% from Q2 '19. Recall, Mir had an unusual in Q2 '20 as its robots were widely deployed in automated COVID disinfectant applications. 
The longer-term outlook in our IA business continues to brighten. We expect continued labor shortages to drive new applications for both our fixed and mobile robots. Mark highlighted the shortage of welders and how that has opened up a new market for our UR cobs, but that is just 1 of many job categories with acute short-term and long-term labor shortages. 
Our strategy is to provide an open platform that creative developers can leverage to solve industry-specific labor shortages. The numerous filling ultraviolet producing solutions built on our platform last year is a shining example of the agility of our partner networks to solve problems. 
We're investing in engineering, support and marketing resources to make Mir platforms even easier to build upon, which will enable the continued proliferation of high-value automated solutions of challenging problems for an expanding range of customers. 
Significantly, these development partners and customers provide great feedback on our R&D development plans. 
From a financial perspective, we expect IA will operate around the low end of our target profit range of 5% and 15%. We do expect IA to operate above the Rule of 40 in 2021. That is, the sum of operating profit and revenue growth over 40%. Longer term, when growth moderates, we expect the IA Group to have a similar operating profit rate as our test portfolio. 
Shifting to supply. We continue to manage through numerous supply constraints along with increased material, manufacturing and logistics costs in both our test and IA businesses. For some products in both Test and IA, the supply constraints have extended our lead times, and we're working closely with customers to minimize the impact of these delays. 
But we've been able to offset these higher costs through operating leverage with higher volumes and other cost-saving measures, so the cost increase impact on the P&L has not been material. 
We do expect to be dealing with supply line related issues in Q3 and Q4 this year, which are reflected in our forecasts. 
[Audio Gap] were $25.69 per share. Regarding our convertible debt. $15.6 million was paid in Q2 to convertible bondholders ahead of maturity. By the end of August 2021, bondholders will have nearly converted a total of $302 million, leaving a face value of [ $58 million ] outstanding. 
Looking at our operating model, I'd like to make 3 quick points. First, our performance over time. From 10 years ago, our gross margin percent has expanded from the low to mid to nearly 60%, and our operating margin from the teens to low 20s to greater than 30% today. 
Second, our flexible business model shifts fixed cost to variable costs where appropriate, through contracted or outsourced manufacturing, variable compensation and other levers which enables resiliency on the downside and is creative when business is strong. 
Third; the operating leverage in the model is evident in our Q2 results. Our test businesses are dropping through over $0.50 per revenue dollar through to the profit line in 2021."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","[ Connected ]",2,"[ Connected ]"
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you.",2,"Thank you."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","You are welcome.",3,"You are welcome."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Ladies and gentlemen, we're going to have a quick transition.",10,"Ladies and gentlemen, we're going to have a quick transition."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","I'll go back -- okay, it's Sanjay again. I'll go back to looking at our operating model. I'd like to make 3 quick points. First, our performance over time from 10 years ago, our gross margin percent has expanded from low to mid-50s to nearly 60% today, an",526,"I'll go back -- okay, it's Sanjay again. I'll go back to looking at our operating model. I'd like to make 3 quick points. First, our performance over time from 10 years ago, our gross margin percent has expanded from low to mid-50s to nearly 60% today, and our operating margin from the teens to low 20s, to greater than 30% today. 
Second, our flexible business model shifts fixed cost to variable costs, where appropriate, through contract or outsourced manufacturing, variable compensation and other means, which enables resiliency on the downside and is accretive when business is strong. 
Third, the operating leverage in the model is evident in our Q2 results. Our test businesses are dropping through over $0.50 per revenue dollar through to the profit line in 2021, even while we continue to increase our R&D, support -- and support investments to strengthen our test business. This enables Teradyne to continue to invest in both our test and IA portfolios. 
For IA, we are building a deeper product ecosystem and distribution differentiation while achieving the Rule of 40 in our IA portfolio. 
Now to our outlook for Q3. As Mark noted, the demand environment across the business remains strong. Our guidance assumes no significant changes, positive or negative, in the availability of materials and also assumes that we won't see additional pandemic-related issues. With that said, sales in Q3 are expected to be between $880 million and $960 million, with non-GAAP EPS in the range of $1.29 to $1.55 and 176 million diluted shares. 
Third quarter guidance excludes the amortization of acquired intangibles and noncash imputed interest on convertible debt. Third quarter gross margins are estimated to be between 59% and 60%. OpEx is expected to run at 27% to 29% of third quarter sales. The non-GAAP operating profit at the midpoint of our third quarter guidance is 32%. 
Regarding OpEx for the full year. While we spent a bit lower than planned in Q2, we expect the full year OpEx will be about in line with the plan we described in April. We expect total operating expenses for 2021 to be about $1 billion, or up approximately 19% from 2020. We recognize that we're on track to meet our 2024 earnings model this year. We'll update the model on our regular cadence in January, after our detailed midterm plan income is complete in Q4 this year. 
In summary, our businesses are performing extremely well, delivering strong revenue and earnings growth while funding the investments that will drive future success. Our first half sales grew 21% and non-GAAP EPS grew 29% above the first half of 2020, which itself was a record. We expect to deliver the highest Q3 sales and profit in history. 
Our employees and production partners around the world have delivered a record number of systems under challenging conditions. Our support teams have done whatever was needed to make our customers successful. And our engineering teams have kept the new product pipeline moving on schedule. It's been an impressive display of teamwork, and I'm proud to be part of the powerful Teradyne team. 
With that, I'll turn things back to Andrew."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Sanjay. And everybody, thanks for dealing with our small technical issue there. Phyllis, we would now like to take some questions. [Operator Instructions]",24,"Thanks, Sanjay. And everybody, thanks for dealing with our small technical issue there. Phyllis, we would now like to take some questions. [Operator Instructions]"
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","[Operator Instructions] Your first question comes from the line of Brian Chin with Stifel.",14,"[Operator Instructions] Your first question comes from the line of Brian Chin with Stifel."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","A couple of questions here. Maybe just to kick things off, I'm just curious to what degree, if any, are the extended lead times in ATE in this sort of the current strong semiconductor environment impacting your shipment outlook or pattern in the second ha",79,"A couple of questions here. Maybe just to kick things off, I'm just curious to what degree, if any, are the extended lead times in ATE in this sort of the current strong semiconductor environment impacting your shipment outlook or pattern in the second half. Obviously, Terry and I no longer disclose bookings, but your competitor appears to be building backlog into the December quarter. So I was wondering if you have better than typical backlog visibility beyond September."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So lead times have definitely been moving out. I'd say auto and industrial demand is still outstripping supply. But our lead times have pushed out, obviously, based on the very, very tight supply chain environment we're dealing with. And so what us",100,"Yes. So lead times have definitely been moving out. I'd say auto and industrial demand is still outstripping supply. But our lead times have pushed out, obviously, based on the very, very tight supply chain environment we're dealing with. 
And so what used to be, let's say, within a quarter has pushed out to 5, 8 weeks incremental to where we were in the past to be, in some cases, in the 20s and weeks of lead time. So with that, we have seen, I guess, improved bookings from our customers, and we're working with them to manage through it."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Sanjay. And then maybe for Mark. I think you touched on how -- at least in the smartphone market, units are kind of a bigger tailwind this year, which hasn't always been the case in recent years. But I think in the 2022, what do you think -- to wh",74,"Got it. Sanjay. And then maybe for Mark. I think you touched on how -- at least in the smartphone market, units are kind of a bigger tailwind this year, which hasn't always been the case in recent years. But I think in the 2022, what do you think -- to what degree could increase packaging complexity across foundries and maybe some IDMs be a more meaningful driver of incremental test intensity next year."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes, that's a good question. We bundle that into the complexity side of life. And there's already been advanced packaging technologies deployed for several years now in phones, but it's increasing. So that trend of multichip multi-die packaging incrementa",91,"Yes, that's a good question. We bundle that into the complexity side of life. And there's already been advanced packaging technologies deployed for several years now in phones, but it's increasing. So that trend of multichip multi-die packaging incrementally adds test time above and beyond what you would get if you were putting all of that silicon on a single integrated die. And there's not a good rule of thumb how much of an adder it is, but it is a trend that's going to continue to grow and drive tests."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of Atif Malik with Citi.",12,"Your next question comes from the line of Atif Malik with Citi."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I have a similar question on the mobility market. It sounds like your mobility outlook has improved for the year versus 90 days ago despite millimeter wave weakness. You talked about units helping. Can you talk about the confidence in test intensity stayi",80,"I have a similar question on the mobility market. It sounds like your mobility outlook has improved for the year versus 90 days ago despite millimeter wave weakness. You talked about units helping. Can you talk about the confidence in test intensity staying elevated for both mobility and compute into next year? And if you can also highlight the steps you're taking to improve your market share in the areas that you're not strong, like x86, GPU and display drivers?"
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So I think the complexity trends looking even into next year are all very strong and positive. In the case of mobility, the newer lithographies that are coming online are being widely adopted by the manufacturers of silicon for phones, which portends",312,"Yes. So I think the complexity trends looking even into next year are all very strong and positive. In the case of mobility, the newer lithographies that are coming online are being widely adopted by the manufacturers of silicon for phones, which portends more transistors, which portends more test time. So that looking into next year, all looks positive. And we get, at this point in the year, early glimpses of what the silicon for next year might actually look like. 
The -- on the compute side, similarly, we not only have the trend of lower lithography nodes, but the new interface standards related to LPDDR5 and DDR5, as I mentioned in my remarks, -- The early adoption of that has been pushed out a little bit as the processors that go with it have been delayed a bit. But all of the complexity required to run at those higher bandwidths is coming in 2022. So those are 2 positive things I look at that gives me confidence that this driver of complexity growth is definitely going to be strong next year. 
In terms of share, what we said before is that penetrating the traditional x86 GPU stalwarts is going to be a long-term endeavor for us that's going to hinge on some kind of technological discontinuity likely shift to DDR5 or like a shift to PAM4 interfaces, to crack into. So that one is episodic and will play out over, let's say, 3 to 5 years. 
On the other front is -- are the emerging hyperscalers and new people coming into the market of creating complex silicon. These are automobile manufacturers, hyperscalers that we've talked about in the past, the Googles, the Facebooks, the Microsofts, the Amazons, That's where we're focused on getting a position to grow with them as they launch their products into the market in the shorter term."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Great. Very helpful. And Sanjay, for you, the largest U.S. phone maker and your biggest indirect customer talked about supply constraints impacting smartphone sales in the September quarter yesterday. Have the materials and parts tightness have gotten wor",46,"Great. Very helpful. And Sanjay, for you, the largest U.S. phone maker and your biggest indirect customer talked about supply constraints impacting smartphone sales in the September quarter yesterday. Have the materials and parts tightness have gotten worse over the last 90 days for your business?"
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Well, first of all, I won't comment on any particular customer, but I will speak in general about the environment. Last year, we were really working through demand increases, but we had fairly good, robust inventory strategies, and we are working through",165,"Well, first of all, I won't comment on any particular customer, but I will speak in general about the environment. Last year, we were really working through demand increases, but we had fairly good, robust inventory strategies, and we are working through the impact of COVID. You have thousands of components that go into these testers. And we did a lot of resiliency improvements there. You fast forward to today's environment and the demand has really kept accelerating. And the environment is tighter, I would say, today. And frankly, we don't see it letting up until the second half of 2022. 
So I think as the semiconductor industry goes through continued growth. You're seeing supply chains really getting tested. And then with the increase in the infection rates of COVID, especially, I'd say, in Southeast Asia, we're working through and managing the best we can, but I believe the net summation is it's a tighter industry now than it was, say, 3, 6 months ago."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of Mehdi Hosseini with SIG.",12,"Your next question comes from the line of Mehdi Hosseini with SIG."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Two questions, 1 on ARM-based ASIC design. I'm trying to get a sense of how you see the TAM. You can either elaborate [Audio Gap] gave a mix of SOC tests. Or perhaps you can tell us how is the test time for an ARM-based ASIC chip compared to like a proc",90,"Two questions, 1 on ARM-based ASIC design. I'm trying to get a sense of how you see the TAM. You can either elaborate [Audio Gap] 
gave a mix of SOC tests. Or perhaps you can tell us how is the test time for an ARM-based ASIC chip compared to like a process or maybe that way we could give a sense of how demand looks like. So either qualitatively or quantitatively, You can -- if you can elaborate on ARM-based SOC test, will be great. And I have a follow-up."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So I guess the first thing I'd say is that a ARM-based high-end map processor, which is what's in most of our phones today, driving most of our phones, has a transistor count that's equivalent to any laptop, x86 kind of product you might have in your",159,"Yes. So I guess the first thing I'd say is that a ARM-based high-end map processor, which is what's in most of our phones today, driving most of our phones, has a transistor count that's equivalent to any laptop, x86 kind of product you might have in your computer. And the test times comparatively between those 2 are not that different. It's kind of proportional to test count. 
The new ARM processors that are coming to market for compute applications, not smartphone applications, have perhaps anywhere from 25% to 60% at or on transistor count above what's at the highest end of smartphones. And the test time associated with them, I would say, is proportionately longer at this point. And so I think it's, generally speaking, scaling with transistor count and the transistor count on the arm side is running a little bit at a faster clip than it is on the more traditional architecture side, if that helps."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Sure. So the follow-up has to do with ARM-based. Actually, I want to just dig in a little bit more. Would you, at some point, break this out so we could better understand how kind of ARM-based SoC tester is tracking or scaling versus the rest of the SSE m",70,"Sure. So the follow-up has to do with ARM-based. Actually, I want to just dig in a little bit more. Would you, at some point, break this out so we could better understand how kind of ARM-based SoC tester is tracking or scaling versus the rest of the SSE market? 
And number two, is there anything you can give us to better understand the competitive landscape for this specific application?"
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I guess, I haven't thought about trying to find a way to break out ARM because most of what mobility is, is ARM; and then there's, let's say, compute applications for ARM; and then there's some processors that are almost dual-use, and they go into ei",224,"Yes. I guess, I haven't thought about trying to find a way to break out ARM because most of what mobility is, is ARM; and then there's, let's say, compute applications for ARM; and then there's some processors that are almost dual-use, and they go into either application. 
So I think it's fair to say that any compute business that we have at Teradyne is ARM-based compute. And perhaps many in the future, we can look at some way to sort of characterize both the market and our associated revenue for that. But I don't have a good number for you now on that. 
And in terms of the applications coming to market, in the short term, we know about the phone applications. We know about some early adopters of ARM for compute. Those are all coming to market or are in the market now. The hyperscalers that we're working with are coming into market at various points over next year with products that are quite interesting but highly speculative as to whether they'll latch in the market. And obviously, I'm not going to talk about those because they're pretty confidential. 
But we'll see what latches. If one of these applications can become a 100-plus million unit application, which most of these design teams are targeting, then that's a significant adder to the market."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of Vivek Arya with Bank of America.",14,"Your next question comes from the line of Vivek Arya with Bank of America."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I was curious, how is your kind of visibility for Q4 as you kind of stand today versus what it is usually? And if you could give us some color by end market in terms of what is in your assumption for Q3 and the second half, that would be very helpful.",52,"I was curious, how is your kind of visibility for Q4 as you kind of stand today versus what it is usually? And if you could give us some color by end market in terms of what is in your assumption for Q3 and the second half, that would be very helpful."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Sure. So Q4, if I look back at my last 2 years here, we've been surprised mainly on the positive side. And I'd say that given the tightness of supply and customers providing a little bit more in the way of backlog, it gives us a little bit more insight. H",216,"Sure. So Q4, if I look back at my last 2 years here, we've been surprised mainly on the positive side. And I'd say that given the tightness of supply and customers providing a little bit more in the way of backlog, it gives us a little bit more insight. However, obviously, in the near term, we have much stronger visibility in Q3 than in Q4. And so -- but we do have, I'd say, a little bit of incremental visibility. 
In color -- in your question in regards to color for Q3, we see continued strength in semiconductor. Obviously, the different components within Semi Test are  going to be a little volatile, but we do see a trend down. It's still what we believe is very strong demand, but we see a trend down. And we see in our IA portfolio, really, strength. Obviously, with the COVID impact in 2020, industrials are really coming back. I'll cite some PMIs in the 60s at the U.S. and Europe. And we really see that in our -- as Mark noted, in our growth in the U.S. But we're seeing that growth in China as well as in Europe and the U.S. So continued expected growth in IA and then from a test perspective coming down a bit."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And then on the UR side, Mark, I'm curious, what are the top 3 applications you're serving today? And how do you expect these applications to evolve? You are maintaining a very strong growth rate in that business. And I'm curious, what is driving",116,"Got it. And then on the UR side, Mark, I'm curious, what are the top 3 applications you're serving today? And how do you expect these applications to evolve? You are maintaining a very strong growth rate in that business. And I'm curious, what is driving that? Is it more number of customers? Is it more applications within the same customer? So what's giving you the confidence you can maintain this very strong growth rate in the UR business? 
And is -- on the gross margin side, is it accretive? I know on the operating margin side, you've given a range. But I imagine on the gross margin side, it might be accretive to your business."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. It's interesting because there's no silver bullet as to what's driving the growth at UR. So for example, we're going to be up about 30% from revenue in 2019, 40% of up from 2020. And in the script, I mentioned this application for welding, which is a",328,"Yes. It's interesting because there's no silver bullet as to what's driving the growth at UR. So for example, we're going to be up about 30% from revenue in 2019, 40% of up from 2020. And in the script, I mentioned this application for welding, which is a brand-new application that is now driving about 6% of our sales for the year. Last quarter, I talked about this service application for servicing high-voltage power lines that's also running at around that 6% of sales applications that was nonexistent -- essentially nonexistent 2 years ago. 
So already, we have 12% of our growth attributed to new applications in new markets with new customers that we didn't have 2 years ago. So it's a combination of expanding applications like those 2 examples as well as established markets growing that's driving this. 
And our top 3 applications tend to be the same. It's automotive supply chain, it's industrial machine tending and its electronic assembly tend to be the ones that are at the top of the pack. But frankly, they are shrinking as a percentage of sales as these new applications come online. 
So what gives me confidence looking forward is that ecosystem of partners who are developing these application solutions on our platform, not our competitors, is just continuing to grow and prosper. And they're not all going to be as successful as high voltage line tending or welding, but it only takes 10% of them to fuel the kind of growth numbers that we've been seeing. And the activity there is very strong, and the technology is maturing to the point that more and more applications can economically be served. 
And over the horizon, when you look at what AI can bring, there's a whole new set of, let's say, features that will enable yet another expansion of the market. It's what gives us the confidence to talk about these kind of decade-long growth rates of 25%, 30%, 35%."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of John Pitzer with Credit Suisse.",13,"Your next question comes from the line of John Pitzer with Credit Suisse."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, maybe another way to ask the calendar fourth quarter question is, over the last 3 years, the business has run in such a way that the second half has been greater than the first half from a top line perspective, which has broken kind of a trend, wher",100,"Mark, maybe another way to ask the calendar fourth quarter question is, over the last 3 years, the business has run in such a way that the second half has been greater than the first half from a top line perspective, which has broken kind of a trend, where if you go back the prior 7 years, it was first half stronger than second half. Did you have any commentary on sort of how you think the second half over the first half looked this year, just given how strong the market environment is and how tight test capacity is?"
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","You're right. Perfect student of the history. And we have been, as Sanjay said, always a bit surprised in the recent years on how strong the fourth quarter has come in and driven second half to be a bit higher than first. So if you asked us today, we'd",162,"You're right. Perfect student of the history. And we have been, as Sanjay said, always a bit surprised in the recent years on how strong the fourth quarter has come in and driven second half to be a bit higher than first. 
So if you asked us today, we'd say first half is a little bit stronger than second but that's no different than kind of what we thought for the last couple of years, too. And that just is a testament to visibility in Q4 as the lack of visibility in Q4. As Sanjay said, though, it's a little bit more visibility now than before because lead times are a little longer, but all the upside that could come in is the -- obviously the piece that's not visible. 
So we feel probably better now about Q4 than we felt in any prior 2 or 3 years, but it's sort of what might happen between now and October that's invisible."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","That's helpful. And then Mark, as my follow-on, I apologize, the audio quality was a little poor during your prepared comments. I wanted to go back to some of the commentary you made around DDR5 adoption. I think the point you were making is perhaps it'",88,"That's helpful. And then Mark, as my follow-on, I apologize, the audio quality was a little poor during your prepared comments. 
I wanted to go back to some of the commentary you made around DDR5 adoption. I think the point you were making is perhaps it's a little bit slower than you thought. Is that correct? And I guess more importantly, can you give us an update on how you think you're positioned for DDR5 when it does start to ramp relative to share in memory test?"
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Yes, sorry about the audio quality. But in fact, yes, DDR5 for server applications has pushed out a bit as the server chips themselves have been delayed. We've seen the impact of that in the demand for DDR5 testers. And some of the things happened",117,"Yes. Yes, sorry about the audio quality. 
But in fact, yes, DDR5 for server applications has pushed out a bit as the server chips themselves have been delayed. We've seen the impact of that in the demand for DDR5 testers. And some of the things happened with LPDDR5 going into mobility applications. 
So despite all that, the share position for Teradyne, we think, is  unchanged from our early estimates at around 40% of the market, and it's going to be a tailwind next year when the DDL5 and LPDDR5 ramp as was originally thought would happen toward the end of this year. So we're well positioned there, and I think that's a tailwind for us next year."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of C.J. Muse with Evercore.",13,"Your next question comes from the line of C.J. Muse with Evercore."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I guess first question, Mark, you've taken SoC test market size higher again. And I guess curious if we were to hit the high end of the range, what would be the driver there? And would your market share still be 48% or could you see greater contribution f",61,"I guess first question, Mark, you've taken SoC test market size higher again. And I guess curious if we were to hit the high end of the range, what would be the driver there? And would your market share still be 48% or could you see greater contribution from what's driving potentially the market to the higher end of the range?"
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Certainly, if the market goes up towards the high end of that range, our revenue would grow probably proportional to that. Would our share go much higher? I gave a number -- I fielded a number of roughly 4% and at the midpoint of our market size guid",154,"Yes. Certainly, if the market goes up towards the high end of that range, our revenue would grow probably proportional to that. Would our share go much higher? I gave a number -- I fielded a number of roughly 4% and at the midpoint of our market size guide. I would expect our market share's probably going to stay around that number, plus or minus 0.5 points at this point in the year. 
But it's hard to sort of prognosticate too much about where the share comes from. As you know, one customer's buying capacity can swing multiple points of share in any given year. And so one of our customers could come in and drive a demand that we don't see right now. We have the manufacturing capacity to serve it. And yes, I guess we could be up at 50% share if that happened. It's just a little opaque at the moment."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. That's helpful. And I guess a follow-on question to a few of the questions that you got earlier. You spoke to DDR5 now being pushed to a tailwind next year. You've spoken to high-performance compute, particularly the non-x86 world, as a tailwind for",110,"Okay. That's helpful. And I guess a follow-on question to a few of the questions that you got earlier. You spoke to DDR5 now being pushed to a tailwind next year. You've spoken to high-performance compute, particularly the non-x86 world, as a tailwind for you guys next year. I think the concern out there is that your 1 large customer could decline meaningfully, and that would cause SOC for you guys to be down next year. So I guess, as you sit here today and you're setting up your supply for customers, and lead times have extended, how are you thinking about the world into 2022 for SoC for Teradyne?"
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Very bullish. Because I think the concern -- let's see, I'm not going to speak too specifically around our customer. But what I would say is that the portfolio of devices that are being developed by our hyperscaler customers continues to expand. And that'",120,"Very bullish. Because I think the concern -- let's see, I'm not going to speak too specifically around our customer. But what I would say is that the portfolio of devices that are being developed by our hyperscaler customers continues to expand. And that's going to, in addition to the complexity growth of the existing portfolio, you add more chips on top of that, it portends a growing market, a growing customer. 
So there's going to be ups and downs, but I think the cataclysmic or sort of a cliff concern, we're now a decade into this almost and it just hasn't happened. So the trend line, I think, is pretty clear. And I think that time line will continue."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Next question comes from the line of Toshiya Hari with Goldman Sachs.",12,"Next question comes from the line of Toshiya Hari with Goldman Sachs."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I had 2 as well. Mark, I guess, somewhat related to C.J.'s question. Just curious in terms of the auto SoC test market. I think in your prepared remarks, you mentioned that you expect the market to exceed $500 million this year and how that's the highest",155,"I had 2 as well. Mark, I guess, somewhat related to C.J.'s question. Just curious in terms of the auto SoC test market. I think in your prepared remarks, you mentioned that you expect the market to exceed $500 million this year and how that's the highest mark since 2017. How are you thinking about sustainability there into '22? Near-term demand is clearly very strong. And when we speak with your customers, they're all kind of complaining about extending lead times. So I guess the bias is to the upside, but curious how you're thinking about that market. 
And then as a follow-up, a question on storage test. It seems like both HDD and SLT are trending very nicely. I think the business was up more than 2x last year in 2020. Curious what you're thinking about the business full year 2021. If you can differentiate between SLT and HDD, that would be super helpful."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","It's Sanjay here. So I'll take a cut at them. So from an auto market perspective, it's true this year, we've seen tremendous growth and just about $500 million or plus or minus a bit from a market size. And yes, as far as we've seen even back to 2017. A",345,"It's Sanjay here. So I'll take a cut at them. So from an auto market perspective, it's true this year, we've seen tremendous growth and just about $500 million or plus or minus a bit from a market size. And yes, as far as we've seen even back to 2017. 
And fundamentally, I think in the last call, there was commentary around the auto industry, for years, has lived on a just-in-time manufacturing. And fundamentally, in back half of 2019, sales weren't so high. And coming into '20, obviously, demand has really picked up. And so you're seeing just a significant replenishment of inventory back into the system. And we're seeing that continue. We see, obviously, the lead times. And currently, the demand is outstripping our supply. And we see that with good visibility until the end of 2021. 
2022 will be interesting because we'll have to take a look at where the inventory levels and what is the market demand in 2022 in first half. And so it's a little bit opaque, I'd say, in 2022, but it will depend on what lead to be the inventory level turns out and the end market demand 
And from a storage perspective, a little bit of color around 2020 and 2021. If I go back to 2020, HDD and our SLT business was kind of split relatively even. One was a little bigger than the other. And from an HDD perspective, we've seen continued end market demand fueling that business. 
But when we look into 2021 from an SLT perspective, we're seeing a broadening of devices being adopted for SLT testing, which is providing a tailwind, which is enabling a larger growth in that segment of the storage business this year relative to the HDD business. So the HDD business is still very strong end market demand, very strong, but the broadening of the SLT -- or sorry, the ASICs being tested under SLT is increasing, which is really good news. So it's growing a little faster than the HDD shipments from a storage perspective."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of Timothy Arcuri with UBS.",12,"Your next question comes from the line of Timothy Arcuri with UBS."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I had a question about your commentary, Mark, about your SOC share for the year and sort of what it implies for SOC in Q4, and more broadly, what it implies for total company revenue in Q4. So you've sort of given us all the different pieces. You guided",164,"I had a question about your commentary, Mark, about your SOC share for the year and sort of what it implies for SOC in Q4, and more broadly, what it implies for total company revenue in Q4. 
So you've sort of given us all the different pieces. You guided wireless for the year, you guided systems for the year, and you gave us the pieces on the test businesses. So if I just look at what that implies for SSC in Q4, I mean, you're going to do about $575 million roughly for SOC in Q3. That's not a big mystery. But the Q4 number implies it goes down to like $425 million, somewhere in the low 4s. That will be down year-over-year. 
So I guess my first question is like why would that be, given that you have all this visibility? And obviously, you're quite bullish about the market. So why would Q4 be down so much? That's my first question, in SoC."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I don't know that it will be down so much or not. It's a portfolio of businesses, and all of those numbers have a margin of plus or minus, let's say, 1% around them. So that creates a large Monte Carlo simulation. And if you go right down the middle,",347,"Yes. I don't know that it will be down so much or not. It's a portfolio of businesses, and all of those numbers have a margin of plus or minus, let's say, 1% around them. So that creates a large Monte Carlo simulation. And if you go right down the middle, I think you probably -- I'm sure you did the math right, that's probably what you come up with. 
But that's typical, as I said earlier, of where we stand at this point in the year looking into Q4 as in past years, where it's come in higher. There's a significant unknown around what we'll book between now and through October that can drive Q4 shipments. And while we have backlog that extends in some product lines, as Sanjay mentioned, all the way through the end of the year, there's others that's more of a turns business. 
And we've positioned ourselves to be very responsive on the SoC front in general to capitalize on these sort of short-demand request to come from our customers. That's why we've in the past been able to, in the quarter, exceed our guidance, and even in the fourth quarter and prior years, exceed what we thought when we were talking back then in July. 
So it could very well turn out that the demand that we've seen in the last couple of years in Q4 yet materializes again, and we end up, and as C.J. was hinting at, having a second half larger than first. It's just that at this point in the year, given what customers are talking about, we just don't see that as the most likely outcome. 
And it's episodic, too. What happens in Q4, a lot of it happens, in the past couple of years, in the December quarter, preparing for product launches that occur in February time frame, new phones and things like that. And so again, with a rash of phone introductions in February, although we don't see it now, we could see a demand for SoC testers to support that driving December shipments."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Yes. No, it's -- I mean, the total company revenue is sort of implied to be below what people are expecting for Q4. So that's kind of what I was asking. So anyway, on your revised TAM for, so can you just update us on the segments? I think before, you w",102,"Yes. No, it's -- I mean, the total company revenue is sort of implied to be below what people are expecting for Q4. So that's kind of what I was asking. 
So anyway, on your revised TAM for, so can you just update us on the segments? I think before, you were thinking compete would be $1 billion, mobility would be $1.6 billion. Auto, you just gave that number is like $500 million. And industrial, I think before, you were talking about $500 million. So is the revision mostly in the compute side? Can you sort of update us on those numbers?"
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. The numbers for compute are about the same. Mobility is probably up a couple of hundred million. Auto is up probably 50% and industrial up about 50%.",28,"Yes. The numbers for compute are about the same. Mobility is probably up a couple of hundred million. Auto is up probably 50% and industrial up about 50%."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of Krish Sankar with Cowen.",12,"Your next question comes from the line of Krish Sankar with Cowen."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","And Mark, thanks for the color earlier on the ARM test opportunity. I just want to ask the question in a different way. When do you think the non-x86 compute TAM, or maybe the total test compute TAM, be similar or bigger than the mobility test market? And",53,"And Mark, thanks for the color earlier on the ARM test opportunity. I just want to ask the question in a different way. When do you think the non-x86 compute TAM, or maybe the total test compute TAM, be similar or bigger than the mobility test market? And then I had a follow-up."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Bigger than the mobility test. So your question is when will the ARM compute test TAM be bigger than the ARM mobility test TAM?",24,"Bigger than the mobility test. So your question is when will the ARM compute test TAM be bigger than the ARM mobility test TAM?"
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mobile just times about $1.6 billion or $1.7 billion, and you said compute is about $1 billion. When do you think the total compute TAM, or maybe just the non-x86 compute TAM, get to be bigger than mobility?",38,"Mobile just times about $1.6 billion or $1.7 billion, and you said compute is about $1 billion. When do you think the total compute TAM, or maybe just the non-x86 compute TAM, get to be bigger than mobility?"
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","I don't think it's going to be in the next 4 or 5 years. I think much of what's being developed in the ARM space by the hyperscalers will more likely fall into the category of mobility. So I don't see compute growing beyond mobility in the next 4 or 5 yea",53,"I don't think it's going to be in the next 4 or 5 years. I think much of what's being developed in the ARM space by the hyperscalers will more likely fall into the category of mobility. So I don't see compute growing beyond mobility in the next 4 or 5 years."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Got it. And then, Mark, on the auto test market, you said it's over $500 million. I'm guessing that includes auto microcontroller, linear, et cetera. If that is the case, Is there any way to give some more color within that? Or I think it's too ha",52,"Got it. Got it. And then, Mark, on the auto test market, you said it's over $500 million. I'm guessing that includes auto microcontroller, linear, et cetera. If that is the case, Is there any way to give some more color within that? Or I think it's too hard to segment it?"
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. It does include microcontrollers. And I would say that auto is outstripped -- most of the growth is auto more than microcontrollers. Microcontrollers is growing too, but it's mostly auto. Auto. And of course, this microcontrollers in auto. So when I",60,"Yes. It does include microcontrollers. And I would say that auto is outstripped -- most of the growth is auto more than microcontrollers. Microcontrollers is growing too, but it's mostly auto. Auto. And of course, this microcontrollers in auto. So when I say auto, I mean microcontrollers for auto versus microcontrollers, let's say, for white goods and things like that."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","And operator, we have time for just 1 more call, please. One more question.",14,"And operator, we have time for just 1 more call, please. One more question."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your final question comes from the line of Joe Moore with Morgan Stanley.",13,"Your final question comes from the line of Joe Moore with Morgan Stanley."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I wanted to ask about the millimeter wave commentary. It seemed like the expectation that was primarily 1 customer in 1 region. So when you say that was kind of short of your expectations, what are you referring to there?",40,"I wanted to ask about the millimeter wave commentary. It seemed like the expectation that was primarily 1 customer in 1 region. So when you say that was kind of short of your expectations, what are you referring to there?"
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","So it's not 1 customer, 1 region. Millimeter wave last year for us grew significantly. We probably had 90% share of the early buying per millimeter wave test in 2020. And I would say that was spread out across 6 or 7 customers. Anybody who's making a chip",91,"So it's not 1 customer, 1 region. Millimeter wave last year for us grew significantly. We probably had 90% share of the early buying per millimeter wave test in 2020. And I would say that was spread out across 6 or 7 customers. Anybody who's making a chipset related to millimeter wave was pretty much using a Teradyne tester in 2020. The deployment of millimeter wave by the telecommunication companies has ground to a halt. And that has proportionately ground to a halt, the need for incremental test in 2021."
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Okay, folks, thanks so much for joining us today. That concludes the call. We apologize for the audio difficulties at the front end of it. We look forward to talking to you in the days and weeks ahead. And those in the queue, I'll get back with you direct",52,"Okay, folks, thanks so much for joining us today. That concludes the call. We apologize for the audio difficulties at the front end of it. We look forward to talking to you in the days and weeks ahead. And those in the queue, I'll get back with you directly here. Thank you"
94728,1674258151,2352597,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Ladies and gentlemen, this concludes today's conference. Thank you for your participation. and have a wonderful day. You may all disconnect.",21,"Ladies and gentlemen, this concludes today's conference. Thank you for your participation. and have a wonderful day. You may all disconnect."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Good morning, ladies and gentlemen, and welcome to the Q2 2021 Teradyne Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is not -- this conference call will resume -- I would now like to turn the conference over to you",47,"Good morning, ladies and gentlemen, and welcome to the Q2 2021 Teradyne Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is not -- this conference call will resume -- I would now like to turn the conference over to your host, Mr. Andy Blanchard."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Phyllis. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined this morning by our CEO, Mark Jagiela; and our CFO, Sanjay Mehta.Following our opening remarks, we'll provide details of ou",310,"Thank you, Phyllis. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined this morning by our CEO, Mark Jagiela; and our CFO, Sanjay Mehta.
Following our opening remarks, we'll provide details of our performance for 2021's second quarter along with our outlook for the third quarter of 2021. The press release containing our second quarter results was issued last [ evening ]. [ We're providing slides ] on the Investor page of the website that may be helpful to you when following the discussion. Replays of this call will be available via the same page after the call ends. 
Matters that we discuss today will include forward-looking statements that involve risk factors that could cause Teradyne's [ results ] to differ materially from management's current expectations. We encourage you to review the safe harbor statement contained in the earnings release as well as our most recent SEC filings. Additionally, those forward-looking statements are made as of today, and we take no obligation to update them as a result of developments occurring after this call. 
During today's call, we'll make reference to non-GAAP [ financial ] measures. We've posted additional information concerning those non-GAAP financial measures, including reconciliation to the most directly comparable GAAP financial measures, where available, on the [ Investor page ] of our website. 
Looking ahead between now and our next earnings call, Teradyne expects to participate in technology or industrial-focused investor conferences hosted by KeyBanc, Rosenblatt Securities, Deutsche Bank and Citi. 
Now let's get on with the agenda. First, Mark will comment on our recent results and the market conditions as we enter the new quarter. Sanjay will then offer more details on our quarterly results along with our guidance for the third quarter. We'll then answer your questions, and this call is scheduled for [ 1 hour ].
Mark?"
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Good morning, everyone, and thanks for joining us. Today, I'll summarize our results for the second quarter and first half of 2021, update on current conditions in both Test and Industrial Automation, and comment on our view for the second half of the yea",1341,"Good morning, everyone, and thanks for joining us. Today, I'll summarize our results for the second quarter and first half of 2021, update on current conditions in both Test and Industrial Automation, and comment on our view for the second half of the year. Sanjay will then provide the financial details on the quarter and our guidance for Q3. 
The strong demand we saw in Q1 accelerated in Q2 as both our Test and Industrial Automation groups grew substantially in the quarter. The long-term demand drivers we've discussed in the past continue to power demand for our products. In Test, it's device complexity and unit growth; in Automation, it's labor scarcity, the need for resiliency and productivity improvement. 
Opening further, performance at the company level from 2016 through 2020 saw our sales and non-GAAP EPS grow at a compounded rate of 16% and 32%, respectively. For the first half of this year, sales are running ahead of that rate at 21%, and non-GAAP earnings per share grew at 29% compared with last year. This demonstrates both the [ vitality ] of the markets we serve and the efficiency of our operating model. 
Significantly, in Q2, we saw Industrial Automation demand recover in all major regions, but particularly in North America. As a result, our production and [ operating teams ] operated at a high pace in Q2, and that pace is [ increasing ] in Q3. For the year, our IA business is on track to grow about 30% from 2019 and about 40% from 2020. 
Looking closely at the segment level. In Semi Test, SOC shipments grew 29% in Q2 from Q2 of 2020 with particular strength in both the compute and mobility end markets. For the first half, SOC sales grew 19%. For the first time in several years, smartphone unit shipments are helping growth in the mobility [ segment ], where as recent years have mostly relied on complexity growth. 
[ IA ] and compute are the 2 largest subsegments in SOC. Automotive, analog and industrial demand continues to be strong. The auto-related semi test market is expected to exceed $500 million this year, the highest level since 2017. This is despite the fact that automobile unit production will be about lower in 2017 -- lower than 2017. A portion of this strength is test equipment. We're also seeing the impact of increased semi content and complexity per automobile, driving the test market. 
Our memory test shipments also grew in Q2 from Q2 of 2020, up 9%, led by flash tester demand. For the 6-month period, overall shipments were up 18% from last year on solid demand for both flash wafer and [ flash ] systems. This reflects significant growth in smartphone demand, the build-out of new memory capacity in China and the growth of SSD demand.
Looking at the full year, we are again revising up the SOC market for 2021 to now be in the range of $4.3 billion to $4.7 billion with increasing strength in the x86 GPU and display driver segments. Recall that we have lower customer exposure in those markets with much of this incremental growth going to our competitors. So we'll likely see our SOC share around 48% for the year. 
In memory, at the macro level, our market estimates are unchanged with the test market this year expected to be about $1 billion and our share to be at about the 40% level. I will note that the expected ramp of DDR5 for server applications and the broader adoption of LPDDR5 is pushing out into 2022. 
Shifting to our System Test group, sales were up 26% in the first half compared with 2020, with strong Storage Test demand and a recovery in our Production Board Test unit driving the growth. For the full year, we see System Test group -- the System Test group grow in the 10% to 20% range. 
At LitePoint, sales in Q2 were up 12% over 2Q 2020. While 5G millimeter wave demand is lower than expected, the environment in Wireless Test is improving as we move through the year due to the continued WiFi 6 growth and early WiFi 7 investments. In addition, ultra-wideband adoption is increasing, adding a new growth vector for LitePoint. For the full year, LitePoint will likely grow in the 10% range. 
Moving on to Industrial Automation. The combination of expanding demand across our major markets and the increase in the range of tests served by our Universal Robots and MiR units drove group sales up 57% in Q2 last year [ to 45% ] in the first half. Compared to pre-pandemic 2019, first half sales are up 22%. Supply chain issues have constrained growth a little bit with lead times pushing out about 1 week. 
The demand environment for IA has recovered in most regions from last year's slowdown. America was the fastest-growing major region in Q2 with sales up over 90% from last year. Although we did see a [ lull ] in some countries in Asia where COVID has spiked in recent months, the second half of the year outlook is quite strong in all our major regions. 
Our long-term growth strategy in IA continues unchanged, and we expect long-term annual growth in the 20% to 35% range. This year, we will likely have a growth of about 40% from 2020, and we will continue to invest to enable this growth, target [ 15% ] gross margins, [ get ] a 5% to 15% operating margin during these high-growth years.
From an investment perspective, we are expanding our engineering programs to shorten deployment times, increase the served market and improve the customer support experience. We are also growing our capacity to support distributors, integrators and UR plus and MiRGo apps development partners as they engage customers. We are also expanding our sales to OEMs that integrate our robots into their products. 
Last quarter, we noted the expanding range of applications for UR robots into high-voltage line application with hundreds of [indiscernible] being deployed. Today, I'd like to highlight the success of UR+ plug-and-play applications for Industrial [ Automation ]..There is a long-standing and chronic shortage of qualified welders worldwide with an estimated 100,000 unfilled welding jobs in the U.S. alone. While automated solutions exist for large applications like auto manufacturing, customers with lower volume and higher mix products are not well served by traditional automation. 
The integration of a force torque sensor into e-Series cobots enabled the precision needed for this application. And with UR+ [ integrating ] with our partners, we began serving this market about 3 years ago. During this time, welding applications have grown to be about 6% of our global [ sales ] and are on [indiscernible] 1,000 cobots sold in 2021, more than tripling our 2020 pace. 
As we continue to extend the performance of our UR platform, we expect these high applications had growth vectors to traditional industrial applications. We have similar market-expanding initiatives in play on our MiR platform, but I'll save those details for a future call. 
Summing it all up, the first half of the year has been a strong sales, strong gross margins and earnings growth [indiscernible]. Longer term, the markets we serve are showing [ increasing demand ] in a future global economy. The importance, pervasiveness and enabling capability of electronics in every [ aspect ] of our lives and industry is driving more fab investment, more complexity and more test. Likewise, the broadening application and fast [ ROI of ] collaborative robots in a world with labor shortages and productivity challenges is another growth trend. 
Strategically, we positioned ourselves in line with [indiscernible] and plan to continue to make [indiscernible] Test and IA as our full potential while driving world-class [ returns ]. While the rate of change in our markets is accelerating, we are well positioned to thrive as a company and to bring additional value to customers and shareholders. 
I'll now turn things over to Sanjay [ to provide ] additional color on the financials."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Mark. Good morning, everyone. Today, I'll [ provide details ] on our Q2 results, comment on current business conditions and describe [ our outlook for ] Q3. Now to Q2. Second quarter sales were $1.086 billion with non-GAAP EPS of $1.91, up 29",1144,"Thank you, Mark. Good morning, everyone. Today, I'll [ provide details ] on our Q2 results, comment on current business conditions and describe [ our outlook for ] Q3. 
Now to Q2. Second quarter sales were $1.086 billion with non-GAAP EPS of $1.91, up 29% and 44%, respectively, from Q2 '20. Non-GAAP gross margins were 59.6%, and our non-GAAP operating expenses were $250 million, but $5 million below the high guidance due to the timing of some nonrecurring engineering expenses.
Non-GAAP operating profit rate was 36.5%. [ Gross margin ] in the quarter was [ 59.6% ] compared with our plan of 58%. The increase was tied to favorable product mix in the quarter versus planned. 
For context, Q2 2020 gross margin was approximately [indiscernible]. In April [indiscernible] earnings, we noted that this level of gross margin would continue in the near term, driven by the introduction of several key test systems in early 2020, which would [ take several ] quarters to come down the cost curve. These new product introductions, coupled with heightened costs driven by COVID shortages, were impacting our gross margins in 2020. One year later, we have now most of these test solutions at volume, and they have come down the cost curve as expected. 
The result contributed to higher margins in the second quarter, which we expect will continue in the second half of the year. A component of gross margin improvement over 2020 is higher revenue yielding of leverage in the gross margin line. We had one 10% customer in the quarter [indiscernible] excluding discrete items of 14.5% on both GAAP and non-GAAP basis. 
Looking at the results from a business unit perspective. [ Semi Test ] revenue of $834 million was up 27% from Q2 2020. SOC revenue was $742 million, up 29%, driven by strength in compute, mobility, industrial and automotive. Memory revenue was $92 million, up 9% from prior year, driven by strength in flash test and flash wafer sort segments. 
System Test group had revenue of $105 million, which was up 46% year-over-year. This is driven by $58 million in Storage Test sales, including both HDD and SLT solutions; [ $27 million ] in Defense & Aerospace and Production Board Test. 
In Storage Test, HDD and SLT demand remains robust as drive densities continue to increase and the number of devices adopting [ SLT spokes ]. At LitePoint, revenue of $55 million was 12% -- was up 12% from prior year due to continued strength at [ WiFi ], increases in [indiscernible] and ultra-wide band test market segments. 
Now to Industrial Automation. As we did in April, I'll provide revenue metrics comparing Q2 '21 results with both Q2 '20 and Q2 '19, so you'll have the full context given the impact of a contracting market tied to COVID last year. Industrial Automation revenue of $92 million was up 57% year-over-year and 23% over Q2 '19. Revenue expanded in all regions in Q2 [ over ] last year, with North America delivering the highest absolute revenue growth. U.S. and Europe represented about 77% of IA revenue in the quarter, with China contributing about 14%. 
UR sales were $76 million in Q2, up 75% year-over-year and [ 80% ] over 2019. MiR sales were $16 million, up 41% from Q2 '20 and 51% from Q2 '19. Recall, MiR had an [indiscernible] on Q2 '20 as its robots were widely deployed in automated COVID disinfectant applications. 
The longer-term outlook in our IA business continues to brighten. We expect continued labor shortages to drive new applications for both our fixed and mobile robots. Mark highlighted the shortage of welders and how that has opened up a new market for our UR cobots, but that is just one of many job categories with acute short-term and long-term labor shortages. 
Our strategy is to provide an open platform that creative developers can leverage to solve industry-specific labor shortages. The numerous filling ultraviolet disinfecting solutions built on our [ platform ] last year is a shining example of the agility of our partner networks to solve problems. 
We're investing in engineering support and marketing resources to make our MiR platforms even easier to build upon, which will enable the continued proliferation of high-value automated solutions to solve challenging problems for an expanding range of customers. Significantly, these development partners and customers provide great feedback on our R&D development plans. 
From a financial perspective, we expect IA will operate around the low end of our target profit range of 5% and 15%. We do expect IA to operate above the Rule of 40 in 2021, that is the sum of operating profit and revenue growth of over [ 40% ]. Longer term, when growth moderates, we expect the IA group to have a similar operating profit rate as our Test portfolio. 
Shifting to supply. We continue to manage through numerous supply constraints along with increased material, manufacturing and logistics costs in both our Test and IA businesses. For some products in both Test and IA, the supply constraints have extended our [ lead times ], and we're working closely with customers to minimize the impact of these delays. 
But we've been able to offset these higher costs through operating leverage with higher volumes and other cost-saving measures, so the cost increase impact on the P&L has not been material. We do expect to be dealing with supply line-related issues in Q3 and Q4 this year, which are reflected in our forecasts. 
Shifting to the balance sheet and cash flow. Our cash and marketable securities at the end of the quarter totaled $1.42 billion, $172 million of free cash flow in the quarter, $151 million and $17 million on buybacks and dividends, respectively. Year-to-date, we've repurchased 1.6 million shares for $197 million at an average [ price ] of $125.69 per share.
Regarding our convertible debt. $15.6 million was paid in Q2 to convertible bondholders ahead of maturity. By the end of August 2021, bondholders will have early converted a total of $302 million, leaving a face value of $58 million outstanding. 
Looking at our operating model, I'd like to make 3 quick points. First, our performance over time. From 10 years ago, our gross margin percent has expanded from the low to [ mid-50s ] to nearly 60% [ today ] and our operating margin from the teens to low 20s to greater than 30% today. 
Second, our flexible business model shifts fixed cost to variable costs where appropriate through [ contract ] or outsourced manufacturing, variable compensation and other [ means ], which enables resiliency on the downside and is creative (sic) [ accretive ] when business is strong. 
Third, the operating leverage in the model is evident in our Q2 results. Our Test businesses are dropping through over $0.50 per revenue dollar through to the profit line in 2021..."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","[Technical Difficulty]",2,"[Technical Difficulty]"
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you.",2,"Thank you."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Ladies and gentlemen, we're going to have a quick transition.",10,"Ladies and gentlemen, we're going to have a quick transition."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","I'll go back -- okay, it's Sanjay again. I'll go back to looking at our operating model. I'd like to make 3 quick points. First, our performance over time from 10 years ago, our gross margin percent has expanded from low to mid-50s to nearly 60% today and",526,"I'll go back -- okay, it's Sanjay again. I'll go back to looking at our operating model. I'd like to make 3 quick points. First, our performance over time from 10 years ago, our gross margin percent has expanded from low to mid-50s to nearly 60% today and our operating margin from the teens to low 20s to greater than 30% today. 
Second, our flexible business model shifts fixed cost to variable costs, where appropriate, through contract or outsourced manufacturing, variable compensation and other means, which enables resiliency on the downside and is accretive when business is strong. 
Third, the operating leverage in the model is evident in our Q2 results. Our Test businesses are dropping through over $0.50 per revenue dollar through to the profit line in 2021, even while we continue to increase our R&D support -- and support investments to strengthen our Test business. This enables Teradyne to continue to invest in both our Test and IA portfolios. For IA, we are building a deeper product ecosystem and distribution differentiation while achieving the Rule of 40 in our IA portfolio. 
Now to our outlook for Q3. As Mark noted, the demand environment across the business remains strong. Our guidance assumes no significant changes, positive or negative, in the availability of materials and also assumes that we won't see additional pandemic-related issues. With that said, sales in Q3 are expected to be between $880 million and $960 million with non-GAAP EPS in the range of $1.29 to $1.55 and 176 million diluted shares. 
Third quarter guidance excludes the amortization of acquired intangibles and noncash imputed interest on convertible debt. Third quarter gross margins are estimated to be between 59% and 60%. OpEx is expected to run at 27% to 29% of third quarter sales. The non-GAAP operating profit at the midpoint of our third quarter guidance is 32%. 
Regarding OpEx for the full year. While we spent a bit lower than planned in Q2, we expect the full year OpEx will be about in line with the plan we described in April. We expect total operating expenses for 2021 to be about $1 billion or up approximately 19% from 2020. We recognize that we're on track to meet our 2024 earnings model this year. We'll update the model on a regular cadence in January after our detailed midterm plan income is complete in Q4 this year. 
In summary, our businesses are performing extremely well, delivering strong revenue and earnings growth while funding the investments that will drive future success. Our first half sales grew 21%, and non-GAAP EPS grew 29% above the first half of 2020, which itself was a record. We expect to deliver the highest Q3 sales and profits in history. 
Our employees and production partners around the world have delivered a record number of systems under challenging conditions. Our support teams have done whatever was needed to make our customers successful. And our engineering teams have kept the new product pipeline moving on schedule. It's been an impressive display of teamwork, and I'm proud to be part of this powerful Teradyne team. 
With that, I'll turn things back to Andrew."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Sanjay. And everybody, thanks for dealing with our small technical issue there. Phyllis, we would now like to take some questions. [Operator Instructions]",24,"Thanks, Sanjay. And everybody, thanks for dealing with our small technical issue there. Phyllis, we would now like to take some questions. [Operator Instructions]"
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","[Operator Instructions] Your first question comes from the line of Brian Chin with Stifel.",14,"[Operator Instructions] Your first question comes from the line of Brian Chin with Stifel."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","A couple of questions here. Maybe just to kick things off, I'm just curious to what degree, if any, are the extended lead times in ATE in this sort of the current strong semiconductor environment impacting your shipment outlook or pattern in the second ha",75,"A couple of questions here. Maybe just to kick things off, I'm just curious to what degree, if any, are the extended lead times in ATE in this sort of the current strong semiconductor environment impacting your shipment outlook or pattern in the second half? Obviously, Teradyne no longer discloses bookings, but your competitor appears to be building backlog into the December quarter. So I was wondering if you have better-than-typical backlog visibility beyond September."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So lead times have definitely been moving out. I'd say auto and industrial demand is still outstripping supply. But our lead times have pushed out, obviously, based on the very, very tight supply chain environment we're dealing with. And so what used",101,"Yes. So lead times have definitely been moving out. I'd say auto and industrial demand is still outstripping supply. But our lead times have pushed out, obviously, based on the very, very tight supply chain environment we're dealing with. And so what used to be, let's say, within a quarter has pushed out to 5, 8 weeks incremental to where we were in the past to be, in some cases, in the 20s in weeks of lead time. So with that, we have been seeing, I guess, improved bookings from our customers, and we're working with them to manage through it."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And then maybe for Mark. I think you touched on how, at least in the smartphone market, units are kind of a bigger tailwind this year, which hasn't always been the case in recent years. But I think in the 2022, what do you think -- to what degree",72,"Got it. And then maybe for Mark. I think you touched on how, at least in the smartphone market, units are kind of a bigger tailwind this year, which hasn't always been the case in recent years. But I think in the 2022, what do you think -- to what degree could increase packaging complexity across foundries and maybe some IDMs be a more meaningful driver of incremental test intensity next year?"
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes, we -- that's a good question. We bundle that into the complexity side of life. And there's already been advanced packaging technologies deployed for several years now in phones, but it's increasing. So that trend of multichip, multi-die packaging inc",94,"Yes, we -- that's a good question. We bundle that into the complexity side of life. And there's already been advanced packaging technologies deployed for several years now in phones, but it's increasing. So that trend of multichip, multi-die packaging incrementally adds test time above and beyond what you would get if you were putting all of that silicon on a single integrated die. And there's not a good rule of thumb of how much of an adder it is, but it is a trend that's going to continue to grow and drive tests."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of Atif Malik with Citi.",12,"Your next question comes from the line of Atif Malik with Citi."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I have a similar question on the mobility side end market. It sounds like your mobility outlook has improved for the year versus 90 days ago despite millimeter wave weakness. You talked about units helping. Can you talk about the confidence in test intens",82,"I have a similar question on the mobility side end market. It sounds like your mobility outlook has improved for the year versus 90 days ago despite millimeter wave weakness. You talked about units helping. Can you talk about the confidence in test intensity staying elevated for both mobility and compute into next year? And if you can also highlight the steps you're taking to improve your market share in the areas that you're not strong, like x86 GPU and display drivers."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So I think the complexity trends looking even into the next year are all very strong and positive. In the case of mobility, the newer lithographies that are coming online are being widely adopted by the manufacturers of silicon for phones, which port",313,"Yes. So I think the complexity trends looking even into the next year are all very strong and positive. In the case of mobility, the newer lithographies that are coming online are being widely adopted by the manufacturers of silicon for phones, which portends more transistors, which portends more test time. So that, looking into next year, all looks positive. And we get, at this point in the year, early glimpses of what the silicon for next year might actually look like. 
The -- on the compute side, similarly, we not only have the trend of lower lithography nodes, but the new interface standards related to LPDDR5 and DDR5, as I mentioned in my remarks, the early adoption of that has been pushed out a little bit as the processors that go with it have been delayed a bit. But all of the complexity required to run at those higher bandwidths is coming in 2022. So those are 2 positive things I look at that gives me confidence that this driver of complexity growth is definitely going to be strong next year. 
In terms of share, what we said before is that penetrating the traditional x86 GPU stalwarts is going to be a long-term endeavor for us that's going to hinge on some kind of technological discontinuity like that shift to DDR5 or like a shift to PAM4 interfaces to crack into. So that one is episodic and will play out over, let's say, 3 to 5 years. 
On the other front is -- are the emerging hyperscalers and new people coming into the market of creating complex silicon. These are automobile manufacturers, hyperscalers that we've talked about in the past, the Googles, the Facebooks, the Microsofts, the Amazons, That's where we're focused on getting a position to grow with them as they launch their products into the market in the shorter term."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Great, very helpful. And Sanjay, for you, the largest U.S. phone maker and your biggest indirect customer talked about supply constraints impacting smartphone sales in the September quarter yesterday. Have the materials and parts tightness have gotten wor",46,"Great, very helpful. And Sanjay, for you, the largest U.S. phone maker and your biggest indirect customer talked about supply constraints impacting smartphone sales in the September quarter yesterday. Have the materials and parts tightness have gotten worse over the last 90 days for your business?"
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Well, first of all, I won't comment on any particular customer, but I will speak in general about the environment. Last year, we were really working through demand increases, but we had fairly good, robust inventory strategies, and we are working through",165,"Well, first of all, I won't comment on any particular customer, but I will speak in general about the environment. Last year, we were really working through demand increases, but we had fairly good, robust inventory strategies, and we are working through the impact of COVID. You have thousands of components that go into these testers, and we did a lot of resiliency improvements there. You fast forward to today's environment, and the demand has really kept accelerating. And the environment is tighter, I would say, today. And frankly, we don't see it letting up until the second half of 2022. 
So I think as the semiconductor industry goes through continued growth, you're seeing supply chains really getting tested. And then with the increase in the infection rates of COVID, especially, I'd say, in Southeast Asia, we're working through and managing the best we can. But I believe the net summation is it's a tighter industry now than it was, say, 3, 6 months ago."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of Mehdi Hosseini with SIG.",12,"Your next question comes from the line of Mehdi Hosseini with SIG."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Two questions, one on ARM-based ASIC design. I'm trying to get a sense of how you see the TAM. You can either elaborate as a mix of SOC tests or perhaps you can tell us how is the test time for an ARM-based ASIC chip compared to like an app process or may",89,"Two questions, one on ARM-based ASIC design. I'm trying to get a sense of how you see the TAM. You can either elaborate as a mix of SOC tests or perhaps you can tell us how is the test time for an ARM-based ASIC chip compared to like an app process or maybe that way we could give a sense of how demand looks like. So either qualitatively or quantitatively, you can -- if you can elaborate on ARM-based SOC test will be great. And I have a follow-up."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So I guess the first thing I'd say is that a ARM-based high-end map processor, which is what's in most of our phones today, driving most of our phones, has a transistor count that's equivalent to any laptop, x86 kind of product you might have in your",159,"Yes. So I guess the first thing I'd say is that a ARM-based high-end map processor, which is what's in most of our phones today, driving most of our phones, has a transistor count that's equivalent to any laptop, x86 kind of product you might have in your computer. And the test times comparatively between those 2 are not that different. It's kind of proportional to test count. 
The new ARM processors that are coming to market for compute applications, not smartphone applications, have perhaps anywhere from 25% to 60% at or on transistor count above what's at the highest end of smartphones. And the test time associated with them, I would say, is proportionately longer at this point. And so I think it's, generally speaking, scaling with transistor count, and the transistor count on the ARM side is running a little bit at a faster clip than it is on the more traditional architecture side, if that helps."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Sure. So the follow-up has to do with ARM-based. Actually, I want to just dig in a little bit more. Would you, at some point, break this out so we could better understand how kind of ARM-based SOC tester is tracking or scaling versus the rest of the SOC m",70,"Sure. So the follow-up has to do with ARM-based. Actually, I want to just dig in a little bit more. Would you, at some point, break this out so we could better understand how kind of ARM-based SOC tester is tracking or scaling versus the rest of the SOC market? And number two, is there anything you can give us to better understand the competitive landscape for this specific application?"
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I guess I haven't thought about trying to find a way to break out ARM because most of what mobility is, is ARM; and then there's, let's say, compute applications for ARM; and then there's some processors that are almost dual-use, and they go into eit",223,"Yes. I guess I haven't thought about trying to find a way to break out ARM because most of what mobility is, is ARM; and then there's, let's say, compute applications for ARM; and then there's some processors that are almost dual-use, and they go into either application. So I think it's fair to say that any compute business that we have at Teradyne is ARM-based compute. And perhaps maybe in the future, we can look at some way to sort of characterize both the market and our associated revenue for that. But I don't have a good number for you now on that. 
And in terms of the applications coming to market, in the short term, we know about the phone applications. We know about some early adopters of ARM for compute. Those are all coming to market or are in the market now. The hyperscalers that we're working with are coming into market at various points next year with products that are quite interesting but highly speculative as to whether they'll latch in the market. And obviously, I'm not going to talk about those because they're pretty confidential. But we'll see what latches. If one of these applications can become a 100-plus million unit application, which most of these design teams are targeting, then that's a significant adder to the market."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of Vivek Arya with Bank of America.",14,"Your next question comes from the line of Vivek Arya with Bank of America."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I was curious, how is your kind of visibility for Q4 as you kind of stand today versus what it is usually? And if you could give us some color by end market in terms of what is in your assumption for Q3 and the second half, that would be very helpful.",52,"I was curious, how is your kind of visibility for Q4 as you kind of stand today versus what it is usually? And if you could give us some color by end market in terms of what is in your assumption for Q3 and the second half, that would be very helpful."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Sure. So Q4, if I look back at my last 2 years here, we've been surprised mainly on the positive side. And I'd say that given the tightness of supply and customers providing a little bit more in the way of backlog, it gives us a little bit more insight. H",215,"Sure. So Q4, if I look back at my last 2 years here, we've been surprised mainly on the positive side. And I'd say that given the tightness of supply and customers providing a little bit more in the way of backlog, it gives us a little bit more insight. However, obviously, in the near term, we have much stronger visibility in Q3 than in Q4. And so -- but we do have, I'd say, a little bit of incremental visibility. 
In color -- in your question in regards to color for Q3, we see continued strength in semiconductor. Obviously, the different components within Semi Test are going to be a little volatile, but we do see a trend down. It's still what we believe is very strong demand, but we see a trend down. And we see in our IA portfolio, really, strength. Obviously, with the COVID impact in 2020, industrials are really coming back. I'll cite some PMIs in the 60s at the U.S. and Europe. And we really see that in our, as Mark noted, in our growth in the U.S. But we're seeing that growth in China as well as in Europe and the U.S. So continued expected growth in IA and then, from a test perspective, coming down a bit."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And then on the UR side, Mark, I'm curious, what are the top 3 applications you're serving today? And how do you expect these applications to evolve? You are maintaining a very strong growth rate in that business. And I'm curious, what is driving",116,"Got it. And then on the UR side, Mark, I'm curious, what are the top 3 applications you're serving today? And how do you expect these applications to evolve? You are maintaining a very strong growth rate in that business. And I'm curious, what is driving that? Is it more number of customers? Is it more applications within the same customer? So what's giving you the confidence you can maintain this very strong growth rate in the UR business? And is -- on the gross margin side, is it accretive? I know on the operating margin side, you've given a range. But I imagine on the gross margin side, it might be accretive to your business."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. It's interesting because there's no silver bullet as to what's driving the growth at UR. So for example, we're going to be up about 30% from revenue in 2019, 40% up from 2020. And in the script, I mentioned this application for welding, which is a br",326,"Yes. It's interesting because there's no silver bullet as to what's driving the growth at UR. So for example, we're going to be up about 30% from revenue in 2019, 40% up from 2020. And in the script, I mentioned this application for welding, which is a brand-new application that is now driving about 6% of our sales for the year. Last quarter, I talked about this service application for servicing high-voltage power lines that's also running at around that 6% of sales applications that was nonexistent -- essentially nonexistent 2 years ago. 
So already, we have 12% of our growth attributed to new applications in new markets with new customers that we didn't have 2 years ago. So it's a combination of expanding applications like those 2 examples as well as established markets growing that's driving this. And our top 3 applications tend to be the same. It's automotive supply chain, it's industrial machine tending and it's electronic assembly tend to be the ones that are at the top of the pack. But frankly, they are shrinking as a percentage of sales as these new applications come online. 
So what gives me confidence looking forward is that ecosystem of partners who are developing these application solutions on our platform, not our competitors, is just continuing to grow and prosper. And they're not all going to be as successful as high-voltage line tending or welding. But it only takes 10% of them to fuel the kind of growth numbers that we've been seeing. And the activity there is very strong, and the technology is maturing to the point that more and more applications can economically be served. 
And over the horizon, when you look at what AI can bring, there's a whole new set of, let's say, features that will enable yet another expansion of the market. It's what gives us the confidence to talk about these kind of decade-long growth rates of 25%, 30%, 35%."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of John Pitzer with Crdit Suisse.",13,"Your next question comes from the line of John Pitzer with Crdit Suisse."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, maybe another way to ask the calendar fourth quarter question is, over the last 3 years, the business has run in such a way that second half has been greater than the first half from a top line perspective, which has broken kind of a trend, where if",99,"Mark, maybe another way to ask the calendar fourth quarter question is, over the last 3 years, the business has run in such a way that second half has been greater than the first half from a top line perspective, which has broken kind of a trend, where if you go back the prior 7 years, it was first half stronger than second half. Did you have any commentary on sort of how you think the second half over the first half looked this year just given how strong the market environment is and how tight test capacity is?"
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","You're right, perfect student of the history. And we have been, as Sanjay said, always a bit surprised in the recent years on how strong the fourth quarter has come in and driven second half to be a bit higher than first. So if you asked us today, we'd sa",163,"You're right, perfect student of the history. And we have been, as Sanjay said, always a bit surprised in the recent years on how strong the fourth quarter has come in and driven second half to be a bit higher than first. So if you asked us today, we'd say first half is a little bit stronger than second, but that's no different than kind of what we thought for the last couple of years, too. And that just is a testament to the visibility in Q4 as -- the lack of visibility in Q4.
As Sanjay said, though, it's a little bit more visibility now than before because lead times are a little longer. But all the upside that could come in is the, obviously, the piece that's not visible. So we feel probably better now about Q4 than we felt in any prior 2 or 3 years, but it's sort of what might happen between now and October that's invisible."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","That's helpful. And then, Mark, as my follow-on, I apologize, the audio quality was a little poor during your prepared comments. I wanted to go back to some of the commentary you made around DDR5 adoption. I think the point you were making is perhaps it's",88,"That's helpful. And then, Mark, as my follow-on, I apologize, the audio quality was a little poor during your prepared comments. I wanted to go back to some of the commentary you made around DDR5 adoption. I think the point you were making is perhaps it's a little bit slower than you thought. Is that correct? And I guess, more importantly, can you give us an update of how you think you're positioned for DDR5 when it does start to ramp relative to share in memory test?"
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Yes, sorry about the audio quality. But in fact, yes, DDR5 for server applications has pushed out a bit as the server chips themselves have been delayed. We've seen the impact of that in the demand for DDR5 testers. And similar things happened with L",115,"Yes. Yes, sorry about the audio quality. But in fact, yes, DDR5 for server applications has pushed out a bit as the server chips themselves have been delayed. We've seen the impact of that in the demand for DDR5 testers. And similar things happened with LPDDR5 going into mobility applications. So despite all that, the share position for Teradyne, we think, is unchanged from our earlier estimates at around 40% of the market. And it's going to be a tailwind next year when the DDR5  and LPDDR5 ramp as was originally thought would happen toward the end of this year. So we're well positioned there, and I think that's a tailwind for us next year."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of C.J. Muse with Evercore.",13,"Your next question comes from the line of C.J. Muse with Evercore."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I guess first question, Mark, you've taken SOC test market size higher again. And I guess curious, if we were to hit the high end of the range, what would be the driver there? And would your market share still be 48%? Or could you see greater contribution",61,"I guess first question, Mark, you've taken SOC test market size higher again. And I guess curious, if we were to hit the high end of the range, what would be the driver there? And would your market share still be 48%? Or could you see greater contribution from what's driving potentially the market to the higher end of the range?"
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Certainly, if the market goes up towards the high end of that range, our revenue would grow probably proportional to that. Would our share go much higher? I gave a number -- I threw in a number of roughly 48% at the midpoint of our market size guide.",156,"Yes. Certainly, if the market goes up towards the high end of that range, our revenue would grow probably proportional to that. Would our share go much higher? I gave a number -- I threw in a number of roughly 48% at the midpoint of our market size guide. I would expect our market share is probably going to stay around that number, plus or minus 0.5 point at this point in the year. 
But it's hard to sort of prognosticate too much about where the share comes from. And as you know, one customer's buying capacity can swing multiple points of share in any given year. And so one of our customers could come in and drive a demand that we don't see right now. We have the manufacturing capacity to serve it. And yes, I guess we could be up at 50% share if that happened. It's just a little opaque at the moment."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. That's helpful. And I guess a follow-on question to a few of the questions that you got earlier. You spoke to DDR5 now being pushed to a tailwind next year. You've spoken to high-performance compute, particularly the non-x86 world as a tailwind for",110,"Okay. That's helpful. And I guess a follow-on question to a few of the questions that you got earlier. You spoke to DDR5 now being pushed to a tailwind next year. You've spoken to high-performance compute, particularly the non-x86 world as a tailwind for you guys next year. I think the concern out there is that your one large customer could decline meaningfully and that would cause SOC for you guys to be down next year. So I guess, as you sit here today and you're setting up your supply for customers and lead times have extended, how are you thinking about the world into 2022 for SOC for Teradyne?"
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Very bullish because I think the concern -- let's see, I'm not going to speak too specifically around our customer. But what I would say is that the portfolio of devices that are being developed by our hyperscaler customers continues to expand. And that's",123,"Very bullish because I think the concern -- let's see, I'm not going to speak too specifically around our customer. But what I would say is that the portfolio of devices that are being developed by our hyperscaler customers continues to expand. And that's going to -- in addition to the complexity growth of the existing portfolio, you add more chips on top of that, it portends a growing market, a growing customer. So there's going to be ups and downs, but I think the cataclysmic or sort of a cliff concern, we're now a decade into this almost, so -- and it just hasn't happened. So the trend line, I think, is pretty clear, and I think that trend line will continue."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Our next question comes from the line of Toshiya Hari with Goldman Sachs.",13,"Our next question comes from the line of Toshiya Hari with Goldman Sachs."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I had 2 as well. Mark, I guess somewhat related to C.J.'s question. Just curious in terms of the auto SOC test market, I think in your prepared remarks, you mentioned that you expect the market to exceed $500 million this year and how that's the highest m",155,"I had 2 as well. Mark, I guess somewhat related to C.J.'s question. Just curious in terms of the auto SOC test market, I think in your prepared remarks, you mentioned that you expect the market to exceed $500 million this year and how that's the highest mark since 2017. How are you thinking about sustainability there into '22? Near-term demand is clearly very strong. And when we speak with your customers, they're all kind of complaining about extending lead times. So I guess the bias is to the upside, but curious how you're thinking about that market. 
And then as a follow-up, a question on Storage Test. It seems like both HDD and SLT are trending very nicely. I think the business was up more than 2x last year in 2020. Curious what you're thinking about the business full year 2021. If you can differentiate between SLT and HDD, that would be super helpful."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","It's Sanjay here. So I'll take a cut at them. So from an auto market perspective, it's true this year, we've seen tremendous growth and just about $500 million or plus or minus a bit from a market size, and yes, as far as we've seen even back to 2017. And",344,"It's Sanjay here. So I'll take a cut at them. So from an auto market perspective, it's true this year, we've seen tremendous growth and just about $500 million or plus or minus a bit from a market size, and yes, as far as we've seen even back to 2017. And fundamentally, I think in the last call, there was commentary around the auto industry, for years, has lived on a just-in-time manufacturing. And fundamentally, in back half of 2019, sales weren't so high. And coming into '20, obviously, demand has really picked up. And so you're seeing just a significant replenishment of inventory back into the system. And we're seeing that continue. We see, obviously, the lead times. And currently, the demand is outstripping our supply. And we see that with good visibility until the end of 2021. 
2022 will be interesting because we'll have to take a look at what are the inventory levels and what is the market demand in 2022 in first half. And so it's a little bit opaque, I'd say, in 2022, but it will depend on what I believe to be the inventory level and, obviously, the end market demand.
And from a storage perspective, a little bit of color around 2020 and 2021. If I go back to 2020, HDD and our SLT business was kind of split relatively even. One was a little bigger than the other. And from an HDD perspective, we've seen continued end-market demand fueling that business. But when we look into 2021 from an SLT perspective, we're seeing a broadening of devices being adopted for SLT testing, which is providing a tailwind, which is enabling a larger growth in that segment of the storage business this year relative to the HDD business.
So the HDD business is still very strong; end-market demand, very strong. But the broadening of the SLT -- or sorry, the ASICs being tested under SLT is increasing, which is really good news. So it's growing a little faster than the HDD shipments from a storage perspective."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of Timothy Arcuri with UBS.",12,"Your next question comes from the line of Timothy Arcuri with UBS."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I had a question about your commentary, Mark, about your SOC share for the year and sort of what it implies for SOC in Q4, and more broadly, what it implies for total company revenue in Q4. So you've sort of given us all the different pieces. You guided w",164,"I had a question about your commentary, Mark, about your SOC share for the year and sort of what it implies for SOC in Q4, and more broadly, what it implies for total company revenue in Q4. So you've sort of given us all the different pieces. You guided wireless for the year, you guided systems for the year and you gave us the pieces on the Test businesses.
So if I just look at what that implies for SOC in Q4, I mean you're going to do about $575 million roughly for SOC in Q3. That's not a big mystery. But the Q4 number implies it goes down to like $425 million, somewhere in the low 4s. That will be down year-over-year. So I guess my first question is like why would that be given that you have all this visibility? And obviously, you're quite bullish about the market. So why would Q4 be down so much? That's my first question in SOC."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I don't know if it will be down so much or not. It's a portfolio of businesses, and all of those numbers have a margin of plus or minus, let's say, 1% around them. So that creates a large Monte Carlo simulation. And if you go right down the middle, I",349,"Yes. I don't know if it will be down so much or not. It's a portfolio of businesses, and all of those numbers have a margin of plus or minus, let's say, 1% around them. So that creates a large Monte Carlo simulation. And if you go right down the middle, I think you probably -- I'm sure you did the math right, that's probably what you come up with. 
But that's typical, as I said earlier, of where we stand at this point in the year looking into Q4 as in past years where it's come in higher. There's a significant unknown around what we'll book between now and through October that can drive Q4 shipments. And while we have backlog that extends in some product lines, as Sanjay mentioned, all the way through the end of the year, there's others that's more of a turns business. 
And we've positioned ourselves to be very responsive on the SOC front in general to capitalize on these sort of short demand request to come from our customers. That's why we've in the past been able to, in the quarter, exceed our guidance and even in the fourth quarter and prior years exceed what we thought when we were talking back then in July. 
So it could very well turn out that the demand that we've seen in the last couple of years in Q4 yet materializes again and we end up, as C.J. was hinting at, having a second half larger than first. It's just that at this point in the year, given what customers are talking about, we just don't see that as the most likely outcome. 
And it's episodic, too. What happens in Q4, a lot of it happens, in the past couple of years, in the December quarter, preparing for product launches that occur in February time frame, new phones and things like that. And so -- and again, with a rash of phone introductions in February, although we don't see it now, we could see a demand for SOC testers to support that driving December shipments."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Yes. No, it's -- I mean the total company revenue is sort of implied to be below what people are expecting for Q4. So that's kind of what I was asking. So anyway, on your revised TAM for Semi Test, so can you just update us on the segment? So I think be",105,"Yes. No, it's -- I mean the total company revenue is sort of implied to be below what people are expecting for Q4. So that's kind of what I was asking. 
So anyway, on your revised TAM for Semi Test, so can you just update us on the segment? So I think before, you were thinking compute would be $1 billion, mobility would be $1.6 billion. Auto, you just gave that number, is like $500 million. And industrial, I think before, you were talking about $500 million. So is the revision mostly in the compute side? Can you sort of update us on those numbers?"
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. The numbers for compute are about the same. Mobility is probably up a couple of hundred million. Auto is up probably $50 million and industrial up about $50 million.",30,"Yes. The numbers for compute are about the same. Mobility is probably up a couple of hundred million. Auto is up probably $50 million and industrial up about $50 million."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of Krish Sankar with Cowen.",12,"Your next question comes from the line of Krish Sankar with Cowen."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","And Mark, thanks for the color earlier on the ARM test opportunity. I just want to ask the question in a different way. When do you think the non-x86 compute TAM or maybe the total test compute TAM be similar or bigger than the mobility test market? And t",53,"And Mark, thanks for the color earlier on the ARM test opportunity. I just want to ask the question in a different way. When do you think the non-x86 compute TAM or maybe the total test compute TAM be similar or bigger than the mobility test market? And then I had a follow-up."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Bigger than the mobility test. So your question is when will the ARM compute test TAM be bigger than the ARM mobility test TAM?",24,"Bigger than the mobility test. So your question is when will the ARM compute test TAM be bigger than the ARM mobility test TAM?"
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Yes, mobility test TAM is about $1.6 billion or $1.7 billion, and you said compute is about $1 billion. When do you think the total compute TAM or maybe just the non-x86 compute TAM get to be bigger than mobility?",40,"Yes, mobility test TAM is about $1.6 billion or $1.7 billion, and you said compute is about $1 billion. When do you think the total compute TAM or maybe just the non-x86 compute TAM get to be bigger than mobility?"
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","I don't think it's going to be in the next 4 or 5 years. I think much of what's being developed in the ARM space by the hyperscalers will more likely fall into the category of mobility. So I don't see compute growing beyond mobility in the next 4 or 5 yea",53,"I don't think it's going to be in the next 4 or 5 years. I think much of what's being developed in the ARM space by the hyperscalers will more likely fall into the category of mobility. So I don't see compute growing beyond mobility in the next 4 or 5 years."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Got it. And then, Mark, on the auto test market, you said it's over $500 million. I'm guessing that includes auto microcontroller, linear, et cetera. If that is the case, is there any way of giving some more color within that? Or you think it's to",52,"Got it. Got it. And then, Mark, on the auto test market, you said it's over $500 million. I'm guessing that includes auto microcontroller, linear, et cetera. If that is the case, is there any way of giving some more color within that? Or you think it's too hard to segment it?"
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes, it does include microcontrollers. And I would say that auto is outstripped -- most of the growth is auto more than microcontrollers. Microcontrollers is growing too, but it's mostly auto. Auto -- and of course, there's microcontrollers in auto. So wh",61,"Yes, it does include microcontrollers. And I would say that auto is outstripped -- most of the growth is auto more than microcontrollers. Microcontrollers is growing too, but it's mostly auto. Auto -- and of course, there's microcontrollers in auto. So when I say auto, I mean microcontrollers for auto versus microcontrollers, let's say, for white goods and things like that."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your final question comes from the line of Joe Moore with Morgan Stanley.",13,"Your final question comes from the line of Joe Moore with Morgan Stanley."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I wanted to ask about the millimeter wave commentary. It seemed like the expectation that was primarily one customer in one region. So when you say that was kind of short of your expectations, what are you referring to there?",40,"I wanted to ask about the millimeter wave commentary. It seemed like the expectation that was primarily one customer in one region. So when you say that was kind of short of your expectations, what are you referring to there?"
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","So it's not one customer, one region. Millimeter wave last year for us grew significantly. We probably had 90% share of the early buying per millimeter wave test in 2020. And I would say that was spread out across 6 or 7 customers. Anybody who's making a",91,"So it's not one customer, one region. Millimeter wave last year for us grew significantly. We probably had 90% share of the early buying per millimeter wave test in 2020. And I would say that was spread out across 6 or 7 customers. Anybody who's making a chipset related to millimeter wave was pretty much using a Teradyne tester in 2020. The deployment of millimeter wave by the telecommunication companies has ground to a halt. And that has proportionately ground to a halt the need for incremental test in 2021."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Okay, folks, thanks so much for joining us today. That concludes the call. We apologize for the audio difficulties at the front end of it. We look forward to talking to you in the days and weeks ahead. And those in the queue, I'll get back with you direct",52,"Okay, folks, thanks so much for joining us today. That concludes the call. We apologize for the audio difficulties at the front end of it. We look forward to talking to you in the days and weeks ahead. And those in the queue, I'll get back with you directly here. Thank you."
94728,1674258151,2353062,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Ladies and gentlemen, this concludes today's conference. Thank you for your participation, and have a wonderful day. You may all disconnect.",21,"Ladies and gentlemen, this concludes today's conference. Thank you for your participation, and have a wonderful day. You may all disconnect."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Good morning, ladies and gentlemen, and welcome to the Q2 2021 Teradyne Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is not -- this conference call will resume -- I would now like to turn the conference over to you",47,"Good morning, ladies and gentlemen, and welcome to the Q2 2021 Teradyne Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is not -- this conference call will resume -- I would now like to turn the conference over to your host, Mr. Andy Blanchard."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Phyllis. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined this morning by our CEO, Mark Jagiela; and our CFO, Sanjay Mehta.Following our opening remarks, we'll provide details of ou",307,"Thank you, Phyllis. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined this morning by our CEO, Mark Jagiela; and our CFO, Sanjay Mehta.
Following our opening remarks, we'll provide details of our performance for 2021's second quarter along with our outlook for the third quarter of 2021. The press release containing our second quarter results was issued last [ evening  . [ We're providing slides   on the Investor page of the website that may be helpful to you when following the discussion. Replays of this call will be available via the same page after the call ends. 
Matters that we discuss today will include forward-looking statements that involve risk factors that could cause Teradyne's [ results   to differ materially from management's current expectations. We encourage you to review the safe harbor statement contained in the earnings release as well as our most recent SEC filings. Additionally, those forward-looking statements are made as of today, and we take no obligation to update them as a result of developments occurring after this call. 
During today's call, we'll make reference to non-GAAP [ financial   measures. We've posted additional information concerning those non-GAAP financial measures, including reconciliation to the most directly comparable GAAP financial measures and were available on the [ Investor page   of our website. 
Looking ahead between now and our next earnings call, Teradyne expects to participate in technology or industrial-focused investor conferences hosted by KeyBanc, Rosenblatt Securities, Deutsche Bank and Citi. 
Now let's get on with the agenda. First, Mark will comment on our recent results and the market conditions as we enter the new quarter. Sanjay will then offer more details on our quarterly results along with our guidance for the third quarter. We'll then answer your questions, and this call is scheduled for [ 1 hour ].
Mark?"
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Good morning, everyone, and thanks for joining us. Today, I'll summarize our results for the second quarter and first half of 2021, update on current conditions in both Test and Industrial Automation, and comment on our view for the second half of the yea",1328,"Good morning, everyone, and thanks for joining us. Today, I'll summarize our results for the second quarter and first half of 2021, update on current conditions in both Test and Industrial Automation, and comment on our view for the second half of the year. Sanjay will then provide the financial details on the quarter and our guidance for Q3. 
The strong demand we saw in Q1 accelerated in Q2 as both our Test and Industrial Automation groups grew substantially in the quarter. The long-term demand drivers we've discussed in the past continue to power demand for our products. In Test, it's device complexity and unit growth; in Automation, it's labor scarcity, the need for resiliency and productivity improvement. 
Opening further, performance at the company level from 2016 through 2020 saw our sales and non-GAAP EPS grow at a compounded rate of 16% and 32%, respectively. For the first half of this year, sales are running ahead of that rate at 21%, and non-GAAP earnings per share grew at 29% compared with last year. This demonstrates both the [ vitality   of the markets we serve and the efficiency of our operating model. 
Significantly, in Q2, we saw Industrial Automation demand recover in all major regions, but particularly in North America. As a result, our production and [ operating teams   operated at a high pace in Q2, and that pace is [ increasing   in Q3. For the year, our IA business is on track to grow about 30% from 2019 and about 40% from 2020. 
Looking closely at the segment level. In Semi Test, SOC shipments grew 29% in Q2 from Q2 of 2020 with particular strength in both the compute and mobility end markets. For the first half, SOC sales grew 19%. For the first time in several years, smartphone unit shipments are helping growth in the mobility [ segment  , where as recent years have mostly relied on complexity growth. 
[ IA   and compute are the 2 largest subsegments in SOC. Automotive, analog and industrial demand continues to be strong. The auto-related semi test market is expected to exceed $500 million this year, the highest level since 2017. This is despite the fact that automobile unit production will be about [indiscernible] lower in 2017 -- lower than 2017. A portion of this strength is test equipment. We're also seeing the impact of increased semi content and complexity per automobile, driving the test market. 
Our memory test shipments also grew in Q2 from Q2 of 2020, up 9%, led by flash tester demand. For the 6-month period, overall shipments were up 18% from last year on solid demand for both flash wafer and [ flash   systems. This reflects significant growth in smartphone demand, the build-out of new memory capacity in China and the growth of SSD demand.
Looking at the full year, we are again revising up the SOC market for 2021 to now be in the range of $4.3 billion to $4.7 billion with increasing strength in the x86 GPU and display driver segments. Recall that we have lower customer exposure in those markets with much of this incremental growth going to our competitors. So we'll likely see our SOC share around 48% for the year. 
In memory, at the macro level, our market estimates are unchanged with the test market this year expected to be about $1 billion and our share to be at about the 40% level. I will note that the expected ramp of DDR5 for server applications and the broader adoption of LPDDR5 is pushing out into 2022. 
Shifting to our System Test group, sales were up 26% in the first half compared with 2020, with strong Storage Test demand and a recovery in our Production Board Test unit driving the growth. For the full year, we see System Test group -- the System Test group grow in the 10% to 20% range. 
At LitePoint, sales in Q2 were up 12% over 2Q 2020. While 5G millimeter wave demand is lower than expected, the environment in Wireless Test is improving as we move through the year due to the continued WiFi 6 growth and early WiFi 7 investments. In addition, ultra-wideband adoption is increasing, adding a new growth vector for LitePoint. For the full year, LitePoint will likely grow in the 10% range. 
Moving on to Industrial Automation. The combination of expanding demand across our major markets and the increase in the range of tests served by our Universal Robots and MiR units drove group sales up 57% in Q2 last year [ to 45%   in the first half. Compared to pre-pandemic 2019, first half sales are up 22%. Supply chain issues have constrained growth a little bit with lead times pushing out about 1 week. 
The demand environment for IA has recovered in most regions from last year's slowdown. America was the fastest-growing major region in Q2 with sales up over 90% from last year. Although we did see a [indiscernible] some countries in Asia where COVID has spiked in recent months, the second half of the year outlook is quite strong in all our major regions. 
Our long-term growth strategy in IA continues unchanged, and we expect long-term annual growth in the 20% to 35% range. This year, we will likely have a growth of about 40% from 2020, and we will continue to invest to enable this growth target of [ 15%   gross margins, [ get   a 5% to 15% operating margin during these high-growth years.
From an investment perspective, we are expanding our engineering programs to shorten deployment times, increase the served market and improve the customer support experience. We are also growing our capacity to support distributors, integrators and UR plus and MiRGo apps development partners as [ they ] engage customers. We are also expanding our sales to OEMs that integrate our robots into their products. 
Last quarter, we noted the expanding range of applications for UR robots into the high-voltage line application with hundreds of                 being deployed. Today, I'd like to highlight the success of UR+ plug-and-play applications for Industrial [ Automation  ..There is a long-standing and chronic shortage of qualified welders worldwide with an estimated 100,000 unfilled welding jobs in the U.S. alone. While automated solutions exist for large applications like auto manufacturing, customers with lower volume and higher mix products are not well served by traditional automation. 
The integration of a force torque sensor into e-Series cobots enabled the precision needed for this application. And with UR+ [ integrating   with our partners, we began serving this market about 3 years ago. During this time, welding applications have grown to be about 6% of our global [ sales   and are on                 1,000 cobots sold in 2021, more than tripling our 2020 pace. 
As we continue to extend the performance of our UR platform, we expect these high applications had growth vectors to traditional industrial applications. We have similar market-expanding initiatives in play on our MiR platform, but I'll save those details for a future call. 
Summing it all up, the first half of the year has been a strong sales, strong gross margins and earnings growth               ]. Longer term, the markets we serve are showing [ increasing demand   in a future global economy. The importance, pervasiveness and enabling capability of electronics in every [ aspect   of our lives and industry is driving more fab investment, more complexity and more test. Likewise, the broadening application and fast [ ROI of   [ collaborative ] robots in a world with labor shortages and productivity challenges is another growth trend. 
Strategically, we positioned ourselves in line with                 and plan to continue to make   System   Test and IA as our full potential while driving world-class [ returns  . While the rate of change in our markets is accelerating, we are well positioned to thrive as a company and to bring additional value to customers and shareholders. 
I'll now turn things over to Sanjay [ to provide   additional color on the financials."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Mark. Good morning, everyone. Today, I'll [ provide details   on our Q2 results, comment on current business conditions and describe [ our outlook for   Q3. Now to Q2. Second quarter sales were $1.086 billion with non-GAAP EPS of $1.91, up 29",1128,"Thank you, Mark. Good morning, everyone. Today, I'll [ provide details   on our Q2 results, comment on current business conditions and describe [ our outlook for   Q3. 
Now to Q2. Second quarter sales were $1.086 billion with non-GAAP EPS of $1.91, up 29% and 44%, respectively, from Q2 '20. Non-GAAP gross margins were 59.6%, and our non-GAAP operating expenses were $250 million, but $5 million below the high guidance due to the timing of some nonrecurring engineering expenses.
Non-GAAP operating profit rate was 36.5%. [ Gross margin   in the quarter was [ 59.6%   compared with our plan of 58%. The increase was tied to favorable product mix in the quarter versus planned. 
For context, Q2 2020 gross margin was approximately   56.2%  . In April                , we noted that this level of gross margin would continue in the near term, driven by the introduction of several key test systems in early 2020, which would [ take several   quarters to come down the cost curve. These new product introductions, coupled with heightened costs driven by COVID shortages, were impacting our gross margins in 2020. One year later, we have now most of these test solutions at volume, and they have come down the cost curve as expected. 
The result contributed to higher margins in the second quarter, which we expect will continue in the second half of the year. A component of gross margin improvement over 2020 is higher revenue yielding of leverage in the gross margin line. We had one 10% customer in the quarter                 excluding discrete items of [ 14.5% ]on both GAAP and non-GAAP basis. 
Looking at the results from a business unit perspective. [ Semi Test   revenue of $834 million was up 27% from Q2 2020. SOC revenue was $742 million, up 29%, driven by strength in compute, mobility, industrial and automotive. Memory revenue was $92 million, up 9% from prior year, driven by strength in flash test and flash wafer sort segments. 
System Test group had revenue of $105 million, which was up 46% year-over-year. This is driven by $58 million in Storage Test sales, including both HDD and SLT solutions; [ $27 million   in Defense & Aerospace and Production Board Test. 
In Storage Test, HDD and SLT demand remains robust as drive densities continue to increase and the number of devices adopting [ SLT spokes  . At LitePoint, revenue of $55 million was 12% -- was up 12% from prior year due to continued strength at [ WiFi ], increases in                 and ultra-wide band test market segments. 
Now to Industrial Automation. As we did in April, I'll provide revenue metrics comparing Q2 '21 results with both Q2 '20 and Q2 '19, so you'll have the full context given the impact of a contracting market tied to COVID last year. Industrial Automation revenue of $92 million was up 57% year-over-year and 23% over Q2 '19. Revenue expanded in all regions in Q2 [ over   last year, with North America delivering the highest absolute revenue growth. U.S. and Europe represented about 77% of IA revenue in the quarter, with China contributing about 14%. 
UR sales were $76 million in Q2, up 75% year-over-year and [ 80%   over 2019. MiR sales were $16 million, up 41% from Q2 '20 and 51% from Q2 '19. Recall, MiR had an                 on Q2 '20 as its robots were widely deployed in automated COVID disinfectant applications. 
The longer-term outlook in our IA business continues to brighten. We expect continued labor shortages to drive new applications for both our fixed and mobile robots. Mark highlighted the shortage of welders and how that has opened up a new market for our UR cobots, but that is just one of many job categories with acute short-term and long-term labor shortages. 
Our strategy is to provide an open platform that creative developers can leverage to solve industry-specific labor shortages. The numerous filling ultraviolet disinfecting solutions built on our [ platform   last year is a shining example of the agility of our partner networks to solve problems. 
We're investing in engineering, support and marketing resources to make our MiR platforms even easier to build upon, which will enable the continued proliferation of high-value automated solutions to solve challenging problems for an expanding range of customers. Significantly, these development partners and customers provide great feedback on our R&D development plans. 
From a financial perspective, we expect IA will operate around the low end of our target profit range of 5% and 15%. We do expect IA to operate above the Rule of 40 in 2021, that is the sum of operating profit and revenue growth of over [ 40%  . Longer term, when growth moderates, we expect the IA group to have a similar operating profit rate as our Test portfolio. 
Shifting to supply. We continue to manage through numerous supply constraints along with increased material, manufacturing and logistics costs in both our Test and IA businesses. For some products in both Test and IA, the supply constraints have extended our [ lead times  , and we're working closely with customers to minimize the impact of these delays. 
But we've been able to offset these higher costs through operating leverage with higher volumes and other cost-saving measures, so the cost increase impact on the P&L has not been material. We do expect to be dealing with supply line-related issues in Q3 and Q4 this year, which are reflected in our forecasts. 
Shifting to the balance sheet and cash flow. Our cash and marketable securities at the end of the quarter totaled $1.42 billion, $172 million of free cash flow in the quarter, $151 million and $17 million on buybacks and dividends, respectively. Year-to-date, we've repurchased 1.6 million shares for $197 million at an average [ price   of $125.69 per share.
Regarding our convertible debt. $15.6 million was paid in Q2 to convertible bondholders ahead of maturity. By the end of August 2021, bondholders will have already converted a total of $302 million, leaving a face value of $58 million outstanding. 
Looking at our operating model, I'd like to make 3 quick points. First, our performance over time. From 10 years ago, our gross margin percent has expanded from the low to [ mid-50s   to nearly 60% [ today   and our operating margin from the teens to low 20s to greater than 30% today. 
Second, our flexible business model shifts fixed cost to variable costs where appropriate through [ contract   or outsourced manufacturing, variable compensation and other [ means  , which enables resiliency on the downside and is creative (sic) [ accretive ] when business is strong. 
Third, the operating leverage in the model is evident in our Q2 results. Our Test businesses are dropping through over $0.50 per revenue dollar through to the profit line in 2021..."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","[Technical Difficulty]",2,"[Technical Difficulty]"
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you.",2,"Thank you."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Ladies and gentlemen, we're going to have a quick transition.",10,"Ladies and gentlemen, we're going to have a quick transition."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","I'll go back -- okay, it's Sanjay again. I'll go back to looking at our operating model. I'd like to make 3 quick points. First, our performance over time from 10 years ago, our gross margin percent has expanded from low to mid-50s to nearly 60% today and",526,"I'll go back -- okay, it's Sanjay again. I'll go back to looking at our operating model. I'd like to make 3 quick points. First, our performance over time from 10 years ago, our gross margin percent has expanded from low to mid-50s to nearly 60% today and our operating margin from the teens to low 20s to greater than 30% today. 
Second, our flexible business model shifts fixed cost to variable costs, where appropriate, through contract or outsourced manufacturing, variable compensation and other means, which enables resiliency on the downside and is accretive when business is strong. 
Third, the operating leverage in the model is evident in our Q2 results. Our Test businesses are dropping through over $0.50 per revenue dollar through to the profit line in 2021, even while we continue to increase our R&D support -- and support investments to strengthen our Test business. This enables Teradyne to continue to invest in both our Test and IA portfolios. For IA, we are building a deeper product ecosystem and distribution differentiation while achieving the Rule of 40 in our IA portfolio. 
Now to our outlook for Q3. As Mark noted, the demand environment across the business remains strong. Our guidance assumes no significant changes, positive or negative, in the availability of materials and also assumes that we won't see additional pandemic-related issues. With that said, sales in Q3 are expected to be between $880 million and $960 million with non-GAAP EPS in the range of $1.29 to $1.55 and 176 million diluted shares. 
Third quarter guidance excludes the amortization of acquired intangibles and noncash imputed interest on convertible debt. Third quarter gross margins are estimated to be between 59% and 60%. OpEx is expected to run at 27% to 29% of third quarter sales. The non-GAAP operating profit at the midpoint of our third quarter guidance is 32%. 
Regarding OpEx for the full year. While we spent a bit lower than planned in Q2, we expect the full year OpEx will be about in line with the plan we described in April. We expect total operating expenses for 2021 to be about $1 billion or up approximately 19% from 2020. We recognize that we're on track to meet our 2024 earnings model this year. We'll update the model on a regular cadence in January after our detailed midterm plan income is complete in Q4 this year. 
In summary, our businesses are performing extremely well, delivering strong revenue and earnings growth while funding the investments that will drive future success. Our first half sales grew 21%, and non-GAAP EPS grew 29% above the first half of 2020, which itself was a record. We expect to deliver the highest Q3 sales and profits in history. 
Our employees and production partners around the world have delivered a record number of systems under challenging conditions. Our support teams have done whatever was needed to make our customers successful. And our engineering teams have kept the new product pipeline moving on schedule. It's been an impressive display of teamwork, and I'm proud to be part of this powerful Teradyne team. 
With that, I'll turn things back to Andrew."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Sanjay. And everybody, thanks for dealing with our small technical issue there. Phyllis, we would now like to take some questions. [Operator Instructions]",24,"Thanks, Sanjay. And everybody, thanks for dealing with our small technical issue there. Phyllis, we would now like to take some questions. [Operator Instructions]"
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","[Operator Instructions] Your first question comes from the line of Brian Chin with Stifel.",14,"[Operator Instructions] Your first question comes from the line of Brian Chin with Stifel."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","A couple of questions here. Maybe just to kick things off. I'm just curious to what degree, if any, are the extended lead times in ATE in this sort of the current strong semiconductor environment impacting your shipment outlook or pattern in the second ha",75,"A couple of questions here. Maybe just to kick things off. I'm just curious to what degree, if any, are the extended lead times in ATE in this sort of the current strong semiconductor environment impacting your shipment outlook or pattern in the second half? Obviously, Teradyne no longer discloses bookings, but your competitor appears to be building backlog into the December quarter. So I was wondering if you have better-than-typical backlog visibility beyond September."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So lead times have definitely been moving out. I'd say auto and industrial demand is still outstripping supply. But our lead times have pushed out, obviously, based on the very, very tight supply chain environment we're dealing with. And so what used",101,"Yes. So lead times have definitely been moving out. I'd say auto and industrial demand is still outstripping supply. But our lead times have pushed out, obviously, based on the very, very tight supply chain environment we're dealing with. And so what used to be, let's say, within a quarter has pushed out to 5, 8 weeks incremental to where we were in the past to be, in some cases, in the 20s in weeks of lead time. So with that, we have been seeing, I guess, improved bookings from our customers, and we're working with them to manage through it."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And then maybe for Mark. I think you touched on how, at least in the smartphone market, units are kind of a bigger tailwind this year, which hasn't always been the case in recent years. But I think in the 2022, what do you think -- to what degree",72,"Got it. And then maybe for Mark. I think you touched on how, at least in the smartphone market, units are kind of a bigger tailwind this year, which hasn't always been the case in recent years. But I think in the 2022, what do you think -- to what degree could increased packaging complexity across foundries and maybe some IDMs be a more meaningful driver of incremental test intensity next year?"
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes, we -- that's a good question. We bundle that into the complexity side of life. And there's already been advanced packaging technologies deployed for several years now in phones, but it's increasing. So that trend of multichip, multi-die packaging inc",94,"Yes, we -- that's a good question. We bundle that into the complexity side of life. And there's already been advanced packaging technologies deployed for several years now in phones, but it's increasing. So that trend of multichip, multi-die packaging incrementally adds test time above and beyond what you would get if you were putting all of that silicon on a single integrated die. And there's not a good rule of thumb of how much of an adder it is, but it is a trend that's going to continue to grow and drive tests."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of Atif Malik with Citi.",12,"Your next question comes from the line of Atif Malik with Citi."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I have a similar question on the mobility side end market. It sounds like your mobility outlook has improved for the year versus 90 days ago despite millimeter wave weakness. You talked about units helping. Can you talk about the confidence in test intens",82,"I have a similar question on the mobility side end market. It sounds like your mobility outlook has improved for the year versus 90 days ago despite millimeter wave weakness. You talked about units helping. Can you talk about the confidence in test intensity staying elevated for both mobility and compute into next year? And if you can also highlight the steps you're taking to improve your market share in the areas that you're not strong, like x86 GPU and display drivers."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So I think the complexity trends looking even into the next year are all very strong and positive. In the case of mobility, the newer lithographies that are coming online are being widely adopted by the manufacturers of silicon for phones, which port",313,"Yes. So I think the complexity trends looking even into the next year are all very strong and positive. In the case of mobility, the newer lithographies that are coming online are being widely adopted by the manufacturers of silicon for phones, which portends more transistors, which portends more test time. So that, looking into next year, all looks positive. And we get, at this point in the year, early glimpses of what the silicon for next year might actually look like. 
The -- on the compute side, similarly, we not only have the trend of lower lithography nodes, but the new interface standards related to LPDDR5 and DDR5, as I mentioned in my remarks, the early adoption of that has been pushed out a little bit as the processors that go with it have been delayed a bit. But all of the complexity required to run at those higher bandwidths is coming in 2022. So those are 2 positive things I look at that gives me confidence that this driver of complexity growth is definitely going to be strong next year. 
In terms of share, what we said before is that penetrating the traditional x86 GPU stalwarts is going to be a long-term endeavor for us that's going to hinge on some kind of technological discontinuity like that shift to DDR5 or like a shift to PAM4 interfaces to crack into. So that one is episodic and will play out over, let's say, 3 to 5 years. 
On the other front is -- are the emerging hyperscalers and new people coming into the market of creating complex silicon. These are automobile manufacturers, hyperscalers that we've talked about in the past, the Googles, the Facebooks, the Microsofts, the Amazons, that's where we're focused on getting a position to grow with them as they launch their products into the market in the shorter term."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Great, very helpful. And Sanjay, for you, the largest U.S. phone maker and your biggest indirect customer talked about supply constraints impacting smartphone sales in the September quarter yesterday. Have the materials and parts tightness gone worse over",45,"Great, very helpful. And Sanjay, for you, the largest U.S. phone maker and your biggest indirect customer talked about supply constraints impacting smartphone sales in the September quarter yesterday. Have the materials and parts tightness gone worse over the last 90 days for your business?"
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Well, first of all, I won't comment on any particular customer, but I will speak in general about the environment. Last year, we were really working through demand increases, but we had fairly good, robust inventory strategies, and we are working through",165,"Well, first of all, I won't comment on any particular customer, but I will speak in general about the environment. Last year, we were really working through demand increases, but we had fairly good, robust inventory strategies, and we are working through the impact of COVID. You have thousands of components that go into these testers, and we did a lot of resiliency improvements there. You fast forward to today's environment, and the demand has really kept accelerating. And the environment is tighter, I would say, today. And frankly, we don't see it letting up until the second half of 2022. 
So I think as the semiconductor industry goes through continued growth, you're seeing supply chains really getting tested. And then with the increase in the infection rates of COVID, especially, I'd say, in Southeast Asia, we're working through and managing the best we can. But I believe the net summation is it's a tighter industry now than it was, say, 3, 6 months ago."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of Mehdi Hosseini with SIG.",12,"Your next question comes from the line of Mehdi Hosseini with SIG."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Two questions, one on ARM-based ASIC design. I'm trying to get a sense of how you see the TAM. You can either elaborate as a mix of SOC tests or perhaps you can tell us how is the test time for an ARM-based ASIC chip compared to like an app process or may",89,"Two questions, one on ARM-based ASIC design. I'm trying to get a sense of how you see the TAM. You can either elaborate as a mix of SOC tests or perhaps you can tell us how is the test time for an ARM-based ASIC chip compared to like an app process or maybe that way we could give a sense of how demand looks like. So either qualitatively or quantitatively, you can -- if you can elaborate on ARM-based SOC test will be great. And I have a follow-up."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So I guess the first thing I'd say is that a ARM-based high-end map processor, which is what's in most of our phones today, driving most of our phones, has a transistor count that's equivalent to any laptop, x86 kind of product you might have in your",160,"Yes. So I guess the first thing I'd say is that a ARM-based high-end map processor, which is what's in most of our phones today, driving most of our phones, has a transistor count that's equivalent to any laptop, x86 kind of product you might have in your computer. And the test times comparatively between those 2 are not that different. It's kind of proportional to test count. 
The new ARM processors that are coming to market for compute applications, not smartphone applications, have perhaps anywhere from a 25% to 60% at or, on transistor count, above what's at the highest end of smartphones. And the test time associated with them, I would say, is proportionately longer at this point. And so I think it's, generally speaking, scaling with transistor count, and the transistor count on the ARM side is running a little bit at a faster clip than it is on the more traditional architecture side, if that helps."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Sure. So the follow-up has to do with ARM-based. Actually, I want to just dig in a little bit more. Would you, at some point, break this out so we could better understand how kind of ARM-based SOC tester is tracking or scaling versus the rest of the SOC m",70,"Sure. So the follow-up has to do with ARM-based. Actually, I want to just dig in a little bit more. Would you, at some point, break this out so we could better understand how kind of ARM-based SOC tester is tracking or scaling versus the rest of the SOC market? And number two, is there anything you can give us to better understand the competitive landscape for this specific application?"
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I guess I haven't thought about trying to find a way to break out ARM because most of what mobility is, is ARM; and then there's, let's say, compute applications for ARM; and then there's some processors that are almost dual-use, and they go into eit",223,"Yes. I guess I haven't thought about trying to find a way to break out ARM because most of what mobility is, is ARM; and then there's, let's say, compute applications for ARM; and then there's some processors that are almost dual-use, and they go into either application. So I think it's fair to say that any compute business that we have at Teradyne is ARM-based compute. And perhaps maybe in the future, we can look at some way to sort of characterize both the market and our associated revenue for that. But I don't have a good number for you now on that. 
And in terms of the applications coming to market, in the short term, we know about the phone applications, we know about some early adopters of ARM for compute. Those are all coming to market or are in the market now. The hyperscalers that we're working with are coming into market at various points next year with products that are quite interesting but highly speculative as to whether they'll latch in the market. And obviously, I'm not going to talk about those because they're pretty confidential. But we'll see what latches. If one of these applications can become a 100-plus million unit application, which most of these design teams are targeting, then that's a significant adder to the market."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of Vivek Arya with Bank of America.",14,"Your next question comes from the line of Vivek Arya with Bank of America."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I was curious, how is your kind of visibility for Q4 as you kind of stand today versus what it is usually? And if you could give us some color by end market in terms of what is in your assumption for Q3 and the second half, that would be very helpful.",52,"I was curious, how is your kind of visibility for Q4 as you kind of stand today versus what it is usually? And if you could give us some color by end market in terms of what is in your assumption for Q3 and the second half, that would be very helpful."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Sure. So Q4, if I look back at my last 2 years here, we've been surprised mainly on the positive side. And I'd say that given the tightness of supply and customers providing a little bit more in the way of backlog, it gives us a little bit more insight. H",216,"Sure. So Q4, if I look back at my last 2 years here, we've been surprised mainly on the positive side. And I'd say that given the tightness of supply and customers providing a little bit more in the way of backlog, it gives us a little bit more insight. However, obviously, in the near term, we have much stronger visibility in Q3 than in Q4. And so -- but we do have, I'd say, a little bit of incremental visibility. 
In color -- in your question in regards to color for Q3, we see continued strength in semiconductor. Obviously, the different components within Semi Test are going to be a little volatile, but we do see a trend down. It's still what we believe is very strong demand, but we see a trend down. And we see in our IA portfolio, really, a strength. Obviously, with the COVID impact in 2020, industrials are really coming back. I'll cite some PMIs in the 60s at the U.S. and Europe. And we really see that in our, as Mark noted, in our growth in the U.S. But we're seeing that growth in China as well as in Europe and the U.S. So continued expected growth in IA and then, from a test perspective, coming down a bit."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And then on the UR side, Mark, I'm curious, what are the top 3 applications you're serving today? And how do you expect these applications to evolve? You are maintaining a very strong growth rate in that business. And I'm curious, what is driving",116,"Got it. And then on the UR side, Mark, I'm curious, what are the top 3 applications you're serving today? And how do you expect these applications to evolve? You are maintaining a very strong growth rate in that business. And I'm curious, what is driving that. Is it more number of customers? Is it more applications within the same customer? So what's giving you the confidence you can maintain this very strong growth rate in the UR business? And is -- on the gross margin side, is it accretive? I know on the operating margin side, you've given a range. But I imagine on the gross margin side, it might be accretive to your business."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. It's interesting because there's no silver bullet as to what's driving the growth at UR. So for example, we're going to be up about 30% from revenue in 2019, 40% up from 2020. And in the script, I mentioned this application for welding, which is a br",326,"Yes. It's interesting because there's no silver bullet as to what's driving the growth at UR. So for example, we're going to be up about 30% from revenue in 2019, 40% up from 2020. And in the script, I mentioned this application for welding, which is a brand-new application that is now driving about 6% of our sales for the year. Last quarter, I talked about this service application for servicing high-voltage power lines that's also running at around that 6% of sales applications that was nonexistent -- essentially nonexistent 2 years ago. 
So already, we have 12% of our growth attributed to new applications in new markets with new customers that we didn't have 2 years ago. So it's a combination of expanding applications like those 2 examples as well as established markets growing that's driving this. And our top 3 applications tend to be the same. It's automotive supply chain, it's industrial machine tending and it's electronic assembly tend to be the ones that are at the top of the pack. But frankly, they are shrinking as a percentage of sales as these new applications come online. 
So what gives me confidence looking forward is that ecosystem of partners who are developing these application solutions on our platform, not our competitors, is just continuing to grow and prosper. And they're not all going to be as successful as high-voltage line tending or welding. But it only takes 10% of them to fuel the kind of growth numbers that we've been seeing. And the activity there is very strong, and the technology is maturing to the point that more and more applications can economically be served. 
And over the horizon, when you look at what AI can bring, there's a whole new set of, let's say, features that will enable yet another expansion of the market. It's what gives us the confidence to talk about these kind of decade-long growth rates of 25%, 30%, 35%."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of John Pitzer with Credit Suisse.",13,"Your next question comes from the line of John Pitzer with Credit Suisse."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, maybe another way to ask the calendar fourth quarter question is, over the last 3 years, the business has run in such a way that second half has been greater than the first half from a top line perspective, which has broken kind of a trend, where if",99,"Mark, maybe another way to ask the calendar fourth quarter question is, over the last 3 years, the business has run in such a way that second half has been greater than the first half from a top line perspective, which has broken kind of a trend, where if you go back the prior 7 years, it was first half stronger than second half. Did you have any commentary on sort of how you think the second half over the first half looked this year just given how strong the market environment is and how tight test capacity is?"
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","You're right, perfect student of the history. And we have been, as Sanjay said, always a bit surprised in the recent years on how strong the fourth quarter has come in and driven second half to be a bit higher than first. So if you asked us today, we'd sa",163,"You're right, perfect student of the history. And we have been, as Sanjay said, always a bit surprised in the recent years on how strong the fourth quarter has come in and driven second half to be a bit higher than first. So if you asked us today, we'd say first half is a little bit stronger than second, but that's no different than kind of what we thought for the last couple of years, too. And that just is a testament to the visibility in Q4 as -- the lack of visibility in Q4.
As Sanjay said, though, it's a little bit more visibility now than before because lead times are a little longer. But all the upside that could come in is the, obviously, the piece that's not visible. So we feel probably better now about Q4 than we felt in any prior 2 or 3 years, but it's sort of what might happen between now and October that's invisible."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","That's helpful. And then, Mark, as my follow-on, I apologize, the audio quality was a little poor during your prepared comments. I wanted to go back to some of the commentary you made around DDR5 adoption. I think the point you were making is perhaps it's",88,"That's helpful. And then, Mark, as my follow-on, I apologize, the audio quality was a little poor during your prepared comments. I wanted to go back to some of the commentary you made around DDR5 adoption. I think the point you were making is perhaps it's a little bit slower than you thought. Is that correct? And I guess, more importantly, can you give us an update of how you think you're positioned for DDR5 when it does start to ramp relative to share in memory test?"
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Yes, sorry about the audio quality. But in fact, yes, DDR5 for server applications has pushed out a bit as the server chips themselves have been delayed. We've seen the impact of that in the demand for DDR5 testers. And similar things happened with L",115,"Yes. Yes, sorry about the audio quality. But in fact, yes, DDR5 for server applications has pushed out a bit as the server chips themselves have been delayed. We've seen the impact of that in the demand for DDR5 testers. And similar things happened with LPDDR5 going into mobility applications. So despite all that, the share position for Teradyne, we think, is unchanged from our earlier estimates at around 40% of the market, and it's going to be a tailwind next year when the DDR5  and LPDDR5 ramp as was originally thought would happen toward the end of this year. So we're well positioned there, and I think that's a tailwind for us next year."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of C.J. Muse with Evercore.",13,"Your next question comes from the line of C.J. Muse with Evercore."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I guess first question, Mark, you've taken SOC test market size higher again. And I guess, curious, if we were to hit the high end of the range, what would be the driver there? And would your market share still be 48%? Or could you see greater contributio",61,"I guess first question, Mark, you've taken SOC test market size higher again. And I guess, curious, if we were to hit the high end of the range, what would be the driver there? And would your market share still be 48%? Or could you see greater contribution from what's driving potentially the market to the higher end of the range?"
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Certainly, if the market goes up towards the high end of that range, our revenue would grow probably proportional to that. Would our share go much higher? I gave a number -- I threw in a number of roughly 48% at the midpoint of our market size guide.",156,"Yes. Certainly, if the market goes up towards the high end of that range, our revenue would grow probably proportional to that. Would our share go much higher? I gave a number -- I threw in a number of roughly 48% at the midpoint of our market size guide. I would expect our market share is probably going to stay around that number, plus or minus 0.5 point at this point in the year. 
But it's hard to sort of prognosticate too much about where the share comes from. And as you know, one customer's buying capacity can swing multiple points of share in any given year. And so one of our customers could come in and drive a demand that we don't see right now. We have the manufacturing capacity to serve it. And yes, I guess we could be up at 50% share if that happened. It's just a little opaque at the moment."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. That's helpful. And I guess a follow-on question to a few of the questions that you got earlier. You spoke to DDR5 now being pushed to a tailwind next year. You've spoken to high-performance compute, particularly the non-x86 world as a tailwind for",110,"Okay. That's helpful. And I guess a follow-on question to a few of the questions that you got earlier. You spoke to DDR5 now being pushed to a tailwind next year. You've spoken to high-performance compute, particularly the non-x86 world as a tailwind for you guys next year. I think the concern out there is that your one large customer could decline meaningfully and that would cause SOC for you guys to be down next year. So I guess, as you sit here today and you're setting up your supply for customers and lead times have extended, how are you thinking about the world into 2022 for SOC for Teradyne?"
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Very bullish because I think the concern -- let's see, I'm not going to speak too specifically around our customer. But what I would say is that the portfolio of devices that are being developed by our hyperscaler customers continues to expand. And that's",123,"Very bullish because I think the concern -- let's see, I'm not going to speak too specifically around our customer. But what I would say is that the portfolio of devices that are being developed by our hyperscaler customers continues to expand. And that's going to -- in addition to the complexity growth of the existing portfolio, you add more chips on top of that, it portends a growing market, a growing customer. So there's going to be ups and downs, but I think the cataclysmic or sort of a cliff concern, we're now a decade into this almost, so -- and it just hasn't happened. So the trend line, I think, is pretty clear, and I think that trend line will continue."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Our next question comes from the line of Toshiya Hari with Goldman Sachs.",13,"Our next question comes from the line of Toshiya Hari with Goldman Sachs."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I had 2 as well. Mark, I guess somewhat related to C.J.'s question. Just curious in terms of the auto SOC test market, I think in your prepared remarks, you mentioned that you expect the market to exceed $500 million this year and now that's the highest m",155,"I had 2 as well. Mark, I guess somewhat related to C.J.'s question. Just curious in terms of the auto SOC test market, I think in your prepared remarks, you mentioned that you expect the market to exceed $500 million this year and now that's the highest mark since 2017. How are you thinking about sustainability there into '22? Near-term demand is clearly very strong. And when we speak with your customers, they're all kind of complaining about extending lead times. So I guess the bias is to the upside, but curious how you're thinking about that market. 
And then as a follow-up, a question on Storage Test. It seems like both HDD and SLT are trending very nicely. I think the business was up more than 2x last year in 2020. Curious what you're thinking about the business full year 2021. If you can differentiate between SLT and HDD, that would be super helpful."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","It's Sanjay here. So I'll take a cut at them. So from an auto market perspective, it's true this year, we've seen tremendous growth and just about $500 million or plus or minus a bit from a market size, and yes, as far as we've seen even back to 2017. And",343,"It's Sanjay here. So I'll take a cut at them. So from an auto market perspective, it's true this year, we've seen tremendous growth and just about $500 million or plus or minus a bit from a market size, and yes, as far as we've seen even back to 2017. And fundamentally, I think in the last call, there was commentary around the auto industry, for years, has lived on a just-in-time manufacturing. And fundamentally, in back half of 2019, sales weren't so high. And coming into '20, obviously, demand has really picked up. And so you're seeing just a significant replenishment of inventory back into the system. And we're seeing that continue. We see, obviously, the lead times. And currently, the demand is outstripping our supply. And we see that good visibility until the end of 2021. 
2022 will be interesting because we'll have to take a look at what are the inventory levels and what is the market demand in 2022 in first half. And so it's a little bit opaque, I'd say, in 2022, but it will depend on what I believe to be the inventory level and, obviously, the end market demand.
And from a storage perspective, a little bit of color around 2020 and 2021. If I go back to 2020, HDD and our SLT business was kind of split relatively even. One was a little bigger than the other. And from an HDD perspective, we've seen continued end-market demand fueling that business. But when we look into 2021 from an SLT perspective, we're seeing a broadening of devices being adopted for SLT testing, which is providing a tailwind, which is enabling a larger growth in that segment of the storage business this year relative to the HDD business.
So the HDD business is still very strong; end-market demand, very strong. But the broadening of the SLT -- or sorry, the ASICs being tested under SLT is increasing, which is really good news. So it's growing a little faster than the HDD shipments from a storage perspective."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of Timothy Arcuri with UBS.",12,"Your next question comes from the line of Timothy Arcuri with UBS."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I had a question about your commentary, Mark, about your SOC share for the year and sort of what it implies for SOC in Q4, and more broadly, what it implies for total company revenue in Q4. So you've sort of given us all the different pieces. You guided w",164,"I had a question about your commentary, Mark, about your SOC share for the year and sort of what it implies for SOC in Q4, and more broadly, what it implies for total company revenue in Q4. So you've sort of given us all the different pieces. You guided wireless for the year, you guided systems for the year and you gave us the pieces on the Test businesses.
So if I just look at what that implies for SOC in Q4, I mean you're going to do about $575 million roughly for SOC in Q3. That's not a big mystery. But the Q4 number implies it goes down to like $425 million, somewhere in the low 4s. That will be down year-over-year. So I guess my first question is like why would that be given that you have all this visibility? And obviously, you're quite bullish about the market. So why would Q4 be down so much? That's my first question in SOC."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I don't know if it will be down so much or not. It's a portfolio of businesses, and all of those numbers have a margin of plus or minus, let's say, 1% around them. So that creates a large Monte Carlo simulation. And if you go right down the middle, I",349,"Yes. I don't know if it will be down so much or not. It's a portfolio of businesses, and all of those numbers have a margin of plus or minus, let's say, 1% around them. So that creates a large Monte Carlo simulation. And if you go right down the middle, I think you probably -- I'm sure you did the math right, that's probably what you come up with. 
But that's typical, as I said earlier, of where we stand at this point in the year looking into Q4 as in past years where it's come in higher. There's a significant unknown around what we'll book between now and through October that can drive Q4 shipments. And while we have backlog that extends in some product lines, as Sanjay mentioned, all the way through the end of the year, there's others that's more of a turns business. 
And we've positioned ourselves to be very responsive on the SOC front, in general, to capitalize on these sort of short demand request to come from our customers. That's why we've in the past been enabled to, in the quarter, exceed our guidance and even in the fourth quarter and prior years exceed what we thought when we were talking back then in July. 
So it could very well turn out that the demand that we've seen in the last couple of years in Q4 yet materializes again and we end up, as C.J. was hinting at, having a second half larger than first. It's just that at this point in the year, given what customers are talking about, we just don't see that as the most likely outcome. 
And it's episodic, too. What happens in Q4, a lot of it happens, in the past couple of years, in the December quarter, preparing for product launches that occur in February time frame, new phones and things like that. And so -- and again, with a rash of phone introductions in February, although we don't see it now, we could see a demand for SOC testers to support that driving December shipments."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Yes. No, it's -- I mean the total company revenue is sort of implied to be below what people are expecting for Q4, so that's kind of why I was asking. So anyway, on your revised TAM for Semi Test, so can you just update us on the segment? So I think bef",105,"Yes. No, it's -- I mean the total company revenue is sort of implied to be below what people are expecting for Q4, so that's kind of why I was asking. 
So anyway, on your revised TAM for Semi Test, so can you just update us on the segment? So I think before, you were thinking compute would be $1 billion, mobility would be $1.6 billion. Auto, you just gave that number, is like $500 million. And industrial, I think before, you were talking about $500 million. So is the revision mostly in the compute side, can you sort of update us on those numbers?"
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. The numbers for compute are about the same. Mobility is probably up a couple of hundred million. Auto is up probably $50 million and industrial up about $50 million.",30,"Yes. The numbers for compute are about the same. Mobility is probably up a couple of hundred million. Auto is up probably $50 million and industrial up about $50 million."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of Krish Sankar with Cowen.",12,"Your next question comes from the line of Krish Sankar with Cowen."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","And Mark, thanks for the color earlier on the ARM test opportunity. I just want to ask the question in a different way. When do you think the non-x86 compute TAM or maybe the total test compute TAM be similar or bigger than the mobility test market? And t",53,"And Mark, thanks for the color earlier on the ARM test opportunity. I just want to ask the question in a different way. When do you think the non-x86 compute TAM or maybe the total test compute TAM be similar or bigger than the mobility test market? And then I had a follow-up."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Bigger than the mobility test. So your question is when will the ARM compute test TAM be bigger than the ARM mobility test TAM?",24,"Bigger than the mobility test. So your question is when will the ARM compute test TAM be bigger than the ARM mobility test TAM?"
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Yes, mobility test TAM is about $1.6 billion or $1.7 billion, and you said compute is about $1 billion. When do you think the total compute TAM or maybe just the non-x86 compute TAM get to be bigger than mobility?",40,"Yes, mobility test TAM is about $1.6 billion or $1.7 billion, and you said compute is about $1 billion. When do you think the total compute TAM or maybe just the non-x86 compute TAM get to be bigger than mobility?"
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","I don't think it's going to be in the next 4 or 5 years. I think much of what's being developed in the ARM space by the hyperscalers will more likely fall into the category of mobility. So I don't see compute growing beyond mobility in the next 4 or 5 yea",53,"I don't think it's going to be in the next 4 or 5 years. I think much of what's being developed in the ARM space by the hyperscalers will more likely fall into the category of mobility. So I don't see compute growing beyond mobility in the next 4 or 5 years."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Got it. And then, Mark, on the auto test market, you said it's over $500 million. I'm guessing that includes auto microcontroller, linear, et cetera. If that is the case, is there any way of giving some more color within that? Or you think it's to",52,"Got it. Got it. And then, Mark, on the auto test market, you said it's over $500 million. I'm guessing that includes auto microcontroller, linear, et cetera. If that is the case, is there any way of giving some more color within that? Or you think it's too hard to segment it?"
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes, it does include microcontrollers. And I would say that auto is outstripped -- most of the growth is auto more than microcontrollers. Microcontrollers is growing too, but it's mostly auto. Auto -- and of course, there's microcontrollers in auto. So wh",61,"Yes, it does include microcontrollers. And I would say that auto is outstripped -- most of the growth is auto more than microcontrollers. Microcontrollers is growing too, but it's mostly auto. Auto -- and of course, there's microcontrollers in auto. So when I say auto, I mean microcontrollers for auto versus microcontrollers, let's say, for white goods and things like that."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your final question comes from the line of Joe Moore with Morgan Stanley.",13,"Your final question comes from the line of Joe Moore with Morgan Stanley."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I wanted to ask about the millimeter wave commentary. It seemed like the expectation was primarily one customer in one region. So when you say that was kind of short of your expectations, what are you referring to there?",39,"I wanted to ask about the millimeter wave commentary. It seemed like the expectation was primarily one customer in one region. So when you say that was kind of short of your expectations, what are you referring to there?"
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","So it's not one customer, one region. Millimeter wave last year for us grew significantly. We probably had 90% share of the early buying per millimeter wave test in 2020. And I would say that was spread out across 6 or 7 customers. Anybody who's making a",91,"So it's not one customer, one region. Millimeter wave last year for us grew significantly. We probably had 90% share of the early buying per millimeter wave test in 2020. And I would say that was spread out across 6 or 7 customers. Anybody who's making a chipset related to millimeter wave was pretty much using a Teradyne tester in 2020. The deployment of millimeter wave by the telecommunication companies has ground to a halt. And that has proportionately ground to a halt the need for incremental test in 2021."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Okay, folks, thanks so much for joining us today. That concludes the call. We apologize for the audio difficulties at the front end of it. We look forward to talking to you in the days and weeks ahead. And those in the queue, I'll get back with you direct",52,"Okay, folks, thanks so much for joining us today. That concludes the call. We apologize for the audio difficulties at the front end of it. We look forward to talking to you in the days and weeks ahead. And those in the queue, I'll get back with you directly here. Thank you."
94728,1674258151,2361745,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Ladies and gentlemen, this concludes today's conference. Thank you for your participation, and have a wonderful day. You may all disconnect.",21,"Ladies and gentlemen, this concludes today's conference. Thank you for your participation, and have a wonderful day. You may all disconnect."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Good morning, ladies and gentlemen, and welcome to the Q2 2021 Teradyne Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is not -- this conference call will resume -- I would now like to turn the conference over to you",47,"Good morning, ladies and gentlemen, and welcome to the Q2 2021 Teradyne Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is not -- this conference call will resume -- I would now like to turn the conference over to your host, Mr. Andy Blanchard."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Phyllis. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined this morning by our CEO, Mark Jagiela; and our CFO, Sanjay Mehta.Following our opening remarks, we'll provide details of ou",311,"Thank you, Phyllis. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined this morning by our CEO, Mark Jagiela; and our CFO, Sanjay Mehta.
Following our opening remarks, we'll provide details of our performance for 2021's second quarter along with our outlook for the third quarter of 2021. The press release containing our second quarter results was issued last [ evening ]. [ We're providing slides ] on the Investor page of the website that may be helpful to you when following the discussion. Replays of this call will be available via the same page after the call ends. 
Matters that we discuss today will include forward-looking statements that involve risk factors that could cause Teradyne's [ results ] to differ materially from management's current expectations. We encourage you to review the safe harbor statement contained in the earnings release as well as our most recent SEC filings. Additionally, those forward-looking statements are made as of today, and we take no obligation to update them as a result of developments occurring after this call. 
During today's call, we'll make reference to non-GAAP [ financial ] measures. We've posted additional information concerning those non-GAAP financial measures, including reconciliation to the most directly comparable GAAP financial measures and were available on the [ Investor page ] of our website. 
Looking ahead between now and our next earnings call, Teradyne expects to participate in technology or industrial-focused investor conferences hosted by KeyBanc, Rosenblatt Securities, Deutsche Bank and Citi. 
Now let's get on with the agenda. First, Mark will comment on our recent results and the market conditions as we enter the new quarter. Sanjay will then offer more details on our quarterly results along with our guidance for the third quarter. We'll then answer your questions, and this call is scheduled for [ 1 hour ].
Mark?"
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Good morning, everyone, and thanks for joining us. Today, I'll summarize our results for the second quarter and first half of 2021, update on current conditions in both Test and Industrial Automation, and comment on our view for the second half of the yea",1346,"Good morning, everyone, and thanks for joining us. Today, I'll summarize our results for the second quarter and first half of 2021, update on current conditions in both Test and Industrial Automation, and comment on our view for the second half of the year. Sanjay will then provide the financial details on the quarter and our guidance for Q3. 
The strong demand we saw in Q1 accelerated in Q2 as both our Test and Industrial Automation groups grew substantially in the quarter. The long-term demand drivers we've discussed in the past continue to power demand for our products. In Test, it's device complexity and unit growth; in Automation, it's labor scarcity, the need for resiliency and productivity improvement. 
Opening further, performance at the company level from 2016 through 2020 saw our sales and non-GAAP EPS grow at a compounded rate of 16% and 32%, respectively. For the first half of this year, sales are running ahead of that rate at 21%, and non-GAAP earnings per share grew at 29% compared with last year. This demonstrates both the [ vitality ] of the markets we serve and the efficiency of our operating model. 
Significantly, in Q2, we saw Industrial Automation demand recover in all major regions, but particularly in North America. As a result, our production and [ operating teams ] operated at a high pace in Q2, and that pace is [ increasing ] in Q3. For the year, our IA business is on track to grow about 30% from 2019 and about 40% from 2020. 
Looking closely at the segment level. In Semi Test, SOC shipments grew 29% in Q2 from Q2 of 2020 with particular strength in both the compute and mobility end markets. For the first half, SOC sales grew 19%. For the first time in several years, smartphone unit shipments are helping growth in the mobility [ segment ], where as recent years have mostly relied on complexity growth. 
[ IA ] and compute are the 2 largest subsegments in SOC. Automotive, analog and industrial demand continues to be strong. The auto-related semi test market is expected to exceed $500 million this year, the highest level since 2017. This is despite the fact that automobile unit production will be about [indiscernible] lower in 2017 -- lower than 2017. A portion of this strength is test equipment. We're also seeing the impact of increased semi content and complexity per automobile, driving the test market. 
Our memory test shipments also grew in Q2 from Q2 of 2020, up 9%, led by flash tester demand. For the 6-month period, overall shipments were up 18% from last year on solid demand for both flash wafer and [ flash ] systems. This reflects significant growth in smartphone demand, the build-out of new memory capacity in China and the growth of SSD demand.
Looking at the full year, we are again revising up the SOC market for 2021 to now be in the range of $4.3 billion to $4.7 billion with increasing strength in the x86 GPU and display driver segments. Recall that we have lower customer exposure in those markets with much of this incremental growth going to our competitors. So we'll likely see our SOC share around 48% for the year. 
In memory, at the macro level, our market estimates are unchanged with the test market this year expected to be about $1 billion and our share to be at about the 40% level. I will note that the expected ramp of DDR5 for server applications and the broader adoption of LPDDR5 is pushing out into 2022. 
Shifting to our System Test group, sales were up 26% in the first half compared with 2020, with strong Storage Test demand and a recovery in our Production Board Test unit driving the growth. For the full year, we see System Test group -- the System Test group grow in the 10% to 20% range. 
At LitePoint, sales in Q2 were up 12% over 2Q 2020. While 5G millimeter wave demand is lower than expected, the environment in Wireless Test is improving as we move through the year due to the continued WiFi 6 growth and early WiFi 7 investments. In addition, ultra-wideband adoption is increasing, adding a new growth vector for LitePoint. For the full year, LitePoint will likely grow in the 10% range. 
Moving on to Industrial Automation. The combination of expanding demand across our major markets and the increase in the range of tests served by our Universal Robots and MiR units drove group sales up 57% in Q2 last year [ to 45% ] in the first half. Compared to pre-pandemic 2019, first half sales are up 22%. Supply chain issues have constrained growth a little bit with lead times pushing out about 1 week. 
The demand environment for IA has recovered in most regions from last year's slowdown. America was the fastest-growing major region in Q2 with sales up over 90% from last year. Although we did see a [indiscernible] some countries in Asia where COVID has spiked in recent months, the second half of the year outlook is quite strong in all our major regions. 
Our long-term growth strategy in IA continues unchanged, and we expect long-term annual growth in the 20% to 35% range. This year, we will likely have a growth of about 40% from 2020, and we will continue to invest to enable this growth target of [ 15% ] gross margins, [ get ] a 5% to 15% operating margin during these high-growth years.
From an investment perspective, we are expanding our engineering programs to shorten deployment times, increase the served market and improve the customer support experience. We are also growing our capacity to support distributors, integrators and UR plus and MiRGo apps development partners as [ they ] engage customers. We are also expanding our sales to OEMs that integrate our robots into their products. 
Last quarter, we noted the expanding range of applications for UR robots into the high-voltage line application with hundreds of [indiscernible] being deployed. Today, I'd like to highlight the success of UR+ plug-and-play applications for Industrial [ Automation ].There is a long-standing and chronic shortage of qualified welders worldwide with an estimated 100,000 unfilled welding jobs in the U.S. alone. While automated solutions exist for large applications like auto manufacturing, customers with lower volume and higher mix products are not well served by traditional automation. 
The integration of a force torque sensor into e-Series cobots enabled the precision needed for this application. And with UR+ [ integrating ] with our partners, we began serving this market about 3 years ago. During this time, welding applications have grown to be about 6% of our global [ sales ]and are on  [indiscernible] 1,000 cobots sold in 2021, more than tripling our 2020 pace. 
As we continue to extend the performance of our UR platform, we expect these high applications had growth vectors to traditional industrial applications. We have similar market-expanding initiatives in play on our MiR platform, but I'll save those details for a future call. 
Summing it all up, the first half of the year has been a strong sales, strong gross margins and earnings growth  [indiscernible]. Longer term, the markets we serve are showing [ increasing demand ] in a future global economy. The importance, pervasiveness and enabling capability of electronics in every [ aspect ] of our lives and industry is driving more fab investment, more complexity and more test. Likewise, the broadening application and fast [ ROI of ] [ collaborative ] robots in a world with labor shortages and productivity challenges is another growth trend. 
Strategically, we positioned ourselves in line with  [indiscernible]  and plan to continue to make [ System ] Test and IA as our full potential while driving world-class [ returns ]. While the rate of change in our markets is accelerating, we are well positioned to thrive as a company and to bring additional value to customers and shareholders. 
I'll now turn things over to Sanjay [ to provide ] additional color on the financials."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Mark. Good morning, everyone. Today, I'll [ provide details ] on our Q2 results, comment on current business conditions and describe [ our outlook for ] Q3. Now to Q2. Second quarter sales were $1.086 billion with non-GAAP EPS of $1.91, up 29",1146,"Thank you, Mark. Good morning, everyone. Today, I'll [ provide details ] on our Q2 results, comment on current business conditions and describe [ our outlook for ] Q3. 
Now to Q2. Second quarter sales were $1.086 billion with non-GAAP EPS of $1.91, up 29% and 44%, respectively, from Q2 '20. Non-GAAP gross margins were 59.6%, and our non-GAAP operating expenses were $250 million, but $5 million below the high guidance due to the timing of some nonrecurring engineering expenses.
Non-GAAP operating profit rate was 36.5%. [ Gross margin ] in the quarter was [ 59.6% ] compared with our plan of 58%. The increase was tied to favorable product mix in the quarter versus planned. 
For context, Q2 2020 gross margin was approximately [ 56.2% ]. In April [indiscernible], we noted that this level of gross margin would continue in the near term, driven by the introduction of several key test systems in early 2020, which would [ take several ] quarters to come down the cost curve. These new product introductions, coupled with heightened costs driven by COVID shortages, were impacting our gross margins in 2020. One year later, we have now most of these test solutions at volume, and they have come down the cost curve as expected. 
The result contributed to higher margins in the second quarter, which we expect will continue in the second half of the year. A component of gross margin improvement over 2020 is higher revenue yielding of leverage in the gross margin line. We had one 10% customer in the quarter [indiscernible] excluding discrete items of [ 14.5% ]on both GAAP and non-GAAP basis. 
Looking at the results from a business unit perspective. [ Semi Test ] revenue of $834 million was up 27% from Q2 2020. SOC revenue was $742 million, up 29%, driven by strength in compute, mobility, industrial and automotive. Memory revenue was $92 million, up 9% from prior year, driven by strength in flash test and flash wafer sort segments. 
System Test group had revenue of $105 million, which was up 46% year-over-year. This is driven by $58 million in Storage Test sales, including both HDD and SLT solutions; [ $27 million ] in Defense & Aerospace and Production Board Test. 
In Storage Test, HDD and SLT demand remains robust as drive densities continue to increase and the number of devices adopting [ SLT spokes ]. At LitePoint, revenue of $55 million was 12% -- was up 12% from prior year due to continued strength at [ WiFi ], increases in [indiscernible] and ultra-wide band test market segments. 
Now to Industrial Automation. As we did in April, I'll provide revenue metrics comparing Q2 '21 results with both Q2 '20 and Q2 '19, so you'll have the full context given the impact of a contracting market tied to COVID last year. Industrial Automation revenue of $92 million was up 57% year-over-year and 23% over Q2 '19. Revenue expanded in all regions in Q2 [ over ] last year, with North America delivering the highest absolute revenue growth. U.S. and Europe represented about 77% of IA revenue in the quarter, with China contributing about 14%. 
UR sales were $76 million in Q2, up 75% year-over-year and [ 80% ] over 2019. MiR sales were $16 million, up 41% from Q2 '20 and 51% from Q2 '19. Recall, MiR had an  [indiscernible]  on Q2 '20 as its robots were widely deployed in automated COVID disinfectant applications.
The longer-term outlook in our IA business continues to brighten. We expect continued labor shortages to drive new applications for both our fixed and mobile robots. Mark highlighted the shortage of welders and how that has opened up a new market for our UR cobots, but that is just one of many job categories with acute short-term and long-term labor shortages. 
Our strategy is to provide an open platform that creative developers can leverage to solve industry-specific labor shortages. The numerous filling ultraviolet disinfecting solutions built on our [ platform ] last year is a shining example of the agility of our partner networks to solve problems. 
We're investing in engineering, support and marketing resources to make our MiR platforms even easier to build upon, which will enable the continued proliferation of high-value automated solutions to solve challenging problems for an expanding range of customers. Significantly, these development partners and customers provide great feedback on our R&D development plans. 
From a financial perspective, we expect IA will operate around the low end of our target profit range of 5% and 15%. We do expect IA to operate above the Rule of 40 in 2021, that is the sum of operating profit and revenue growth of over [ 40% ]. Longer term, when growth moderates, we expect the IA group to have a similar operating profit rate as our Test portfolio. 
Shifting to supply. We continue to manage through numerous supply constraints along with increased material, manufacturing and logistics costs in both our Test and IA businesses. For some products in both Test and IA, the supply constraints have extended our [ lead times ], and we're working closely with customers to minimize the impact of these delays. 
But we've been able to offset these higher costs through operating leverage with higher volumes and other cost-saving measures, so the cost increase impact on the P&L has not been material. We do expect to be dealing with supply line-related issues in Q3 and Q4 this year, which are reflected in our forecasts. 
Shifting to the balance sheet and cash flow. Our cash and marketable securities at the end of the quarter totaled $1.42 billion, $172 million of free cash flow in the quarter, $151 million and $17 million on buybacks and dividends, respectively. Year-to-date, we've repurchased 1.6 million shares for $197 million at an average [ price ] of $125.69 per share.
Regarding our convertible debt. $15.6 million was paid in Q2 to convertible bondholders ahead of maturity. By the end of August 2021, bondholders will have already converted a total of $302 million, leaving a face value of $58 million outstanding. 
Looking at our operating model, I'd like to make 3 quick points. First, our performance over time. From 10 years ago, our gross margin percent has expanded from the low to [ mid-50s ] to nearly 60% [ today ] and our operating margin from the teens to low 20s to greater than 30% today. 
Second, our flexible business model shifts fixed cost to variable costs where appropriate through [ contract ] or outsourced manufacturing, variable compensation and other [ means ], which enables resiliency on the downside and is creative (sic) [ accretive ] when business is strong. 
Third, the operating leverage in the model is evident in our Q2 results. Our Test businesses are dropping through over $0.50 per revenue dollar through to the profit line in 2021..."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","[Technical Difficulty]",2,"[Technical Difficulty]"
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Thank you.",2,"Thank you."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Ladies and gentlemen, we're going to have a quick transition.",10,"Ladies and gentlemen, we're going to have a quick transition."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","I'll go back -- okay, it's Sanjay again. I'll go back to looking at our operating model. I'd like to make 3 quick points. First, our performance over time from 10 years ago, our gross margin percent has expanded from low to mid-50s to nearly 60% today and",526,"I'll go back -- okay, it's Sanjay again. I'll go back to looking at our operating model. I'd like to make 3 quick points. First, our performance over time from 10 years ago, our gross margin percent has expanded from low to mid-50s to nearly 60% today and our operating margin from the teens to low 20s to greater than 30% today. 
Second, our flexible business model shifts fixed cost to variable costs, where appropriate, through contract or outsourced manufacturing, variable compensation and other means, which enables resiliency on the downside and is accretive when business is strong. 
Third, the operating leverage in the model is evident in our Q2 results. Our Test businesses are dropping through over $0.50 per revenue dollar through to the profit line in 2021, even while we continue to increase our R&D support -- and support investments to strengthen our Test business. This enables Teradyne to continue to invest in both our Test and IA portfolios. For IA, we are building a deeper product ecosystem and distribution differentiation while achieving the Rule of 40 in our IA portfolio. 
Now to our outlook for Q3. As Mark noted, the demand environment across the business remains strong. Our guidance assumes no significant changes, positive or negative, in the availability of materials and also assumes that we won't see additional pandemic-related issues. With that said, sales in Q3 are expected to be between $880 million and $960 million with non-GAAP EPS in the range of $1.29 to $1.55 and 176 million diluted shares. 
Third quarter guidance excludes the amortization of acquired intangibles and noncash imputed interest on convertible debt. Third quarter gross margins are estimated to be between 59% and 60%. OpEx is expected to run at 27% to 29% of third quarter sales. The non-GAAP operating profit at the midpoint of our third quarter guidance is 32%. 
Regarding OpEx for the full year. While we spent a bit lower than planned in Q2, we expect the full year OpEx will be about in line with the plan we described in April. We expect total operating expenses for 2021 to be about $1 billion or up approximately 19% from 2020. We recognize that we're on track to meet our 2024 earnings model this year. We'll update the model on a regular cadence in January after our detailed midterm plan income is complete in Q4 this year. 
In summary, our businesses are performing extremely well, delivering strong revenue and earnings growth while funding the investments that will drive future success. Our first half sales grew 21%, and non-GAAP EPS grew 29% above the first half of 2020, which itself was a record. We expect to deliver the highest Q3 sales and profits in history. 
Our employees and production partners around the world have delivered a record number of systems under challenging conditions. Our support teams have done whatever was needed to make our customers successful. And our engineering teams have kept the new product pipeline moving on schedule. It's been an impressive display of teamwork, and I'm proud to be part of this powerful Teradyne team. 
With that, I'll turn things back to Andrew."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Sanjay. And everybody, thanks for dealing with our small technical issue there. Phyllis, we would now like to take some questions. [Operator Instructions]",24,"Thanks, Sanjay. And everybody, thanks for dealing with our small technical issue there. Phyllis, we would now like to take some questions. [Operator Instructions]"
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","[Operator Instructions] Your first question comes from the line of Brian Chin with Stifel.",14,"[Operator Instructions] Your first question comes from the line of Brian Chin with Stifel."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","A couple of questions here. Maybe just to kick things off. I'm just curious to what degree, if any, are the extended lead times in ATE in this sort of the current strong semiconductor environment impacting your shipment outlook or pattern in the second ha",75,"A couple of questions here. Maybe just to kick things off. I'm just curious to what degree, if any, are the extended lead times in ATE in this sort of the current strong semiconductor environment impacting your shipment outlook or pattern in the second half? Obviously, Teradyne no longer discloses bookings, but your competitor appears to be building backlog into the December quarter. So I was wondering if you have better-than-typical backlog visibility beyond September."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So lead times have definitely been moving out. I'd say auto and industrial demand is still outstripping supply. But our lead times have pushed out, obviously, based on the very, very tight supply chain environment we're dealing with. And so what used",101,"Yes. So lead times have definitely been moving out. I'd say auto and industrial demand is still outstripping supply. But our lead times have pushed out, obviously, based on the very, very tight supply chain environment we're dealing with. And so what used to be, let's say, within a quarter has pushed out to 5, 8 weeks incremental to where we were in the past to be, in some cases, in the 20s in weeks of lead time. So with that, we have been seeing, I guess, improved bookings from our customers, and we're working with them to manage through it."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And then maybe for Mark. I think you touched on how, at least in the smartphone market, units are kind of a bigger tailwind this year, which hasn't always been the case in recent years. But I think in the 2022, what do you think -- to what degree",72,"Got it. And then maybe for Mark. I think you touched on how, at least in the smartphone market, units are kind of a bigger tailwind this year, which hasn't always been the case in recent years. But I think in the 2022, what do you think -- to what degree could increased packaging complexity across foundries and maybe some IDMs be a more meaningful driver of incremental test intensity next year?"
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes, we -- that's a good question. We bundle that into the complexity side of life. And there's already been advanced packaging technologies deployed for several years now in phones, but it's increasing. So that trend of multichip, multi-die packaging inc",94,"Yes, we -- that's a good question. We bundle that into the complexity side of life. And there's already been advanced packaging technologies deployed for several years now in phones, but it's increasing. So that trend of multichip, multi-die packaging incrementally adds test time above and beyond what you would get if you were putting all of that silicon on a single integrated die. And there's not a good rule of thumb of how much of an adder it is, but it is a trend that's going to continue to grow and drive tests."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of Atif Malik with Citi.",12,"Your next question comes from the line of Atif Malik with Citi."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I have a similar question on the mobility side end market. It sounds like your mobility outlook has improved for the year versus 90 days ago despite millimeter wave weakness. You talked about units helping. Can you talk about the confidence in test intens",82,"I have a similar question on the mobility side end market. It sounds like your mobility outlook has improved for the year versus 90 days ago despite millimeter wave weakness. You talked about units helping. Can you talk about the confidence in test intensity staying elevated for both mobility and compute into next year? And if you can also highlight the steps you're taking to improve your market share in the areas that you're not strong, like x86 GPU and display drivers."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So I think the complexity trends looking even into the next year are all very strong and positive. In the case of mobility, the newer lithographies that are coming online are being widely adopted by the manufacturers of silicon for phones, which port",313,"Yes. So I think the complexity trends looking even into the next year are all very strong and positive. In the case of mobility, the newer lithographies that are coming online are being widely adopted by the manufacturers of silicon for phones, which portends more transistors, which portends more test time. So that, looking into next year, all looks positive. And we get, at this point in the year, early glimpses of what the silicon for next year might actually look like. 
The -- on the compute side, similarly, we not only have the trend of lower lithography nodes, but the new interface standards related to LPDDR5 and DDR5, as I mentioned in my remarks, the early adoption of that has been pushed out a little bit as the processors that go with it have been delayed a bit. But all of the complexity required to run at those higher bandwidths is coming in 2022. So those are 2 positive things I look at that gives me confidence that this driver of complexity growth is definitely going to be strong next year. 
In terms of share, what we said before is that penetrating the traditional x86 GPU stalwarts is going to be a long-term endeavor for us that's going to hinge on some kind of technological discontinuity like that shift to DDR5 or like a shift to PAM4 interfaces to crack into. So that one is episodic and will play out over, let's say, 3 to 5 years. 
On the other front is -- are the emerging hyperscalers and new people coming into the market of creating complex silicon. These are automobile manufacturers, hyperscalers that we've talked about in the past, the Googles, the Facebooks, the Microsofts, the Amazons, that's where we're focused on getting a position to grow with them as they launch their products into the market in the shorter term."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Great, very helpful. And Sanjay, for you, the largest U.S. phone maker and your biggest indirect customer talked about supply constraints impacting smartphone sales in the September quarter yesterday. Have the materials and parts tightness gone worse over",45,"Great, very helpful. And Sanjay, for you, the largest U.S. phone maker and your biggest indirect customer talked about supply constraints impacting smartphone sales in the September quarter yesterday. Have the materials and parts tightness gone worse over the last 90 days for your business?"
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Well, first of all, I won't comment on any particular customer, but I will speak in general about the environment. Last year, we were really working through demand increases, but we had fairly good, robust inventory strategies, and we are working through",165,"Well, first of all, I won't comment on any particular customer, but I will speak in general about the environment. Last year, we were really working through demand increases, but we had fairly good, robust inventory strategies, and we are working through the impact of COVID. You have thousands of components that go into these testers, and we did a lot of resiliency improvements there. You fast forward to today's environment, and the demand has really kept accelerating. And the environment is tighter, I would say, today. And frankly, we don't see it letting up until the second half of 2022. 
So I think as the semiconductor industry goes through continued growth, you're seeing supply chains really getting tested. And then with the increase in the infection rates of COVID, especially, I'd say, in Southeast Asia, we're working through and managing the best we can. But I believe the net summation is it's a tighter industry now than it was, say, 3, 6 months ago."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of Mehdi Hosseini with SIG.",12,"Your next question comes from the line of Mehdi Hosseini with SIG."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Two questions, one on ARM-based ASIC design. I'm trying to get a sense of how you see the TAM. You can either elaborate as a mix of SOC tests or perhaps you can tell us how is the test time for an ARM-based ASIC chip compared to like an app process or may",89,"Two questions, one on ARM-based ASIC design. I'm trying to get a sense of how you see the TAM. You can either elaborate as a mix of SOC tests or perhaps you can tell us how is the test time for an ARM-based ASIC chip compared to like an app process or maybe that way we could give a sense of how demand looks like. So either qualitatively or quantitatively, you can -- if you can elaborate on ARM-based SOC test will be great. And I have a follow-up."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So I guess the first thing I'd say is that a ARM-based high-end map processor, which is what's in most of our phones today, driving most of our phones, has a transistor count that's equivalent to any laptop, x86 kind of product you might have in your",160,"Yes. So I guess the first thing I'd say is that a ARM-based high-end map processor, which is what's in most of our phones today, driving most of our phones, has a transistor count that's equivalent to any laptop, x86 kind of product you might have in your computer. And the test times comparatively between those 2 are not that different. It's kind of proportional to test count. 
The new ARM processors that are coming to market for compute applications, not smartphone applications, have perhaps anywhere from a 25% to 60% at or, on transistor count, above what's at the highest end of smartphones. And the test time associated with them, I would say, is proportionately longer at this point. And so I think it's, generally speaking, scaling with transistor count, and the transistor count on the ARM side is running a little bit at a faster clip than it is on the more traditional architecture side, if that helps."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Sure. So the follow-up has to do with ARM-based. Actually, I want to just dig in a little bit more. Would you, at some point, break this out so we could better understand how kind of ARM-based SOC tester is tracking or scaling versus the rest of the SOC m",70,"Sure. So the follow-up has to do with ARM-based. Actually, I want to just dig in a little bit more. Would you, at some point, break this out so we could better understand how kind of ARM-based SOC tester is tracking or scaling versus the rest of the SOC market? And number two, is there anything you can give us to better understand the competitive landscape for this specific application?"
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I guess I haven't thought about trying to find a way to break out ARM because most of what mobility is, is ARM; and then there's, let's say, compute applications for ARM; and then there's some processors that are almost dual-use, and they go into eit",223,"Yes. I guess I haven't thought about trying to find a way to break out ARM because most of what mobility is, is ARM; and then there's, let's say, compute applications for ARM; and then there's some processors that are almost dual-use, and they go into either application. So I think it's fair to say that any compute business that we have at Teradyne is ARM-based compute. And perhaps maybe in the future, we can look at some way to sort of characterize both the market and our associated revenue for that. But I don't have a good number for you now on that. 
And in terms of the applications coming to market, in the short term, we know about the phone applications, we know about some early adopters of ARM for compute. Those are all coming to market or are in the market now. The hyperscalers that we're working with are coming into market at various points next year with products that are quite interesting but highly speculative as to whether they'll latch in the market. And obviously, I'm not going to talk about those because they're pretty confidential. But we'll see what latches. If one of these applications can become a 100-plus million unit application, which most of these design teams are targeting, then that's a significant adder to the market."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of Vivek Arya with Bank of America.",14,"Your next question comes from the line of Vivek Arya with Bank of America."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I was curious, how is your kind of visibility for Q4 as you kind of stand today versus what it is usually? And if you could give us some color by end market in terms of what is in your assumption for Q3 and the second half, that would be very helpful.",52,"I was curious, how is your kind of visibility for Q4 as you kind of stand today versus what it is usually? And if you could give us some color by end market in terms of what is in your assumption for Q3 and the second half, that would be very helpful."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Sure. So Q4, if I look back at my last 2 years here, we've been surprised mainly on the positive side. And I'd say that given the tightness of supply and customers providing a little bit more in the way of backlog, it gives us a little bit more insight. H",216,"Sure. So Q4, if I look back at my last 2 years here, we've been surprised mainly on the positive side. And I'd say that given the tightness of supply and customers providing a little bit more in the way of backlog, it gives us a little bit more insight. However, obviously, in the near term, we have much stronger visibility in Q3 than in Q4. And so -- but we do have, I'd say, a little bit of incremental visibility. 
In color -- in your question in regards to color for Q3, we see continued strength in semiconductor. Obviously, the different components within Semi Test are going to be a little volatile, but we do see a trend down. It's still what we believe is very strong demand, but we see a trend down. And we see in our IA portfolio, really, a strength. Obviously, with the COVID impact in 2020, industrials are really coming back. I'll cite some PMIs in the 60s at the U.S. and Europe. And we really see that in our, as Mark noted, in our growth in the U.S. But we're seeing that growth in China as well as in Europe and the U.S. So continued expected growth in IA and then, from a test perspective, coming down a bit."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And then on the UR side, Mark, I'm curious, what are the top 3 applications you're serving today? And how do you expect these applications to evolve? You are maintaining a very strong growth rate in that business. And I'm curious, what is driving",116,"Got it. And then on the UR side, Mark, I'm curious, what are the top 3 applications you're serving today? And how do you expect these applications to evolve? You are maintaining a very strong growth rate in that business. And I'm curious, what is driving that. Is it more number of customers? Is it more applications within the same customer? So what's giving you the confidence you can maintain this very strong growth rate in the UR business? And is -- on the gross margin side, is it accretive? I know on the operating margin side, you've given a range. But I imagine on the gross margin side, it might be accretive to your business."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. It's interesting because there's no silver bullet as to what's driving the growth at UR. So for example, we're going to be up about 30% from revenue in 2019, 40% up from 2020. And in the script, I mentioned this application for welding, which is a br",326,"Yes. It's interesting because there's no silver bullet as to what's driving the growth at UR. So for example, we're going to be up about 30% from revenue in 2019, 40% up from 2020. And in the script, I mentioned this application for welding, which is a brand-new application that is now driving about 6% of our sales for the year. Last quarter, I talked about this service application for servicing high-voltage power lines that's also running at around that 6% of sales applications that was nonexistent -- essentially nonexistent 2 years ago. 
So already, we have 12% of our growth attributed to new applications in new markets with new customers that we didn't have 2 years ago. So it's a combination of expanding applications like those 2 examples as well as established markets growing that's driving this. And our top 3 applications tend to be the same. It's automotive supply chain, it's industrial machine tending and it's electronic assembly tend to be the ones that are at the top of the pack. But frankly, they are shrinking as a percentage of sales as these new applications come online. 
So what gives me confidence looking forward is that ecosystem of partners who are developing these application solutions on our platform, not our competitors, is just continuing to grow and prosper. And they're not all going to be as successful as high-voltage line tending or welding. But it only takes 10% of them to fuel the kind of growth numbers that we've been seeing. And the activity there is very strong, and the technology is maturing to the point that more and more applications can economically be served. 
And over the horizon, when you look at what AI can bring, there's a whole new set of, let's say, features that will enable yet another expansion of the market. It's what gives us the confidence to talk about these kind of decade-long growth rates of 25%, 30%, 35%."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of John Pitzer with Credit Suisse.",13,"Your next question comes from the line of John Pitzer with Credit Suisse."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, maybe another way to ask the calendar fourth quarter question is, over the last 3 years, the business has run in such a way that second half has been greater than the first half from a top line perspective, which has broken kind of a trend, where if",99,"Mark, maybe another way to ask the calendar fourth quarter question is, over the last 3 years, the business has run in such a way that second half has been greater than the first half from a top line perspective, which has broken kind of a trend, where if you go back the prior 7 years, it was first half stronger than second half. Did you have any commentary on sort of how you think the second half over the first half looked this year just given how strong the market environment is and how tight test capacity is?"
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","You're right, perfect student of the history. And we have been, as Sanjay said, always a bit surprised in the recent years on how strong the fourth quarter has come in and driven second half to be a bit higher than first. So if you asked us today, we'd sa",163,"You're right, perfect student of the history. And we have been, as Sanjay said, always a bit surprised in the recent years on how strong the fourth quarter has come in and driven second half to be a bit higher than first. So if you asked us today, we'd say first half is a little bit stronger than second, but that's no different than kind of what we thought for the last couple of years, too. And that just is a testament to the visibility in Q4 as -- the lack of visibility in Q4.
As Sanjay said, though, it's a little bit more visibility now than before because lead times are a little longer. But all the upside that could come in is the, obviously, the piece that's not visible. So we feel probably better now about Q4 than we felt in any prior 2 or 3 years, but it's sort of what might happen between now and October that's invisible."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","That's helpful. And then, Mark, as my follow-on, I apologize, the audio quality was a little poor during your prepared comments. I wanted to go back to some of the commentary you made around DDR5 adoption. I think the point you were making is perhaps it's",88,"That's helpful. And then, Mark, as my follow-on, I apologize, the audio quality was a little poor during your prepared comments. I wanted to go back to some of the commentary you made around DDR5 adoption. I think the point you were making is perhaps it's a little bit slower than you thought. Is that correct? And I guess, more importantly, can you give us an update of how you think you're positioned for DDR5 when it does start to ramp relative to share in memory test?"
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Yes, sorry about the audio quality. But in fact, yes, DDR5 for server applications has pushed out a bit as the server chips themselves have been delayed. We've seen the impact of that in the demand for DDR5 testers. And similar things happened with L",115,"Yes. Yes, sorry about the audio quality. But in fact, yes, DDR5 for server applications has pushed out a bit as the server chips themselves have been delayed. We've seen the impact of that in the demand for DDR5 testers. And similar things happened with LPDDR5 going into mobility applications. So despite all that, the share position for Teradyne, we think, is unchanged from our earlier estimates at around 40% of the market, and it's going to be a tailwind next year when the DDR5  and LPDDR5 ramp as was originally thought would happen toward the end of this year. So we're well positioned there, and I think that's a tailwind for us next year."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of C.J. Muse with Evercore.",13,"Your next question comes from the line of C.J. Muse with Evercore."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I guess first question, Mark, you've taken SOC test market size higher again. And I guess, curious, if we were to hit the high end of the range, what would be the driver there? And would your market share still be 48%? Or could you see greater contributio",61,"I guess first question, Mark, you've taken SOC test market size higher again. And I guess, curious, if we were to hit the high end of the range, what would be the driver there? And would your market share still be 48%? Or could you see greater contribution from what's driving potentially the market to the higher end of the range?"
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Certainly, if the market goes up towards the high end of that range, our revenue would grow probably proportional to that. Would our share go much higher? I gave a number -- I threw in a number of roughly 48% at the midpoint of our market size guide.",156,"Yes. Certainly, if the market goes up towards the high end of that range, our revenue would grow probably proportional to that. Would our share go much higher? I gave a number -- I threw in a number of roughly 48% at the midpoint of our market size guide. I would expect our market share is probably going to stay around that number, plus or minus 0.5 point at this point in the year. 
But it's hard to sort of prognosticate too much about where the share comes from. And as you know, one customer's buying capacity can swing multiple points of share in any given year. And so one of our customers could come in and drive a demand that we don't see right now. We have the manufacturing capacity to serve it. And yes, I guess we could be up at 50% share if that happened. It's just a little opaque at the moment."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. That's helpful. And I guess a follow-on question to a few of the questions that you got earlier. You spoke to DDR5 now being pushed to a tailwind next year. You've spoken to high-performance compute, particularly the non-x86 world as a tailwind for",110,"Okay. That's helpful. And I guess a follow-on question to a few of the questions that you got earlier. You spoke to DDR5 now being pushed to a tailwind next year. You've spoken to high-performance compute, particularly the non-x86 world as a tailwind for you guys next year. I think the concern out there is that your one large customer could decline meaningfully and that would cause SOC for you guys to be down next year. So I guess, as you sit here today and you're setting up your supply for customers and lead times have extended, how are you thinking about the world into 2022 for SOC for Teradyne?"
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Very bullish because I think the concern -- let's see, I'm not going to speak too specifically around our customer. But what I would say is that the portfolio of devices that are being developed by our hyperscaler customers continues to expand. And that's",123,"Very bullish because I think the concern -- let's see, I'm not going to speak too specifically around our customer. But what I would say is that the portfolio of devices that are being developed by our hyperscaler customers continues to expand. And that's going to -- in addition to the complexity growth of the existing portfolio, you add more chips on top of that, it portends a growing market, a growing customer. So there's going to be ups and downs, but I think the cataclysmic or sort of a cliff concern, we're now a decade into this almost, so -- and it just hasn't happened. So the trend line, I think, is pretty clear, and I think that trend line will continue."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Our next question comes from the line of Toshiya Hari with Goldman Sachs.",13,"Our next question comes from the line of Toshiya Hari with Goldman Sachs."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I had 2 as well. Mark, I guess somewhat related to C.J.'s question. Just curious in terms of the auto SOC test market, I think in your prepared remarks, you mentioned that you expect the market to exceed $500 million this year and now that's the highest m",155,"I had 2 as well. Mark, I guess somewhat related to C.J.'s question. Just curious in terms of the auto SOC test market, I think in your prepared remarks, you mentioned that you expect the market to exceed $500 million this year and now that's the highest mark since 2017. How are you thinking about sustainability there into '22? Near-term demand is clearly very strong. And when we speak with your customers, they're all kind of complaining about extending lead times. So I guess the bias is to the upside, but curious how you're thinking about that market. 
And then as a follow-up, a question on Storage Test. It seems like both HDD and SLT are trending very nicely. I think the business was up more than 2x last year in 2020. Curious what you're thinking about the business full year 2021. If you can differentiate between SLT and HDD, that would be super helpful."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","It's Sanjay here. So I'll take a cut at them. So from an auto market perspective, it's true this year, we've seen tremendous growth and just about $500 million or plus or minus a bit from a market size, and yes, as far as we've seen even back to 2017. And",343,"It's Sanjay here. So I'll take a cut at them. So from an auto market perspective, it's true this year, we've seen tremendous growth and just about $500 million or plus or minus a bit from a market size, and yes, as far as we've seen even back to 2017. And fundamentally, I think in the last call, there was commentary around the auto industry, for years, has lived on a just-in-time manufacturing. And fundamentally, in back half of 2019, sales weren't so high. And coming into '20, obviously, demand has really picked up. And so you're seeing just a significant replenishment of inventory back into the system. And we're seeing that continue. We see, obviously, the lead times. And currently, the demand is outstripping our supply. And we see that good visibility until the end of 2021. 
2022 will be interesting because we'll have to take a look at what are the inventory levels and what is the market demand in 2022 in first half. And so it's a little bit opaque, I'd say, in 2022, but it will depend on what I believe to be the inventory level and, obviously, the end market demand.
And from a storage perspective, a little bit of color around 2020 and 2021. If I go back to 2020, HDD and our SLT business was kind of split relatively even. One was a little bigger than the other. And from an HDD perspective, we've seen continued end-market demand fueling that business. But when we look into 2021 from an SLT perspective, we're seeing a broadening of devices being adopted for SLT testing, which is providing a tailwind, which is enabling a larger growth in that segment of the storage business this year relative to the HDD business.
So the HDD business is still very strong; end-market demand, very strong. But the broadening of the SLT -- or sorry, the ASICs being tested under SLT is increasing, which is really good news. So it's growing a little faster than the HDD shipments from a storage perspective."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of Timothy Arcuri with UBS.",12,"Your next question comes from the line of Timothy Arcuri with UBS."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I had a question about your commentary, Mark, about your SOC share for the year and sort of what it implies for SOC in Q4, and more broadly, what it implies for total company revenue in Q4. So you've sort of given us all the different pieces. You guided w",164,"I had a question about your commentary, Mark, about your SOC share for the year and sort of what it implies for SOC in Q4, and more broadly, what it implies for total company revenue in Q4. So you've sort of given us all the different pieces. You guided wireless for the year, you guided systems for the year and you gave us the pieces on the Test businesses.
So if I just look at what that implies for SOC in Q4, I mean you're going to do about $575 million roughly for SOC in Q3. That's not a big mystery. But the Q4 number implies it goes down to like $425 million, somewhere in the low 4s. That will be down year-over-year. So I guess my first question is like why would that be given that you have all this visibility? And obviously, you're quite bullish about the market. So why would Q4 be down so much? That's my first question in SOC."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I don't know if it will be down so much or not. It's a portfolio of businesses, and all of those numbers have a margin of plus or minus, let's say, 1% around them. So that creates a large Monte Carlo simulation. And if you go right down the middle, I",349,"Yes. I don't know if it will be down so much or not. It's a portfolio of businesses, and all of those numbers have a margin of plus or minus, let's say, 1% around them. So that creates a large Monte Carlo simulation. And if you go right down the middle, I think you probably -- I'm sure you did the math right, that's probably what you come up with. 
But that's typical, as I said earlier, of where we stand at this point in the year looking into Q4 as in past years where it's come in higher. There's a significant unknown around what we'll book between now and through October that can drive Q4 shipments. And while we have backlog that extends in some product lines, as Sanjay mentioned, all the way through the end of the year, there's others that's more of a turns business. 
And we've positioned ourselves to be very responsive on the SOC front, in general, to capitalize on these sort of short demand request to come from our customers. That's why we've in the past been enabled to, in the quarter, exceed our guidance and even in the fourth quarter and prior years exceed what we thought when we were talking back then in July. 
So it could very well turn out that the demand that we've seen in the last couple of years in Q4 yet materializes again and we end up, as C.J. was hinting at, having a second half larger than first. It's just that at this point in the year, given what customers are talking about, we just don't see that as the most likely outcome. 
And it's episodic, too. What happens in Q4, a lot of it happens, in the past couple of years, in the December quarter, preparing for product launches that occur in February time frame, new phones and things like that. And so -- and again, with a rash of phone introductions in February, although we don't see it now, we could see a demand for SOC testers to support that driving December shipments."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Yes. No, it's -- I mean the total company revenue is sort of implied to be below what people are expecting for Q4, so that's kind of why I was asking. So anyway, on your revised TAM for Semi Test, so can you just update us on the segment? So I think bef",105,"Yes. No, it's -- I mean the total company revenue is sort of implied to be below what people are expecting for Q4, so that's kind of why I was asking. 
So anyway, on your revised TAM for Semi Test, so can you just update us on the segment? So I think before, you were thinking compute would be $1 billion, mobility would be $1.6 billion. Auto, you just gave that number, is like $500 million. And industrial, I think before, you were talking about $500 million. So is the revision mostly in the compute side, can you sort of update us on those numbers?"
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes. The numbers for compute are about the same. Mobility is probably up a couple of hundred million. Auto is up probably $50 million and industrial up about $50 million.",30,"Yes. The numbers for compute are about the same. Mobility is probably up a couple of hundred million. Auto is up probably $50 million and industrial up about $50 million."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from the line of Krish Sankar with Cowen.",12,"Your next question comes from the line of Krish Sankar with Cowen."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","And Mark, thanks for the color earlier on the ARM test opportunity. I just want to ask the question in a different way. When do you think the non-x86 compute TAM or maybe the total test compute TAM be similar or bigger than the mobility test market? And t",53,"And Mark, thanks for the color earlier on the ARM test opportunity. I just want to ask the question in a different way. When do you think the non-x86 compute TAM or maybe the total test compute TAM be similar or bigger than the mobility test market? And then I had a follow-up."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Bigger than the mobility test. So your question is when will the ARM compute test TAM be bigger than the ARM mobility test TAM?",24,"Bigger than the mobility test. So your question is when will the ARM compute test TAM be bigger than the ARM mobility test TAM?"
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Yes, mobility test TAM is about $1.6 billion or $1.7 billion, and you said compute is about $1 billion. When do you think the total compute TAM or maybe just the non-x86 compute TAM get to be bigger than mobility?",40,"Yes, mobility test TAM is about $1.6 billion or $1.7 billion, and you said compute is about $1 billion. When do you think the total compute TAM or maybe just the non-x86 compute TAM get to be bigger than mobility?"
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","I don't think it's going to be in the next 4 or 5 years. I think much of what's being developed in the ARM space by the hyperscalers will more likely fall into the category of mobility. So I don't see compute growing beyond mobility in the next 4 or 5 yea",53,"I don't think it's going to be in the next 4 or 5 years. I think much of what's being developed in the ARM space by the hyperscalers will more likely fall into the category of mobility. So I don't see compute growing beyond mobility in the next 4 or 5 years."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Got it. And then, Mark, on the auto test market, you said it's over $500 million. I'm guessing that includes auto microcontroller, linear, et cetera. If that is the case, is there any way of giving some more color within that? Or you think it's to",52,"Got it. Got it. And then, Mark, on the auto test market, you said it's over $500 million. I'm guessing that includes auto microcontroller, linear, et cetera. If that is the case, is there any way of giving some more color within that? Or you think it's too hard to segment it?"
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Yes, it does include microcontrollers. And I would say that auto is outstripped -- most of the growth is auto more than microcontrollers. Microcontrollers is growing too, but it's mostly auto. Auto -- and of course, there's microcontrollers in auto. So wh",61,"Yes, it does include microcontrollers. And I would say that auto is outstripped -- most of the growth is auto more than microcontrollers. Microcontrollers is growing too, but it's mostly auto. Auto -- and of course, there's microcontrollers in auto. So when I say auto, I mean microcontrollers for auto versus microcontrollers, let's say, for white goods and things like that."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Your final question comes from the line of Joe Moore with Morgan Stanley.",13,"Your final question comes from the line of Joe Moore with Morgan Stanley."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Analysts","I wanted to ask about the millimeter wave commentary. It seemed like the expectation was primarily one customer in one region. So when you say that was kind of short of your expectations, what are you referring to there?",39,"I wanted to ask about the millimeter wave commentary. It seemed like the expectation was primarily one customer in one region. So when you say that was kind of short of your expectations, what are you referring to there?"
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","So it's not one customer, one region. Millimeter wave last year for us grew significantly. We probably had 90% share of the early buying per millimeter wave test in 2020. And I would say that was spread out across 6 or 7 customers. Anybody who's making a",91,"So it's not one customer, one region. Millimeter wave last year for us grew significantly. We probably had 90% share of the early buying per millimeter wave test in 2020. And I would say that was spread out across 6 or 7 customers. Anybody who's making a chipset related to millimeter wave was pretty much using a Teradyne tester in 2020. The deployment of millimeter wave by the telecommunication companies has ground to a halt. And that has proportionately ground to a halt the need for incremental test in 2021."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Executives","Okay, folks, thanks so much for joining us today. That concludes the call. We apologize for the audio difficulties at the front end of it. We look forward to talking to you in the days and weeks ahead. And those in the queue, I'll get back with you direct",52,"Okay, folks, thanks so much for joining us today. That concludes the call. We apologize for the audio difficulties at the front end of it. We look forward to talking to you in the days and weeks ahead. And those in the queue, I'll get back with you directly here. Thank you."
94728,1674258151,2361752,"Teradyne, Inc., Q2 2021 Earnings Call, Jul 28, 2021",2021-07-28,"Earnings Calls","Teradyne, Inc.","Operator","Ladies and gentlemen, this concludes today's conference. Thank you for your participation, and have a wonderful day. You may all disconnect.",21,"Ladies and gentlemen, this concludes today's conference. Thank you for your participation, and have a wonderful day. You may all disconnect."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Ladies and gentlemen, thank you for standing by, and welcome to the Teradyne Third Quarter 2021 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Andrew Blanchard. Thank you. Please go",42,"Ladies and gentlemen, thank you for standing by, and welcome to the Teradyne Third Quarter 2021 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Andrew Blanchard. 
Thank you. Please go ahead, sir."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Patrice. Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined this morning by our CEO, Mark Jagiela; and our CFO, Sanjay Mehta. Following our opening remarks, we'll provide details of o",289,"Thank you, Patrice. 
Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined this morning by our CEO, Mark Jagiela; and our CFO, Sanjay Mehta. Following our opening remarks, we'll provide details of our performance for 2021's third quarter along with our outlook for the fourth quarter. 
The press release containing our third quarter results was issued last evening. We're providing slides on the Investor page of the website that may be helpful to you in following the discussion. Replays of this call will be available via the same page after the call ends. 
The matters that we discussed will include forward-looking statements that involve risk factors that could cause Teradyne's results to differ materially from management's current expectations. We encourage you to review the safe harbor statement contained in the earnings release as well as our most recent SEC filings. Additionally, those forward-looking statements are made as of today, and we take no obligation to update them as a result of developments occurring after this call. 
During today's call, we'll make reference to non-GAAP financial measures. We've posted additional information concerning these non-GAAP financial where appropriate on the Investor page of the website. Looking ahead between now and our next earnings call, Teradyne expects to participate in technology or industrial-focused investor conferences hosted by Baird, Credit Suisse, Davidson and UBS. 
Now let's get on with the rest of the agenda. First, Mark will comment on our recent results, current market conditions and thoughts on the rest of 2021 and '22. Sanjay will then offer more details on our quarterly results along with our guidance for the fourth quarter. We'll then answer your questions, and this call is scheduled for 1 hour. 
Mark?"
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Andy. Good morning, everyone, and thanks for joining us. Today, I'll cover 4 topics: the highlights of our third quarter and the first 9 months of the year, the changes we're observing in the SOC test market, our outlook for the industrial autom",1471,"Thanks, Andy. 
Good morning, everyone, and thanks for joining us. Today, I'll cover 4 topics: the highlights of our third quarter and the first 9 months of the year, the changes we're observing in the SOC test market, our outlook for the industrial automation market and how we're thinking about the test and automation markets as we close out this year and look into 2022 and beyond. 
As our Q3 results demonstrate, demand remains strong across all of our businesses. At the company level, Q3 sales grew 16% from last year's record Q3 and non-GAAP EPS grew 35%. We did experience increased supply chain bottlenecks in our Industrial Automation business in the quarter and under ship demand. Sanjay will describe this in more detail, but we expect these constraints to persist into Q4. Despite this, for the first 9 months of 2021, company-wide sales grew 19% and non-GAAP EPS grew 31% from the year ago level. 
In each of our businesses, we are writing long-term secular trends that we expect will drive revenue and earnings growth for years to come. In our test businesses, the unit growth and complexity drivers that power these markets continue unabated. For example, our semiconductor test business grew 18% through Q3, while -- with SOC leading the charge growing 22%. Sales continue to be dominated by our UltraFLEX product line, which is well aligned to the performance requirements of the growing compute and mobility markets. 
Additionally, sales of our Eagle Test systems more than doubled in the 9-month period as automotive and industrial test markets have also rapidly expanded. Eagle's unique architecture hits the sweet spot of these markets by balancing high precision with the stress testing needed for these demanding applications. 
Within SOC, there's been a clear shift this year to higher demand from the compute, automotive and industrial markets. While mobility is still the largest subsegment of SOC and growing, it has dropped from the high 50% range of the SOC test market in recent years to the high 40% range this year. Over the midterm, we expect mobility will remain the largest SOC submarket and continue to grow but we also expect compute to grow at a faster rate, while automotive should remain at its current elevated levels. 
For the last decade or so, mobility has made rapid annual advances in semiconductor complexity that has enabled the advancement of smartphone sophistication. The refresh pace has been much faster than traditional PCs, graphics, automotive and industrial end markets, leading to smartphone ICs rapidly progressing along the complexity scale. This is true in many areas of smartphone silicon, apps processor compute engines, graphics engines, AI engines, image sensors, power management and more. Our leading position in testing these key technologies has driven our growth. 
At the same time, up until recently, the traditional compute testing market has been relatively flat with slower refresh rates and slower complexity growth. However, the groundwork laid by mobility designs combined with advancing lithography nodes and design tools has enabled new entrants into the chip design space for compute engines. The complexity of these chips whether for laptops, servers, autonomous driving, AI or graphics is incredible and advancing at an accelerated rate. For example, laptop CPUs are now crossing the 30 billion transistor level, which is a huge leap over previous legacy designs. 
As we've said in the past, increased transistor counts drives increased test time and increased tester demand. We've seen that this year and there's more to come. We're targeting this expanding collection of new players and new designs, leaning heavily into our UltraFLEX family's hardware performance and time-to-market advantages of our software. We've been adding new design wins every quarter. And while development pipelines can be long and these new designs can be speculative, we're confident we'll see growing production business from these wins in the future. It's also notable that the traditional chip suppliers in these markets aren't standing still, they are doubling down on their advanced designs too, which is collectively driving WFE investments higher as applications expand and competition heats up. 
We expect this rate to lead to higher test TAMs and given the higher performance and faster design to market cycle times, more share gain opportunities for Teradyne over the midterm. Our System Test segment last year -- sorry, our System Test segment year-to-date sales grew 11% from 2020 and Storage Test continued its multiyear growth trajectory, expanding sales 12% in the same period. Higher capacity HDDs and more complex SOC devices, which require system-level test are driving this demand. 
Both trends are expected to continue into the foreseeable future. At LitePoint, sales were up 24% through 9 months compared with 2020, driven by WiFi 6 production WiFi 7 R&D demand as well as ultra wideband. More connected devices demanding more bandwidth while managing growing congestion drives complexity increases in each new WiFi standard and more tests. UWB, on the other hand, is a whole new wireless standard and application space. It's a new proximity detection wireless technology with the future of many promising security applications. We expect these trends to continue and to provide a long-term tailwind to our wireless test business. 
Shifting to Industrial Automation. Universal Robots revenue grew 50% through the first 9 months of the year, while MiR grew 40% despite supply chain challenges. Each has a unique story. At UR, it's a combination of increasing sales for existing tasks and the expanding number of UR+ offerings, making it easier for customers to deploy our cobots to do new applications. We highlighted welding in our last call, but other examples include screwdriving and palletizing. The UR+ ecosystem is key to expanding these tasks and now totals over 360 products created by over 300 partners, both riding on and broadening the [indiscernible] of our UR platform. This is a key advantage in the combination of our organic investments and our UR+ and OEM partners R&D dollars and creativity that's going into expanding the UR platform and it's unmatched. 
At MiR, the story is about new products. The MiR250 which was introduced just as COVID hit last March of last year, is now our largest seller by far. This year, we added the MiR Hook to the 250 family to expand its applications into tugging. We've introduced higher payload products such as the MiR 600 and 1350 to expand our footprint in the fast-growing logistics market. 
Unfortunately, with all this good news come supply chain issues that will limit IA growth in 2021 to be between 30% to 40% year-on-year, but demand is strong. The long-term outlook in IA remains very bright. Looking at the capabilities of UR cobots today, we estimate the penetration rate is less than 2% of the servable market. UR's approximate 45% market share puts us clearly in the lead, and we continue to drive R&D and distribution investments to extend our competitive advantages, expand the servable market and drive penetration higher. 
It's a similar story at MiR, where we estimate the autonomous mobile robot penetration is under 3%. The AMR market doesn't have a single dominant player like UR cobots, and we estimate we're close to #2 in the broadly defined market. And like at UR, we're making investments in both the distribution and product level to both reinforce our advantages and extend our product reach. 
In both IA businesses, the fact that our penetration of today's servable market is low single digits and that the servable market continues to expand each year with product enhancements, sets up a fantastic future. So even with very high growth rates in our IA business, we expect the penetration rates to remain low for many years, sustaining our long-term annual growth forecast of 20% to 35%. In January, we will update you on the outlook for 2022 and our midterm earnings model. Between now and then, we'll be looking at the rate and timing of new semiconductor fab capacity coming online, especially at the more advanced lithography nodes. And we'll also be looking at the rate of adoption of DDR5 as key swing factors. 
In IA, we will be looking at the manufacturing output expansion, on-shoring trends and PMIs in our principal geographies as tailwinds for continued robust growth. On the other hand, in both markets, supply chain bottlenecks could slow certain industries and become a headwind to growth demand. Short-term demand is influenced by many factors, but we manage our business aligned to the long-term trends. The trend of growing prevalence of increasingly complex semiconductors and a myriad of applications drives our semiconductor business and investments. The trend of new increasingly smart, cost-effective automation in a world with labor scarcity and onshoring challenges drives our IA business and investment strategy. These systemic long-term trends paid an exciting future for Teradyne. 
With that, I'll turn it over to Sanjay."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Mark, and hello, everyone. In my remarks, I'll review our Q3 financial results, discuss our supply line strategy in this challenging environment, provide Q4 guidance and comment on our full year financial outlook at the midpoint of our Q4 guidan",1461,"Thanks, Mark, and hello, everyone. 
In my remarks, I'll review our Q3 financial results, discuss our supply line strategy in this challenging environment, provide Q4 guidance and comment on our full year financial outlook at the midpoint of our Q4 guidance to the financial headlines for Q3. 
Our third quarter sales were $951 million was near the high end of guidance driven by strength in Semi Test and wireless test. Gross margin in the quarter was approximately 60%. Our non-GAAP operating expenses were $242 million or 25.5% of revenue. The favorability in OpEx drove a non-GAAP operating margin of approximately 35% and and non-GAAP EPS of $1.59. 
A few more components of third quarter data. Our tax rate, excluding discrete items, was 14.8% on both a GAAP and non-GAAP basis. Non-GAAP diluted share count was approximately $176 million. We had 2 10% customers. 
Looking at the results from a business unit perspective. Semi Test revenue of $688 million was up 16% from Q3 '20. SOC revenue was $575 million, up 28%, driven by strength in applications processors, RF, industrial and automotive applications. Automotive and industrials doubled revenue year-over-year. Memory revenue was the second highest in history at $113 million, but down 21% from Q3 of last year's record. Flash final test demand was the strongest segment on handset and SSD end market demand. System Test group had revenue of $103 million, which was down 13% year-over-year. Recall Storage is the largest business in this segment and has lumpy shipments. While Storage Test will still grow more than 15% for the year, sales, including HDD and SLT declined to $56 million on the timing of shipments in Q3. 
Defense and aerospace and production board test combined grew 10% year-on-year to $47 million. At LitePoint, revenue of $69 million was up 70% from prior year due to early success of our new WiFi 7 product, continued strength in 4G cellular and EEB. 
Now to Industrial Automation. As in July, given COVID shutdowns had impaired the UR business in 2020, I'll provide revenue metrics comparing Q3 '21 results with both Q3 '20 and Q3 '19. Industrial Automation revenue of $91 million was up 32% from both Q3 '19 and Q3 '20. North America delivered the highest revenue growth from last year, but all regions expanded year-on-year. As Mark noted, supply issues, primarily semiconductors, reduced our IA shipments in the quarter. UR sales were $78 million in Q3, up 46% year-over-year and 31% over Q3 '19. MiR sales were $13 million, up 27% from Q3 '20 and 35% from Q3 '19. IA was about breakeven in the quarter and full -- breakeven in the quarter and full year, we expect low single-digit profitability. As we've noted before, we continue our strategy of investing during this high-growth era while maintaining gross margins to enable mid-20s operating profit in the future. 
Shifting to supply. We continue to deal with numerous supply constraints across the company. While semiconductor shortages are well reported, we're also seeing delays in mechanical parts and logistics, all exacerbated by rolling COVID-related shutdowns or labor shortages. We expect these issues will continue through the first half of 2022. Despite these issues, we've been able to deliver record shipments and a big part of that performance is a result of the supply line management, operations teams and engineering teams working with our supply chain and contract manufacturing manufacturing partners. 
We view our operational business model and execution against it as a core competence. Our gross margin performance over the last 10 years displays the financial value of this model. In our test portfolio, our execution has kept most of our tester lead times within the range that meet customers' needs to expand their production capacity in this dynamic environment. The significance of this lead time performance is that customer orders more closely reflect true test demand. So while a bit counterintuitive, we feel that maintaining short lead times are a more accurate indicator of test demand with lower risk than holding orders with lead times far beyond chip manufacturing cycle times. Of course, our supply line and operations model isn't static. We began adding resiliency through both geographic and supplier diversity prior to COVID. Those efforts have accelerated over the last 20 months. 
This work is paying dividends in the current environment, and we'll continue to invest to harden our supply chain further. Our lead time performance is an example of our resilience and execution. Another example is the ability to scale to significantly increase demand. Auto and industrial sales have more than doubled year-over-year. While we're not perfectly aligned to all customer requested delivery dates, we are managing through delivery issues in a reasonable manner. The value of these efforts can also be seen in the operating leverage in our gross margin line. In IA, we've seen lead times extend from our normal 1 to 2 weeks to 4 to 6 weeks for some products. While this is a challenge, with the business growing so quickly and ongoing industry supply issues, we've already seen the positive impact of our work in material sourcing and manufacturing cycle times. 
We expect to bring lead times back to model over the next 2 to 3 quarters. Shifting to the balance sheet and cash flow. Our cash and marketable securities at the end of the quarter totaled $1.45 billion. We had $493 million in free cash flow in the quarter, and through 9 months, we've spent $103 million on CapEx, and we expect we'll spend $148 million for the full year. We spent $210 million and $16 million on buybacks and dividends, respectively. Year-to-date, we've repurchased 3.3 million shares for $406 million at an average price of $123.53. In 2021, we expect to return over 80% of our free cash flow to shareholders. And from 2015, when we began repurchasing shares, we've returned 85% of our free cash flow to owners. 
Regarding our convertible debt, $302 million of principal was paid in the first 9 months to the convertible bondholders ahead of maturity. By mid-December, bondholders will have converted approximately $343 million, leaving a face value of $117 million. 
Now to our outlook for Q4. Sales in Q4 are expected to be between $820 million and $900 million, with non-GAAP EPS in a range of $1.14 to $1.40 on 174 million diluted shares. Fourth quarter guidance excludes the amortization of acquired intangibles and noncash imputed interest on the convertible debt. Our guidance assumes no significant changes, positive or negative, in the availability of materials and assumes that we won't see additional pandemic-related issues. Fourth quarter gross margins are estimated at 59% to 60%. OpEx is expected to run at 28% to 31% of fourth quarter sales. The non-GAAP operating profit at the midpoint of our third quarter guidance is 30%. 
Regarding OpEx for the full year. We spent a bit lower than planned in Q3, and we expect the full year OpEx will be about $980 million, up 17% from 2020. At the midpoint of our guidance, 2021 will be another year of growth in both revenue and EPS, while sales growing -- or sorry, with sales growing 18% to $3.7 billion and non-GAAP EPS growing to $5.88, up 27%. Gross margin for the full year should be approximately 59.5%, up from 57.2% in 2020, reflecting the ramp of new products, product mix and operating leverage, offsetting component and logistics cost increases. 
Our 2021 non-GAAP operating profit rate is expected to be about 33%, up from last year's 30%. Our full year tax rate is expected to be 14.8%. These results put us comfortably in the range of our 2024 earnings model this year. We'll update the model on our regular cadence in January. The breadth of our customer buying in 2021 is also broader than last year. In 2020, we had 1 customer that drove 25% of sales. In 2021, we do not expect to have any customer larger than 20% of our yearly revenue. This reflects the trend Mark noted about 2021's higher growth in compute, auto and industrial demand compared with mobility demand in SemiTest. IA growth of over 30% year-over-year continues to diversify our revenue. This growth is expected to continue over the midterm and become a larger portion of our revenue. 
In summary, we expect to end the year with another quarter of strong year-on-year revenue and EPS growth. On a full year basis, we'll exceed our midterm targets on stronger-than-expected demand on our test businesses, continued high growth in IA and excellent execution across the company. While we don't have a clear picture of 2022 yet, we're confident in the long-term industry trends powering our test and IA businesses remain firmly in place. 
With that, I'll turn the call back to Andy."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Sanjay. Patrice, we would now like to take some questions. And as a reminder, please limit yourself to 1 question and a follow-up.",24,"Thanks, Sanjay. Patrice, we would now like to take some questions. And as a reminder, please limit yourself to 1 question and a follow-up."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","[Operator Instructions] Your first question comes from Atif Malik with Citi.",11,"[Operator Instructions] Your first question comes from Atif Malik with Citi."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Good job in the top supply environment. Mark, if I look at some of the recent ARM-based notebook processors, the transistor count is growing 2 to 4x versus prior generation. You commented mobility to grow and compute auto and allowed to grow faster than m",71,"Good job in the top supply environment. Mark, if I look at some of the recent ARM-based notebook processors, the transistor count is growing 2 to 4x versus prior generation. You commented mobility to grow and compute auto and allowed to grow faster than mobility in the midterm understand you guys in January talk about next year outlook in January. How confident do you feel about your SOC growth next year?"
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Well, I think at this point, pretty confident. I mean we look at the trends that I just -- you cited and I cited and see that there's very little standing in the way of sort of this increased growth, but the caveat I would mention is there's a lot of supp",176,"Well, I think at this point, pretty confident. I mean we look at the trends that I just -- you cited and I cited and see that there's very little standing in the way of sort of this increased growth, but the caveat I would mention is there's a lot of supply chain bottlenecks in the system. So if end products get bottlenecked, that can slow down the unit volume demand for new semiconductors. And the other thing we're looking at is when do these new nodes really come online in terms of capacity. All that $90 billion of WFE that was put in place this year hasn't yet had a single impact on test. That's all to come. But it kind of depends on when do those additional 5- and 3-nanometer fabs come online. That is kind of a big swing factor in the calendar year 2022 as to how our growth will shrunk out. And that's kind of why we wait until January because we don't get good enough visibility on that right now."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Great. And Sanjay, as a follow-up, can you talk about concentration within mobility and compute customer and impact on long-term gross margins? There have been talks about price discounts with equipment suppliers by Tier 1 foundry.",36,"Great. And Sanjay, as a follow-up, can you talk about concentration within mobility and compute customer and impact on long-term gross margins? There have been talks about price discounts with equipment suppliers by Tier 1 foundry."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. As I stated in my prepared remarks, we won't have any customer above 20%. So it's a broader breadth of customers. And regarding gross margins, in throughout the year, we've improved gross margins. And as I said in earlier calls, really driven by a co",127,"Yes. As I stated in my prepared remarks, we won't have any customer above 20%. So it's a broader breadth of customers. And regarding gross margins, in throughout the year, we've improved gross margins. And as I said in earlier calls, really driven by a couple of key test systems coming online and we're shipping in volume that have come down the cost curve. We've seen some benefits to product mix shift as well as our operating leverage offsetting the component costs and logistic cost increases. From a look forward and sustainability of that gross margin, obviously, we'll give an update to our earnings model in January. But I see the second half of our gross margin performance kind of going into the first half of 2022."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Mehdi Hasani with SIG.",9,"Your next question comes from Mehdi Hasani with SIG."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Yes, the first 1 has to do with your largest customer. Given your commentary in terms of revenue mix, it seems to me that that particular customer is going to be down like 5% to 6%. In that context, should we assume a return to growth in '22, and this is",77,"Yes, the first 1 has to do with your largest customer. Given your commentary in terms of revenue mix, it seems to me that that particular customer is going to be down like 5% to 6%. In that context, should we assume a return to growth in '22, and this is trend that has happened over the past several years? And should that happen again? Should that pattern happen again into '22? And I have a follow-up."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. We, of course, maybe can't talk about any individual customer and what they might do or not do in the future. So that I have to leave aside. But I just point out in your first point that, yes, our largest customer is dropping below 20% in a growing r",73,"Yes. We, of course, maybe can't talk about any individual customer and what they might do or not do in the future. So that I have to leave aside. But I just point out in your first point that, yes, our largest customer is dropping below 20% in a growing revenue year. So the amount that you might think compute that they're falling has to be taken against our numerator of higher revenue."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And then wanted to follow up to the question that came up 3 months ago. when we were looking into your market share in the compute. Can you update us where you are with that market share in 2021? And as hyperscalers ramp their own ARM-based CPUs,",62,"Got it. And then wanted to follow up to the question that came up 3 months ago. when we were looking into your market share in the compute. Can you update us where you are with that market share in 2021? And as hyperscalers ramp their own ARM-based CPUs, how will your market share change over the next 1 or 2 years?"
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Well, like the total SOC market, year-to-year market share is very volatile. It depends on whose customers are buying what in any given year. So what our market share might be in any given year, it can -- in a submarket like compute, it can swing 20 point",118,"Well, like the total SOC market, year-to-year market share is very volatile. It depends on whose customers are buying what in any given year. So what our market share might be in any given year, it can -- in a submarket like compute, it can swing 20 points year-to-year depending on who's buying. So for this year, it tends to be a very good compute year for us. Our compute market share is up in, I would say, close to what our average share is in SOC this year. But I would say that it's not steady eddie. It's going to be pretty volatile year-to-year it has been in the past. It probably will be going forward, too."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","I know we're supposed to ask only 2 questions, but just a quick follow-up. I think what I'm trying to understand is I think on the GPU side, it's pretty clear that your competitor has dominated. And assuming that, that work to remain unchanged, I think th",86,"I know we're supposed to ask only 2 questions, but just a quick follow-up. I think what I'm trying to understand is I think on the GPU side, it's pretty clear that your competitor has dominated. And assuming that, that work to remain unchanged, I think the incremental change to the compute is all driven by ARM-based. And I was just trying to better understand how you look at your competitive position as these new chips coming to the market addressing the compute end market?"
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","We look -- we're very pleased and confident with our progress in ARM-based compute and design-ins in that realm, but I would say that it's not -- there's the tester market for compute is also driven by more traditional x86 demand as well. You've got a cou",82,"We look -- we're very pleased and confident with our progress in ARM-based compute and design-ins in that realm, but I would say that it's not -- there's the tester market for compute is also driven by more traditional x86 demand as well. You've got a couple of suppliers there that are not standing still, as I mentioned, and are upping their kind of complexity growth curve. And so there will be certainly a lot of growth there as well, I believe."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Toshiya Hari, Goldman Sachs.",9,"Your next question comes from Toshiya Hari, Goldman Sachs."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Congrats on the strong execution. I had 2 questions as well. My first 1 is on the supply constraints, maybe for Mark, maybe for Sanjay. Just curious how significant the headwinds were for IA in Q3 and what's embedded in your Q4 guidance? If you can share",102,"Congrats on the strong execution. I had 2 questions as well. My first 1 is on the supply constraints, maybe for Mark, maybe for Sanjay. Just curious how significant the headwinds were for IA in Q3 and what's embedded in your Q4 guidance? If you can share that, that would be helpful. And I just wanted to confirm that there was little to no impact on your semi test business. And then on gross margins, similarly, you came in at the high end of your guided range, but was there any impact on your profitability in the quarter from supply chain shortages."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Sure. So I'll take those. So from an Industrial Automation perspective, year-to-date, we've grown 40% in IA, and Q4 demand is high. if we can't supply at all, that's why we've -- I think it's going to be growth year-on-year of about 30% to 40%. And so pre",214,"Sure. So I'll take those. So from an Industrial Automation perspective, year-to-date, we've grown 40% in IA, and Q4 demand is high. if we can't supply at all, that's why we've -- I think it's going to be growth year-on-year of about 30% to 40%. And so predominantly, it's in semiconductors. And I expect we'll be out of the supply chain crunch given our visibility in Q2 or Q3 for IA. So that's the IA side. And then from a supply chain perspective on the test side, we've seen the supply chain tightening on the test portfolio quarter-over-quarter, where we don't think it's going to be abated until the end of Q2 of 2022. And again, mainly semiconductor parts. And really, we see that coming back online in the second half, really tied to the wafer and the substrate capacity coming online. 
And then from a gross margin perspective, we've been managing through the component increases, logistics increases in cost. And we've -- as I've said earlier, we've had favorable product mix. And as our volumes or our revenues are higher, we're gaining operating leverage along with coming down the cost curve of our new products that we've introduced late last year. So we're managing through it, and it's true well-publicized component cost increases."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. That's super helpful. And then as my follow-up, Mark, I wanted to ask about your Eagle Test business. In your prepared remarks, you noted that the business is up more than 2x year-to-date. I guess historically, like many other parts of your busine",143,"Got it. That's super helpful. And then as my follow-up, Mark, I wanted to ask about your Eagle Test business. In your prepared remarks, you noted that the business is up more than 2x year-to-date. I guess historically, like many other parts of your business, I think the Eagle Test has been quite cyclical. You would be up for a year, 1.5 years, 4 to 6 quarters and then down a little bit as customers digest their test capacity. Based on what you said, it seemed like you're expecting 2022 to be another strong year. I guess the question is what's different this time as you think about Eagle Test into '22. I realize there's complexity growth, but you could argue there's been complexity growth for a very long time. So just curious how different this cycle could be relative to past cycles."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Right. Good question. And in addition, automobile unit volume isn't near its historical peak either. So how could this thing keep going beyond the normal 6-quarter surge in automotive, which is you're right, again, that's kind of the traditional pattern.",189,"Right. Good question. And in addition, automobile unit volume isn't near its historical peak either. So how could this thing keep going beyond the normal 6-quarter surge in automotive, which is you're right, again, that's kind of the traditional pattern. But I think what we see happening and makes us believe this will persist at least through 2022 is there's a lot of silicon refresh going on that's new in the automotive space. New -- kind of racing to get new more current generation lithography node silicon into automotive design because the legacy lines out there are hard to get at chip suppliers are trying to obsolete those fabs. And so the automotive customers don't have as much, I would say, power in this frothy demand environment on the semiconductor supply side. And so the semiconductor suppliers are kind of same, get with the program, move to more advanced nodes. And a little bit of that's happening, which is what -- that means complexity, yield issues, and that means a little more test than you might expect. And I think that's what's giving us a different view this time."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from John Pitzer, Credit Suisse.",9,"Your next question comes from John Pitzer, Credit Suisse."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Congratulations on the set of results. Mark, I want to go back to increasing test times in the semi test business. You've done a good job kind of helping us understand complexity and transistor count. I'm kind of curious, as we move from a world of sort o",97,"Congratulations on the set of results. Mark, I want to go back to increasing test times in the semi test business. You've done a good job kind of helping us understand complexity and transistor count. I'm kind of curious, as we move from a world of sort of general purpose compute to 1 of more optimized silicon, you're going to move from a world where you're testing huge volumes in 1 device to smaller volumes across multiple devices. What does that do for test efficiency at your customers? And hence, test times as that trend takes hold."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","It is a -- building, let's say, 100 billion transistors on 1 chip versus 4, to give an example, isn't equivalent test time. The 4-chip version is likely to -- these are going to be rough rules of thumb, but let's say, 25% more test intensive than the sing",259,"It is a -- building, let's say, 100 billion transistors on 1 chip versus 4, to give an example, isn't equivalent test time. The 4-chip version is likely to -- these are going to be rough rules of thumb, but let's say, 25% more test intensive than the single chip design because there's a premium on sort of known good die testing to -- when you put those together in an advanced package. And then the advanced package itself has more potential defect failure modes that need to be tested. So that's 1 thing around the whole chiplet, multi-chip package thing. The other thing, though, that's happening, and this is really going to become prevalent at 3-nanometer and beyond is the move from FinFET to gate all around transistor architectures. 
And if you remember, when the world moved from planar to FinFET, it was back in 2012, '13, '14 era, that drove -- if you go back and look at the history of sort of the test market, that drove incremental test intensity and complexity in the market. And we're headed for another 1 of those with gate all around. There's going to be new defect modes, new kind of test intensity boosts coming from this new architecture on the transistor. So even at equivalent transistor counts, we're going to see a little bit more test intensity because of that. So these 2 trends of chiplets and gate all around and 3-nanometer, that's probably all the 2023 and beyond story given where 3-nanometer is right now, but it's coming."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","That's helpful. And that's my second question, Mark, just going back to your largest customer, I'm kind of curious if you can help me better understand the diversity of business with that customer. I mean clearly, it's been mobility led for the last sever",104,"That's helpful. And that's my second question, Mark, just going back to your largest customer, I'm kind of curious if you can help me better understand the diversity of business with that customer. I mean clearly, it's been mobility led for the last several years. Now you've got them doing more in the compute space. You've talked about in the past the complexity around these air tags. Are you seeing a meaningful diversification of demand drivers at that customer? And can you help me because I just don't know how fungible is your -- is there test capacity across those different product families?"
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes, I'm not going to be able to talk too much about the sort of breadth there. I think you can imagine it, and you've rattled off some examples. In terms of fungibility, they're pretty fungible to testers across what's used for compute engine in a phone",299,"Yes, I'm not going to be able to talk too much about the sort of breadth there. I think you can imagine it, and you've rattled off some examples. In terms of fungibility, they're pretty fungible to testers across what's used for compute engine in a phone versus a compute engine in a laptop or a desktop or anything else. The one that's a little bit unique is when you get into things like the RF type products, of course, have a bit of a different architecture, power management type products have a bit of a different architecture. And so those testers tend to be a little more unique. But we've talked about in the past that -- I think people have looked at us and said, well, in a world where cell phones are kind of plateauing, doesn't that -- unit growth of cell phones doesn't that portends some kind of slowing for us. And what we've always said is that, look, cell phone unit growth can slow, complexity isn't. And some of these customers are diversifying into more silicon, both in the phone and now more silicon outside the phone into compute. There are these emerging hyperscalers that are building silicon for both cloud computing and other new yet to be introduced consumer products. So the ability of a design team today to be formed and put together a $10 billion-plus transistor chip for a consumer application is easier and easier and easier. And as I said in my script, we worked with a lot of them. Maybe a small fraction of them will be hits in the future, but they can bring entirely new classes of sector high compute engine semiconductor applications to the market. And all of those are kind of UltraFLEX, UltraFLEXplus family devices."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from CJ Muse of Evercore.",9,"Your next question comes from CJ Muse of Evercore."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","I guess, Mark, another technology question. you've kind of taught us to think about transistor count and kind of thinking about test times for mobility compute. And curious, as we go to more high-performance compute, where there are more thermal issues, p",58,"I guess, Mark, another technology question. you've kind of taught us to think about transistor count and kind of thinking about test times for mobility compute. And curious, as we go to more high-performance compute, where there are more thermal issues, perhaps more complex software algorithms, how should we be thinking about the test times in that transition?"
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Well, I think the test times have less to do with the application. The only place where the application drives really fundamentally different test times as automotive because of the issues there. It's more the technology. So I go back to CJ, what I said b",81,"Well, I think the test times have less to do with the application. The only place where the application drives really fundamentally different test times as automotive because of the issues there. It's more the technology. So I go back to CJ, what I said before about 3-nanometer is going to be more impactful to both test times in phones and in computers and in servers and in graphics and in everything else, probably than any of those end market applications."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. That's helpful. And then I guess, Sanjay, a question for you. Clearly, you're making investments, particularly in IA. But as you look to 2022, can you speak to your outlook for operating leverage. And as part of that, how we should think about OpEx",50,"Okay. That's helpful. And then I guess, Sanjay, a question for you. Clearly, you're making investments, particularly in IA. But as you look to 2022, can you speak to your outlook for operating leverage. And as part of that, how we should think about OpEx relative to top line growth?"
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Sure. I'd say we're in the early innings of looking at 2022. And obviously, we'll provide an update in in January. But OpEx is growing in kind of a couple of key areas this year, obviously tied to higher volume, we have variable compensation as well as en",151,"Sure. I'd say we're in the early innings of looking at 2022. And obviously, we'll provide an update in in January. But OpEx is growing in kind of a couple of key areas this year, obviously tied to higher volume, we have variable compensation as well as engineering spends tied to our operations to qualify new suppliers et cetera. And then we continue to invest in both go-to-market and engineering across the test portfolio. And as you noted, we're leaning in, obviously, in -- as I noted in my prepared remarks, we're leaning into our IA investments really to help drive going forward. The other component is the G&A expenses going forward. This was a big year of OpEx growth. The only thing I'd say is that next year is we're not going to be as large percentage-wise growth, but that's really all I have to say on it right now."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Timothy Arcuri, UBS.",8,"Your next question comes from Timothy Arcuri, UBS."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, I just wanted to see if you can update us on the SOC TAM. You had said 4, 5 last call and segment of that was compute was about $1 billion. Mobility was [ 1 8 ] to [ 1 8 5. ] Autos were about 500, Industrial was [ 5, 550 ]. I'm just kind of wonderin",67,"Mark, I just wanted to see if you can update us on the SOC TAM. You had said 4, 5 last call and segment of that was compute was about $1 billion. Mobility was [ 1 8 ] to [ 1 8 5. ] Autos were about 500, Industrial was [ 5, 550 ]. I'm just kind of wondering if you can update us on those numbers."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Good question. So fundamentally, it's in the same range. It's probably trending more up towards the higher end of that range. So I think the numbers, the submarkets you got right on what we talked about last time, maybe compute is driving us a little",71,"Yes. Good question. So fundamentally, it's in the same range. It's probably trending more up towards the higher end of that range. So I think the numbers, the submarkets you got right on what we talked about last time, maybe compute is driving us a little bit higher in that range at this point in time. But it's pretty close. And memory is still at about $1 billion TAM as well."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Great. And then I guess I had a question just on profitability in IA. I noted, Sanjay, you just answered a question about operating leverage next year. But what's the catalyst maybe -- this time last year, we were thinking IA would be 10% to 15% op",131,"Okay. Great. And then I guess I had a question just on profitability in IA. I noted, Sanjay, you just answered a question about operating leverage next year. But what's the catalyst maybe -- this time last year, we were thinking IA would be 10% to 15% op margin and then it got cut to 10% and then it went to 5%, and now it's kind of low single digits. And I get that the penetration there is very low. But what's the catalyst for you to look at? Maybe we shouldn't be investing so much money and maybe we can optimize OpEx investment. So I guess I'm just kind of wondering how you think about about sort of what's going on at IA and what the long-term profitability target is?"
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So our range, as we said prior is 5% to 15%, and we expect to be low single digits, as I said in my prepared remarks. But really, how we think about it is we manage the business on a -- think about it as a rule of 40, combining the year-over-year gro",214,"Yes. So our range, as we said prior is 5% to 15%, and we expect to be low single digits, as I said in my prepared remarks. But really, how we think about it is we manage the business on a -- think about it as a rule of 40, combining the year-over-year growth with the operating profit. And fundamentally, we're -- as we see or as been noted by Mark, where penetration is very, very low and we look at all the jobs that can be automated and the scarcity of labor and economic growth, we really see a strong tailwind for the portfolio. And with that, we're very focused and conscious on both engineering and go-to-market investments. And so how we think about it is quite simple. And that is where we have a strong belief that we're going to grow and it's going to accelerate that revenue growth, we're going to lean into the investment. And again, think about it in the rule of 40. And as I said in my prepared remarks, our gross margins are actually improving in that portfolio. And so when we see that growth start to moderate, then we'll start to moderate the OpEx to get to an operating profit of, let's say, in the mid-20s."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Vivek Arya, Bank of America.",10,"Your next question comes from Vivek Arya, Bank of America."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, this move to 3-nanometer, is that a benefit for Teradyne in '22 or '23. I thought it would be '23, but I wanted to confirm. And kind of following on for that, what are the top 1 or 2 end markets that you are the most excited about in terms of growth",56,"Mark, this move to 3-nanometer, is that a benefit for Teradyne in '22 or '23. I thought it would be '23, but I wanted to confirm. And kind of following on for that, what are the top 1 or 2 end markets that you are the most excited about in terms of growth for next year?"
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","So on the 3-nanometer question, that was 1 of the things I mentioned that we'll be looking at carefully between now and January when we update you on the 2022 view. And we've seen some pushouts on some of those nodes for a -- by a few months. So the abili",203,"So on the 3-nanometer question, that was 1 of the things I mentioned that we'll be looking at carefully between now and January when we update you on the 2022 view. And we've seen some pushouts on some of those nodes for a -- by a few months. So the ability to intercept them in a meaningful way in Q -- or sorry, in 2022 is a swing factor. We don't see that exactly yet. But whatever happens in 2022, it might get some early ramping, but the bulk of it is going to be 2023, '24, '25 kind of and beyond. So a little bit could happen in '22, how much we won't know more until January. In terms of markets next year that are interesting and exciting. I think it goes back to these emergent hyperscalers that are developing some new applications and very complex silicon for those new applications. Some of those could latch in the market with new product introductions and drive a whole new sort of demand stream for semiconductors and the testers associated with them. So that's kind of what we're rooting for and what we're close to, and we're seeing could be breakouts for 2022."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Very helpful. And maybe just following up on that. Is there a way, Mark, to contrast the additional complexity in a product that's going into a hyperscaler application versus a mobility application. I understand by sizes might be different than pa",123,"Got it. Very helpful. And maybe just following up on that. Is there a way, Mark, to contrast the additional complexity in a product that's going into a hyperscaler application versus a mobility application. I understand by sizes might be different than packaging, et cetera, might be different. But in conceptually, what does the mix shift from a more mobility heavy end market to something that is taking you more into the compute and hyperscaler land mean for Teradyne in terms of your growth prospects and also the -- just the seasonality because mobility tends to be in a lot more seasonal markets. Those other markets are perhaps less seasonal. So what does that mix shift mean for Teradyne over the long term?"
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes, that's a good question. And the range of devices being developed at hyperscalers is quite large. Some of them are simpler than a classic cellphone device, apps processor in a cell phone. So those aren't going to have much of an impact even if they la",173,"Yes, that's a good question. And the range of devices being developed at hyperscalers is quite large. Some of them are simpler than a classic cellphone device, apps processor in a cell phone. So those aren't going to have much of an impact even if they latch. But some of them that are more, I would say, leverage AI, machine learning and high res displays are equal to or greater complexity than what you might find in a typical cell phone application for those technologies. So it's a broad spectrum is, I guess, the bottom line. But if you sort of play it out. I'd say the hyperscalers are going to, on average, bring cell phone-like complexity applications to the market. It's probably not going to be something that's -- take the $50 billion transistor device that kind of surprised everybody. It's probably not at that extreme. It's probably more in the $10 billion transistor range on average and then moving up year-over-year over year after that as they iterate on the design."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Krish Sankar with Cowen and Company.",11,"Your next question comes from Krish Sankar with Cowen and Company."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Back to Mark, just want to ask the 3-nanometer question in a different way, you spoke about how test investments have to catch up to front-end WFE spending. But during the 3D NAND investment cycle, WFE grew in 2016 and '17, while the memory test spending",79,"Back to Mark, just want to ask the 3-nanometer question in a different way, you spoke about how test investments have to catch up to front-end WFE spending. But during the 3D NAND investment cycle, WFE grew in 2016 and '17, while the memory test spending kind of came in 2018 in a meaningful way. So I'm kind of curious, how should we think about the time lag effect of sets to front-end foundry logic WFE this time around?"
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Good questions. So all of the WFE investment gets recognized before a single testers associated with that investment. So the way to think about test is whenever you see some silicon coming off a new node, I assume that the testers were installed mayb",184,"Yes. Good questions. So all of the WFE investment gets recognized before a single testers associated with that investment. So the way to think about test is whenever you see some silicon coming off a new node, I assume that the testers were installed maybe 3 months or so prior to that. So once the 3-nanometer fab comes online and you start to see product coming off of it in reasonable volume more than sort of pilot line volume. I assume that the tester installations occurred about 3 months prior. That's kind of the best guidance I can give you there. And then the only other thing I would caution about memory versus SOC is that the curve of test time to transistor count is not the same in memory as it is in SOC. Memory tends to be a bit more efficient for reasons I won't get into here. So you can double transistors and memory, and you're not going to probably move test time more than 20%, 30% or so, let's say, whereas an SoC, it's not quite linear, but it's closer."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Got it. That's very helpful, Mark. Then I have a follow-up for Sanjay, on gross margins. Despite the constrained environment, gross margins have stepped up about 200-plus basis points over the last like 4 quarters or so to a 59% to 60% range. Is t",60,"Got it. Got it. That's very helpful, Mark. Then I have a follow-up for Sanjay, on gross margins. Despite the constrained environment, gross margins have stepped up about 200-plus basis points over the last like 4 quarters or so to a 59% to 60% range. Is this kind of the new baseline we should assume at these revenue run rates?"
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think I talked about that earlier. So we're going through our strategic planning process in Q4, and it's really the basis of our earnings model update in January. As I've said, just having some visibility into the first half of next year, I think y",155,"Yes. I think I talked about that earlier. So we're going through our strategic planning process in Q4, and it's really the basis of our earnings model update in January. As I've said, just having some visibility into the first half of next year, I think you should expect to see that gross margin be similar in the first half of next year as we have in the second half of 2021. From -- and so there's many different variables in there. I noted that we've been managing through the component and logistics cost increase. We've had good mix and come down the cost curve of our new products and gaining operating leverage. So there's many variables in there that we're going to look at closely. And as our revenue gets more and more diversified. There's a lot of puts and takes, but we'll provide more guidance on that in the in the January call."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Brian Chin, Stifel.",8,"Your next question comes from Brian Chin, Stifel."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Nice results, and thanks for laying us ask a few questions. Sorry, first to clarify something going back on the commentary. If you had more chips, you would be able to ship to an appreciably higher level of revenue in both the Semi Test and Industrial Aut",55,"Nice results, and thanks for laying us ask a few questions. Sorry, first to clarify something going back on the commentary. If you had more chips, you would be able to ship to an appreciably higher level of revenue in both the Semi Test and Industrial Automation businesses in Q4. Did I hear that correctly?"
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","In industrial automation, percentage-wise, we'd be able to ship more. In the test portfolio, we think we're going to manage through the majority of the supply issues at this point.",30,"In industrial automation, percentage-wise, we'd be able to ship more. In the test portfolio, we think we're going to manage through the majority of the supply issues at this point."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Okay. Great. And then interesting discussion here on 3-nanometer and sort of like a fulcrum event in terms of test intensity again at 3-nanometer or data all around. Maybe a couple of questions as my follow-up. What is it about that, that -- I know",193,"Okay. Okay. Great. And then interesting discussion here on 3-nanometer and sort of like a fulcrum event in terms of test intensity again at 3-nanometer or data all around. Maybe a couple of questions as my follow-up. What is it about that, that -- I know it probably is a longer-form discussion, but in short form, what is it about 3-nanometer or 3-nanometer gate all around. Is it sort of what the yield modeling suggests for kind of lower yield rates there compounded by die sizes, compounded by transistors or advanced packaging? Or is it also sort of a combination of the types of devices that you think that enables in terms of the intersection point of various customers and their kind of chip road maps. Just kind of want to get at that. And then like in kind of bigger picture, if the high-performance compute test TAM is a little bit more secular, a little bit more growthy, if you've kind of benchmarked test growth at sort of 4% to 8%, how much of a premium do you think we're looking at over the next several years in terms of HPC TAM?"
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Okay. there's a lot in there, Brian. So let me, first of all, take on 3-nanometer. So the issues about 3-nanometer certainly enables more dense, more transistors per die. That's not what I'm talking about. That's a big driver of test in the future. that w",351,"Okay. there's a lot in there, Brian. So let me, first of all, take on 3-nanometer. So the issues about 3-nanometer certainly enables more dense, more transistors per die. That's not what I'm talking about. That's a big driver of test in the future. that would absolutely be something that would give us a positive outlook for the next midterm. There's the chiplet thing that we talked about where you have mixed nodes going into chips, and then you need known good die testing and then the multi-packaging needs increasingly test intensity. That's not what I'm talking about. But that's real and that's there, too. The thing that I'm talking about with 3-nanometer that's unique, let's say, is the change in the transistor architecture from FinFET to gate all around. That happens once per decade. Again, he it happened with FinFETs earlier in the last decade. It's happening with data all around here in the next few years. Those transitions, everything else being equal, introduce additional, typically, failure modes that need more test methodologies to make sure the device is functionally correctly. And so let's say, the average test time per transistor can tend to be higher because of the additional verification needed related to that new architecture. Now early in the architecture's life, that tends to be higher as the architecture matures over time, that premium, let's say, comes down. So -- and the world doesn't shift to 3-nanometer in mass day 1 either. So there's this bleeding up of certain devices using 3-nanometer that are highly test-intensive and more and more come online year after year, and then the learning curve comes on. But net-net, again, if you look at the test market from 2000 to 2012, it had been a declining market. In 2012 to now, it's been growing quite well in excess of 10%. Part of that is the parallel testing, ameliorating that we've talked about, part of it's the FinFET story that we've talked about and the growing transistor count. So we're at another 1 of those junctures with gate all around. 
And then sorry, HPC."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","HBC higher or lower.",4,"HBC higher or lower."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Okay. Yes. So the -- the growth rate in compute is certainly going to be at the higher end of our mix of submarkets, we think, over the midterm. So if you think the average market growth rate, we're going to update this in January, but pick a number, is 8",65,"Okay. Yes. So the -- the growth rate in compute is certainly going to be at the higher end of our mix of submarkets, we think, over the midterm. So if you think the average market growth rate, we're going to update this in January, but pick a number, is 8%. We think compute is probably leading that by at least a couple of points."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","And operator, we have time for 1 more question, please.",10,"And operator, we have time for 1 more question, please."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your final question comes from Sidney Ho, Deutsche Bank.",9,"Your final question comes from Sidney Ho, Deutsche Bank."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","So I have 2 quick ones. The first 1 is, you talked about supply constraints impacting the IE business. I'm just curious, the gross margin has been pretty good overall, you talked about offering the leverage is one of the reasons. To the extent that your i",74,"So I have 2 quick ones. The first 1 is, you talked about supply constraints impacting the IE business. I'm just curious, the gross margin has been pretty good overall, you talked about offering the leverage is one of the reasons. To the extent that your input cost on logistics and freight cost increase, both in your test and IA business, are you able to pass along some of those costs to your customers?"
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","So at this point, we've been managing through it. So materially, no.",12,"So at this point, we've been managing through it. So materially, no."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Maybe my follow-up question is a lot of discussion on 3 nanometers today, but it's really an opportunity in 2023 and beyond. But if you kind of look at next year, I know you're going to update us in January. How does this impact your tester business",89,"Okay. Maybe my follow-up question is a lot of discussion on 3 nanometers today, but it's really an opportunity in 2023 and beyond. But if you kind of look at next year, I know you're going to update us in January. How does this impact your tester business, if a customer chooses to move from instead going to 3 nanometers, they go to a different generation of 5 nanometers, what is the test to reuse rate when you compare the 2 notes between the 3 nanometers and the alternative?"
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. The tester reuse, people will reuse 5-nanometer generation testers in the 3-nanometer era. So a new tester is not required. And testers tend to have a useful life of a decade or more at a customer, and they can span usability across many, many nodes",250,"Yes. The tester reuse, people will reuse 5-nanometer generation testers in the 3-nanometer era. So a new tester is not required. And testers tend to have a useful life of a decade or more at a customer, and they can span usability across many, many nodes and many, many generations of devices. So there's nothing in terms of a new tester here that comes with 3-nanometer. And yes, by and large, it's a 2023 and beyond type story. But absent that story, what we've been seeing for the past 10 years in test, since 3-nanometer in 2022 is likely not going to be a huge event because it's likely to be later in the year. People will still move down the complexity curve at 5- and 5-plus nanometer nodes and increase transistor counts and such along that that path. So even absent 3-nanometer, we have an optimistic view of what '22 looks like. We'll probably start out the year similar to how we started out years in the past. And at the beginning of the year with some modest growth in the first quarter and then it kind of swings on what's going to happen over the summer, which is our peak quarters. around the refreshes. Will those refreshes of silicon be in 3-nanometer, Will they be in 5 plus with the traditional normal transistor count growth that we've seen for the past 10 years. Those are things that we have to get closer to next year to really understand."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Okay, everybody. We are out of time. Thanks so much for joining us today. And those in the queue, I'll get back to you later today. And again, thanks, everyone, for joining. Bye-bye.",33,"Okay, everybody. We are out of time. Thanks so much for joining us today. And those in the queue, I'll get back to you later today. And again, thanks, everyone, for joining. Bye-bye."
94728,1685270027,2414042,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Ladies and gentlemen, this concludes today's conference call. Thank you participating. You may now disconnect.",15,"Ladies and gentlemen, this concludes today's conference call. Thank you participating. You may now disconnect."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Ladies and gentlemen, thank you for standing by, and welcome to the Teradyne Third Quarter 2021 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Andrew Blanchard.  Thank you. Please go",42,"Ladies and gentlemen, thank you for standing by, and welcome to the Teradyne Third Quarter 2021 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Andrew Blanchard.  
Thank you. Please go ahead, sir."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Patrice.  Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined this morning by our CEO, Mark Jagiela; and our CFO, Sanjay Mehta. Following our opening remarks, we'll provide details of",290,"Thank you, Patrice.  
Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined this morning by our CEO, Mark Jagiela; and our CFO, Sanjay Mehta. Following our opening remarks, we'll provide details of our performance for 2021's third quarter along with our outlook for the fourth quarter.  
The press release containing our third quarter results was issued last evening. We're providing slides on the Investor page of the website that may be helpful to you in following the discussion. Replays of this call will be available via the same page after the call ends.  
The matters that we discussed will include forward-looking statements that involve risk factors that could cause Teradyne's results to differ materially from management's current expectations. We encourage you to review the safe harbor statement contained in the earnings release as well as our most recent SEC filings. Additionally, those forward-looking statements are made as of today, and we take no obligation to update them as a result of developments occurring after this call.  
During today's call, we'll make reference to non-GAAP financial measures. We've posted additional information concerning these non-GAAP financial measures where appropriate on the Investor page of the website. Looking ahead between now and our next earnings call, Teradyne expects to participate in technology or industrial-focused investor conferences hosted by Baird, Credit Suisse, Davidson and UBS.  
Now let's get on with the rest of the agenda. First, Mark will comment on our recent results, current market conditions and thoughts on the rest of 2021 and '22. Sanjay will then offer more details on our quarterly results along with our guidance for the fourth quarter. We'll then answer your questions, and this call is scheduled for 1 hour.  
Mark?"
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Andy.  Good morning, everyone, and thanks for joining us. Today, I'll cover 4 topics: the highlights of our third quarter and the first 9 months of the year, the changes we're observing in the SOC test market, our outlook for the industrial auto",1471,"Thanks, Andy.  
Good morning, everyone, and thanks for joining us. Today, I'll cover 4 topics: the highlights of our third quarter and the first 9 months of the year, the changes we're observing in the SOC test market, our outlook for the industrial automation market and how we're thinking about the test and automation markets as we close out this year and look into 2022 and beyond.  
As our Q3 results demonstrate, demand remains strong across all of our businesses. At the company level, Q3 sales grew 16% from last year's record Q3 and non-GAAP EPS grew 35%. We did experience increased supply chain bottlenecks in our Industrial Automation business in the quarter and under ship demand. Sanjay will describe this in more detail, but we expect these constraints to persist into Q4. Despite this, for the first 9 months of 2021, company-wide sales grew 19% and non-GAAP EPS grew 31% from the year ago level.  
In each of our businesses, we are writing long-term secular trends that we expect will drive revenue and earnings growth for years to come. In our Test businesses, the unit growth and complexity drivers that power these markets continue unabated. For example, our semiconductor test business grew 18% through Q3, while -- with SOC leading the charge growing 22%. Sales continue to be dominated by our UltraFLEX product line, which is well aligned to the performance requirements of the growing compute and mobility markets.  
Additionally, sales of our Eagle Test systems more than doubled in the 9-month period as Automotive and Industrial Test markets have also rapidly expanded. Eagle's unique architecture hits the sweet spot of these markets by balancing high precision with the stress testing needed for these demanding applications.  
Within SOC, there's been a clear shift this year to higher demand from the compute, automotive and industrial markets. While mobility is still the largest subsegment of SOC and growing, it has dropped from the high 50% range of the SOC test market in recent years to the high 40% range this year. Over the midterm, we expect mobility will remain the largest SOC submarket and continue to grow but we also expect compute to grow at a faster rate, while automotive should remain at its current elevated levels.  
For the last decade or so, mobility has made rapid annual advances in semiconductor complexity that has enabled the advancement of smartphone sophistication. The refresh pace has been much faster than traditional PCs, graphics, automotive and industrial end markets, leading to smartphone ICs rapidly progressing along the complexity scale. This is true in many areas of smartphone silicon, apps processor compute engines, graphics engines, AI engines, image sensors, power management and more. Our leading position in testing these key technologies has driven our growth.  
At the same time, up until recently, the traditional compute testing market has been relatively flat with slower refresh rates and slower complexity growth. However, the groundwork laid by mobility designs combined with advancing lithography nodes and design tools has enabled new entrants into the chip design space for compute engines. The complexity of these chips whether for laptops, servers, autonomous driving, AI or graphics is incredible and advancing at an accelerated rate. For example, laptop CPUs are now crossing the 30 billion transistor level, which is a huge leap over previous legacy designs.  
As we've said in the past, increased transistor counts drives increased test time and increased tester demand. We've seen that this year and there's more to come. We're targeting this expanding collection of new players and new designs, leaning heavily into our UltraFLEX family's hardware performance and time-to-market advantages of our software. We've been adding new design wins every quarter. And while development pipelines can be long and these new designs can be speculative, we're confident we'll see growing production business from these wins in the future. It's also notable that the traditional chip suppliers in these markets aren't standing still, they are doubling down on their advanced designs too, which is collectively driving WFE investments higher as applications expand and competition heats up.  
We expect this rate to lead to higher test TAMs and given the higher performance and faster design to market cycle times, more share gain opportunities for Teradyne over the midterm. Our System Test segment last year -- sorry, our System Test segment year-to-date sales grew 11% from 2020 and Storage Test continued its multiyear growth trajectory, expanding sales 12% in the same period. Higher capacity HDDs and more complex SOC devices, which require system-level test are driving this demand.  
Both trends are expected to continue into the foreseeable future. At LitePoint, sales were up 24% through 9 months compared with 2020, driven by WiFi 6E production, WiFi 7 R&D demand as well as ultra wideband. More connected devices demanding more bandwidth while managing growing congestion drives complexity increases in each new WiFi standard and more tests. UWB, on the other hand, is a whole new wireless standard and application space. It's a new proximity detection wireless technology with the future of many promising security applications. We expect these trends to continue and to provide a long-term tailwind to our wireless Test business.  
Shifting to Industrial Automation. Universal Robots revenue grew 50% through the first 9 months of the year, while MiR grew 40% despite supply chain challenges. Each has a unique story. At UR, it's a combination of increasing sales for existing tasks and the expanding number of UR+ offerings, making it easier for customers to deploy our cobots to do new applications. We highlighted welding in our last call, but other examples include screwdriving and palletizing. The UR+ ecosystem is key to expanding these tasks and now totals over 360 products created by over 300 partners, both riding on and broadening the coattails of our UR platform. This is a key advantage in the combination of our organic investments and our UR+ and OEM partners R&D dollars and creativity that's going into expanding the UR platform and it's unmatched.  
At MiR, the story is about new products. The MiR250 which was introduced just as COVID hit last March of last year, is now our largest seller by far. This year, we added the MiR Hook to the 250 family to expand its applications into tugging. We've introduced higher payload products such as the MiR 600 and 1350 to expand our footprint in the fast-growing logistics market.  
Unfortunately, with all this good news come supply chain issues that will limit IA growth in 2021 to be between 30% to 40% year-on-year, but demand is strong. The long-term outlook in IA remains very bright. Looking at the capabilities of UR cobots today, we estimate the penetration rate is less than 2% of the servable market. UR's approximate 45% market share puts us clearly in the lead, and we continue to drive R&D and distribution investments to extend our competitive advantages, expand the servable market and drive penetration higher.  
It's a similar story at MiR, where we estimate the autonomous mobile robot penetration is under 3%. The AMR market doesn't have a single dominant player like UR cobots, and we estimate we're close to #2 in the broadly defined market. And like at UR, we're making investments in both the distribution and product level to both reinforce our advantages and extend our product reach.  
In both IA businesses, the fact that our penetration of today's servable market is low single digits and that the servable market continues to expand each year with product enhancements, sets up a fantastic future. So even with very high growth rates in our IA business, we expect the penetration rates to remain low for many years, sustaining our long-term annual growth forecast of 20% to 35%. In January, we will update you on the outlook for 2022 and our midterm earnings model. Between now and then, we'll be looking at the rate and timing of new semiconductor fab capacity coming online, especially at the more advanced lithography nodes. And we'll also be looking at the rate of adoption of DDR5 as key swing factors.  
In IA, we will be looking at the manufacturing output expansion, onshoring trends and PMIs in our principal geographies as tailwinds for continued robust growth. On the other hand, in both markets, supply chain bottlenecks could slow certain industries and become a headwind to growth demand. Short-term demand is influenced by many factors, but we manage our business aligned to the long-term trends. The trend of growing prevalence of increasingly complex semiconductors and a myriad of applications drives our semiconductor business and investments. The trend of new increasingly smart, cost-effective automation in a world with labor scarcity and onshoring challenges drives our IA business and investment strategy. These systemic long-term trends paid an exciting future for Teradyne.  
With that, I'll turn it over to Sanjay."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Mark, and hello, everyone.  In my remarks, I'll review our Q3 financial results, discuss our supply line strategy in this challenging environment, provide Q4 guidance and comment on our full year financial outlook at the midpoint of our Q4 guida",1463,"Thanks, Mark, and hello, everyone.  
In my remarks, I'll review our Q3 financial results, discuss our supply line strategy in this challenging environment, provide Q4 guidance and comment on our full year financial outlook at the midpoint of our Q4 guidance to the financial headlines for Q3.  
Our third quarter sales were $951 million was near the high end of guidance driven by strength in Semi Test and wireless test. Gross margin in the quarter was approximately 60%. Our non-GAAP operating expenses were $242 million or 25.5% of revenue. The favorability in OpEx drove a non-GAAP operating margin of approximately 35% and non-GAAP EPS of $1.59, a few more components of third quarter data. Our tax rate, excluding discrete items, was 14.8% on both a GAAP and non-GAAP basis. Non-GAAP diluted share count was approximately $176 million. We had two 10% customers.  
Looking at the results from a business unit perspective. Semi Test revenue of $688 million was up 16% from Q3 '20. SOC revenue was $575 million, up 28%, driven by strength in applications processors, RF, industrial and automotive applications. Automotive and industrials doubled revenue year-over-year. Memory revenue was the second highest in history at $113 million, but down 21% from Q3 of last year's record. 
FLASH final test demand was the strongest segment on handset and SSD end market demand. System Test group had revenue of $103 million, which was down 13% year-over-year. Recall Storage is the largest business in this segment and has lumpy shipments. While Storage Test will still grow more than 15% for the year, sales, including HDD and SLT declined to $56 million on the timing of shipments in Q3.  
Defense and aerospace and production board test combined grew 10% year-on-year to $47 million. At LitePoint, revenue of $69 million was up 70% from prior year due to early success of our new WiFi 7 product, continued strength in 4G cellular and [ Utilev ].  
Now to Industrial Automation. As in July, given COVID shutdowns had impaired the UR business in 2020, I'll provide revenue metrics comparing Q3 '21 results with both Q3 '20 and Q3 '19. Industrial Automation revenue of $91 million was up 32% from both Q3 '19 and Q3 '20. North America delivered the highest revenue growth from last year, but all regions expanded year-on-year. As Mark noted, supply issues, primarily semiconductors, reduced our IA shipments in the quarter. UR sales were $78 million in Q3, up 46% year-over-year and 31% over Q3 '19. MiR sales were $13 million, up 27% from Q3 '20 and 35% from Q3 '19. IA was about breakeven in the quarter and full -- breakeven in the quarter and full year, we expect low single-digit profitability. As we've noted before, we continue our strategy of investing during this high-growth era while maintaining gross margins to enable mid-20s operating profit in the future.  
Shifting to supply. We continue to deal with numerous supply constraints across the company. While semiconductor shortages are well reported, we're also seeing delays in mechanical parts and logistics, all exacerbated by rolling COVID-related shutdowns or labor shortages. We expect these issues will continue through the first half of 2022. Despite these issues, we've been able to deliver record shipments and a big part of that performance is a result of the supply line management, operations teams and engineering teams working with our supply chain and contract manufacturing partners.  
We view our operational business model and execution against it as a core competence. Our gross margin performance over the last 10 years displays the financial value of this model. In our test portfolio, our execution has kept most of our tester lead times within the range that meet customers' needs to expand their production capacity in this dynamic environment. The significance of this lead time performance is that customer orders more closely reflect true test demand. So while a bit counterintuitive, we feel that maintaining short lead times are a more accurate indicator of test demand with lower risk than holding orders with lead times far beyond chip manufacturing cycle times. Of course, our supply line and operations model isn't static. We begin in adding resiliency through both geographic and supplier diversity prior to COVID. Those efforts have accelerated over the last 20 months.  
This work is paying dividends in the current environment, and we'll continue to invest to harden our supply chain further. Our lead time performance is an example of our resilience and execution. Another example is the ability to scale to significantly increase demand. Auto and industrial sales have more than doubled year-over-year. While we're not perfectly aligned to all customer requested delivery dates, we are managing through delivery issues in a reasonable manner. The value of these efforts can also be seen in the operating leverage in our gross margin line. In IA, we've seen lead times extend from our normal 1 to 2 weeks to 4 to 6 weeks for some products. While this is a challenge, with the business growing so quickly and ongoing industry supply issues, we've already seen the positive impact of our work in material sourcing and manufacturing cycle times.  
We expect to bring lead times back to model over the next 2 to 3 quarters. Shifting to the balance sheet and cash flow. Our cash and marketable securities at the end of the quarter totaled $1.45 billion. We had $493 million in free cash flow in the quarter, and through 9 months, we've spent $103 million on CapEx, and we expect we'll spend $148 million for the full year. We spent $210 million and $16 million on buybacks and dividends, respectively. Year-to-date, we've repurchased 3.3 million shares for $406 million at an average price of $123.53. In 2021, we expect to return over 80% of our free cash flow to shareholders. And from 2015, when we began repurchasing shares, we've returned 85% of our free cash flow to owners.  
Regarding our convertible debt, $302 million of principal was paid in the first 9 months to the convertible bondholders ahead of maturity. By mid-December, bondholders will have converted approximately $343 million, leaving a face value of $117 million.  
Now to our outlook for Q4. Sales in Q4 are expected to be between $820 million and $900 million, with non-GAAP EPS in a range of $1.14 to $1.40 on 174 million diluted shares. Fourth quarter guidance excludes the amortization of acquired intangibles and noncash imputed interest on the convertible debt. Our guidance assumes no significant changes, positive or negative, in the availability of materials and assumes that we won't see additional pandemic-related issues. Fourth quarter gross margins are estimated at 59% to 60%. OpEx is expected to run at 28% to 31% of fourth quarter sales. The non-GAAP operating profit at the midpoint of our third quarter guidance is 30%.  
Regarding OpEx for the full year. We spent a bit lower than planned in Q3, and we expect the full year OpEx will be about $980 million, up 17% from 2020. At the midpoint of our guidance, 2021 will be another year of growth in both revenue and EPS, while sales growing -- or sorry, with sales growing 18% to $3.7 billion and non-GAAP EPS growing to $5.88, up 27%. Gross margin for the full year should be approximately 59.5%, up from 57.2% in 2020, reflecting the ramp of new products, product mix and operating leverage, offsetting component and logistics cost increases.  
Our 2021 non-GAAP operating profit rate is expected to be about 33%, up from last year's 30%. Our full year tax rate is expected to be 14.8%. These results put us comfortably in the range of our 2024 earnings model this year. We'll update the model on our regular cadence in January. The breadth of our customer buying in 2021 is also broader than last year. In 2020, we had 1 customer that drove 25% of sales. In 2021, we do not expect to have any customer larger than 20% of our yearly revenue. This reflects the trend Mark noted about 2021's higher growth in compute, auto and industrial demand compared with mobility demand in Semi Test. IA growth of over 30% year-over-year continues to diversify our revenue. This growth is expected to continue over the midterm and become a larger portion of our revenue.  
In summary, we expect to end the year with another quarter of strong year-on-year revenue and EPS growth. On a full year basis, we'll exceed our midterm targets on stronger-than-expected demand on our test businesses, continued high growth in IA and excellent execution across the company. While we don't have a clear picture of 2022 yet, we're confident in the long-term industry trends powering our test and IA businesses remain firmly in place.  
With that, I'll turn the call back to Andy."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Sanjay. Patrice, we would now like to take some questions. And as a reminder, please limit yourself to 1 question and a follow-up.",24,"Thanks, Sanjay. Patrice, we would now like to take some questions. And as a reminder, please limit yourself to 1 question and a follow-up."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","[Operator Instructions] Your first question comes from Atif Malik with Citi.",11,"[Operator Instructions] Your first question comes from Atif Malik with Citi."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Good job in the top supply environment. Mark, if I look at some of the recent ARM-based notebook processors, the transistor count is growing 2 to 4x versus prior generation. You commented mobility to grow and compute auto and allowed to grow faster than m",71,"Good job in the top supply environment. Mark, if I look at some of the recent ARM-based notebook processors, the transistor count is growing 2 to 4x versus prior generation. You commented mobility to grow and compute auto and allowed to grow faster than mobility in the midterm understand you guys in January talk about next year outlook in January. How confident do you feel about your SOC growth next year?"
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Well, I think at this point, pretty confident. I mean we look at the trends that I just -- you cited and I cited and see that there's very little standing in the way of sort of this increased growth, but the caveat I would mention is there's a lot of supp",176,"Well, I think at this point, pretty confident. I mean we look at the trends that I just -- you cited and I cited and see that there's very little standing in the way of sort of this increased growth, but the caveat I would mention is there's a lot of supply chain bottlenecks in the system. So if end products get bottlenecked, that can slow down the unit volume demand for new semiconductors. And the other thing we're looking at is when do these new nodes really come online in terms of capacity. All that $90 billion of WFE that was put in place this year hasn't yet had a single impact on test. That's all to come. But it kind of depends on when do those additional 5- and 3-nanometer fabs come online. That is kind of a big swing factor in the calendar year 2022 as to how our growth will shrunk out. And that's kind of why we wait until January because we don't get good enough visibility on that right now."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Great. And Sanjay, as a follow-up, can you talk about concentration within mobility and compute customer and impact on long-term gross margins? There have been talks about price discounts with equipment suppliers by Tier 1 foundry.",36,"Great. And Sanjay, as a follow-up, can you talk about concentration within mobility and compute customer and impact on long-term gross margins? There have been talks about price discounts with equipment suppliers by Tier 1 foundry."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. As I stated in my prepared remarks, we won't have any customer above 20%. So it's a broader breadth of customers. And regarding gross margins, in throughout the year, we've improved gross margins. And as I said in earlier calls, really driven by a co",127,"Yes. As I stated in my prepared remarks, we won't have any customer above 20%. So it's a broader breadth of customers. And regarding gross margins, in throughout the year, we've improved gross margins. And as I said in earlier calls, really driven by a couple of key test systems coming online and we're shipping in volume that have come down the cost curve. We've seen some benefits to product mix shift as well as our operating leverage offsetting the component costs and logistic cost increases. From a look forward and sustainability of that gross margin, obviously, we'll give an update to our earnings model in January. But I see the second half of our gross margin performance kind of going into the first half of 2022."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Mehdi Hosseini with SIG.",9,"Your next question comes from Mehdi Hosseini with SIG."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Yes, the first one has to do with your largest customer. Given your commentary in terms of revenue mix, it seems to me that that particular customer is going to be down like 5% to 6%. In that context, should we assume a return to growth in '22, and this i",77,"Yes, the first one has to do with your largest customer. Given your commentary in terms of revenue mix, it seems to me that that particular customer is going to be down like 5% to 6%. In that context, should we assume a return to growth in '22, and this is trend that has happened over the past several years? And should that happen again? Should that pattern happen again into '22? And I have a follow-up."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. We, of course, maybe can't talk about any individual customer and what they might do or not do in the future. So that I have to leave aside. But I just point out in your first point that, yes, our largest customer is dropping below 20% in a growing r",73,"Yes. We, of course, maybe can't talk about any individual customer and what they might do or not do in the future. So that I have to leave aside. But I just point out in your first point that, yes, our largest customer is dropping below 20% in a growing revenue year. So the amount that you might think compute that they're falling has to be taken against our numerator of higher revenue."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And then wanted to follow up to the question that came up 3 months ago, when we were looking into your market share in the compute. Can you update us where you are with that market share in 2021? And as hyperscalers ramp their own ARM-based CPUs,",62,"Got it. And then wanted to follow up to the question that came up 3 months ago, when we were looking into your market share in the compute. Can you update us where you are with that market share in 2021? And as hyperscalers ramp their own ARM-based CPUs, how will your market share change over the next 1 or 2 years?"
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Well, like the total SOC market, year-to-year market share is very volatile. It depends on whose customers are buying what in any given year. So what our market share might be in any given year, it can -- in a submarket like compute, it can swing 20 point",118,"Well, like the total SOC market, year-to-year market share is very volatile. It depends on whose customers are buying what in any given year. So what our market share might be in any given year, it can -- in a submarket like compute, it can swing 20 points year-to-year depending on who's buying. So for this year, it tends to be a very good compute year for us. Our compute market share is up in, I would say, close to what our average share is in SOC this year. But I would say that it's not steady eddie. It's going to be pretty volatile year-to-year it has been in the past. It probably will be going forward, too."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","I know we're supposed to ask only 2 questions, but just a quick follow-up. I think what I'm trying to understand is I think on the GPU side, it's pretty clear that your competitor has dominated. And assuming that, that work to remain unchanged, I think th",86,"I know we're supposed to ask only 2 questions, but just a quick follow-up. I think what I'm trying to understand is I think on the GPU side, it's pretty clear that your competitor has dominated. And assuming that, that work to remain unchanged, I think the incremental change to the compute is all driven by ARM-based. And I was just trying to better understand how you look at your competitive position as these new chips coming to the market addressing the compute end market?"
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","We look -- we're very pleased and confident with our progress in ARM-based compute and design-ins in that realm, but I would say that it's not -- there's the tester market for compute is also driven by more traditional x86 demand as well. You've got a cou",82,"We look -- we're very pleased and confident with our progress in ARM-based compute and design-ins in that realm, but I would say that it's not -- there's the tester market for compute is also driven by more traditional x86 demand as well. You've got a couple of suppliers there that are not standing still, as I mentioned, and are upping their kind of complexity growth curve. And so there will be certainly a lot of growth there as well, I believe."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Your next question comes from Toshiya Hari, Goldman Sachs.",9,"Your next question comes from Toshiya Hari, Goldman Sachs."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Congrats on the strong execution. I had 2 questions as well. My first 1 is on the supply constraints, maybe for Mark, maybe for Sanjay. Just curious how significant the headwinds were for IA in Q3 and what's embedded in your Q4 guidance? If you can share",102,"Congrats on the strong execution. I had 2 questions as well. My first 1 is on the supply constraints, maybe for Mark, maybe for Sanjay. Just curious how significant the headwinds were for IA in Q3 and what's embedded in your Q4 guidance? If you can share that, that would be helpful. And I just wanted to confirm that there was little to no impact on your semi test business. And then on gross margins, similarly, you came in at the high end of your guided range, but was there any impact on your profitability in the quarter from supply chain shortages."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Sure. So I'll take those. So from an Industrial Automation perspective, year-to-date, we've grown 40% in IA, and Q4 demand is high. if we can't supply at all, that's why we've -- I think it's going to be growth year-on-year of about 30% to 40%. And so pre",214,"Sure. So I'll take those. So from an Industrial Automation perspective, year-to-date, we've grown 40% in IA, and Q4 demand is high. if we can't supply at all, that's why we've -- I think it's going to be growth year-on-year of about 30% to 40%. And so predominantly, it's in semiconductors. And I expect we'll be out of the supply chain crunch given our visibility in Q2 or Q3 for IA. So that's the IA side. And then from a supply chain perspective on the test side, we've seen the supply chain tightening on the test portfolio quarter-over-quarter, where we don't think it's going to be abated until the end of Q2 of 2022. And again, mainly semiconductor parts. And really, we see that coming back online in the second half, really tied to the wafer and the substrate capacity coming online.  
And then from a gross margin perspective, we've been managing through the component increases, logistics increases in cost. And we've -- as I've said earlier, we've had favorable product mix. And as our volumes or our revenues are higher, we're gaining operating leverage along with coming down the cost curve of our new products that we've introduced late last year. So we're managing through it, and it's true well-publicized component cost increases."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. That's super helpful. And then as my follow-up, Mark, I wanted to ask about your Eagle Test business. In your prepared remarks, you noted that the business is up more than 2x year-to-date. I guess historically, like many other parts of your busine",143,"Got it. That's super helpful. And then as my follow-up, Mark, I wanted to ask about your Eagle Test business. In your prepared remarks, you noted that the business is up more than 2x year-to-date. I guess historically, like many other parts of your business, I think the Eagle Test has been quite cyclical. You would be up for a year, 1.5 years, 4 to 6 quarters and then down a little bit as customers digest their test capacity based on what you said, it seemed like you're expecting 2022 to be another strong year. I guess the question is what's different this time as you think about Eagle Test into '22. I realize there's complexity growth, but you could argue there's been complexity growth for a very long time. So just curious how different this cycle could be relative to past cycles."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Right. Good question. And in addition, automobile unit volume isn't near its historical peak either. So how could this thing keep going beyond the normal 6-quarter surge in automotive, which is you're right, again, that's kind of the traditional pattern.",189,"Right. Good question. And in addition, automobile unit volume isn't near its historical peak either. So how could this thing keep going beyond the normal 6-quarter surge in automotive, which is you're right, again, that's kind of the traditional pattern. But I think what we see happening and makes us believe this will persist at least through 2022 is there's a lot of silicon refresh going on that's new in the automotive space. New -- kind of racing to get new, more current generation lithography node silicon into automotive design because the legacy lines out there are hard to get at chip suppliers are trying to obsolete those fabs. And so the automotive customers don't have as much, I would say, power in this frothy demand environment on the semiconductor supply side. And so the semiconductor suppliers are kind of same, get with the program, move to more advanced nodes. And a little bit of that's happening, which is what -- that means complexity, yield issues, and that means a little more test than you might expect. And I think that's what's giving us a different view this time."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from John Pitzer, Credit Suisse.",9,"Your next question comes from John Pitzer, Credit Suisse."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Congratulations on the solid results. Mark, I want to go back to increasing test times in the semi test business. You've done a good job kind of helping us understand complexity and transistor count. I'm kind of curious, as we move from a world of sort of",96,"Congratulations on the solid results. Mark, I want to go back to increasing test times in the semi test business. You've done a good job kind of helping us understand complexity and transistor count. I'm kind of curious, as we move from a world of sort of general purpose compute to one of more optimized silicon, you're going to move from a world where you're testing huge volumes in 1 device to smaller volumes across multiple devices. What does that do for test efficiency at your customers? And hence, test times as that trend takes hold."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","It is a -- building, let's say, 100 billion transistors on 1 chip versus 4, to give an example, isn't equivalent test time. The 4-chip version is likely to -- these are going to be rough rules of thumb, but let's say, 25% more test intensive than the sing",259,"It is a -- building, let's say, 100 billion transistors on 1 chip versus 4, to give an example, isn't equivalent test time. The 4-chip version is likely to -- these are going to be rough rules of thumb, but let's say, 25% more test intensive than the single chip design because there's a premium on sort of known good die testing to -- when you put those together in an advanced package. And then the advanced package itself has more potential defect failure modes that need to be tested. So that's 1 thing around the whole chiplet, multi-chip package thing. The other thing, though, that's happening, and this is really going to become prevalent at 3-nanometer and beyond is the move from FinFET to gate all around transistor architectures. 
And if you remember, when the world moved from planar to FinFET, it was back in 2012, '13, '14 era, that drove -- if you go back and look at the history of sort of the test market, that drove incremental test intensity and complexity in the market. And we're headed for another one of those with gate all around. There's going to be new defect modes, new kind of test intensity boosts coming from this new architecture on the transistor. So even at equivalent transistor counts, we're going to see a little bit more test intensity because of that. So these 2 trends of chiplets and gate all around and 3-nanometer, that's probably all the 2023 and beyond story given where 3-nanometer is right now, but it's coming."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","That's helpful. And that's my second question, Mark, just going back to your largest customer, I'm kind of curious if you can help me better understand the diversity of business with that customer. I mean clearly, it's been mobility led for the last sever",104,"That's helpful. And that's my second question, Mark, just going back to your largest customer, I'm kind of curious if you can help me better understand the diversity of business with that customer. I mean clearly, it's been mobility led for the last several years. Now you've got them doing more in the compute space. You've talked about in the past the complexity around these air tags. Are you seeing a meaningful diversification of demand drivers at that customer? And can you help me because I just don't know how fungible is your -- is there test capacity across those different product families?"
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes, I'm not going to be able to talk too much about the sort of breadth there. I think you can imagine it, and you've rattled off some examples. In terms of fungibility, they're pretty fungible to testers across what's used for compute engine in a phone",299,"Yes, I'm not going to be able to talk too much about the sort of breadth there. I think you can imagine it, and you've rattled off some examples. In terms of fungibility, they're pretty fungible to testers across what's used for compute engine in a phone versus a compute engine in a laptop or a desktop or anything else. The one that's a little bit unique is when you get into things like the RF type products, of course, have a bit of a different architecture, power management type products have a bit of a different architecture. And so those testers tend to be a little more unique. But we've talked about in the past that -- I think people have looked at us and said, well, in a world where cell phones are kind of plateauing, doesn't that -- unit growth of cell phones doesn't that portends some kind of slowing for us. 
And what we've always said is that, look, cell phone unit growth can slow, complexity isn't. And some of these customers are diversifying into more silicon, both in the phone and now more silicon outside the phone into compute. There are these emerging hyperscalers that are building silicon for both cloud computing and other new yet to be introduced consumer products. So the ability of a design team today to be formed and put together a $10 billion-plus transistor chip for a consumer application is easier and easier and easier. And as I said in my script, we worked with a lot of them. Maybe a small fraction of them will be hits in the future, but they can bring entirely new classes of sector high compute engine semiconductor applications to the market. And all of those are kind of UltraFLEX, UltraFLEXplus family devices."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from CJ Muse of Evercore.",9,"Your next question comes from CJ Muse of Evercore."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","I guess, Mark, another technology question. you've kind of taught us to think about transistor count and kind of thinking about test times for mobility compute. And curious, as we go to more high-performance compute, where there are more thermal issues, p",58,"I guess, Mark, another technology question. you've kind of taught us to think about transistor count and kind of thinking about test times for mobility compute. And curious, as we go to more high-performance compute, where there are more thermal issues, perhaps more complex software algorithms, how should we be thinking about the test times in that transition?"
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Well, I think the test times have less to do with the application. The only place where the application drives really fundamentally different test times as automotive because of the issues there. It's more the technology. So I go back to CJ, what I said b",81,"Well, I think the test times have less to do with the application. The only place where the application drives really fundamentally different test times as automotive because of the issues there. It's more the technology. So I go back to CJ, what I said before about 3-nanometer is going to be more impactful to both test times in phones and in computers and in servers and in graphics and in everything else, probably than any of those end market applications."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. That's helpful. And then I guess, Sanjay, a question for you. Clearly, you're making investments, particularly in IA. But as you look to 2022, can you speak to your outlook for operating leverage. And as part of that, how we should think about OpEx",50,"Okay. That's helpful. And then I guess, Sanjay, a question for you. Clearly, you're making investments, particularly in IA. But as you look to 2022, can you speak to your outlook for operating leverage. And as part of that, how we should think about OpEx relative to top line growth?"
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Sure. I'd say we're in the early innings of looking at 2022. And obviously, we'll provide an update in January. But OpEx is growing in kind of a couple of key areas this year, obviously tied to higher volume, we have variable compensation as well as engin",150,"Sure. I'd say we're in the early innings of looking at 2022. And obviously, we'll provide an update in January. But OpEx is growing in kind of a couple of key areas this year, obviously tied to higher volume, we have variable compensation as well as engineering spends tied to our operations to qualify new suppliers et cetera. And then we continue to invest in both go-to-market and engineering across the test portfolio. And as you noted, we're leaning in, obviously, in -- as I noted in my prepared remarks, we're leaning into our IA investments really to help drive going forward. The other component is the G&A expenses going forward. This was a big year of OpEx growth. The only thing I'd say is that next year is we're not going to be as large percentage-wise growth, but that's really all I have to say on it right now."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Timothy Arcuri, UBS.",8,"Your next question comes from Timothy Arcuri, UBS."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, I just wanted to see if you can update us on the SOC TAM. You had said 4, 5 last call and segment of that was compute was about $1 billion. Mobility was [ 18 ] to [ 18.5. ] Autos were about 500, Industrial was [ 5, 550 ]. I'm just kind of wondering",64,"Mark, I just wanted to see if you can update us on the SOC TAM. You had said 4, 5 last call and segment of that was compute was about $1 billion. Mobility was [ 18 ] to [ 18.5. ] Autos were about 500, Industrial was [ 5, 550 ]. I'm just kind of wondering if you can update us on those numbers."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Good question. So fundamentally, it's in the same range. It's probably trending more up towards the higher end of that range. So I think the numbers, the submarkets you got right on what we talked about last time, maybe compute is driving us a little",71,"Yes. Good question. So fundamentally, it's in the same range. It's probably trending more up towards the higher end of that range. So I think the numbers, the submarkets you got right on what we talked about last time, maybe compute is driving us a little bit higher in that range at this point in time. But it's pretty close. And memory is still at about $1 billion TAM as well."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Great. And then I guess I had a question just on profitability in IA. I noted, Sanjay, you just answered a question about operating leverage next year. But what's the catalyst maybe -- this time last year, we were thinking IA would be 10% to 15% op",130,"Okay. Great. And then I guess I had a question just on profitability in IA. I noted, Sanjay, you just answered a question about operating leverage next year. But what's the catalyst maybe -- this time last year, we were thinking IA would be 10% to 15% op margin and then it got cut to 10% and then it went to 5%, and now it's kind of low single digits. And I get that the penetration there is very low. But what's the catalyst for you to look at? Maybe we shouldn't be investing so much money and maybe we can optimize OpEx investment. So I guess I'm just kind of wondering how you think about sort of what's going on at IA and what the long-term profitability target is?"
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So our range, as we said prior is 5% to 15%, and we expect to be low single digits, as I said in my prepared remarks. But really, how we think about it is we manage the business on a -- think about it as a rule of 40, combining the year-over-year gro",214,"Yes. So our range, as we said prior is 5% to 15%, and we expect to be low single digits, as I said in my prepared remarks. But really, how we think about it is we manage the business on a -- think about it as a rule of 40, combining the year-over-year growth with the operating profit. And fundamentally, we're -- as we see or as been noted by Mark, where penetration is very, very low and we look at all the jobs that can be automated and the scarcity of labor and economic growth, we really see a strong tailwind for the portfolio. And with that, we're very focused and conscious on both engineering and go-to-market investments. And so how we think about it is quite simple. And that is where we have a strong belief that we're going to grow and it's going to accelerate that revenue growth, we're going to lean into the investment. And again, think about it in the rule of 40. And as I said in my prepared remarks, our gross margins are actually improving in that portfolio. And so when we see that growth start to moderate, then we'll start to moderate the OpEx to get to an operating profit of, let's say, in the mid-20s."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Vivek Arya, Bank of America.",10,"Your next question comes from Vivek Arya, Bank of America."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, this move to 3-nanometer, is that a benefit for Teradyne in '22 or '23? I thought it would be '23, but I wanted to confirm. And kind of following on for that, what are the top 1 or 2 end markets that you are the most excited about in terms of growth",56,"Mark, this move to 3-nanometer, is that a benefit for Teradyne in '22 or '23? I thought it would be '23, but I wanted to confirm. And kind of following on for that, what are the top 1 or 2 end markets that you are the most excited about in terms of growth for next year?"
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","So on the 3-nanometer question, that was one of the things I mentioned that we'll be looking at carefully between now and January when we update you on the 2022 view. And we've seen some pushouts on some of those nodes for a -- by a few months. So the abi",203,"So on the 3-nanometer question, that was one of the things I mentioned that we'll be looking at carefully between now and January when we update you on the 2022 view. And we've seen some pushouts on some of those nodes for a -- by a few months. So the ability to intercept them in a meaningful way in Q -- or sorry, in 2022 is a swing factor. We don't see that exactly yet. But whatever happens in 2022, it might get some early ramping, but the bulk of it is going to be 2023, '24, '25 kind of and beyond. So a little bit could happen in '22, how much we won't know more until January. In terms of markets next year that are interesting and exciting. I think it goes back to these emergent hyperscalers that are developing some new applications and very complex silicon for those new applications. Some of those could latch in the market with new product introductions and drive a whole new sort of demand stream for semiconductors and the testers associated with them. So that's kind of what we're rooting for and what we're close to, and we're seeing could be breakouts for 2022."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Very helpful. And maybe just following up on that. Is there a way, Mark, to contrast the additional complexity in a product that's going into a hyperscaler application versus a mobility application. I understand by sizes might be different than pa",123,"Got it. Very helpful. And maybe just following up on that. Is there a way, Mark, to contrast the additional complexity in a product that's going into a hyperscaler application versus a mobility application. I understand by sizes might be different than packaging, et cetera, might be different. But in conceptually, what does the mix shift from a more mobility heavy end market to something that is taking you more into the compute and hyperscaler land mean for Teradyne in terms of your growth prospects and also the -- just the seasonality because mobility tends to be in a lot more seasonal markets. Those other markets are perhaps less seasonal. So what does that mix shift mean for Teradyne over the long term?"
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes, that's a good question. And the range of devices being developed at hyperscalers is quite large. Some of them are simpler than a classic cellphone device, apps processor in a cell phone. So those aren't going to have much of an impact even if they la",173,"Yes, that's a good question. And the range of devices being developed at hyperscalers is quite large. Some of them are simpler than a classic cellphone device, apps processor in a cell phone. So those aren't going to have much of an impact even if they latch. But some of them that are more, I would say, leverage AI, machine learning and high res displays are equal to or greater complexity than what you might find in a typical cell phone application for those technologies. So it's a broad spectrum is, I guess, the bottom line. But if you sort of play it out. I'd say the hyperscalers are going to, on average, bring cell phone-like complexity applications to the market. It's probably not going to be something that's -- take the $50 billion transistor device that kind of surprised everybody. It's probably not at that extreme. It's probably more in the $10 billion transistor range on average and then moving up year-over-year over year after that as they iterate on the design."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Krish Sankar with Cowen and Company.",11,"Your next question comes from Krish Sankar with Cowen and Company."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Back to Mark, just want to ask the 3-nanometer question in a different way, you spoke about how test investments have to catch up to front-end WFE spending. But during the 3D NAND investment cycle WFE grew in 2016 and '17, while the memory test spending k",79,"Back to Mark, just want to ask the 3-nanometer question in a different way, you spoke about how test investments have to catch up to front-end WFE spending. But during the 3D NAND investment cycle WFE grew in 2016 and '17, while the memory test spending kind of came in 2018 in a meaningful way. So I'm kind of curious, how should we think about the time lag effect of sets to front-end foundry logic WFE this time around?"
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Good questions. So all of the WFE investment gets recognized before a single testers associated with that investment. So the way to think about test is whenever you see some silicon coming off a new node, I assume that the testers were installed mayb",184,"Yes. Good questions. So all of the WFE investment gets recognized before a single testers associated with that investment. So the way to think about test is whenever you see some silicon coming off a new node, I assume that the testers were installed maybe 3 months or so prior to that. So once the 3-nanometer fab comes online and you start to see product coming off of it in reasonable volume more than sort of pilot line volume. I assume that the tester installations occurred about 3 months prior. That's kind of the best guidance I can give you there. And then the only other thing I would caution about memory versus SOC is that the curve of test time to transistor count is not the same in memory as it is in SOC. Memory tends to be a bit more efficient for reasons I won't get into here. So you can double transistors and memory, and you're not going to probably move test time more than 20%, 30% or so, let's say, whereas in SOC, it's not quite linear, but it's closer."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Got it. That's very helpful, Mark. Then I have a follow-up for Sanjay, on gross margins. Despite the constrained environment, gross margins have stepped up about 200-plus basis points over the last like 4 quarters or so to a 59% to 60% range. Is t",60,"Got it. Got it. That's very helpful, Mark. Then I have a follow-up for Sanjay, on gross margins. Despite the constrained environment, gross margins have stepped up about 200-plus basis points over the last like 4 quarters or so to a 59% to 60% range. Is this kind of the new baseline we should assume at these revenue run rates?"
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think I talked about that earlier. So we're going through our strategic planning process in Q4, and it's really the basis of our earnings model update in January. As I've said, just having some visibility into the first half of next year, I think y",153,"Yes. I think I talked about that earlier. So we're going through our strategic planning process in Q4, and it's really the basis of our earnings model update in January. As I've said, just having some visibility into the first half of next year, I think you should expect to see that gross margin be similar in the first half of next year as we have in the second half of 2021. From -- and so there's many different variables in there. I noted that we've been managing through the component and logistics cost increase. We've had good mix and come down the cost curve of our new products and gaining operating leverage. So there's many variables in there that we're going to look at closely. And as our revenue gets more and more diversified. There's a lot of puts and takes, but we'll provide more guidance on that in the January call."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Brian Chin, Stifel.",8,"Your next question comes from Brian Chin, Stifel."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Nice results, and thanks for letting us ask a few questions. Sorry, first to clarify something going back on the commentary. If you had more chips, you would be able to ship to an appreciably higher level of revenue in both the Semi Test and Industrial Au",55,"Nice results, and thanks for letting us ask a few questions. Sorry, first to clarify something going back on the commentary. If you had more chips, you would be able to ship to an appreciably higher level of revenue in both the Semi Test and Industrial Automation businesses in Q4. Did I hear that correctly?"
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","In industrial automation, percentage-wise, we'd be able to ship more. In the test portfolio, we think we're going to manage through the majority of the supply issues at this point.",30,"In industrial automation, percentage-wise, we'd be able to ship more. In the test portfolio, we think we're going to manage through the majority of the supply issues at this point."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Okay. Great. And then interesting discussion here on 3-nanometer and sort of like a fulcrum event in terms of test intensity again at 3-nanometer or data all around. Maybe a couple of questions as my follow-up. What is it about that, that -- I know",193,"Okay. Okay. Great. And then interesting discussion here on 3-nanometer and sort of like a fulcrum event in terms of test intensity again at 3-nanometer or data all around. Maybe a couple of questions as my follow-up. What is it about that, that -- I know it probably is a longer-form discussion, but in short form, what is it about 3-nanometer or 3-nanometer gate all around. Is it sort of what the yield modeling suggests for kind of lower yield rates there compounded by die sizes, compounded by transistors or advanced packaging? Or is it also sort of a combination of the types of devices that you think that enables in terms of the intersection point of various customers and their kind of chip road maps. Just kind of want to get at that. And then like in kind of bigger picture, if the high-performance compute test TAM is a little bit more secular, a little bit more growthy, if you've kind of benchmarked test growth at sort of 4% to 8%, how much of a premium do you think we're looking at over the next several years in terms of HPC TAM?"
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Okay. there's a lot in there, Brian. So let me, first of all, take on 3-nanometer. So the issues about 3-nanometer certainly enables more dense, more transistors per die. That's not what I'm talking about. That's a big driver of test in the future. that w",351,"Okay. there's a lot in there, Brian. So let me, first of all, take on 3-nanometer. So the issues about 3-nanometer certainly enables more dense, more transistors per die. That's not what I'm talking about. That's a big driver of test in the future. that would absolutely be something that would give us a positive outlook for the next midterm. There's the chiplet thing that we talked about where you have mixed nodes going into chips, and then you need known good die testing and then the multi-packaging needs increasingly test intensity. That's not what I'm talking about. But that's real and that's there, too. The thing that I'm talking about with 3-nanometer that's unique, let's say, is the change in the transistor architecture from FinFET to gate all around. 
That happens once per decade. Again, he it happened with FinFETs earlier in the last decade. It's happening with data all around here in the next few years. Those transitions, everything else being equal, introduce additional, typically, failure modes that need more test methodologies to make sure the device is functioning correctly. And so let's say, the average test time per transistor can tend to be higher because of the additional verification needed related to that new architecture. Now early in the architecture's life, that tends to be higher as the architecture matures over time, that premium, let's say, comes down. So -- and the world doesn't shift to 3-nanometer in mass day 1 either. 
So there's this bleeding up of certain devices using 3-nanometer that are highly test-intensive and more and more come online year after year, and then the learning curve comes on. But net-NAND, again, if you look at the test market from 2000 to 2012, it had been a declining market. In 2012 to now, it's been growing quite well in excess of 10%. Part of that is the parallel testing, ameliorating that we've talked about, part of it's the FinFET story that we've talked about and the growing transistor count. So we're at another one of those junctures with gate all around. 
And then sorry, HPC."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","HPC higher or lower.",4,"HPC higher or lower."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Okay. Yes. So the -- the growth rate in compute is certainly going to be at the higher end of our mix of submarkets, we think, over the midterm. So if you think the average market growth rate, we're going to update this in January, but pick a number, is 8",65,"Okay. Yes. So the -- the growth rate in compute is certainly going to be at the higher end of our mix of submarkets, we think, over the midterm. So if you think the average market growth rate, we're going to update this in January, but pick a number, is 8%. We think compute is probably leading that by at least a couple of points."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","And operator, we have time for 1 more question, please.",10,"And operator, we have time for 1 more question, please."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your final question comes from Sidney Ho, Deutsche Bank.",9,"Your final question comes from Sidney Ho, Deutsche Bank."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","So I have 2 quick ones. The first 1 is, you talked about supply constraints impacting the IE business. I'm just curious, the gross margin has been pretty good overall, you talked about offering the leverage is one of the reasons. To the extent that your i",74,"So I have 2 quick ones. The first 1 is, you talked about supply constraints impacting the IE business. I'm just curious, the gross margin has been pretty good overall, you talked about offering the leverage is one of the reasons. To the extent that your input cost on logistics and freight cost increase, both in your test and IA business, are you able to pass along some of those costs to your customers?"
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","So at this point, we've been managing through it. So materially, no.",12,"So at this point, we've been managing through it. So materially, no."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Maybe my follow-up question is a lot of discussion on 3 nanometers today, but it's really an opportunity in 2023 and beyond. But if you kind of look at next year, I know you're going to update us in January. How does this impact your tester business",89,"Okay. Maybe my follow-up question is a lot of discussion on 3 nanometers today, but it's really an opportunity in 2023 and beyond. But if you kind of look at next year, I know you're going to update us in January. How does this impact your tester business, if a customer chooses to move from instead going to 3 nanometers, they go to a different generation of 5 nanometers, what is the test to reuse rate when you compare the 2 nodes between the 3 nanometers and the alternative?"
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. The tester reuse, people will reuse 5-nanometer generation testers in the 3-nanometer era. So a new tester is not required. And testers tend to have a useful life of a decade or more at a customer, and they can span usability across many, many nodes",249,"Yes. The tester reuse, people will reuse 5-nanometer generation testers in the 3-nanometer era. So a new tester is not required. And testers tend to have a useful life of a decade or more at a customer, and they can span usability across many, many nodes and many, many generations of devices. So there's nothing in terms of a new tester here that comes with 3-nanometer. And yes, by and large, it's a 2023 and beyond type story. But absent that story, what we've been seeing for the past 10 years in test, since 3-nanometer in 2022 is likely not going to be a huge event because it's likely to be later in the year. People will still move down the complexity curve at 5- and 5-plus nanometer nodes and increase transistor counts and such along that path. So even absent 3-nanometer, we have an optimistic view of what '22 looks like. 
We'll probably start out the year similar to how we started out years in the past. And at the beginning of the year with some modest growth in the first quarter and then it kind of swings on what's going to happen over the summer, which is our peak quarters. around the refreshes. Will those refreshes of silicon be in 3-nanometer, Will they be in 5 plus with the traditional normal transistor count growth that we've seen for the past 10 years. Those are things that we have to get closer to next year to really understand."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Okay, everybody. We are out of time. Thanks so much for joining us today. And those in the queue, I'll get back to you later today. And again, thanks, everyone, for joining. Bye-bye.",33,"Okay, everybody. We are out of time. Thanks so much for joining us today. And those in the queue, I'll get back to you later today. And again, thanks, everyone, for joining. Bye-bye."
94728,1685270027,2414212,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Ladies and gentlemen, this concludes today's conference call. Thank you participating. You may now disconnect.",15,"Ladies and gentlemen, this concludes today's conference call. Thank you participating. You may now disconnect."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Ladies and gentlemen, thank you for standing by, and welcome to the Teradyne Third Quarter 2021 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Andrew Blanchard.  Thank you. Please go",42,"Ladies and gentlemen, thank you for standing by, and welcome to the Teradyne Third Quarter 2021 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Andrew Blanchard.  
Thank you. Please go ahead, sir."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Patrice.  Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined this morning by our CEO, Mark Jagiela; and our CFO, Sanjay Mehta. Following our opening remarks, we'll provide details of",291,"Thank you, Patrice.  
Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined this morning by our CEO, Mark Jagiela; and our CFO, Sanjay Mehta. Following our opening remarks, we'll provide details of our performance for 2021's third quarter along with our outlook for the fourth quarter.  
The press release containing our third quarter results was issued last evening. We're providing slides on the Investor page of the website that may be helpful to you in following the discussion. Replays of this call will be available via the same page after the call ends.  
The matters that we discuss today will include forward-looking statements that involve risk factors that could cause Teradyne's results to differ materially from management's current expectations. We encourage you to review the safe harbor statement contained in the earnings release as well as our most recent SEC filings. Additionally, those forward-looking statements are made as of today and we take no obligation to update them as a result of developments occurring after this call.  
During today's call, we'll make reference to non-GAAP financial measures. We've posted additional information concerning these non-GAAP financial measures where appropriate on the Investor page of the website. Looking ahead between now and our next earnings call, Teradyne expects to participate in technology or industrial-focused investor conferences hosted by Baird, Credit Suisse, Davidson and UBS.  
Now let's get on with the rest of the agenda. First, Mark will comment on our recent results, current market conditions and thoughts on the rest of 2021 and '22. Sanjay will then offer more details on our quarterly results along with our guidance for the fourth quarter. We'll then answer your questions, and this call is scheduled for 1 hour.  
Mark?"
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Andy.  Good morning, everyone, and thanks for joining us. Today, I'll cover 4 topics: the highlights of our third quarter and the first 9 months of the year, the changes we're observing in the SOC test market, our outlook for the industrial auto",1470,"Thanks, Andy.  
Good morning, everyone, and thanks for joining us. Today, I'll cover 4 topics: the highlights of our third quarter and the first 9 months of the year, the changes we're observing in the SOC test market, our outlook for the industrial automation market and how we're thinking about the test and automation markets as we close out this year and look into 2022 and beyond.  
As our Q3 results demonstrate, demand remains strong across all of our businesses. At the company level, Q3 sales grew 16% from last year's record Q3 and non-GAAP EPS grew 35%. We did experience increased supply chain bottlenecks in our Industrial Automation business in the quarter and under ship demand. Sanjay will describe this in more detail, but we expect these constraints to persist into Q4. Despite this, for the first 9 months of 2021, company-wide sales grew 19% and non-GAAP EPS grew 31% from the year ago level.  
In each of our businesses, we are riding long-term secular trends that we expect will drive revenue and earnings growth for years to come. In our Test businesses, the unit growth and complexity drivers that power these markets continue unabated. For example, our semiconductor test business grew 18% through Q3, while -- with SOC leading the charge growing 22%. Sales continue to be dominated by our UltraFLEX product line which is well aligned to the performance requirements of the growing compute and mobility markets.  
Additionally, sales of our Eagle Test Systems more than doubled in the 9-month period as Automotive and Industrial Test markets have also rapidly expanded. Eagle's unique architecture hits the sweet spot in these markets by balancing high precision with the stress testing needed for these demanding applications.  
Within SOC, there's been a clear shift this year to higher demand from the compute, automotive and industrial markets. While mobility is still the largest subsegment of SOC and growing, it has dropped from the high 50% range of the SOC test market in recent years to the high 40% range this year. Over the midterm, we expect mobility will remain the largest SOC submarket and continue to grow but we also expect compute to grow at a faster rate, while automotive should remain at its current elevated levels.  
For the last decade or so, mobility has made rapid annual advances in semiconductor complexity that has enabled the advancement of smartphone sophistication. The refresh pace has been much faster than traditional PCs, graphics, automotive and industrial end markets, leading to smartphone ICs rapidly progressing along the complexity scale. This is true in many areas of smartphone silicon, apps processor compute engines, graphics engines, AI engines, image sensors, power management and more. Our leading position in testing these key technologies has driven our growth.  
At the same time, up until recently, the traditional compute testing market has been relatively flat with slower refresh rates and slower complexity growth. However, the groundwork laid by mobility designs combined with advancing lithography nodes and design tools has enabled new entrants into the chip design space for compute engines. The complexity of these chips whether for laptops, servers, autonomous driving, AI or graphics is incredible and advancing at an accelerated rate. For example, laptop CPUs are now crossing the 30 billion transistor level, which is a huge leap over previous legacy designs.  
As we've said in the past, increased transistor counts drives increased test time and increased tester demand. We've seen that this year and there's more to come. We're targeting this expanding collection of new players and new designs, leaning heavily into our UltraFLEX family's hardware performance and time-to-market advantages of our software. We've been adding new design wins every quarter. And while development pipelines can be long and these new designs can be speculative, we're confident we'll see growing production business from these wins in the future. It's also notable that the traditional chip suppliers in these markets aren't standing still, they are doubling down on their advanced designs too, which is collectively driving WFE investments higher as applications expand and competition heats up.  
We expect this race to lead to higher test TAMs and given the higher performance and faster design to market cycle times, more share gain opportunities for Teradyne over the midterm. 
 
Our System Test segment last year -- sorry, our System Test segment year-to-date sales grew 11% from 2020 and Storage Test continued its multiyear growth trajectory, expanding sales 12% in the same period. Higher capacity HDDs and more complex SOC devices, which require system-level test, are driving this demand. Both trends are expected to continue into the foreseeable future. 
At LitePoint, sales were up 24% through 9 months compared with 2020, driven by WiFi 6E production, WiFi 7 R&D demand as well as ultra-wideband. More connected devices demanding more bandwidth while managing growing congestion drive complexity increases in each new WiFi standard and more tests. UWB, on the other hand, is a whole new wireless standard in application space. It's a new proximity detection wireless technology with the future of many promising security applications. We expect these trends to continue and to provide a long-term tailwind to our Wireless Test business.  
Shifting to Industrial Automation. Universal Robots revenue grew 50% through the first 9 months of the year, while MiR grew 40% despite supply chain challenges. Each has a unique story. At UR, it's a combination of increasing sales for existing tasks and the expanding number of UR+ offerings, making it easier for customers to deploy our cobots to do new applications. We highlighted welding in our last call, but other examples include screw-driving and palletizing. 
The UR+ ecosystem is key to expanding these tasks and now totals over 360 products created by over 300 partners, both riding on and broadening the coattails of our UR platform. This is a key advantage in the combination of our organic investments and our UR+ and OEM partners R&D dollars and creativity that's going into expanding the UR platform and it's unmatched.  
At MiR, the story is about new products. The MiR250 which was introduced just as COVID hit last March of last year, is now our largest seller by far. This year, we added the MiR Hook to the 250 family to expand its applications into tugging. We've introduced higher payload products such as the MiR 600 and 1350 to expand our footprint in the fast-growing logistics market.  
Unfortunately, with all this good news come supply chain issues that will limit IA growth in 2021 to be between 30% to 40% year-on-year, but demand is strong. The long-term outlook in IA remains very bright. Looking at the capabilities of UR cobots today, we estimate the penetration rate is less than 2% of the servable market. UR's approximate 45% market share puts us clearly in the lead, and we continue to drive R&D and distribution investments to extend our competitive advantages, expand the servable market and drive penetration higher.  
It's a similar story at MiR, where we estimate the autonomous mobile robot penetration is under 3%. The AMR market doesn't have a single dominant player like UR cobots, and we estimate we're close to #2 in the broadly defined market. And like at UR, we're making investments in both the distribution and product level to both reinforce our advantages and extend our product reach.  
In both IA businesses, the fact that our penetration of today's servable market is low single digits and that the servable market continues to expand each year with product enhancements, sets up a fantastic future. So even with very high growth rates in our IA business, we expect the penetration rates to remain low for many years, sustaining our long-term annual growth forecast of 20% to 35%. In January, we will update you on the outlook for 2022 and our midterm earnings model. Between now and then, we'll be looking at the rate and timing of new semiconductor fab capacity coming online, especially at the more advanced lithography nodes. And we'll also be looking at the rate of adoption of DDR5 as key swing factors.  
In IA, we will be looking at the manufacturing output expansion, onshoring trends and PMIs in our principal geographies as tailwinds for continued robust growth. On the other hand, in both markets, supply chain bottlenecks could slow certain industries and become a headwind to growth demand. Short-term demand is influenced by many factors, but we manage our business aligned to the long-term trends. The trend of growing prevalence of increasingly complex semiconductors and a myriad of applications drives our semiconductor business and investments. The trend of new increasingly smart, cost-effective automation in a world with labor scarcity and onshoring challenges drives our IA business and investment strategy. These systemic long-term trends paint an exciting future for Teradyne.  
With that, I'll turn it over to Sanjay."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Mark, and hello, everyone.  In my remarks, I'll review our Q3 financial results, discuss our supply line strategy in this challenging environment, provide Q4 guidance and comment on our full year financial outlook at the midpoint of our Q4 guida",1460,"Thanks, Mark, and hello, everyone.  
In my remarks, I'll review our Q3 financial results, discuss our supply line strategy in this challenging environment, provide Q4 guidance and comment on our full year financial outlook at the midpoint of our Q4 guidance. 
To the financial headlines for Q3. Our third quarter sales were $951 million was near the high end of guidance driven by strength in Semi Test and Wireless Test. Gross margin in the quarter was approximately 60%. Our non-GAAP operating expenses were $242 million or 25.5% of revenue. The favorability in OpEx drove a non-GAAP operating margin of approximately 35% and non-GAAP EPS of $1.59. A few more components of third quarter data. Our tax rate, excluding discrete items, was 14.8% on both a GAAP and non-GAAP basis. Non-GAAP diluted share count was approximately 176 million. We had two 10% customers.  
Looking at the results from a business unit perspective. Semi Test revenue of $688 million was up 16% from Q3 '20. SOC revenue was $575 million, up 28%, driven by strength in applications processors, RF, industrial and automotive applications. Automotive and industrials doubled revenue year-over-year. Memory revenue was the second highest in history at $113 million, but down 21% from Q3 of last year's record. 
FLASH final test demand was the strongest segment on handset and SSD end market demand. System Test group had revenue of $103 million, which was down 13% year-over-year. Recall Storage is the largest business in this segment and has lumpy shipments. While Storage Test will still grow more than 15% for the year, sales, including HDD and SLT declined to $56 million on the timing of shipments in Q3.  
Defense and aerospace and production board test combined grew 10% year-on-year to $47 million. At LitePoint, revenue of $69 million was up 70% from prior year due to early success of our new WiFi 7 product, continued strength in 4G cellular and UWB.  
Now to Industrial Automation. As in July, given COVID shutdowns had impaired the UR business in 2020, I'll provide revenue metrics comparing Q3 '21 results with both Q3 '20 and Q3 '19. Industrial Automation revenue of $91 million was up 32% from both Q3 '19 and Q3 '20. North America delivered the highest revenue growth from last year, but all regions expanded year-on-year. As Mark noted, supply issues, primarily semiconductors, reduced our IA shipments in the quarter. UR sales were $78 million in Q3, up 46% year-over-year and 31% over Q3 '19. MiR sales were $13 million, up 27% from Q3 '20 and 35% from Q3 '19. IA was about breakeven in the quarter and full -- breakeven in the quarter and full year, we expect low single-digit profitability. As we've noted before, we continue our strategy of investing during this high-growth era while maintaining gross margins to enable mid-20s operating profit in the future.  
Shifting to supply. We continue to deal with numerous supply constraints across the company. While semiconductor shortages are well reported, we're also seeing delays in mechanical parts and logistics, all exacerbated by rolling COVID-related shutdowns or labor shortages. We expect these issues will continue through the first half of 2022. Despite these issues, we've been able to deliver record shipments and a big part of that performance is a result of the supply line management, operations teams and engineering teams working with our supply chain and contract manufacturing partners.  
We view our operational business model and execution against it as a core competence. Our gross margin performance over the last 10 years displays the financial value of this model. 
In our test portfolio, our execution has kept most of our tester lead times within the range that meet customers' needs to expand their production capacity in this dynamic environment. The significance of this lead time performance is that customer orders more closely reflect true test demand. So while a bit counterintuitive, we feel that maintaining short lead times are a more accurate indicator of test demand with lower risk than holding orders with lead times far beyond chip manufacturing cycle times. Of course, our supply line and operations model isn't static. We began adding resiliency through both geographic and supplier diversity prior to COVID. Those efforts have accelerated over the last 20 months.  
This work is paying dividends in the current environment, and we'll continue to invest to harden our supply chain further. Our lead time performance is an example of our resilience and execution. Another example is the ability to scale to significantly increase demand. Auto and industrial sales have more than doubled year-over-year. While we're not perfectly aligned to all customer requested delivery dates, we are managing through delivery issues in a reasonable manner. The value of these efforts can also be seen in the operating leverage in our gross margin line. 
 
In IA, we've seen lead times extend from our normal 1 to 2 weeks to 4 to 6 weeks for some products. While this is a challenge with the business growing so quickly and ongoing industry supply issues, we've already seen the positive impact of our work in material sourcing and manufacturing cycle times.  We expect to bring lead times back to model over the next 2 to 3 quarters. 
Shifting to the balance sheet and cash flow. Our cash and marketable securities at the end of the quarter totaled $1.45 billion. We had $493 million in free cash flow in the quarter, and through 9 months, we've spent $103 million on CapEx, and we expect we'll spend $148 million for the full year. We spent $210 million and $16 million on buybacks and dividends, respectively. Year-to-date, we've repurchased 3.3 million shares for $406 million at an average price of $123.53. In 2021, we expect to return over 80% of our free cash flow to shareholders. And from 2015, when we began repurchasing shares, we've returned 85% of our free cash flow to owners.  
Regarding our convertible debt, $302 million of principal was paid in the first 9 months to the convertible bondholders ahead of maturity. By mid-December, bondholders will have converted approximately $343 million, leaving a face value of $117 million.  
Now to our outlook for Q4. Sales in Q4 are expected to be between $820 million and $900 million, with non-GAAP EPS in a range of $1.14 to $1.40 on 174 million diluted shares. Fourth quarter guidance excludes the amortization of acquired intangibles and noncash imputed interest on the convertible debt. Our guidance assumes no significant changes, positive or negative, in the availability of materials and assumes that we won't see additional pandemic-related issues. Fourth quarter gross margins are estimated at 59% to 60%. OpEx is expected to run at 28% to 31% of fourth quarter sales. The non-GAAP operating profit at the midpoint of our third quarter guidance is 30%.  
Regarding OpEx for the full year. We spent a bit lower than planned in Q3, and we expect the full year OpEx will be about $980 million, up 17% from 2020. At the midpoint of our guidance, 2021 will be another year of growth in both revenue and EPS, while sales growing -- or sorry, with sales growing 18% to $3.7 billion and non-GAAP EPS growing to $5.88, up 27%. Gross margin for the full year should be approximately 59.5%, up from 57.2% in 2020, reflecting the ramp of new products, product mix and operating leverage, offsetting component and logistics cost increases.   
Our 2021 non-GAAP operating profit rate is expected to be about 33%, up from last year's 30%. Our full year tax rate is expected to be 14.8%. These results put us comfortably in the range of our 2024 earnings model this year. We'll update the model on our regular cadence in January. 
The breadth of our customer buying in 2021 is also broader than last year. In 2020, we had 1 customer that drove 25% of sales. In 2021, we do not expect to have any customer larger than 20% of our yearly revenue. This reflects the trend Mark noted about 2021's higher growth in compute, auto and industrial demand compared with mobility demand in Semi Test. IA growth of over 30% year-over-year continues to diversify our revenue. This growth is expected to continue over the midterm and become a larger portion of our revenue.  
In summary, we expect to end the year with another quarter of strong year-on-year revenue and EPS growth. On a full year basis, we'll exceed our midterm targets on stronger-than-expected demand on our test businesses, continued high growth in IA and excellent execution across the company. While we don't have a clear picture of 2022 yet, we're confident that the long-term industry trends powering our test and IA businesses remain firmly in place.  
With that, I'll turn the call back to Andy."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Sanjay. Patrice, we would now like to take some questions. [Operator Instructions]",13,"Thanks, Sanjay. Patrice, we would now like to take some questions. [Operator Instructions]"
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","[Operator Instructions] Your first question comes from Atif Malik with Citi.",11,"[Operator Instructions] Your first question comes from Atif Malik with Citi."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Good job in the tough supply environment. And Mark, if I look at some of the recent ARM-based notebook processors, the transistor count is growing 2 to 4x versus prior generation. You commented mobility to grow and compute, auto, analog to grow faster tha",70,"Good job in the tough supply environment. And Mark, if I look at some of the recent ARM-based notebook processors, the transistor count is growing 2 to 4x versus prior generation. You commented mobility to grow and compute, auto, analog to grow faster than mobility in the midterm, understand you guys generally talk about next year outlook in January. How confident do you feel about your SOC growth next year?"
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Well, I think at this point, pretty confident. I mean we look at the trends that I just -- you cited and I cited and see that there's very little standing in the way of sort of this increased growth, but the caveat I would mention is there's a lot of supp",177,"Well, I think at this point, pretty confident. I mean we look at the trends that I just -- you cited and I cited and see that there's very little standing in the way of sort of this increased growth, but the caveat I would mention is there's a lot of supply chain bottlenecks in the system. So if end products get bottlenecked, that can slow down the unit volume demand for new semiconductors. And the other thing we're looking at is when do these new nodes really come online in terms of capacity. All that $90 billion of WFE that was put in place this year hasn't yet had a single impact on test. That's all to come. But it kind of depends on when do those additional 5- and 3-nanometer fabs come online. That is kind of a big swing factor in the calendar year 2022 as to how our growth will chunk up. And that's kind of why we wait until January because we don't get a good enough visibility on that right now."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Great. And Sanjay, as a follow-up, can you talk about concentration within mobility and compute customer and impact on long-term gross margins? There have been talks about price discounts with equipment suppliers by Tier 1 foundry.",36,"Great. And Sanjay, as a follow-up, can you talk about concentration within mobility and compute customer and impact on long-term gross margins? There have been talks about price discounts with equipment suppliers by Tier 1 foundry."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. As I stated in my prepared remarks, we won't have any customer above 20%. So it's a broader breadth of customers. And regarding gross margins, in throughout the year, we've improved gross margins. And as I said in earlier calls, really driven by a co",127,"Yes. As I stated in my prepared remarks, we won't have any customer above 20%. So it's a broader breadth of customers. And regarding gross margins, in throughout the year, we've improved gross margins. And as I said in earlier calls, really driven by a couple of key test systems coming online and we're shipping in volume that have come down the cost curve. We've seen some benefits to product mix shift as well as our operating leverage offsetting the component costs and logistic cost increases. From a look forward and sustainability of that gross margin, obviously, we'll give an update to our earnings model in January. But I see the second half of our gross margin performance kind of going into the first half of 2022."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Mehdi Hosseini with SIG.",9,"Your next question comes from Mehdi Hosseini with SIG."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Yes, the first one has to do with your largest customer. And given your commentary in terms of revenue mix, it seems to me that that particular customer is going to be down like 5% to 6%. In that context, should we assume a return to growth in '22, and th",80,"Yes, the first one has to do with your largest customer. And given your commentary in terms of revenue mix, it seems to me that that particular customer is going to be down like 5% to 6%. In that context, should we assume a return to growth in '22, and this is a trend that has happened over the past several years? And should that happen again -- Should that pattern happen again into '22? And I have a follow-up."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. We, of course, maybe can't talk about any individual customer and what they might do or not do in the future. So that I have to leave aside. But I just point out in your first point that, yes, our largest customer is dropping below 20% in a growing r",73,"Yes. We, of course, maybe can't talk about any individual customer and what they might do or not do in the future. So that I have to leave aside. But I just point out in your first point that, yes, our largest customer is dropping below 20% in a growing revenue year. So the amount that you might think compute that they're falling has to be taken against our numerator of higher revenue."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And then I wanted to follow up to the question that came up 3 months ago when we were looking into your market share in the compute. Can you update us where you are with that market share in 2021? And as hyperscalers ramp their own ARM-based CPUs,",63,"Got it. And then I wanted to follow up to the question that came up 3 months ago when we were looking into your market share in the compute. Can you update us where you are with that market share in 2021? And as hyperscalers ramp their own ARM-based CPUs, how will your market share change over the next 1 or 2 years?"
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Well, like the total SOC market, year-to-year market share is very volatile. It depends on whose customers are buying what in any given year. So what our market share might be in any given year, it can -- in a submarket like compute, it can swing 20 point",118,"Well, like the total SOC market, year-to-year market share is very volatile. It depends on whose customers are buying what in any given year. So what our market share might be in any given year, it can -- in a submarket like compute, it can swing 20 points year-to-year depending on who's buying. So for this year, it tends to be a very good compute year for us. Our compute market share is up in, I would say, close to what our average share is in SOC this year. But I would say that it's not steady Eddie. It's going to be pretty volatile year-to-year, it has been in the past. It probably will be going forward, too."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","I know we're supposed to ask only 2 questions, but just a quick follow-up. I think what I'm trying to understand is I think on the GPU side, it's pretty clear that your competitor has dominated. And assuming that that work to remain unchanged, I think the",86,"I know we're supposed to ask only 2 questions, but just a quick follow-up. I think what I'm trying to understand is I think on the GPU side, it's pretty clear that your competitor has dominated. And assuming that that work to remain unchanged, I think the incremental change to the compute is all driven by ARM-based. And I was just trying to better understand how you look at your competitive position as these new chips coming to the market addressing the compute end market?"
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","We -- look, we're very pleased and confident with our progress in ARM-based compute and design-ins in that realm, but I would say that it's not -- there's the tester market for compute also driven by more traditional x86 demand as well. You've got a coupl",81,"We -- look, we're very pleased and confident with our progress in ARM-based compute and design-ins in that realm, but I would say that it's not -- there's the tester market for compute also driven by more traditional x86 demand as well. You've got a couple of suppliers there that are not standing still, as I mentioned, and are upping their kind of complexity growth curve. And so there will be certainly a lot of growth there as well, I believe."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Toshiya Hari, Goldman Sachs.",9,"Your next question comes from Toshiya Hari, Goldman Sachs."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Congrats on the strong execution. I had 2 questions as well. My first one is on the supply constraints, maybe for Mark, maybe for Sanjay. Just curious how significant the headwinds were for IA in Q3 and what's embedded in your Q4 guidance? If you can shar",102,"Congrats on the strong execution. I had 2 questions as well. My first one is on the supply constraints, maybe for Mark, maybe for Sanjay. Just curious how significant the headwinds were for IA in Q3 and what's embedded in your Q4 guidance? If you can share that, that would be helpful. And I just wanted to confirm that there was little to no impact on your Semi Test business. And then on gross margins, similarly, you came in at the high end of your guided range, but was there any impact on your profitability in the quarter from supply chain shortages?"
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Sure. So I'll take those. So from an Industrial Automation perspective, year-to-date, we've grown 40% in IA, and Q4 demand is high. If we can't supply at all, that's why we've -- I think it's going to be growth year-on-year of about 30% to 40%. And so pre",215,"Sure. So I'll take those. So from an Industrial Automation perspective, year-to-date, we've grown 40% in IA, and Q4 demand is high. If we can't supply at all, that's why we've -- I think it's going to be growth year-on-year of about 30% to 40%. And so predominantly, it's in semiconductors. And I expect we'll be out of the supply chain crunch given our visibility in Q2 or Q3 for IA. So that's the IA side. And then from a supply chain perspective on the test side, we've seen the supply chain tightening on the test portfolio quarter-over-quarter, where we don't think it's going to be abated until the end of Q2 of 2022. And again, mainly semiconductor parts. And really, we see that coming back online in the second half, really tied to the wafer and the substrate capacity coming online.  
And then from a gross margin perspective, we've been managing through the component increases and logistics increases in cost. And we've -- as I've said earlier, we've had favorable product mix. And as our volumes or our revenues are higher, we're gaining operating leverage along with coming down the cost curve of our new products that we've introduced late last year. So we're managing through it, and it's true well-publicized component cost increases."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. That's super helpful. And then as my follow-up, Mark, I wanted to ask about your Eagle Test business. In your prepared remarks, you noted that the business is up more than 2x year-to-date. I guess historically, like many other parts of your busine",143,"Got it. That's super helpful. And then as my follow-up, Mark, I wanted to ask about your Eagle Test business. In your prepared remarks, you noted that the business is up more than 2x year-to-date. I guess historically, like many other parts of your business, I think the Eagle Test has been quite cyclical. You would be up for 1 year, 1.5 years, 4 to 6 quarters and then down a little bit as customers digest their test capacity. Based on what you said, it seemed like you're expecting 2022 to be another strong year. I guess the question is what's different this time as you think about Eagle Test into '22. I realize there's complexity growth, but you could argue there's been complexity growth for a very long time. So just curious how different this cycle could be relative to past cycles."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Right. Good question. And in addition, automobile unit volume isn't near its historical peak either. So how could this thing keep going beyond the normal 6-quarter surge in automotive, which is you're right, again, that's kind of the traditional pattern.",189,"Right. Good question. And in addition, automobile unit volume isn't near its historical peak either. So how could this thing keep going beyond the normal 6-quarter surge in automotive, which is you're right, again, that's kind of the traditional pattern. But I think what we see happening and makes us believe this will persist at least through 2022 is there's a lot of silicon refresh going on that's new in the automotive space. New -- kind of racing to get new, more current generation lithography node silicon into automotive design because the legacy lines out there are hard to get at. Chip suppliers are trying to obsolete those fabs. And so the automotive customers don't have as much, I would say, power in this frothy demand environment on the semiconductor supply side. And so the semiconductor suppliers are kind of same, get with the program, move to more advanced nodes. And a little bit of that's happening, which is what -- that means complexity, yield issues, and that means a little more test than you might expect. And I think that's what's giving us a different view this time."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from John Pitzer, Credit Suisse.",9,"Your next question comes from John Pitzer, Credit Suisse."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Congratulations on the solid results. Mark, I want to go back to increasing test times in the Semi Test business. You've done a good job kind of helping us understand complexity and transistor count. I'm kind of curious, as we move from a world of sort of",96,"Congratulations on the solid results. Mark, I want to go back to increasing test times in the Semi Test business. You've done a good job kind of helping us understand complexity and transistor count. I'm kind of curious, as we move from a world of sort of general purpose compute to one of more optimized silicon, you're going to move from a world where you're testing huge volumes in one device to smaller volumes across multiple devices. What does that do for test efficiency at your customers and hence, test times as that trend takes hold?"
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","It is a -- building, let's say, 100 billion transistors on 1 chip versus 4, to give an example, isn't equivalent test time. The 4-chip version is likely -- these are going to be rough rules of thumb, but let's say, 25% more test intensive than the single",252,"It is a -- building, let's say, 100 billion transistors on 1 chip versus 4, to give an example, isn't equivalent test time. The 4-chip version is likely -- these are going to be rough rules of thumb, but let's say, 25% more test intensive than the single chip design because there's a premium on sort of known good die testing to -- when you put those together in an advanced package. And then the advanced package itself has more potential defect failure modes that need to be tested. So that's one thing around the whole chiplet, multi-chip package thing. 
The other thing, though, that's happening, and this is really going to become prevalent at 3-nanometer and beyond is the move from FinFET to gate-all-around transistor architectures. And if you remember, when the world moved from planar to FinFET, it was back in 2012, '13, '14 era, that drove -- if you go back and look at the history of sort of the test market, that drove incremental test intensity and complexity in the market. And we're headed for another one of those with gate-all-around. There's going to be new defect modes, new kind of test intensity boosts coming from this new architecture on the transistor. So even at equivalent transistor counts, we're going to see a little bit more test intensity because of that. So these 2 trends of chiplets and gate-all-around and 3-nanometer, that's probably all the 2023 and beyond story given where 3-nanometer is right now, but it's coming."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","That's helpful. And that's my second question, Mark, just going back to your largest customer, I'm kind of curious if you can help me better understand the diversity of business with that customer. I mean clearly, it's been mobility-led for the last sever",103,"That's helpful. And that's my second question, Mark, just going back to your largest customer, I'm kind of curious if you can help me better understand the diversity of business with that customer. I mean clearly, it's been mobility-led for the last several years. Now you've got them doing more in the compute space. You've talked about in the past the complexity around these AirTags. Are you seeing a meaningful diversification of demand drivers at that customer? And can you help me -- because I just don't know how fungible is your -- is their test capacity across those different product families?"
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes, I'm not going to be able to talk too much about the sort of breadth there. I think you can imagine it, and you've rattled off some examples. In terms of fungibility, they're pretty fungible to testers across what's used for compute engine in a phone",299,"Yes, I'm not going to be able to talk too much about the sort of breadth there. I think you can imagine it, and you've rattled off some examples. In terms of fungibility, they're pretty fungible to testers across what's used for compute engine in a phone versus a compute engine in a laptop or a desktop or anything else. The one that's a little bit unique is when you get into things like, the RF type products, of course, have a bit of a different architecture, power management type products have a bit of a different architecture. And so those testers tend to be a little more unique. But we've talked about in the past that -- I think people have looked at us and said, well, in a world where cell phones are kind of plateauing, doesn't that -- unit growth of cell phones doesn't that that portends some kind of slowing for us. 
And what we've always said is that, look, cell phone unit growth can slow, complexity isn't. And some of these customers are diversifying into more silicon, both in the phone and now more silicon outside the phone into compute. There are these emerging hyperscalers that are building silicon for both cloud computing and other new yet-to-be introduced consumer products. So the ability of a design team today to be formed and put together a $10 billion-plus transistor chip for a consumer application is easier and easier and easier. And as I said in my script, we work with a lot of them. Maybe a small fraction of them will be hits in the future, but they can bring entirely new classes of semiconductor -- high compute engine semiconductor applications to the market. And all of those are kind of UltraFLEX, UltraFLEXplus family devices."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from C.J. Muse of Evercore.",10,"Your next question comes from C.J. Muse of Evercore."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","I guess, Mark, another technology question. You've kind of taught us to think about transistor count in kind of thinking about test times for mobility compute. And curious, as we go to more high-performance compute, where there are more thermal issues, pe",58,"I guess, Mark, another technology question. You've kind of taught us to think about transistor count in kind of thinking about test times for mobility compute. And curious, as we go to more high-performance compute, where there are more thermal issues, perhaps more complex software algorithms, how should we be thinking about the test times in that transition?"
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Well, I think the test times have less to do with the application. The only place where the application drives really fundamentally different test times as automotive because of the issues there. It's more the technology. So I go back to C.J., what I said",81,"Well, I think the test times have less to do with the application. The only place where the application drives really fundamentally different test times as automotive because of the issues there. It's more the technology. So I go back to C.J., what I said before about 3-nanometer is going to be more impactful to both test times in phones and in computers and in servers and in graphics and in everything else, probably than any of those end market applications."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. That's helpful. And then I guess, Sanjay, a question for you. Clearly, you're making investments, particularly in IA. But as you look to 2022, can you speak to your outlook for operating leverage. And as part of that, how we should think about OpEx",50,"Okay. That's helpful. And then I guess, Sanjay, a question for you. Clearly, you're making investments, particularly in IA. But as you look to 2022, can you speak to your outlook for operating leverage. And as part of that, how we should think about OpEx relative to top line growth?"
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Sure. I'd say we're in the early innings of looking at 2022 and obviously, we'll provide an update in January. But OpEx is growing in kind of a couple of key areas this year, obviously tied to higher volume, we have variable compensation as well as engine",149,"Sure. I'd say we're in the early innings of looking at 2022 and obviously, we'll provide an update in January. But OpEx is growing in kind of a couple of key areas this year, obviously tied to higher volume, we have variable compensation as well as engineering spends tied to our operations to qualify new suppliers et cetera. And then we continue to invest in both go-to-market and engineering across the test portfolio. And as you noted, we're leaning in, obviously, in -- as I noted in my prepared remarks, we're leaning into our IA investments really to help drive going forward. The other component is the G&A expenses going forward. This was a big year of OpEx growth. The only thing I'd say is that next year we're not going to be as large percentage-wise growth, but that's really all I have to say on it right now."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Timothy Arcuri, UBS.",8,"Your next question comes from Timothy Arcuri, UBS."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, I just wanted to see if you can update us on the SOC TAM. You had said 4, 5 last call and segments of that was compute was about $1 billion. Mobility was 1.8 to 1.85. Autos were about 500, Industrial was 500, 550. I'm just kind of wondering if you c",58,"Mark, I just wanted to see if you can update us on the SOC TAM. You had said 4, 5 last call and segments of that was compute was about $1 billion. Mobility was 1.8 to 1.85. Autos were about 500, Industrial was 500, 550. I'm just kind of wondering if you can update us on those numbers."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Good question. So fundamentally, it's in the same range. It's probably trending more up towards the higher end of that range. So I think the numbers, the submarkets you got right on what we talked about last time, maybe compute is driving us a little",71,"Yes. Good question. So fundamentally, it's in the same range. It's probably trending more up towards the higher end of that range. So I think the numbers, the submarkets you got right on what we talked about last time, maybe compute is driving us a little bit higher in that range at this point in time. But it's pretty close. And memory is still at about $1 billion TAM as well."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Great. And then I guess I had a question just on profitability in IA. I note, Sanjay, you just answered a question about operating leverage next year. But what's the catalyst maybe -- this time last year, we were thinking IA would be 10% to 15% op m",130,"Okay. Great. And then I guess I had a question just on profitability in IA. I note, Sanjay, you just answered a question about operating leverage next year. But what's the catalyst maybe -- this time last year, we were thinking IA would be 10% to 15% op margin and then it got cut to 10% and then it went to 5%, and now it's kind of low single digits. And I get that the penetration there is very low. But what's the catalysts for you to look at maybe we shouldn't be investing so much money and maybe we can optimize OpEx investment? So I guess I'm just kind of wondering how you think about sort of what's going on at IA and what the long-term profitability target is?"
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So our range, as we said prior is 5% to 15%, and we expect to be low single digits, as I said in my prepared remarks. But really, how we think about it is we manage the business on a -- think about it as a rule of 40, combining the year-over-year gro",214,"Yes. So our range, as we said prior is 5% to 15%, and we expect to be low single digits, as I said in my prepared remarks. But really, how we think about it is we manage the business on a -- think about it as a rule of 40, combining the year-over-year growth with the operating profit. And fundamentally, we're -- as we see or as been noted by Mark, where penetration is very, very low and we look at all the jobs that can be automated and the scarcity of labor and economic growth, we really see a strong tailwind for the portfolio. And with that, we're very focused and conscious on both engineering and go-to-market investments. And so how we think about it is quite simple. And that is where we have a strong belief that we're going to grow and it's going to accelerate that revenue growth, we're going to lean into the investment. And again, think about it in the rule of 40. And as I said in my prepared remarks, our gross margins are actually improving in that portfolio. And so when we see that growth start to moderate, then we'll start to moderate the OpEx to get to an operating profit of, let's say, in the mid-20s."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Vivek Arya, Bank of America.",10,"Your next question comes from Vivek Arya, Bank of America."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, this move to 3-nanometer, is that a benefit for Teradyne in '22 or '23? I thought it would be '23, but I wanted to confirm. And kind of following on for that, what are the top 1 or 2 end markets that you are most excited about in terms of growth for",55,"Mark, this move to 3-nanometer, is that a benefit for Teradyne in '22 or '23? I thought it would be '23, but I wanted to confirm. And kind of following on for that, what are the top 1 or 2 end markets that you are most excited about in terms of growth for next year?"
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","So on the 3-nanometer question, that was one of the things I mentioned that we'll be looking at carefully between now and January when we update you on the 2022 view. And we've seen some pushouts on some of those nodes for a -- by a few months. So the abi",203,"So on the 3-nanometer question, that was one of the things I mentioned that we'll be looking at carefully between now and January when we update you on the 2022 view. And we've seen some pushouts on some of those nodes for a -- by a few months. So the ability to intercept them in a meaningful way in Q -- or sorry, in 2022 is a swing factor. We don't see that exactly yet. But whatever happens in 2022, it might get some early ramping, but the bulk of it is going to be 2023, '24, '25 kind of and beyond. So a little bit could happen in '22, how much we won't know more until January. 
In terms of markets next year that are interesting and exciting, I think it goes back to these emergent hyperscalers that are developing some new applications and very complex silicon for those new applications. Some of those could latch in the market with new product introductions and drive a whole new sort of demand stream for semiconductors and the testers associated with them. So that's kind of what we're rooting for and what we're close to, and we're seeing could be breakouts for 2022."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Very helpful. And maybe just following up on that. Is there a way, Mark, to contrast the additional complexity in a product that's going into a hyperscaler application versus a mobility application. I understand die sizes might be different, then",123,"Got it. Very helpful. And maybe just following up on that. Is there a way, Mark, to contrast the additional complexity in a product that's going into a hyperscaler application versus a mobility application. I understand die sizes might be different, then packaging, et cetera, might be different. But in -- conceptually, what does the mix shift from a more mobility heavy end market to something that is taking you more into the compute and hyperscaler land means for Teradyne in terms of your growth prospects? And also the -- just the seasonality because mobility tends to be a lot more seasonal markets. Those other markets are perhaps less seasonal. So what does that mix shift mean for Teradyne over the long term?"
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes, that's a good question. And the range of devices being developed at hyperscalers is quite large. Some of them are simpler than a classic cellphone device, apps processor in a cell phone. So those aren't going to have much of an impact even if they la",171,"Yes, that's a good question. And the range of devices being developed at hyperscalers is quite large. Some of them are simpler than a classic cellphone device, apps processor in a cell phone. So those aren't going to have much of an impact even if they latch. But some of them that are more, I would say, leverage AI, machine learning and high res displays are equal to or greater complexity than what you might find in a typical cell phone application for those technologies. So it's a broad spectrum is, I guess, the bottom line. But if you sort of play it out, I'd say the hyperscalers are going to, on average, bring cell phone-like complexity applications to the market. It's probably not going to be something that's -- take the $50 billion transistor device that kind of surprised everybody. It's probably not at that extreme. It's probably more in the $10 billion transistor range on average and then moving up year-over-year-over-year after that as they iterate on the design."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Krish Sankar with Cowen and Company.",11,"Your next question comes from Krish Sankar with Cowen and Company."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","I have 2 questions. Mark, just want to ask the 3-nanometer question in a different way, you spoke about how test investments have to catch up to front end WFE spending. But during the 3D NAND investment cycle WFE grew in 2016 and '17, while the memory tes",83,"I have 2 questions. Mark, just want to ask the 3-nanometer question in a different way, you spoke about how test investments have to catch up to front end WFE spending. But during the 3D NAND investment cycle WFE grew in 2016 and '17, while the memory test spending kind of came in 2018 in a meaningful way. So I'm kind of curious, how should we think about the time lag effect of test to front end foundry logic WFE this time around?"
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Good questions. So all of the WFE investment gets recognized before single testers associated with that investment. So the way to think about test is whenever you see some silicon coming off a new node, assume that the testers were installed maybe 3",181,"Yes. Good questions. So all of the WFE investment gets recognized before single testers associated with that investment. So the way to think about test is whenever you see some silicon coming off a new node, assume that the testers were installed maybe 3 months or so prior to that. So once the 3-nanometer fab comes online and you start to see product coming off of it in reasonable volume more than sort of pilot line volume, assume that the tester installations occurred about 3 months prior. That's kind of the best guidance I can give you there. And then the only other thing I would caution about memory versus SOC is that the curve of test time to transistor count is not the same in memory as it is in SOC. Memory tends to be a bit more efficient for reasons I won't get into here. So you can double transistors and memory, and you're not going to probably move test time more than 20%, 30% or so, let's say, whereas in SOC, it's not quite linear, but it's closer."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Got it. That's very helpful, Mark. Then I have a follow-up for Sanjay on gross margins. Despite the constrained environment, gross margins have stepped up about 200-plus basis points over the last like 4 quarters or so to a 59% to 60% range. Is th",60,"Got it. Got it. That's very helpful, Mark. Then I have a follow-up for Sanjay on gross margins. Despite the constrained environment, gross margins have stepped up about 200-plus basis points over the last like 4 quarters or so to a 59% to 60% range. Is this kind of the new baseline we should assume at these revenue run rates?"
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think I talked about that earlier. So we're going through our strategic planning process in Q4, and it's really the basis of our earnings model update in January. As I've said, just having some visibility into the first half of next year, I think y",153,"Yes. I think I talked about that earlier. So we're going through our strategic planning process in Q4, and it's really the basis of our earnings model update in January. As I've said, just having some visibility into the first half of next year, I think you should expect to see that gross margin be similar in the first half of next year as we have in the second half of 2021. From -- and so there's many different variables in there. I noted that we've been managing through the component and logistics cost increase. We've had good mix and come down the cost curve of our new products and gaining operating leverage. So there's many variables in there that we're going to look at closely and as our revenue gets more and more diversified. There's a lot of puts and takes, but we'll provide more guidance on that in the January call."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Brian Chin, Stifel.",8,"Your next question comes from Brian Chin, Stifel."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Nice results. Sorry, first to clarify something going back on the commentary. If you had more chips, you would be able to ship to an appreciably higher level of revenue in both the Semi Test and Industrial Automation businesses in Q4. Did I hear that corr",46,"Nice results. Sorry, first to clarify something going back on the commentary. If you had more chips, you would be able to ship to an appreciably higher level of revenue in both the Semi Test and Industrial Automation businesses in Q4. Did I hear that correctly?"
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","In Industrial Automation, percentage-wise, we'd be able to ship more. In the Test portfolio, we think we're going to manage through the majority of the supply issues at this point.",30,"In Industrial Automation, percentage-wise, we'd be able to ship more. In the Test portfolio, we think we're going to manage through the majority of the supply issues at this point."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Okay. Great. And then interesting discussion here on 3-nanometer and sort of like a fulcrum event in terms of test intensity again at 3-nanometer or gate-all-around. Maybe a couple of questions as my follow-up. What is it about that, that -- I know",189,"Okay. Okay. Great. And then interesting discussion here on 3-nanometer and sort of like a fulcrum event in terms of test intensity again at 3-nanometer or gate-all-around. Maybe a couple of questions as my follow-up. What is it about that, that -- I know it probably is a longer-form discussion, but in short form, what is it about 3-nanometer or 3-nanometer gate-all-around, is it sort of what the yield modeling suggests for kind of lower yield rates there compounded by die sizes, compounded by transistors or advanced packaging? Or is it also sort of a combination of the types of devices that you think that enables in terms of the intersection point of various customers and their kind of chip road maps? Just kind of want to get at that. And then like in kind of bigger picture, if the high-performance compute test TAM is a little bit more secular, a little bit more growthy, if you've kind of benchmarked test growth at sort of 4% to 8%, how much of a premium do you think we're looking at over the next several years in terms of HPC TAM?"
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Okay. there's a lot in there, Brian. So let me, first of all, take on 3-nanometer. So the issues about 3-nanometer certainly enables more dense, more transistors per die. That's not what I'm talking about. That's a big driver of test in the future. That w",345,"Okay. there's a lot in there, Brian. So let me, first of all, take on 3-nanometer. So the issues about 3-nanometer certainly enables more dense, more transistors per die. That's not what I'm talking about. That's a big driver of test in the future. That would absolutely be something that would give us a positive outlook for the next midterm. There's the chiplet thing that we talked about where you have mixed nodes going into chips, and then you need known good die testing and then the multi-packaging needs increasingly test intensity. That's not what I'm talking about. But that's real and that's there, too. The thing that I'm talking about with 3-nanometer that's unique, let's say, is the change in the transistor architecture from FinFET to gate-all-around. 
That happens once per decade. Again, it happened with FinFETs earlier in the last decade. It's happening with gate-all-around here in the next few years. Those transitions, everything else being equal, introduce additional, typically, failure modes that need more test methodologies to make sure the device is functioning correctly. And so let's say, the average test time per transistor can tend to be higher because of the additional verification needed related to that new architecture. Now early in the architecture's life, that tends to be higher. As the architecture matures over time, that premium, let's say, comes down. So -- and the world doesn't shift to 3-nanometer en masse day 1 either. 
So there's this bleeding up of certain devices using 3-nanometer that are highly test-intensive and more and more come online year after year, and then the learning curve comes on. But net-net, again, if you look at the test market from 2000 to 2012, it had been a declining market. And 2012 to now, it's been growing quite well in excess of 10%. Part of that is the parallel testing, ameliorating that we've talked about, part of it's the FinFET story that we've talked about and the growing transistor count. So we're at another one of those junctures with gate-all-around. 
And then sorry, HPC and..."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Test HPC higher or lower...",6,"Test HPC higher or lower..."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Okay. Yes. So the -- the growth rate in compute is certainly going to be at the higher end of our mix of submarkets, we think, over the midterm. So if you think the average market growth rate, we're going to update this in January, but pick a number, is 8",65,"Okay. Yes. So the -- the growth rate in compute is certainly going to be at the higher end of our mix of submarkets, we think, over the midterm. So if you think the average market growth rate, we're going to update this in January, but pick a number, is 8%. We think compute is probably leading that by at least a couple of points."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","And operator, we have time for one more question, please.",10,"And operator, we have time for one more question, please."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your final question comes from Sidney Ho, Deutsche Bank.",9,"Your final question comes from Sidney Ho, Deutsche Bank."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","So I have 2 quick ones. The first one is, you talk about supply constraints impacting the IA business. I'm just curious, the gross margin has been pretty good overall, you talk about offering the leverage is one of the reasons. To the extent that your inp",74,"So I have 2 quick ones. The first one is, you talk about supply constraints impacting the IA business. I'm just curious, the gross margin has been pretty good overall, you talk about offering the leverage is one of the reasons. To the extent that your input cost on logistics and freight cost increase, both in your test and IA business, are you able to pass along some of those costs to your customers?"
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","So at this point, we've been managing through it. So materially, no.",12,"So at this point, we've been managing through it. So materially, no."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Maybe my follow-up question is, a lot of discussion on 3 nanometers today, but it's really an opportunity in 2023 and beyond. But if you kind of look at next year, I know you're going to update us in January, how does this impact your tester busines",89,"Okay. Maybe my follow-up question is, a lot of discussion on 3 nanometers today, but it's really an opportunity in 2023 and beyond. But if you kind of look at next year, I know you're going to update us in January, how does this impact your tester business, if a customer chooses to move from instead of going to 3 nanometers, they go to a different generation of 5 nanometers? What is the tester reuse rate when you compare the 2 nodes between the 3 nanometers and the alternative?"
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. The tester reuse, people will reuse 5-nanometer generation testers in the 3-nanometer era. So a new tester is not required. And testers tend to have a useful life of a decade or more at a customer, and they can span usability across many, many nodes",249,"Yes. The tester reuse, people will reuse 5-nanometer generation testers in the 3-nanometer era. So a new tester is not required. And testers tend to have a useful life of a decade or more at a customer, and they can span usability across many, many nodes and many, many generations of devices. So there's nothing in terms of a new tester here that comes with 3-nanometer. And yes, by and large, it's a 2023 and beyond type story. But absent that story, what we've been seeing for the past 10 years in test, since 3-nanometer in 2022 is likely not going to be a huge event because it's likely to be later in the year, people will still move down the complexity curve at 5- and 5-plus nanometer nodes and increase transistor counts and such along that path. So even absent 3-nanometer, we have an optimistic view of what '22 looks like. 
We'll probably start out the year similar to how we started out years in the past and at the beginning of the year with some modest growth in the first quarter and then it kind of swings on what's going to happen over the summer, which is our peak quarters, around the refreshes. Will those refreshes of silicon be in 3-nanometer, will they be in 5 plus with the traditional normal transistor count growth that we've seen for the past 10 years, those are things that we have to get closer to next year to really understand."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Okay, everybody. We are out of time. Thanks so much for joining us today. And those in the queue, I'll get back to you later today. And again, thanks, everyone, for joining. Bye-bye.",33,"Okay, everybody. We are out of time. Thanks so much for joining us today. And those in the queue, I'll get back to you later today. And again, thanks, everyone, for joining. Bye-bye."
94728,1685270027,2442421,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Ladies and gentlemen, this concludes today's conference call. Thank you participating. You may now disconnect.",15,"Ladies and gentlemen, this concludes today's conference call. Thank you participating. You may now disconnect."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Ladies and gentlemen, thank you for standing by, and welcome to the Teradyne Third Quarter 2021 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Andrew Blanchard.  Thank you. Please go",42,"Ladies and gentlemen, thank you for standing by, and welcome to the Teradyne Third Quarter 2021 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Andrew Blanchard.  
Thank you. Please go ahead, sir."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Thank you, Patrice.  Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined this morning by our CEO, Mark Jagiela; and our CFO, Sanjay Mehta. Following our opening remarks, we'll provide details of",291,"Thank you, Patrice.  
Good morning, everyone, and welcome to our discussion of Teradyne's most recent financial results. I'm joined this morning by our CEO, Mark Jagiela; and our CFO, Sanjay Mehta. Following our opening remarks, we'll provide details of our performance for 2021's third quarter along with our outlook for the fourth quarter.  
The press release containing our third quarter results was issued last evening. We're providing slides on the Investor page of the website that may be helpful to you in following the discussion. Replays of this call will be available via the same page after the call ends.  
The matters that we discuss today will include forward-looking statements that involve risk factors that could cause Teradyne's results to differ materially from management's current expectations. We encourage you to review the safe harbor statement contained in the earnings release as well as our most recent SEC filings. Additionally, those forward-looking statements are made as of today and we take no obligation to update them as a result of developments occurring after this call.  
During today's call, we'll make reference to non-GAAP financial measures. We've posted additional information concerning these non-GAAP financial measures where appropriate on the Investor page of the website. Looking ahead between now and our next earnings call, Teradyne expects to participate in technology or industrial-focused investor conferences hosted by Baird, Credit Suisse, Davidson and UBS.  
Now let's get on with the rest of the agenda. First, Mark will comment on our recent results, current market conditions and thoughts on the rest of 2021 and '22. Sanjay will then offer more details on our quarterly results along with our guidance for the fourth quarter. We'll then answer your questions, and this call is scheduled for 1 hour.  
Mark?"
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Andy.  Good morning, everyone, and thanks for joining us. Today, I'll cover 4 topics: the highlights of our third quarter and the first 9 months of the year, the changes we're observing in the SOC test market, our outlook for the industrial auto",1470,"Thanks, Andy.  
Good morning, everyone, and thanks for joining us. Today, I'll cover 4 topics: the highlights of our third quarter and the first 9 months of the year, the changes we're observing in the SOC test market, our outlook for the industrial automation market and how we're thinking about the test and automation markets as we close out this year and look into 2022 and beyond.  
As our Q3 results demonstrate, demand remains strong across all of our businesses. At the company level, Q3 sales grew 16% from last year's record Q3 and non-GAAP EPS grew 35%. We did experience increased supply chain bottlenecks in our Industrial Automation business in the quarter and under ship demand. Sanjay will describe this in more detail, but we expect these constraints to persist into Q4. Despite this, for the first 9 months of 2021, company-wide sales grew 19% and non-GAAP EPS grew 31% from the year ago level.  
In each of our businesses, we are riding long-term secular trends that we expect will drive revenue and earnings growth for years to come. In our Test businesses, the unit growth and complexity drivers that power these markets continue unabated. For example, our semiconductor test business grew 18% through Q3, while -- with SOC leading the charge growing 22%. Sales continue to be dominated by our UltraFLEX product line which is well aligned to the performance requirements of the growing compute and mobility markets.  
Additionally, sales of our Eagle Test Systems more than doubled in the 9-month period as Automotive and Industrial Test markets have also rapidly expanded. Eagle's unique architecture hits the sweet spot in these markets by balancing high precision with the stress testing needed for these demanding applications.  
Within SOC, there's been a clear shift this year to higher demand from the compute, automotive and industrial markets. While mobility is still the largest subsegment of SOC and growing, it has dropped from the high 50% range of the SOC test market in recent years to the high 40% range this year. Over the midterm, we expect mobility will remain the largest SOC submarket and continue to grow but we also expect compute to grow at a faster rate, while automotive should remain at its current elevated levels.  
For the last decade or so, mobility has made rapid annual advances in semiconductor complexity that has enabled the advancement of smartphone sophistication. The refresh pace has been much faster than traditional PCs, graphics, automotive and industrial end markets, leading to smartphone ICs rapidly progressing along the complexity scale. This is true in many areas of smartphone silicon, apps processor compute engines, graphics engines, AI engines, image sensors, power management and more. Our leading position in testing these key technologies has driven our growth.  
At the same time, up until recently, the traditional compute testing market has been relatively flat with slower refresh rates and slower complexity growth. However, the groundwork laid by mobility designs combined with advancing lithography nodes and design tools has enabled new entrants into the chip design space for compute engines. The complexity of these chips whether for laptops, servers, autonomous driving, AI or graphics is incredible and advancing at an accelerated rate. For example, laptop CPUs are now crossing the 30 billion transistor level, which is a huge leap over previous legacy designs.  
As we've said in the past, increased transistor counts drives increased test time and increased tester demand. We've seen that this year and there's more to come. We're targeting this expanding collection of new players and new designs, leaning heavily into our UltraFLEX family's hardware performance and time-to-market advantages of our software. We've been adding new design wins every quarter. And while development pipelines can be long and these new designs can be speculative, we're confident we'll see growing production business from these wins in the future. It's also notable that the traditional chip suppliers in these markets aren't standing still, they are doubling down on their advanced designs too, which is collectively driving WFE investments higher as applications expand and competition heats up.  
We expect this race to lead to higher test TAMs and given the higher performance and faster design to market cycle times, more share gain opportunities for Teradyne over the midterm. 
 
Our System Test segment last year -- sorry, our System Test segment year-to-date sales grew 11% from 2020 and Storage Test continued its multiyear growth trajectory, expanding sales 12% in the same period. Higher capacity HDDs and more complex SOC devices, which require system-level test, are driving this demand. Both trends are expected to continue into the foreseeable future. 
At LitePoint, sales were up 24% through 9 months compared with 2020, driven by WiFi 6E production, WiFi 7 R&D demand as well as ultra-wideband. More connected devices demanding more bandwidth while managing growing congestion drive complexity increases in each new WiFi standard and more tests. UWB, on the other hand, is a whole new wireless standard in application space. It's a new proximity detection wireless technology with the future of many promising security applications. We expect these trends to continue and to provide a long-term tailwind to our Wireless Test business.  
Shifting to Industrial Automation. Universal Robots revenue grew 50% through the first 9 months of the year, while MiR grew 40% despite supply chain challenges. Each has a unique story. At UR, it's a combination of increasing sales for existing tasks and the expanding number of UR+ offerings, making it easier for customers to deploy our cobots to do new applications. We highlighted welding in our last call, but other examples include screw-driving and palletizing. 
The UR+ ecosystem is key to expanding these tasks and now totals over 360 products created by over 300 partners, both riding on and broadening the coattails of our UR platform. This is a key advantage in the combination of our organic investments and our UR+ and OEM partners R&D dollars and creativity that's going into expanding the UR platform and it's unmatched.  
At MiR, the story is about new products. The MiR250 which was introduced just as COVID hit last March of last year, is now our largest seller by far. This year, we added the MiR Hook to the 250 family to expand its applications into tugging. We've introduced higher payload products such as the MiR 600 and 1350 to expand our footprint in the fast-growing logistics market.  
Unfortunately, with all this good news come supply chain issues that will limit IA growth in 2021 to be between 30% to 40% year-on-year, but demand is strong. The long-term outlook in IA remains very bright. Looking at the capabilities of UR cobots today, we estimate the penetration rate is less than 2% of the servable market. UR's approximate 45% market share puts us clearly in the lead, and we continue to drive R&D and distribution investments to extend our competitive advantages, expand the servable market and drive penetration higher.  
It's a similar story at MiR, where we estimate the autonomous mobile robot penetration is under 3%. The AMR market doesn't have a single dominant player like UR cobots, and we estimate we're close to #2 in the broadly defined market. And like at UR, we're making investments in both the distribution and product level to both reinforce our advantages and extend our product reach.  
In both IA businesses, the fact that our penetration of today's servable market is low single digits and that the servable market continues to expand each year with product enhancements, sets up a fantastic future. So even with very high growth rates in our IA business, we expect the penetration rates to remain low for many years, sustaining our long-term annual growth forecast of 20% to 35%. In January, we will update you on the outlook for 2022 and our midterm earnings model. Between now and then, we'll be looking at the rate and timing of new semiconductor fab capacity coming online, especially at the more advanced lithography nodes. And we'll also be looking at the rate of adoption of DDR5 as key swing factors.  
In IA, we will be looking at the manufacturing output expansion, onshoring trends and PMIs in our principal geographies as tailwinds for continued robust growth. On the other hand, in both markets, supply chain bottlenecks could slow certain industries and become a headwind to growth demand. Short-term demand is influenced by many factors, but we manage our business aligned to the long-term trends. The trend of growing prevalence of increasingly complex semiconductors and a myriad of applications drives our semiconductor business and investments. The trend of new increasingly smart, cost-effective automation in a world with labor scarcity and onshoring challenges drives our IA business and investment strategy. These systemic long-term trends paint an exciting future for Teradyne.  
With that, I'll turn it over to Sanjay."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Mark, and hello, everyone.  In my remarks, I'll review our Q3 financial results, discuss our supply line strategy in this challenging environment, provide Q4 guidance and comment on our full year financial outlook at the midpoint of our Q4 guida",1460,"Thanks, Mark, and hello, everyone.  
In my remarks, I'll review our Q3 financial results, discuss our supply line strategy in this challenging environment, provide Q4 guidance and comment on our full year financial outlook at the midpoint of our Q4 guidance. 
To the financial headlines for Q3. Our third quarter sales were $951 million was near the high end of guidance driven by strength in Semi Test and Wireless Test. Gross margin in the quarter was approximately 60%. Our non-GAAP operating expenses were $242 million or 25.5% of revenue. The favorability in OpEx drove a non-GAAP operating margin of approximately 35% and non-GAAP EPS of $1.59. A few more components of third quarter data. Our tax rate, excluding discrete items, was 14.8% on both a GAAP and non-GAAP basis. Non-GAAP diluted share count was approximately 176 million. We had two 10% customers.  
Looking at the results from a business unit perspective. Semi Test revenue of $688 million was up 16% from Q3 '20. SOC revenue was $575 million, up 28%, driven by strength in applications processors, RF, industrial and automotive applications. Automotive and industrials doubled revenue year-over-year. Memory revenue was the second highest in history at $113 million, but down 21% from Q3 of last year's record. 
FLASH final test demand was the strongest segment on handset and SSD end market demand. System Test group had revenue of $103 million, which was down 13% year-over-year. Recall Storage is the largest business in this segment and has lumpy shipments. While Storage Test will still grow more than 15% for the year, sales, including HDD and SLT declined to $56 million on the timing of shipments in Q3.  
Defense and aerospace and production board test combined grew 10% year-on-year to $47 million. At LitePoint, revenue of $69 million was up 70% from prior year due to early success of our new WiFi 7 product, continued strength in 4G cellular and UWB.  
Now to Industrial Automation. As in July, given COVID shutdowns had impaired the UR business in 2020, I'll provide revenue metrics comparing Q3 '21 results with both Q3 '20 and Q3 '19. Industrial Automation revenue of $91 million was up 32% from both Q3 '19 and Q3 '20. North America delivered the highest revenue growth from last year, but all regions expanded year-on-year. As Mark noted, supply issues, primarily semiconductors, reduced our IA shipments in the quarter. UR sales were $78 million in Q3, up 46% year-over-year and 31% over Q3 '19. MiR sales were $13 million, up 27% from Q3 '20 and 35% from Q3 '19. IA was about breakeven in the quarter and full -- breakeven in the quarter and full year, we expect low single-digit profitability. As we've noted before, we continue our strategy of investing during this high-growth era while maintaining gross margins to enable mid-20s operating profit in the future.  
Shifting to supply. We continue to deal with numerous supply constraints across the company. While semiconductor shortages are well reported, we're also seeing delays in mechanical parts and logistics, all exacerbated by rolling COVID-related shutdowns or labor shortages. We expect these issues will continue through the first half of 2022. Despite these issues, we've been able to deliver record shipments and a big part of that performance is a result of the supply line management, operations teams and engineering teams working with our supply chain and contract manufacturing partners.  
We view our operational business model and execution against it as a core competence. Our gross margin performance over the last 10 years displays the financial value of this model. 
In our test portfolio, our execution has kept most of our tester lead times within the range that meet customers' needs to expand their production capacity in this dynamic environment. The significance of this lead time performance is that customer orders more closely reflect true test demand. So while a bit counterintuitive, we feel that maintaining short lead times are a more accurate indicator of test demand with lower risk than holding orders with lead times far beyond chip manufacturing cycle times. Of course, our supply line and operations model isn't static. We began adding resiliency through both geographic and supplier diversity prior to COVID. Those efforts have accelerated over the last 20 months.  
This work is paying dividends in the current environment, and we'll continue to invest to harden our supply chain further. Our lead time performance is an example of our resilience and execution. Another example is the ability to scale to significantly increase demand. Auto and industrial sales have more than doubled year-over-year. While we're not perfectly aligned to all customer requested delivery dates, we are managing through delivery issues in a reasonable manner. The value of these efforts can also be seen in the operating leverage in our gross margin line. 
 
In IA, we've seen lead times extend from our normal 1 to 2 weeks to 4 to 6 weeks for some products. While this is a challenge with the business growing so quickly and ongoing industry supply issues, we've already seen the positive impact of our work in material sourcing and manufacturing cycle times.  We expect to bring lead times back to model over the next 2 to 3 quarters. 
Shifting to the balance sheet and cash flow. Our cash and marketable securities at the end of the quarter totaled $1.45 billion. We had $493 million in free cash flow in the quarter, and through 9 months, we've spent $103 million on CapEx, and we expect we'll spend $148 million for the full year. We spent $210 million and $16 million on buybacks and dividends, respectively. Year-to-date, we've repurchased 3.3 million shares for $406 million at an average price of $123.53. In 2021, we expect to return over 80% of our free cash flow to shareholders. And from 2015, when we began repurchasing shares, we've returned 85% of our free cash flow to owners.  
Regarding our convertible debt, $302 million of principal was paid in the first 9 months to the convertible bondholders ahead of maturity. By mid-December, bondholders will have converted approximately $343 million, leaving a face value of $117 million.  
Now to our outlook for Q4. Sales in Q4 are expected to be between $820 million and $900 million, with non-GAAP EPS in a range of $1.14 to $1.40 on 174 million diluted shares. Fourth quarter guidance excludes the amortization of acquired intangibles and noncash imputed interest on the convertible debt. Our guidance assumes no significant changes, positive or negative, in the availability of materials and assumes that we won't see additional pandemic-related issues. Fourth quarter gross margins are estimated at 59% to 60%. OpEx is expected to run at 28% to 31% of fourth quarter sales. The non-GAAP operating profit at the midpoint of our third quarter guidance is 30%.  
Regarding OpEx for the full year. We spent a bit lower than planned in Q3, and we expect the full year OpEx will be about $980 million, up 17% from 2020. At the midpoint of our guidance, 2021 will be another year of growth in both revenue and EPS, while sales growing -- or sorry, with sales growing 18% to $3.7 billion and non-GAAP EPS growing to $5.88, up 27%. Gross margin for the full year should be approximately 59.5%, up from 57.2% in 2020, reflecting the ramp of new products, product mix and operating leverage, offsetting component and logistics cost increases.   
Our 2021 non-GAAP operating profit rate is expected to be about 33%, up from last year's 30%. Our full year tax rate is expected to be 14.8%. These results put us comfortably in the range of our 2024 earnings model this year. We'll update the model on our regular cadence in January. 
The breadth of our customer buying in 2021 is also broader than last year. In 2020, we had 1 customer that drove 25% of sales. In 2021, we do not expect to have any customer larger than 20% of our yearly revenue. This reflects the trend Mark noted about 2021's higher growth in compute, auto and industrial demand compared with mobility demand in Semi Test. IA growth of over 30% year-over-year continues to diversify our revenue. This growth is expected to continue over the midterm and become a larger portion of our revenue.  
In summary, we expect to end the year with another quarter of strong year-on-year revenue and EPS growth. On a full year basis, we'll exceed our midterm targets on stronger-than-expected demand on our test businesses, continued high growth in IA and excellent execution across the company. While we don't have a clear picture of 2022 yet, we're confident that the long-term industry trends powering our test and IA businesses remain firmly in place.  
With that, I'll turn the call back to Andy."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Thanks, Sanjay. Patrice, we would now like to take some questions. [Operator Instructions]",13,"Thanks, Sanjay. Patrice, we would now like to take some questions. [Operator Instructions]"
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","[Operator Instructions] Your first question comes from Atif Malik with Citi.",11,"[Operator Instructions] Your first question comes from Atif Malik with Citi."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Good job in the tough supply environment. And Mark, if I look at some of the recent ARM-based notebook processors, the transistor count is growing 2 to 4x versus prior generation. You commented mobility to grow and compute, auto, analog to grow faster tha",70,"Good job in the tough supply environment. And Mark, if I look at some of the recent ARM-based notebook processors, the transistor count is growing 2 to 4x versus prior generation. You commented mobility to grow and compute, auto, analog to grow faster than mobility in the midterm, understand you guys generally talk about next year outlook in January. How confident do you feel about your SOC growth next year?"
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Well, I think at this point, pretty confident. I mean we look at the trends that I just -- you cited and I cited and see that there's very little standing in the way of sort of this increased growth, but the caveat I would mention is there's a lot of supp",177,"Well, I think at this point, pretty confident. I mean we look at the trends that I just -- you cited and I cited and see that there's very little standing in the way of sort of this increased growth, but the caveat I would mention is there's a lot of supply chain bottlenecks in the system. So if end products get bottlenecked, that can slow down the unit volume demand for new semiconductors. And the other thing we're looking at is when do these new nodes really come online in terms of capacity. All that $90 billion of WFE that was put in place this year hasn't yet had a single impact on test. That's all to come. But it kind of depends on when do those additional 5- and 3-nanometer fabs come online. That is kind of a big swing factor in the calendar year 2022 as to how our growth will chunk up. And that's kind of why we wait until January because we don't get a good enough visibility on that right now."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Great. And Sanjay, as a follow-up, can you talk about concentration within mobility and compute customer and impact on long-term gross margins? There have been talks about price discounts with equipment suppliers by Tier 1 foundry.",36,"Great. And Sanjay, as a follow-up, can you talk about concentration within mobility and compute customer and impact on long-term gross margins? There have been talks about price discounts with equipment suppliers by Tier 1 foundry."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. As I stated in my prepared remarks, we won't have any customer above 20%. So it's a broader breadth of customers. And regarding gross margins, in throughout the year, we've improved gross margins. And as I said in earlier calls, really driven by a co",127,"Yes. As I stated in my prepared remarks, we won't have any customer above 20%. So it's a broader breadth of customers. And regarding gross margins, in throughout the year, we've improved gross margins. And as I said in earlier calls, really driven by a couple of key test systems coming online and we're shipping in volume that have come down the cost curve. We've seen some benefits to product mix shift as well as our operating leverage offsetting the component costs and logistic cost increases. From a look forward and sustainability of that gross margin, obviously, we'll give an update to our earnings model in January. But I see the second half of our gross margin performance kind of going into the first half of 2022."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Mehdi Hosseini with SIG.",9,"Your next question comes from Mehdi Hosseini with SIG."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Yes, the first one has to do with your largest customer. And given your commentary in terms of revenue mix, it seems to me that that particular customer is going to be down like 5% to 6%. In that context, should we assume a return to growth in '22, and th",80,"Yes, the first one has to do with your largest customer. And given your commentary in terms of revenue mix, it seems to me that that particular customer is going to be down like 5% to 6%. In that context, should we assume a return to growth in '22, and this is a trend that has happened over the past several years? And should that happen again -- Should that pattern happen again into '22? And I have a follow-up."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. We, of course, maybe can't talk about any individual customer and what they might do or not do in the future. So that I have to leave aside. But I just point out in your first point that, yes, our largest customer is dropping below 20% in a growing r",73,"Yes. We, of course, maybe can't talk about any individual customer and what they might do or not do in the future. So that I have to leave aside. But I just point out in your first point that, yes, our largest customer is dropping below 20% in a growing revenue year. So the amount that you might think compute that they're falling has to be taken against our numerator of higher revenue."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. And then I wanted to follow up to the question that came up 3 months ago when we were looking into your market share in the compute. Can you update us where you are with that market share in 2021? And as hyperscalers ramp their own ARM-based CPUs,",63,"Got it. And then I wanted to follow up to the question that came up 3 months ago when we were looking into your market share in the compute. Can you update us where you are with that market share in 2021? And as hyperscalers ramp their own ARM-based CPUs, how will your market share change over the next 1 or 2 years?"
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Well, like the total SOC market, year-to-year market share is very volatile. It depends on whose customers are buying what in any given year. So what our market share might be in any given year, it can -- in a submarket like compute, it can swing 20 point",118,"Well, like the total SOC market, year-to-year market share is very volatile. It depends on whose customers are buying what in any given year. So what our market share might be in any given year, it can -- in a submarket like compute, it can swing 20 points year-to-year depending on who's buying. So for this year, it tends to be a very good compute year for us. Our compute market share is up in, I would say, close to what our average share is in SOC this year. But I would say that it's not steady Eddie. It's going to be pretty volatile year-to-year, it has been in the past. It probably will be going forward, too."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","I know we're supposed to ask only 2 questions, but just a quick follow-up. I think what I'm trying to understand is I think on the GPU side, it's pretty clear that your competitor has dominated. And assuming that that work to remain unchanged, I think the",86,"I know we're supposed to ask only 2 questions, but just a quick follow-up. I think what I'm trying to understand is I think on the GPU side, it's pretty clear that your competitor has dominated. And assuming that that work to remain unchanged, I think the incremental change to the compute is all driven by ARM-based. And I was just trying to better understand how you look at your competitive position as these new chips coming to the market addressing the compute end market?"
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","We -- look, we're very pleased and confident with our progress in ARM-based compute and design-ins in that realm, but I would say that it's not -- there's the tester market for compute also driven by more traditional x86 demand as well. You've got a coupl",81,"We -- look, we're very pleased and confident with our progress in ARM-based compute and design-ins in that realm, but I would say that it's not -- there's the tester market for compute also driven by more traditional x86 demand as well. You've got a couple of suppliers there that are not standing still, as I mentioned, and are upping their kind of complexity growth curve. And so there will be certainly a lot of growth there as well, I believe."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Toshiya Hari, Goldman Sachs.",9,"Your next question comes from Toshiya Hari, Goldman Sachs."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Congrats on the strong execution. I had 2 questions as well. My first one is on the supply constraints, maybe for Mark, maybe for Sanjay. Just curious how significant the headwinds were for IA in Q3 and what's embedded in your Q4 guidance? If you can shar",102,"Congrats on the strong execution. I had 2 questions as well. My first one is on the supply constraints, maybe for Mark, maybe for Sanjay. Just curious how significant the headwinds were for IA in Q3 and what's embedded in your Q4 guidance? If you can share that, that would be helpful. And I just wanted to confirm that there was little to no impact on your Semi Test business. And then on gross margins, similarly, you came in at the high end of your guided range, but was there any impact on your profitability in the quarter from supply chain shortages?"
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Sure. So I'll take those. So from an Industrial Automation perspective, year-to-date, we've grown 40% in IA, and Q4 demand is high. If we can't supply at all, that's why we've -- I think it's going to be growth year-on-year of about 30% to 40%. And so pre",215,"Sure. So I'll take those. So from an Industrial Automation perspective, year-to-date, we've grown 40% in IA, and Q4 demand is high. If we can't supply at all, that's why we've -- I think it's going to be growth year-on-year of about 30% to 40%. And so predominantly, it's in semiconductors. And I expect we'll be out of the supply chain crunch given our visibility in Q2 or Q3 for IA. So that's the IA side. And then from a supply chain perspective on the test side, we've seen the supply chain tightening on the test portfolio quarter-over-quarter, where we don't think it's going to be abated until the end of Q2 of 2022. And again, mainly semiconductor parts. And really, we see that coming back online in the second half, really tied to the wafer and the substrate capacity coming online.  
And then from a gross margin perspective, we've been managing through the component increases and logistics increases in cost. And we've -- as I've said earlier, we've had favorable product mix. And as our volumes or our revenues are higher, we're gaining operating leverage along with coming down the cost curve of our new products that we've introduced late last year. So we're managing through it, and it's true well-publicized component cost increases."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. That's super helpful. And then as my follow-up, Mark, I wanted to ask about your Eagle Test business. In your prepared remarks, you noted that the business is up more than 2x year-to-date. I guess historically, like many other parts of your busine",143,"Got it. That's super helpful. And then as my follow-up, Mark, I wanted to ask about your Eagle Test business. In your prepared remarks, you noted that the business is up more than 2x year-to-date. I guess historically, like many other parts of your business, I think the Eagle Test has been quite cyclical. You would be up for 1 year, 1.5 years, 4 to 6 quarters and then down a little bit as customers digest their test capacity. Based on what you said, it seemed like you're expecting 2022 to be another strong year. I guess the question is what's different this time as you think about Eagle Test into '22. I realize there's complexity growth, but you could argue there's been complexity growth for a very long time. So just curious how different this cycle could be relative to past cycles."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Right. Good question. And in addition, automobile unit volume isn't near its historical peak either. So how could this thing keep going beyond the normal 6-quarter surge in automotive, which is you're right, again, that's kind of the traditional pattern.",189,"Right. Good question. And in addition, automobile unit volume isn't near its historical peak either. So how could this thing keep going beyond the normal 6-quarter surge in automotive, which is you're right, again, that's kind of the traditional pattern. But I think what we see happening and makes us believe this will persist at least through 2022 is there's a lot of silicon refresh going on that's new in the automotive space. New -- kind of racing to get new, more current generation lithography node silicon into automotive design because the legacy lines out there are hard to get at. Chip suppliers are trying to obsolete those fabs. And so the automotive customers don't have as much, I would say, power in this frothy demand environment on the semiconductor supply side. And so the semiconductor suppliers are kind of same, get with the program, move to more advanced nodes. And a little bit of that's happening, which is what -- that means complexity, yield issues, and that means a little more test than you might expect. And I think that's what's giving us a different view this time."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from John Pitzer, Credit Suisse.",9,"Your next question comes from John Pitzer, Credit Suisse."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Congratulations on the solid results. Mark, I want to go back to increasing test times in the Semi Test business. You've done a good job kind of helping us understand complexity and transistor count. I'm kind of curious, as we move from a world of sort of",96,"Congratulations on the solid results. Mark, I want to go back to increasing test times in the Semi Test business. You've done a good job kind of helping us understand complexity and transistor count. I'm kind of curious, as we move from a world of sort of general purpose compute to one of more optimized silicon, you're going to move from a world where you're testing huge volumes in one device to smaller volumes across multiple devices. What does that do for test efficiency at your customers and hence, test times as that trend takes hold?"
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","It is a -- building, let's say, 100 billion transistors on 1 chip versus 4, to give an example, isn't equivalent test time. The 4-chip version is likely -- these are going to be rough rules of thumb, but let's say, 25% more test intensive than the single",252,"It is a -- building, let's say, 100 billion transistors on 1 chip versus 4, to give an example, isn't equivalent test time. The 4-chip version is likely -- these are going to be rough rules of thumb, but let's say, 25% more test intensive than the single chip design because there's a premium on sort of known good die testing to -- when you put those together in an advanced package. And then the advanced package itself has more potential defect failure modes that need to be tested. So that's one thing around the whole chiplet, multi-chip package thing. 
The other thing, though, that's happening, and this is really going to become prevalent at 3-nanometer and beyond is the move from FinFET to gate-all-around transistor architectures. And if you remember, when the world moved from planar to FinFET, it was back in 2012, '13, '14 era, that drove -- if you go back and look at the history of sort of the test market, that drove incremental test intensity and complexity in the market. And we're headed for another one of those with gate-all-around. There's going to be new defect modes, new kind of test intensity boosts coming from this new architecture on the transistor. So even at equivalent transistor counts, we're going to see a little bit more test intensity because of that. So these 2 trends of chiplets and gate-all-around and 3-nanometer, that's probably all the 2023 and beyond story given where 3-nanometer is right now, but it's coming."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","That's helpful. And that's my second question, Mark, just going back to your largest customer, I'm kind of curious if you can help me better understand the diversity of business with that customer. I mean clearly, it's been mobility-led for the last sever",103,"That's helpful. And that's my second question, Mark, just going back to your largest customer, I'm kind of curious if you can help me better understand the diversity of business with that customer. I mean clearly, it's been mobility-led for the last several years. Now you've got them doing more in the compute space. You've talked about in the past the complexity around these AirTags. Are you seeing a meaningful diversification of demand drivers at that customer? And can you help me -- because I just don't know how fungible is your -- is their test capacity across those different product families?"
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes, I'm not going to be able to talk too much about the sort of breadth there. I think you can imagine it, and you've rattled off some examples. In terms of fungibility, they're pretty fungible to testers across what's used for compute engine in a phone",299,"Yes, I'm not going to be able to talk too much about the sort of breadth there. I think you can imagine it, and you've rattled off some examples. In terms of fungibility, they're pretty fungible to testers across what's used for compute engine in a phone versus a compute engine in a laptop or a desktop or anything else. The one that's a little bit unique is when you get into things like, the RF type products, of course, have a bit of a different architecture, power management type products have a bit of a different architecture. And so those testers tend to be a little more unique. But we've talked about in the past that -- I think people have looked at us and said, well, in a world where cell phones are kind of plateauing, doesn't that -- unit growth of cell phones doesn't that that portends some kind of slowing for us. 
And what we've always said is that, look, cell phone unit growth can slow, complexity isn't. And some of these customers are diversifying into more silicon, both in the phone and now more silicon outside the phone into compute. There are these emerging hyperscalers that are building silicon for both cloud computing and other new yet-to-be introduced consumer products. So the ability of a design team today to be formed and put together a $10 billion-plus transistor chip for a consumer application is easier and easier and easier. And as I said in my script, we work with a lot of them. Maybe a small fraction of them will be hits in the future, but they can bring entirely new classes of semiconductor -- high compute engine semiconductor applications to the market. And all of those are kind of UltraFLEX, UltraFLEXplus family devices."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from C.J. Muse of Evercore.",10,"Your next question comes from C.J. Muse of Evercore."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","I guess, Mark, another technology question. You've kind of taught us to think about transistor count in kind of thinking about test times for mobility compute. And curious, as we go to more high-performance compute, where there are more thermal issues, pe",58,"I guess, Mark, another technology question. You've kind of taught us to think about transistor count in kind of thinking about test times for mobility compute. And curious, as we go to more high-performance compute, where there are more thermal issues, perhaps more complex software algorithms, how should we be thinking about the test times in that transition?"
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Well, I think the test times have less to do with the application. The only place where the application drives really fundamentally different test times as automotive because of the issues there. It's more the technology. So I go back to C.J., what I said",81,"Well, I think the test times have less to do with the application. The only place where the application drives really fundamentally different test times as automotive because of the issues there. It's more the technology. So I go back to C.J., what I said before about 3-nanometer is going to be more impactful to both test times in phones and in computers and in servers and in graphics and in everything else, probably than any of those end market applications."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. That's helpful. And then I guess, Sanjay, a question for you. Clearly, you're making investments, particularly in IA. But as you look to 2022, can you speak to your outlook for operating leverage. And as part of that, how we should think about OpEx",50,"Okay. That's helpful. And then I guess, Sanjay, a question for you. Clearly, you're making investments, particularly in IA. But as you look to 2022, can you speak to your outlook for operating leverage. And as part of that, how we should think about OpEx relative to top line growth?"
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Sure. I'd say we're in the early innings of looking at 2022 and obviously, we'll provide an update in January. But OpEx is growing in kind of a couple of key areas this year, obviously tied to higher volume, we have variable compensation as well as engine",149,"Sure. I'd say we're in the early innings of looking at 2022 and obviously, we'll provide an update in January. But OpEx is growing in kind of a couple of key areas this year, obviously tied to higher volume, we have variable compensation as well as engineering spends tied to our operations to qualify new suppliers et cetera. And then we continue to invest in both go-to-market and engineering across the test portfolio. And as you noted, we're leaning in, obviously, in -- as I noted in my prepared remarks, we're leaning into our IA investments really to help drive going forward. The other component is the G&A expenses going forward. This was a big year of OpEx growth. The only thing I'd say is that next year we're not going to be as large percentage-wise growth, but that's really all I have to say on it right now."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Timothy Arcuri, UBS.",8,"Your next question comes from Timothy Arcuri, UBS."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, I just wanted to see if you can update us on the SOC TAM. You had said 4, 5 last call and segments of that was compute was about $1 billion. Mobility was 1.8 to 1.85. Autos were about 500, Industrial was 500, 550. I'm just kind of wondering if you c",58,"Mark, I just wanted to see if you can update us on the SOC TAM. You had said 4, 5 last call and segments of that was compute was about $1 billion. Mobility was 1.8 to 1.85. Autos were about 500, Industrial was 500, 550. I'm just kind of wondering if you can update us on those numbers."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Good question. So fundamentally, it's in the same range. It's probably trending more up towards the higher end of that range. So I think the numbers, the submarkets you got right on what we talked about last time, maybe compute is driving us a little",71,"Yes. Good question. So fundamentally, it's in the same range. It's probably trending more up towards the higher end of that range. So I think the numbers, the submarkets you got right on what we talked about last time, maybe compute is driving us a little bit higher in that range at this point in time. But it's pretty close. And memory is still at about $1 billion TAM as well."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Great. And then I guess I had a question just on profitability in IA. I note, Sanjay, you just answered a question about operating leverage next year. But what's the catalyst maybe -- this time last year, we were thinking IA would be 10% to 15% op m",130,"Okay. Great. And then I guess I had a question just on profitability in IA. I note, Sanjay, you just answered a question about operating leverage next year. But what's the catalyst maybe -- this time last year, we were thinking IA would be 10% to 15% op margin and then it got cut to 10% and then it went to 5%, and now it's kind of low single digits. And I get that the penetration there is very low. But what's the catalysts for you to look at maybe we shouldn't be investing so much money and maybe we can optimize OpEx investment? So I guess I'm just kind of wondering how you think about sort of what's going on at IA and what the long-term profitability target is?"
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. So our range, as we said prior is 5% to 15%, and we expect to be low single digits, as I said in my prepared remarks. But really, how we think about it is we manage the business on a -- think about it as a rule of 40, combining the year-over-year gro",214,"Yes. So our range, as we said prior is 5% to 15%, and we expect to be low single digits, as I said in my prepared remarks. But really, how we think about it is we manage the business on a -- think about it as a rule of 40, combining the year-over-year growth with the operating profit. And fundamentally, we're -- as we see or as been noted by Mark, where penetration is very, very low and we look at all the jobs that can be automated and the scarcity of labor and economic growth, we really see a strong tailwind for the portfolio. And with that, we're very focused and conscious on both engineering and go-to-market investments. And so how we think about it is quite simple. And that is where we have a strong belief that we're going to grow and it's going to accelerate that revenue growth, we're going to lean into the investment. And again, think about it in the rule of 40. And as I said in my prepared remarks, our gross margins are actually improving in that portfolio. And so when we see that growth start to moderate, then we'll start to moderate the OpEx to get to an operating profit of, let's say, in the mid-20s."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Vivek Arya, Bank of America.",10,"Your next question comes from Vivek Arya, Bank of America."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Mark, this move to 3-nanometer, is that a benefit for Teradyne in '22 or '23? I thought it would be '23, but I wanted to confirm. And kind of following on for that, what are the top 1 or 2 end markets that you are most excited about in terms of growth for",55,"Mark, this move to 3-nanometer, is that a benefit for Teradyne in '22 or '23? I thought it would be '23, but I wanted to confirm. And kind of following on for that, what are the top 1 or 2 end markets that you are most excited about in terms of growth for next year?"
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","So on the 3-nanometer question, that was one of the things I mentioned that we'll be looking at carefully between now and January when we update you on the 2022 view. And we've seen some pushouts on some of those nodes for a -- by a few months. So the abi",203,"So on the 3-nanometer question, that was one of the things I mentioned that we'll be looking at carefully between now and January when we update you on the 2022 view. And we've seen some pushouts on some of those nodes for a -- by a few months. So the ability to intercept them in a meaningful way in Q -- or sorry, in 2022 is a swing factor. We don't see that exactly yet. But whatever happens in 2022, it might get some early ramping, but the bulk of it is going to be 2023, '24, '25 kind of and beyond. So a little bit could happen in '22, how much we won't know more until January. 
In terms of markets next year that are interesting and exciting, I think it goes back to these emergent hyperscalers that are developing some new applications and very complex silicon for those new applications. Some of those could latch in the market with new product introductions and drive a whole new sort of demand stream for semiconductors and the testers associated with them. So that's kind of what we're rooting for and what we're close to, and we're seeing could be breakouts for 2022."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Very helpful. And maybe just following up on that. Is there a way, Mark, to contrast the additional complexity in a product that's going into a hyperscaler application versus a mobility application. I understand die sizes might be different, then",123,"Got it. Very helpful. And maybe just following up on that. Is there a way, Mark, to contrast the additional complexity in a product that's going into a hyperscaler application versus a mobility application. I understand die sizes might be different, then packaging, et cetera, might be different. But in -- conceptually, what does the mix shift from a more mobility heavy end market to something that is taking you more into the compute and hyperscaler land means for Teradyne in terms of your growth prospects? And also the -- just the seasonality because mobility tends to be a lot more seasonal markets. Those other markets are perhaps less seasonal. So what does that mix shift mean for Teradyne over the long term?"
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes, that's a good question. And the range of devices being developed at hyperscalers is quite large. Some of them are simpler than a classic cellphone device, apps processor in a cell phone. So those aren't going to have much of an impact even if they la",171,"Yes, that's a good question. And the range of devices being developed at hyperscalers is quite large. Some of them are simpler than a classic cellphone device, apps processor in a cell phone. So those aren't going to have much of an impact even if they latch. But some of them that are more, I would say, leverage AI, machine learning and high res displays are equal to or greater complexity than what you might find in a typical cell phone application for those technologies. So it's a broad spectrum is, I guess, the bottom line. But if you sort of play it out, I'd say the hyperscalers are going to, on average, bring cell phone-like complexity applications to the market. It's probably not going to be something that's -- take the $50 billion transistor device that kind of surprised everybody. It's probably not at that extreme. It's probably more in the $10 billion transistor range on average and then moving up year-over-year-over-year after that as they iterate on the design."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Krish Sankar with Cowen and Company.",11,"Your next question comes from Krish Sankar with Cowen and Company."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","I have 2 questions. Mark, just want to ask the 3-nanometer question in a different way, you spoke about how test investments have to catch up to front end WFE spending. But during the 3D NAND investment cycle WFE grew in 2016 and '17, while the memory tes",83,"I have 2 questions. Mark, just want to ask the 3-nanometer question in a different way, you spoke about how test investments have to catch up to front end WFE spending. But during the 3D NAND investment cycle WFE grew in 2016 and '17, while the memory test spending kind of came in 2018 in a meaningful way. So I'm kind of curious, how should we think about the time lag effect of test to front end foundry logic WFE this time around?"
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. Good questions. So all of the WFE investment gets recognized before single testers associated with that investment. So the way to think about test is whenever you see some silicon coming off a new node, assume that the testers were installed maybe 3",181,"Yes. Good questions. So all of the WFE investment gets recognized before single testers associated with that investment. So the way to think about test is whenever you see some silicon coming off a new node, assume that the testers were installed maybe 3 months or so prior to that. So once the 3-nanometer fab comes online and you start to see product coming off of it in reasonable volume more than sort of pilot line volume, assume that the tester installations occurred about 3 months prior. That's kind of the best guidance I can give you there. And then the only other thing I would caution about memory versus SOC is that the curve of test time to transistor count is not the same in memory as it is in SOC. Memory tends to be a bit more efficient for reasons I won't get into here. So you can double transistors and memory, and you're not going to probably move test time more than 20%, 30% or so, let's say, whereas in SOC, it's not quite linear, but it's closer."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Got it. Got it. That's very helpful, Mark. Then I have a follow-up for Sanjay on gross margins. Despite the constrained environment, gross margins have stepped up about 200-plus basis points over the last like 4 quarters or so to a 59% to 60% range. Is th",60,"Got it. Got it. That's very helpful, Mark. Then I have a follow-up for Sanjay on gross margins. Despite the constrained environment, gross margins have stepped up about 200-plus basis points over the last like 4 quarters or so to a 59% to 60% range. Is this kind of the new baseline we should assume at these revenue run rates?"
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. I think I talked about that earlier. So we're going through our strategic planning process in Q4, and it's really the basis of our earnings model update in January. As I've said, just having some visibility into the first half of next year, I think y",153,"Yes. I think I talked about that earlier. So we're going through our strategic planning process in Q4, and it's really the basis of our earnings model update in January. As I've said, just having some visibility into the first half of next year, I think you should expect to see that gross margin be similar in the first half of next year as we have in the second half of 2021. From -- and so there's many different variables in there. I noted that we've been managing through the component and logistics cost increase. We've had good mix and come down the cost curve of our new products and gaining operating leverage. So there's many variables in there that we're going to look at closely and as our revenue gets more and more diversified. There's a lot of puts and takes, but we'll provide more guidance on that in the January call."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your next question comes from Brian Chin, Stifel.",8,"Your next question comes from Brian Chin, Stifel."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Nice results. Sorry, first to clarify something going back on the commentary. If you had more chips, you would be able to ship to an appreciably higher level of revenue in both the Semi Test and Industrial Automation businesses in Q4. Did I hear that corr",46,"Nice results. Sorry, first to clarify something going back on the commentary. If you had more chips, you would be able to ship to an appreciably higher level of revenue in both the Semi Test and Industrial Automation businesses in Q4. Did I hear that correctly?"
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","In Industrial Automation, percentage-wise, we'd be able to ship more. In the Test portfolio, we think we're going to manage through the majority of the supply issues at this point.",30,"In Industrial Automation, percentage-wise, we'd be able to ship more. In the Test portfolio, we think we're going to manage through the majority of the supply issues at this point."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Okay. Great. And then interesting discussion here on 3-nanometer and sort of like a fulcrum event in terms of test intensity again at 3-nanometer or gate-all-around. Maybe a couple of questions as my follow-up. What is it about that, that -- I know",189,"Okay. Okay. Great. And then interesting discussion here on 3-nanometer and sort of like a fulcrum event in terms of test intensity again at 3-nanometer or gate-all-around. Maybe a couple of questions as my follow-up. What is it about that, that -- I know it probably is a longer-form discussion, but in short form, what is it about 3-nanometer or 3-nanometer gate-all-around, is it sort of what the yield modeling suggests for kind of lower yield rates there compounded by die sizes, compounded by transistors or advanced packaging? Or is it also sort of a combination of the types of devices that you think that enables in terms of the intersection point of various customers and their kind of chip road maps? Just kind of want to get at that. And then like in kind of bigger picture, if the high-performance compute test TAM is a little bit more secular, a little bit more growthy, if you've kind of benchmarked test growth at sort of 4% to 8%, how much of a premium do you think we're looking at over the next several years in terms of HPC TAM?"
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Okay. there's a lot in there, Brian. So let me, first of all, take on 3-nanometer. So the issues about 3-nanometer certainly enables more dense, more transistors per die. That's not what I'm talking about. That's a big driver of test in the future. That w",345,"Okay. there's a lot in there, Brian. So let me, first of all, take on 3-nanometer. So the issues about 3-nanometer certainly enables more dense, more transistors per die. That's not what I'm talking about. That's a big driver of test in the future. That would absolutely be something that would give us a positive outlook for the next midterm. There's the chiplet thing that we talked about where you have mixed nodes going into chips, and then you need known good die testing and then the multi-packaging needs increasingly test intensity. That's not what I'm talking about. But that's real and that's there, too. The thing that I'm talking about with 3-nanometer that's unique, let's say, is the change in the transistor architecture from FinFET to gate-all-around. 
That happens once per decade. Again, it happened with FinFETs earlier in the last decade. It's happening with gate-all-around here in the next few years. Those transitions, everything else being equal, introduce additional, typically, failure modes that need more test methodologies to make sure the device is functioning correctly. And so let's say, the average test time per transistor can tend to be higher because of the additional verification needed related to that new architecture. Now early in the architecture's life, that tends to be higher. As the architecture matures over time, that premium, let's say, comes down. So -- and the world doesn't shift to 3-nanometer en masse day 1 either. 
So there's this bleeding up of certain devices using 3-nanometer that are highly test-intensive and more and more come online year after year, and then the learning curve comes on. But net-net, again, if you look at the test market from 2000 to 2012, it had been a declining market. And 2012 to now, it's been growing quite well in excess of 10%. Part of that is the parallel testing, ameliorating that we've talked about, part of it's the FinFET story that we've talked about and the growing transistor count. So we're at another one of those junctures with gate-all-around. 
And then sorry, HPC and..."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Test HPC higher or lower...",6,"Test HPC higher or lower..."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Okay. Yes. So the -- the growth rate in compute is certainly going to be at the higher end of our mix of submarkets, we think, over the midterm. So if you think the average market growth rate, we're going to update this in January, but pick a number, is 8",65,"Okay. Yes. So the -- the growth rate in compute is certainly going to be at the higher end of our mix of submarkets, we think, over the midterm. So if you think the average market growth rate, we're going to update this in January, but pick a number, is 8%. We think compute is probably leading that by at least a couple of points."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","And operator, we have time for one more question, please.",10,"And operator, we have time for one more question, please."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Your final question comes from Sidney Ho, Deutsche Bank.",9,"Your final question comes from Sidney Ho, Deutsche Bank."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","So I have 2 quick ones. The first one is, you talk about supply constraints impacting the IA business. I'm just curious, the gross margin has been pretty good overall, you talk about offering the leverage is one of the reasons. To the extent that your inp",74,"So I have 2 quick ones. The first one is, you talk about supply constraints impacting the IA business. I'm just curious, the gross margin has been pretty good overall, you talk about offering the leverage is one of the reasons. To the extent that your input cost on logistics and freight cost increase, both in your test and IA business, are you able to pass along some of those costs to your customers?"
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","So at this point, we've been managing through it. So materially, no.",12,"So at this point, we've been managing through it. So materially, no."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Analysts","Okay. Maybe my follow-up question is, a lot of discussion on 3 nanometers today, but it's really an opportunity in 2023 and beyond. But if you kind of look at next year, I know you're going to update us in January, how does this impact your tester busines",89,"Okay. Maybe my follow-up question is, a lot of discussion on 3 nanometers today, but it's really an opportunity in 2023 and beyond. But if you kind of look at next year, I know you're going to update us in January, how does this impact your tester business, if a customer chooses to move from instead of going to 3 nanometers, they go to a different generation of 5 nanometers? What is the tester reuse rate when you compare the 2 nodes between the 3 nanometers and the alternative?"
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Yes. The tester reuse, people will reuse 5-nanometer generation testers in the 3-nanometer era. So a new tester is not required. And testers tend to have a useful life of a decade or more at a customer, and they can span usability across many, many nodes",249,"Yes. The tester reuse, people will reuse 5-nanometer generation testers in the 3-nanometer era. So a new tester is not required. And testers tend to have a useful life of a decade or more at a customer, and they can span usability across many, many nodes and many, many generations of devices. So there's nothing in terms of a new tester here that comes with 3-nanometer. And yes, by and large, it's a 2023 and beyond type story. But absent that story, what we've been seeing for the past 10 years in test, since 3-nanometer in 2022 is likely not going to be a huge event because it's likely to be later in the year, people will still move down the complexity curve at 5- and 5-plus nanometer nodes and increase transistor counts and such along that path. So even absent 3-nanometer, we have an optimistic view of what '22 looks like. 
We'll probably start out the year similar to how we started out years in the past and at the beginning of the year with some modest growth in the first quarter and then it kind of swings on what's going to happen over the summer, which is our peak quarters, around the refreshes. Will those refreshes of silicon be in 3-nanometer, will they be in 5 plus with the traditional normal transistor count growth that we've seen for the past 10 years, those are things that we have to get closer to next year to really understand."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Executives","Okay, everybody. We are out of time. Thanks so much for joining us today. And those in the queue, I'll get back to you later today. And again, thanks, everyone, for joining. Bye-bye.",33,"Okay, everybody. We are out of time. Thanks so much for joining us today. And those in the queue, I'll get back to you later today. And again, thanks, everyone, for joining. Bye-bye."
94728,1685270027,2442424,"Teradyne, Inc., Q3 2021 Earnings Call, Oct 27, 2021",2021-10-27,"Earnings Calls","Teradyne, Inc.","Operator","Ladies and gentlemen, this concludes today's conference call. Thank you participating. You may now disconnect.",15,"Ladies and gentlemen, this concludes today's conference call. Thank you participating. You may now disconnect."
